<SEC-DOCUMENT>0001159036-25-000016.txt : 20250318
<SEC-HEADER>0001159036-25-000016.hdr.sgml : 20250318
<ACCEPTANCE-DATETIME>20250318161039
ACCESSION NUMBER:		0001159036-25-000016
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		28
CONFORMED PERIOD OF REPORT:	20241231
FILED AS OF DATE:		20250318
DATE AS OF CHANGE:		20250318

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HALOZYME THERAPEUTICS, INC.
		CENTRAL INDEX KEY:			0001159036
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				880488686
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-32335
		FILM NUMBER:		25748384

	BUSINESS ADDRESS:	
		STREET 1:		12390 EL CAMINO REAL
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130
		BUSINESS PHONE:		(858) 794-8889

	MAIL ADDRESS:	
		STREET 1:		12390 EL CAMINO REAL
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HALOZYME THERAPEUTICS INC
		DATE OF NAME CHANGE:	20040312

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GLOBAL YACHT SERVICES INC
		DATE OF NAME CHANGE:	20010912
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>halo-20250318.htm
<DESCRIPTION>DEF 14A
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:39b8bf14-7331-4741-9722-11882a8adb3b,g:431cca2c-da85-4fa8-92f7-0ac43b2f4488,d:e4c4aeb18032482191ecd6127f77fc6d-->
<html xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns="http://www.w3.org/1999/xhtml" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:halo="http://www.halozyme.com/20250318" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xmlns:ecd="http://xbrl.sec.gov/ecd/2024" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>halo-20250318</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-2">0001159036</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-3">DEF 14A</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-4">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="halo-20250318.xsd"/></ix:references><ix:resources><xbrli:unit id="usd"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-2"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-01-01</xbrli:startDate><xbrli:endDate>2023-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-3"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2022-01-01</xbrli:startDate><xbrli:endDate>2022-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-4"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2021-01-01</xbrli:startDate><xbrli:endDate>2021-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-5"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2020-01-01</xbrli:startDate><xbrli:endDate>2020-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-6"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-7"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-8"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-9"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-10"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-11"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-12"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-13"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-14"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-15"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-16"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-17"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember><xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-18"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-19"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-20"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="c-21"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001159036</xbrli:identifier><xbrli:segment><xbrldi:typedMember dimension="ecd:MeasureAxis"><ecd:MeasureAxis.domain>4</ecd:MeasureAxis.domain></xbrldi:typedMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-01-01</xbrli:startDate><xbrli:endDate>2024-12-31</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_1"></div><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">UNITED STATES </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Washington, D.C. 20549 </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:14pt;font-weight:700;line-height:120%">SCHEDULE 14A </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">PROXY STATEMENT PURSUANT TO SECTION 14(a) </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">OF THE SECURITIES EXCHANGE ACT OF 1934 </span></div><div style="margin-top:8pt;padding-left:11.25pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by the Registrant </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">x</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:8pt;padding-left:11.25pt;text-indent:-11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Filed by a Party other than the Registrant </span><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:120%">o</span></div><div style="padding-left:18pt;text-indent:-18pt"><span><br/></span></div><div style="padding-left:18pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box:</span></div><div style="margin-top:5pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.345%"><tr><td style="width:1.0%"/><td style="width:4.514%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.541%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.271%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.274%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Preliminary Proxy Statement</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Confidential, For Use of the Commission Only (as permitted by Rule 14a-6(e)(2))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Proxy Statement</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Definitive Additional Materials</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting Materials Pursuant to &#167;240.14a-12</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:22pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-1">Halozyme Therapeutics, Inc.</ix:nonNumeric></span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Name of Registrant as Specified in Its Charter)</span></td></tr><tr><td colspan="12" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">(Name of Person(s) Filing Proxy Statement, if Other Than the Registrant)</span></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Payment of Filing Fee (Check all boxes that apply):</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">x</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No fee required</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee paid previously with preliminary materials</span></td><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">o</span></td><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11</span></td></tr></table></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:98.900%"/><td style="width:0.1%"/></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;border-top:2pt solid #000000;padding:0 1pt"/></tr></table></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_7"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><img src="halo-20250318_g1.jpg" alt="halologobwa09.jpg" style="height:82px;margin-bottom:5pt;vertical-align:text-bottom;width:201px"/></div><div style="text-align:right"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;18, 2025</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dear Stockholder: </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You are cordially invited to attend the 2025 Annual Meeting of Stockholders of Halozyme Therapeutics, Inc., which will be held on May&#160;1, 2025, at 8:00 a.m. Pacific Time. The meeting will be online only, so there is no physical meeting location.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Notice of Annual Meeting of Stockholders and a Proxy Statement, which describes the formal business to be conducted at the meeting, follow this letter. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">It is important that you use this opportunity to take part in the affairs of Halozyme Therapeutics, Inc. by voting on the business to come before this meeting. Whether or not you plan to attend the Annual Meeting online, we hope you vote as soon as possible to assure your representation. You can vote your shares over the Internet, by telephone or if you requested printed proxy material by mail, by using a traditional proxy card. Instructions on each of these voting methods are outlined in the enclosed proxy statement. Regardless of the number of shares you own, your careful consideration of, and vote on, the matters before our stockholders is important. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of Halozyme&#8217;s Annual Report on Form 10-K accompanies these proxy materials for your information. At the Annual Meeting, we will review Halozyme&#8217;s activities over the past year and our plans for the future. The Board of Directors and management look forward to seeing you at the Annual Meeting. </span></div><div style="margin-top:12.6pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Sincerely yours, </span></div><div style="padding-left:306pt;text-indent:-45pt"><img src="halo-20250318_g2.jpg" alt="htsignaturea10.jpg" style="height:82px;margin-bottom:5pt;vertical-align:text-bottom;width:188px"/></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">H</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ELEN</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> I. T</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:120%">ORLEY</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, M.B. Ch.B., M.R.C.P. </span></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">President and Chief Executive Officer</span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_10"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-bottom:5pt;margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TABLE OF CONTENTS</span></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:92.081%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.557%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.962%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_13">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_16">PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_16">1</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_22">SOLICITATION AND VOTING</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_22">2</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_25">PROPOSAL NO. 1 - ELECTION OF DIRECTORS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_25">4</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_28">CORPORATE GOVERNANCE</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_28">15</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_31">PROPOSAL NO. 2 - ADVISORY (NON-BINDING) VOTE ON EXECUTIVE COMPENSATION</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_31">(SAY-ON-PAY)</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_31">19</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_37">PROPOSAL NO. 3 - RATIFICATION OF SELECTION OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_37">20</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_40">REPORT OF THE AUDIT COMMITTEE</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_40">21</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_43">EXECUTIVE COMPENSATION AND RELATED INFORMATION</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_43">22</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_67">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_67">53</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_70">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_70">AND RELATED STOCKHOLDER MATTERS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_70">54</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_73">STOCKHOLDER PROPOSALS TO BE PRESENTED AT NEXT ANNUAL MEETING</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_73">56</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_76">TRANSACTION OF OTHER BUSINESS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_76">56</a></span></div></td></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_79">DELIVERY OF PROXY MATERIALS AND ANNUAL REPORTS</a></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:right"><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="#ie4c4aeb18032482191ecd6127f77fc6d_79">57</a></span></div></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_13"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><img src="halo-20250318_g1.jpg" alt="Image3.jpg" style="height:74px;margin-bottom:5pt;vertical-align:text-bottom;width:184px"/></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">HALOZYME THERAPEUTICS, INC.</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">12390 El Camino Real </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">San Diego, California 92130 </span></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">NOTICE OF ANNUAL MEETING OF STOCKHOLDERS </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%">To Be Held on May&#160;1, 2025 </span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TO THE STOCKHOLDERS OF HALOZYME THERAPEUTICS, INC.: </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notice is hereby given that the Annual Meeting of the Stockholders of Halozyme Therapeutics, Inc., a Delaware corporation, will be held on May&#160;1, 2025, at 8:00 a.m. Pacific Time. The meeting will be online only, so there is no physical meeting location. The Annual Meeting is being held for the following purposes: </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To elect two Class III directors to hold office for a three-year term and until their respective successors are elected and qualified; </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To approve, by a non-binding advisory vote, the compensation of our Named Executive Officers;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025; and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.5pt">To transact such other business as may properly come before the Annual Meeting. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You will be able to attend the Annual Meeting, submit questions and vote during the live webcast by visiting </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">www.virtualshareholdermeeting.com/HALO2025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and entering the 16 digit control number included in your Notice of Internet Availability, on your proxy card, or voting instruction form, or in the instructions you received by email. Please refer to the additional logistical details and recommendations in the accompanying proxy statement. Only stockholders of record at the close of business on March&#160;4, 2025 are entitled to notice of, and to vote at, this Annual Meeting and any adjournment or postponement thereof. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board of Directors recommends that you vote FOR each of the nominees to the Board of Directors named in the accompanying Proxy Statement and FOR Proposals 2 and 3.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:9pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By order of the Board of Directors,</span></div><div style="margin-top:9pt;padding-left:306pt;text-indent:-45pt"><img src="halo-20250318_g3.jpg" alt="Mark's signature.jpg" style="height:105px;margin-bottom:5pt;vertical-align:text-bottom;width:278px"/></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Mark Snyder</span></div><div style="margin-top:3pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Vice President, General Counsel, </span></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Corporate Secretary </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, California </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;18, 2025</span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Important Notice Regarding the Availability of Proxy Materials for </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Annual Meeting of Stockholder To Be Held on May&#160;1, 2025 </span></div><div style="margin-top:5pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Proxy Statement and the 2024 Annual Report to Stockholders and the means to vote by Internet are available at www.proxyvote.com. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.491%"><tr><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.900%"/><td style="width:0.1%"/></tr><tr><td colspan="15" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">IMPORTANT: You are cordially invited to attend the virtual meeting online. Whether or not you expect to attend the virtual meeting online, please vote as soon as possible by using the Internet or telephone or for those receiving paper copies of these proxy materials by completing, signing, dating and mailing your proxy card in the accompanying postage-paid envelope. Even if you have voted by proxy, you may still vote in person if you attend the virtual meeting online. </span></td></tr></table></div><div style="height:13.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_16"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROXY STATEMENT FOR ANNUAL MEETING OF STOCKHOLDERS </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The accompanying proxy is solicited on behalf of the Board of Directors of Halozyme Therapeutics, Inc., a Delaware corporation (&#8220;Halozyme&#8221; or the &#8220;Company&#8221;), for use at Halozyme&#8217;s Annual Meeting of Stockholders to be held online on May&#160;1, 2025 at 8:00 a.m. Pacific Time and at any adjournment or postponement thereof, for the purposes set forth in the accompanying Notice of Annual Meeting of Stockholders. This Proxy Statement, notice, the notice of internet availability of the proxy materials, and the proxy card are first being made available and/or mailed to stockholders on or about March&#160;18, 2025. </span></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_19"></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ANNUAL MEETING AGENDA AND BOARD OF DIRECTORS VOTE RECOMMENDATIONS</span></div><div style="margin-top:6pt;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders are being asked to vote on each of the following items at the Annual Meeting:</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 1.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The election of two Class III director nominees named in this Proxy Statement to the Board of Directors, each to serve a three-year term and until their respective successors are elected and qualified;</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 2</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The approval of a non-binding advisory resolution approving the compensation of our Named Executive Officers;  and</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%;padding-left:14.5pt">Proposal 3</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. The ratification of the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board of Directors recommends that you vote FOR the nominees to the Board of Directors named in this Proxy Statement and FOR Proposals 2 and 3.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_22"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SOLICITATION AND VOTING </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting Securities. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Only stockholders of record as of the close of business on March&#160;4, 2025, the record date for the Annual Meeting, will be entitled to vote at the meeting and any adjournment or postponement thereof. As of that date, we had 123,533,310 shares of common stock outstanding, all of which are entitled to vote with respect to all matters to be acted upon at the Annual Meeting. Each stockholder of record as of that date is entitled to one vote for each share of common stock held by him or her. Our Bylaws provide that a majority of all of the shares of the stock entitled to vote, whether present in person or represented by proxy, shall constitute a quorum for the transaction of business at the meeting. When a quorum is present at the meeting, all matters other than the election of directors will be determined by a majority in voting power of the shares present in person or represented by proxy and entitled to vote on the matter. The election of directors will be determined by a majority in voting power of the shares present in person or represented by proxy at the meeting and voting on the matter. Votes for and against, abstentions and &#8220;broker non-votes&#8221; will each be counted as present for purposes of determining the presence of a quorum.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As permitted by rules adopted by the Securities and Exchange Commission (&#8220;SEC&#8221;), we are furnishing our proxy statement, 2024 Annual Report to Stockholders and proxy card over the internet to most of our stockholders. This means that most of our stockholders will initially receive only a Notice of Internet Availability of Proxy Materials containing instructions on how to access the proxy materials over the Internet. If you would like to receive a paper copy of the proxy materials, the Notice of Internet Availability of Proxy Materials contains instructions on how you can request copies of these documents at no cost to you.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting of Proxies. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All valid proxies received before the meeting will be exercised. All shares represented by a proxy will be voted, and where a proxy specifies a stockholder&#8217;s choice with respect to any matter to be acted upon, the shares will be voted in accordance with that specification. If no choice is indicated on the proxy provided by a stockholder of record, the shares will be voted for the nominees and for proposals 2 and 3. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may vote by attending the Annual Meeting online, by using the Internet or telephone to submit a proxy or by completing and returning a proxy by mail, if you requested printed proxy material by mail. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting by Internet</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To vote by Internet, go to </span><span style="background-color:#ffffff;color:#0563c1;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">www.proxyvote.com</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Internet voting is available 24 hours a day, although your vote by Internet must be received by 11:59 p.m. Eastern Time on April&#160;30, 2025. You will need the control number found either on the Notice of Internet Availability of Proxy Materials or on the proxy card if you are receiving a printed copy of these materials. If you vote by Internet, you should not return your proxy card or voting instruction card. If you hold your shares in &#8220;street name&#8221; as explained below, please refer to the voting instruction form or notice provided to you by your broker, bank or other holder of record for Internet voting instructions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting by Telephone</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To vote by telephone, call </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1-800-690-6903</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and follow the instructions. Telephone voting is available 24 hours a day, although your vote by telephone must be received by 11:59 p.m. Eastern Time on April&#160;30, 2025. You will need the control number found on your Notice of Internet Availability of Proxy Materials, voting instruction form or on the proxy card if you are receiving a printed copy of these materials. If you vote by telephone, you should not return your proxy card or voting instruction card. If you hold your shares in &#8220;street name&#8221; as explained below, please refer to the Notice of Internet Availability of Proxy Materials or voting instruction card provided to you by your broker, bank or other holder of record for telephone voting instructions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting by Mail.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> If you requested printed proxy materials by mail, by completing, signing and returning the proxy card in the prepaid and addressed envelope enclosed with proxy materials delivered by mail, you are authorizing the individuals named on the proxy card to vote your shares at the Annual Meeting in the manner you indicate. You are encouraged to sign and return the proxy card even if you plan to attend the Annual Meeting so that your shares will be voted if you are unable to attend the Annual Meeting. If you receive more than one proxy card, it is an indication that your shares are held in multiple accounts. Please complete, sign and return all proxy cards to ensure that all your shares are voted. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Voting Online During Annual Meeting. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You are entitled to participate in the Annual Meeting if you were a shareholder as of the close of business on March&#160;4, 2025, the record date, or hold a legal proxy for the meeting provided by your bank, broker, or nominee. To be admitted to the Annual Meeting at </span><span style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">www.virtualshareholdermeeting.com/HALO2025</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, you must enter the </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">control number found on your Notice of Internet Availability of Proxy Materials, proxy card, or voting instruction form you previously received. You may vote during the Annual Meeting by following the instructions available on the meeting website during the meeting. The meeting&#8217;s virtual attendance format will provide you the ability to participate and ask questions in writing during the meeting. Whether or not you plan to participate in the Annual Meeting, we urge you to vote and submit your proxy in advance of the meeting by one of the methods described in the proxy materials for the Annual Meeting. If your shares are registered directly in your name with our transfer agent, EQ by Equiniti, you are considered the stockholder of record and you have the right to vote in person at the Annual Meeting. If your shares are held in the name of your broker or other nominee, you are considered the beneficial owner of shares held in &#8220;street name.&#8221; Beneficial owners whose stock is held in the name of a bank, broker or other nominee generally will receive instructions for voting from their banks, brokers or other nominees, rather than directly from us. You can vote your shares held through a bank, broker or other nominee by following the voting instructions sent to you by that institution. Shares for which you are the beneficial owner but not the stockholder of record may also be voted electronically during the Annual Meeting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Revocability of Proxies</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. A stockholder giving a proxy has the power to revoke it at any time before it is exercised by delivering to the Secretary of Halozyme a written instrument revoking the proxy or by executing a duly executed proxy with a later date, or by attending the Annual Meeting online and voting in person.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Broker Non-Votes.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> A broker non-vote occurs when a broker submits a proxy card with respect to shares held in street name on behalf of a beneficial owner but is prohibited from voting on a particular matter because the broker has not received voting instructions from the beneficial owner and therefore does not have discretion to vote the beneficial owner&#8217;s shares with respect to that matter. Under the rules that govern brokers who are voting with respect to shares held in street name, brokers have the discretion to vote such shares on routine matters, but not on non-routine matters. Routine matters include the ratification of our independent registered public accounting firm. Non-routine matters include the election of directors and the advisory vote on executive compensation matters.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Solicitation of Proxies.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> We will bear the entire cost of soliciting proxies for the upcoming meeting. In addition to soliciting stockholders by mail through our employees, we will request banks, brokers and other custodians, nominees and fiduciaries to solicit customers for whom they hold our stock and will reimburse them for their reasonable, out-of-pocket costs. We may use the services of our officers, directors and others to solicit proxies, personally or by telephone, without additional compensation.</span></div><div><span><br/></span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_25"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 1</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ELECTION OF DIRECTORS</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have a classified Board of Directors that currently consists of three Class I directors, two Class II directors and three Class III directors. Our directors are elected for a term of three years, with one class of directors up for election every year. At the 2025 Annual Meeting of Stockholders, we will be electing two Class III directors, while the Class I directors will be elected at the 2026 Annual Meeting of Stockholders and the Class II directors will be elected at the 2027 Annual Meeting of Stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Class III nominees recommended by the Board of Directors for election at the 2025 Annual Meeting are: Jeffrey W. Henderson and Helen I. Torley. Mr. Henderson and Dr. Torley are current member of our Board of Directors and, if elected, will serve as directors until our Annual Meeting of Stockholders in 2028 or until their successors are elected and qualified. Ms. Matsui is not standing for re-election and her term will expire as of the meeting date. If any nominee declines to serve or becomes unavailable for any reason, or if a vacancy occurs before the election (although we know of no reason to anticipate that this will occur), the proxies may be voted for such substitute nominees as our Board of Directors may designate.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Majority Voting Standard</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Bylaws provide that in any election of one or more directors at a meeting at which a quorum is present, other than in a contested election, each director is elected by the vote of a majority of the votes cast by the stockholders with respect to the director. If a director does not receive in an election, other than a contested election, a majority of the votes, the director must tender his or her resignation to the Board of Directors. Within 90 days after the date of the certification of the election results, the Nominating and Corporate Governance Committee of the Board of Directors (or other committee that may be designated by the Board of Directors) will make a recommendation to the Board of Directors on whether to accept or reject the resignation, or whether other action should be taken. The Board of Directors will promptly act on such committee&#8217;s recommendation and publicly disclose within four business days on a Current Report on Form 8-K filed with the SEC its decision and the rationale behind such decision.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If a quorum is present at the meeting, election of each of the two nominees for Class III directors requires the vote of a majority of the votes cast by the stockholders with respect to the director at the meeting and voting on the matter. Abstentions and broker non-votes will have no effect on the outcome of the vote.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation</span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board of Directors recommends a vote &#8220;FOR&#8221; each of the nominees named above.</span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="margin-top:9pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Candidate Expertise Selection Criteria</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Nominating and Corporate Governance Committee, with input from the Board of Directors, has determined that the following areas of expertise are of particular importance in providing appropriate oversight of the Company&#8217;s business and operations. Accordingly, the Nominating and Corporate Governance Committee seeks candidates for the Board of Directors from diverse professional backgrounds in order to ensure that the Board of Directors is comprised of individuals possessing extensive expertise in one or more of the following areas:</span></div><div style="margin-top:12pt;text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:47.584%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:50.216%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Skill</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:100%">Rationale</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Medicine and Science</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">As a Company directly and indirectly involved in the development, approval and commercialization of drugs, expertise in medicine and science is a key to the ongoing assessment of potential new technologies we may acquire.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pharma Business Leadership and Operations<br/></span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience in, and knowledge of, the pharmaceutical business contributes to deep understanding of business strategy, operations, key performance indicators and the competitive environment.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Complementary Business/Industry Segment Experience</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Diverse experience gained from adjacent and complementary industries contributes to identification and evaluation of new opportunities and ideas.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Business</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">International Business experience adds to our understanding of diverse business environments, economic conditions and cultural perspectives that informs our global business initiatives and strategy.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Human Capital Management</span></div><div><span><br/></span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Execution of our strategy requires the development and retention of highly skilled and diverse set of leaders and team members.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Finance and Capital Markets</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience overseeing financial transactions provides knowledge and skills necessary to evaluate and oversee the Company&#8217;s design and implementation of financial and capital allocation strategies.</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">M&amp;A</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience in the identification, negotiation and execution of M&amp;A transactions provides knowledge to oversee the Company&#8217;s potential M&amp;A activities.</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk Management</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Experience in risk management contributes to the identification, prioritization, assessment and mitigation of significant risk facing the company.</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on its review of each director&#8217;s and director nominee&#8217;s professional experience and background, the Nominating and Corporate Governance Committee has determined that our current board members and director nominee possess expertise in the following areas noted below:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:10.595%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.940%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.014%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Director</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Medicine and Science</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Pharma Business Leadership and Operations</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Complementary Business/Industry Segment Experience</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">International Business</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Human Capital Management</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Finance and Capital Markets</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">M&amp;A</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">Risk Management</span></div></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bernadette Connaughton</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Barbara Duncan</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jeffrey W. Henderson</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mahesh Krishnan, M.D.</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:0pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Matthew L. Posard</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:0pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:0pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:0pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:0pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:0pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:0pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-top:0pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:0pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Moni Miyashita</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></td><td colspan="3" style="background-color:#cceeff;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Helen I. Torley, M.B. Ch.B., M.R.C.P.</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td><td colspan="3" style="background-color:#ffffff;border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">X</span></div></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Diversity</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">              </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based upon responses received from each of our directors with respect to diversity, the Company&#8217;s Board of Directors is currently comprised of individuals from the following diverse backgrounds:</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:83.187%"><tr><td style="width:1.0%"/><td style="width:62.696%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.001%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.003%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Diversity Matrix (As of March&#160;18, 2025)</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Total Number of Directors</span></div></td><td colspan="6" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">8</span></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Female</span></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Male</span></div></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Part I: Gender Identity</span></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Directors</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">5</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</span></td></tr><tr><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Part II: Demographic Background</span></div></td><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#d9d9d9;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">African American or Black</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Alaskan Native or Native American</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Asian</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">1</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Hispanic or Latinx</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Native Hawaiian or Pacific Islander</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">White</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">3</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Two or More Races or Ethnicities</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">0</span></div></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> To see our Board Diversity Matrix as of March&#160;15, 2024, please see our proxy statement filed with the SEC on March&#160;15, 2024.</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Directors Nominated for Election at the 2025 Annual Meeting</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Jeffrey W. Henderson </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(age 60)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2015</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Board Chair</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Audit Committee </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Pharma Business Leadership and Operations, Complementary Business/Industry Segment Experience, International Business, Human Capital Management, Finance and Capital Markets, M&amp;A, Risk Management</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Other Current Public Company Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: </span></div><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Becton Dickinson and Company, a medical technology company</span></div><div style="text-indent:72pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Qualcomm, Inc., a wireless communications and semiconductor company</span></div><div style="text-indent:72pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Past Public Company Board Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Fibrogen, Inc., a biotechnology company</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Henderson brings over 30 years of financial, commercial and pharmaceutical industry expertise to the Board of Directors. He has served as President of JWH Consulting LLC, an investment and business advisory firm, since January 2018. From 2015 to 2019, he served as a Healthcare Advisory Director to Berkshire Partners LLC. Mr. Henderson previously served as the Chief Financial Officer of Cardinal Health, Inc., a multinational health care services company, from May 2005 to November 2014, and in an executive capacity until his retirement from Cardinal in August 2015. From 1998 to 2005, Mr. Henderson held various senior management positions at Eli Lilly and Company, a multinational pharmaceutical company, including President and General Manager, Eli Lilly Canada, Inc. and Controller and Treasurer of Eli Lilly, Inc. He received his BS in electrical engineering from Kettering University, Flint, Mich., and his MBA from Harvard Graduate School of Business Administration.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharma Business Leadership and Operations and International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Henderson gained deep experience in a broad range of business and operational topics during his nearly 10-year tenure as Chief Financial Officer for Cardinal Health, a $100 billion health care products and services company. During a portion of this tenure he was also responsible for commercial operations in China and Canada. These experiences built on prior expertise, </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">specifically gained in pharmaceuticals, when he served as general manager of Eli Lilly Canada and Controller/Treasurer of Eli Lilly Inc.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Complementary Business/Industry Segment Experience</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As a member of the board of directors of Becton Dickinson, a leading global medical technology company, and during his time as an executive at Cardinal Health, Mr. Henderson has gained a deep exposure to, and experience in, key aspects of the medical device business and market.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finance and Capital Markets and M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In his almost 15 years experience as Chief Financial Officer at Cardinal Health and Controller/Treasurer at Eli Lilly, Mr. Henderson gained extensive experience in finance and capital markets. During his tenure at Cardinal Health, the company acquired more than 30 companies, spun-off or sold multi-billion-dollar businesses and expanded into new geographic locations and market segments. During his time with the PE firm of Berkshire Partners, he was involved in the identification, evaluation and execution of multiple acquisition opportunities in the healthcare sector.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In his positions as a Chief Financial Officer for Cardinal Health and Controller/Treasurer at Eli Lilly, Mr. Henderson played a key role in risk identification and risk mitigation. Further, Mr. Henderson has been operationally accountable for commercial operations in both China (Cardinal Health) and Canada (Eli Lilly and Cardinal Health). These unique experiences in both staff and line roles enable a broad perspective on identifying potential risks and risk management.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Henderson has substantial experience leading organizations with multi-thousands of employees, including related aspects of organizational and compensation/incentive design.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  As further described in Mr. Henderson&#8217;s biography, the Nominating and Corporate Governance Committee believes Mr. Henderson has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors:  (i) pharma business leadership and operations, (ii) complementary business and industry segment experience, (iii) international business, (iv) human capital management, (v) finance and capital markets, (vi) M&amp;A and (vii) risk management. Mr. Henderson&#8217;s extensive experience serving in executive leadership positions, including as Chief Financial Officer, with large publicly-traded healthcare and pharmaceutical corporations, combined with his business acumen and judgment, including his qualifications as an audit committee financial expert, provide our Board with valuable financial, strategic and operational expertise and leadership skills, leading the Nominating and Corporate Governance Committee to determine that Mr. Henderson should serve as one of our directors.</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Helen I. Torley, M.B. Ch.B., M.R.C.P.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 62)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2014</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">President and Chief Executive Officer</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Medicine and Science, Pharma Business Leadership and Operations, Human Capital Management, Finance and Capital Markets, Risk Management </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Past Public Company Board Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Quest Diagnostics Incorporated, a diagnostic information services company</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr Torley brings over 30 years of drug development, drug commercialization and general management expertise in pharmaceutical and biotechnology to the Board of Directors. She has served as Chief Executive Officer (&#8220;CEO&#8221;) of Halozyme since 2014, successfully leading the company through a critical strategic transition in 2019. Dr Torley previously served as Chief Commercial Officer at Onyx Pharmaceuticals from 2011-2013, leading the successful US launch for Kyprolis </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Carfilzomib), until the acquisition of Onyx by Amgen in 2013. From 2002-2011 Dr Torley held several senior commercial positions at Amgen including Vice President and General Manager US Bone Health and Vice President and General Manager US Nephrology. In these positions she led the successful launches of Prolia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(denosumab) and Sensipar</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (cinacalcet) and significantly grew Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(Epoetin alfa) and Aranesp</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(darbepoetin alfa) revenue. From 1997-2002 she held a range of senior sales and marketing leadership positions at Bristol Myers Squib. She began her industry career at Sandoz, which merged with Ciba-Geigy to become Novartis in 1996, where she held a range of positions of increasing responsibility in Clinical Development, culminating in the position of Vice President of Medical Affairs, responsible for overseeing the design and </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">conduct of a broad portfolio of clinical studies across nephrology, rheumatology, oncology and CNS indications. She received her M.B.Ch.B. degree (US equivalent to MD) from the University of Glasgow, Scotland and her M.R.C.P from the Royal College of Physicians, Glasgow, Scotland. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicine and Science </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Torley is a trained physician who while in clinical practice specialized in Internal Medicine and Rheumatology. She served in leadership positions at Sandoz/Novartis from1990 to 1997, most recently as Vice President, Medical Affairs where she oversaw the design and conduct of Phase 1 through 4 clinical studies across multiple disease areas. While at Sandoz/Novartis she led clinical development programs for new products being evaluated in organ transplantation and rheumatoid arthritis and wrote and submitted New Drug Application filings. She has led and played key strategic positions in multiple successful FDA Advisory Committee meetings including for Neoral</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(cyclosporin) in Rheumatoid Arthritis, Neoral (cyclosporin) in Organ Transplantation, Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (Epoetin alfa) in anemia in chronic renal failure and HyQvia (immune Globulin infusion 10% with Recombinant Human Hyaluronidase) in Primary Immune Deficiency.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharma Business Leadership and Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Torley gained deep experience in a broad range of business and operational topics in her commercial positions. In particular, as General Manager of Bone Health and Nephrology at Amgen and as Chief Commercial Officer at Onyx, she was responsible for hiring and leading sales and marketing organizations, including hiring and training a more than 650-person team for a new drug launch, working on policy topics related to her products and leading three successful new product launches. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Torley has substantial experience leading large organizations, ranging from 120 to approximately 700 people. Her human capital management experiences include hiring and successfully onboarding large new sales teams into an established culture and effective reorganizations as dictated by changes in strategy. She has a strong focus on and understanding of the important role organizational culture, diverse teams, talent development and accountability play in driving results and success. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Finance and Capital Markets and M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As CEO of Halozyme, Dr. Torley has gained experience in Finance and Capital Markets including direct experience with raising over $1.5 billion through follow-on offerings and through three convertible debt offerings, and executing three share repurchase programs resulting in approximately $1.55 billion in capital returned to stockholders to date. During her time at Amgen, Onyx and Halozyme, she has been involved with and has led the identification and evaluation of multiple acquisition opportunities, and the execution of several.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In her position as CEO of Halozyme, Dr. Torley plays a key role in risk identification and mitigation. In addition, in her previous positions with other organizations as Chief Commercial Officer and General Manager in which she was accountable for commercial launches, a key accountability was risk identification and mitigation. This wide range of experiences enable a broad perspective on identifying potential risks and executing appropriate mitigations strategies.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in her biography, the Nominating and Corporate Governance Committee believes Dr. Torley has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) medicine and science, (ii) pharma business leadership and operations, (iii) human capital management, (iv) finance and capital markets and (v) risk management. Dr. Torley&#8217;s extensive commercial and operational experience, including successful launches of products, and her deep knowledge of the biotechnology industry and the competitive environment, her service as our Chief Executive Officer, combined with her business acumen and judgment, provide our Board with valuable commercial and operational expertise and leadership skills, leading the Nominating and Corporate Governance Committee to determine that Dr. Torley should serve as one of our directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Directors Continuing in Office Until the 2026 Annual Meeting</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Bernadette Connaughton</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 66)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2018</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Compensation Committee (Chair)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Pharma Business Leadership and Operations, International Business, Human Capital Management</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Current Public Company Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Editas Medicine, Inc., a clinical stage biotechnology company</span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Zealand Pharma A/S, a biotechnology company</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Recent Past Public Company Board Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Syneos Health Inc., a biopharmaceutical services company</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Connaughton brings more than 30 years of global strategic, commercial and biopharmaceutical industry expertise to the Board of Directors. From 2004 to October, 2017, she served in senior management position at Bristol-Myers Squibb Pharmaceutical Company, most recently served as president, China, Latin America, Central and Eastern Europe and Middle East. In this position, she developed the multi-year strategy for the successful commercialization of a number of oncology, virology and immunology products, including Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Daklinza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and Orencia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Prior to serving in that role, Ms. Connaughton served as Bristol-Myers Squibb&#8217;s president, European Markets, Canada and Australia; president, Intercontinental; and president, Japan, Pacific Rim, Australia and Canada; senior vice president, Cardiovascular and Metabolic Business Unit, U.S.; and senior vice president, Primary Care Marketing, U.S. Ms. Connaughton also served on the European Federation of Pharmaceutical Industry Association, Patient Access and European Markets Committees from 2014 to 2016. She received her Bachelor of Arts from Johns Hopkins University and her Master of Business Administration from The Wharton School, University of Pennsylvania.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Pharma Business Leadership and Operations</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Connaughton&#8217;s extensive experience in business and operations was developed during her 30-year career at Bristol-Myers Squibb where she built a consistent track record of achieving sales growth, improving profitability and transforming operational models in U.S. and international markets. She built expertise and demonstrated success across a wide range of therapeutic areas, including cardiovascular, metabolic diseases, virology and oncology.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Through her positions leading large global business regions for Bristol Myers Squibb, Ms. Connaughton brings deep experience in international markets. Specific achievements include developing and leading execution of the multi-year strategy for the successful commercialization of Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Yervoy</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Sprycel</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Daklinza</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and Orencia</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. She most recently served as President Intercontinental Region, which included China, Latin America, Central and Eastern Europe and Middle East. Other positions included President, European Markets, Canada and Australia; President, Intercontinental Region; and President, Japan, Pacific Rim, Australia and Canada.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In each of her senior management positions, Ms. Connaughton led diverse, cross-functional teams, building the capabilities to successfully develop and commercialize pharmaceutical products. She has broad experience selecting and developing talent and building high performance teams with the skills, motivation and culture to achieve sustainable results.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As further described in Ms. Connaughton&#8217;s biography, the Nominating and Corporate Governance Committee believes Ms. Connaughton has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) pharma business leadership and operations, (ii) international business and (iii) human capital management. Ms. Connaughton&#8217;s extensive operations and commercialization experience in the pharmaceutical industry including the development of successful commercialization strategies for a number of oncology products and her consistent track record of achieving sales growth provides valuable experience and perspective to our Board, leading the Nominating and Corporate Governance Committee to determine that Ms. Connaughton should serve as one of our directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Moni Miyashita</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 69)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2022</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Nominating and Corporate Governance Committee</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Complementary Business/Industry Segment Expertise, International Business, M&amp;A, Risk Management</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Miyashita brings over 25 years of global experience leading business transformations and building new businesses through strategy, new business models, and mergers &amp; acquisitions.  Since October 2024, she has served as the managing partner of </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Beacon Hill Stategy Group, a growth strategy and M&amp;A consulting firm. From May 2019 to September 2024, she served as Executive Vice President and Chief Strategy Officer of Valo Health, LLC, a technology company using human-centric data and artificial intelligence to transform drug discovery and development. Prior to Valo Health, from August 2015 to May 2019, she was a Partner at Innosight Consulting, where she provided growth strategy consulting services for businesses in the biotech, healthcare and technology industries. From 2011 to 2015, she was a Senior Advisor at McKinsey where she advised senior executive leadership teams on executing strategic M&amp;A. Prior to McKinsey, she served as Vice President, Corporate Development at IBM, Inc., a multinational technology and consulting company, from 1998 to 2011. She received her BS degree in marketing from the University of Colorado and her MBA from the University of Denver.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Complementary Business/Industry Segment Expertise</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2019, Ms. Miyashita joined Valo Health as Chief Strategy Officer where she develops and drives complex business models, building a disruptive technology platform, and applying it to drug discovery, clinical development, and strategic partnerships across a regulated pharmaceutical ecosystem. While serving as Partner at Innosight Consulting, she advised and supported CEOs and their executive leadership teams on disruptive growth strategies in the biotech and healthcare industries. While serving as Senior Advisor at McKinsey, Ms. Miyashita provided global advisory services on M&amp;A to executive and senior leadership teams across the pharmaceutical, biotech, and healthcare industries.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Business and M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During her tenure as Vice President at IBM, Ms. Miyashita was a key architect in developing and executing M&amp;A globally, anchored on strategy, with successful deal flow, transaction execution and post-merger integration. This strategy and effort resulted in over 40 quarters of double-digit earnings per share growth and creating the highest revenue and market capitalization in IBM&#8217;s history. Prior to this position, Ms. Miyashita had executive positions in IBM Asia. While serving as Senior Advisor at McKinsey, Ms. Miyashita helped build McKinsey&#8217;s M&amp;A practice and provided global advisory services to executive and senior leadership teams in the Americas, Europe, and Asia on transforming and growing their businesses through M&amp;A.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Miyashita has extensive human capital management experience having led human capital integration efforts in over 100 acquisitions during her tenure as Vice President at IBM. In her prior roles at McKinsey and Innosight, she advised chief executive officers and executive leadership teams on human capital management matters as they transitioned their companies when executing transformational M&amp;A transactions or when transforming their core business. In her current role at Valo Health, she influences the human capital management needed to build a novel platform to accelerate drug discovery and development.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Risk Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">During her tenure as Vice President at IBM, Ms. Miyashita was involved in over 100 acquisitions or transactions and multiple business carve outs for divestiture from IBM to other companies which included developing cross functional processes and approaches to manage risk. Under her leadership, cross functional teams prepared for and passed multiple business audits to ensure risk was identified, mitigated and managed for executing all acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria:  </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in Ms. Miyashita&#8217;s biography, the Nominating and Corporate Governance Committee believes Ms. Miyashita has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) complementary business and industry experience, (ii) international business, (iii) human capital management, (iv) M&amp;A and (v) risk management. Ms. Miyashita&#8217;s extensive experience in developing and executing complex corporate transactions and her experience providing strategy execution advice to senior leadership teams provide our Board with valuable strategic and operational expertise, leading the Nominating and Corporate Governance Committee to determine that Ms. Miyashita should serve as one of our directors.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Matthew L. Posard</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 57)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Director Since: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">2013</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Nominating and Corporate Governance Committee (Chair)</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Medicine and Science, Complementary Business/Industry Segment Expertise, International Business, Human Capital Management, M&amp;A</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Current Public Company Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">DermTech, Inc. (Chairman), a precision dermatology company</span></div><div style="padding-left:36pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nautilus Biotechnology, Inc., (Chairman) a development stage life sciences company </span></div><div style="padding-left:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Recent Past Public Company Board Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:  Talis Biomedical, a developer of diagnostic tests for infectious diseases</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Posard brings over 30 years of general management and commercialization experience in the biotechnology and diagnostics industry to the Board of Directors. He is Founding Principal of Explore DNA, a life sciences executive consulting firm, a position he has held since March 2016. Since 2017, he has provided advisory services to CEOs for several emerging life sciences companies. From February 2017 to April 2018, Mr. Posard served as President and Chief Commercial Officer of GenePeeks, Inc., a genetic research company. From March 2015 to April 2016, he served as Chief Commercial Officer of Trovagene, Inc., a molecular diagnostic biotechnology company. From February 2006 to February 2015, he held various commercial and general management positions at Illumina, Inc., a genomics company focusing on DNA sequencing, including senior executive positions overseeing Global Sales, Marketing, and General Manager of Clinical and Consumer Genomics as well as New and Emerging Markets. Mr. Posard holds a BA degree in Management Science from the University of San Diego.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicine and Science</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Posard has deep expertise introducing novel and transformative products to medical and research markets while scaling organizations efficiently. He is a Founding Principal of Explore DNA and provides advisory services to executive officers of several emerging life sciences companies.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Complementary Business/Industry Segment Expertise</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Posard adds to his biotech expertise with deep knowledge in the diagnostics area, having served in senior positions at Illumina, Biosite, Inc. and Gen-Probe, Inc. At Illumina he was part of the executive management team that led the company to its first $1 billion in revenue. At Biosite he was instrumental in the successful introduction of the company&#8217;s BNP congestive heart failure biomarker and its BNP co-marketing collaboration with Beckman Coulter. At Gen-Probe, Mr. Posard helped the company attain leading market positions in DNA probe-based infectious disease diagnostics and blood banking.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Posard has extensive international business experience, having served as the Vice President of Global Sales for Illumina where he led an international commercial sales team. He also served as Senior Vice President and General Manager of Illumina&#8217;s Translational and Consumer Genomics and New and Emerging Markets business units and was responsible for over $100 million of sales growth in his first year in this position. This experience provided substantial exposure to commercial markets around the world.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Human Capital Management</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In his senior commercial marketing positions with various companies, Mr. Posard has managed and led a number of large and diverse marketing teams. A seasoned executive in the genomics and life science space, Mr. Posard has extensive background in effectively scaling organizations.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mr. Posard has served on the board of directors and in senior leadership positions at a variety of startup and emerging companies and has extensive experience in the area of mergers and acquisitions in the biotech and diagnostics space. In his position as advisor to senior executives of life science companies, he has provided guidance and effective consultation in the execution of strategic acquisitions.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria:</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> As further described in his biography, the Nominating and Corporate Governance Committee believes Mr. Posard has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors:  (i) medicine and science, (ii) complementary business and industry segment expertise, (iii) international business, (iv) human capital management and (v) M&amp;A. Mr. Posard&#8217;s general management, sales and marketing experience including the successful launch of products and management of sales operations provides valuable experience and perspective to our Board, leading the Nominating and Corporate Governance Committee to determine that Mr. Posard should serve as one of our directors.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">Directors Continuing in Office Until the 2027 Annual Meeting</span></div><div style="text-align:justify"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Barbara Duncan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 60)<br/>Director Since: 2023</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Audit Committee (Chair) and Compensation Committee</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:  Pharma Business Leadership and Operations, International Business, Finance and Capital Markets, M&amp;A</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Current Public Company Boards</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">:</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Atea Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ovid Therapeutics, Inc., a biopharmaceutical company</span></div><div style="padding-left:36pt;text-align:justify;text-indent:36pt"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recent Past Public Company Board Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: Aevi Genomics Medicine, Inc., Adaptimmune Therapeutics, plc,, Fusion Pharmaceuticals, Inc., Immunomedics, Inc., Innoviva, Inc., Jounce Therapeutics, Inc., ObsEva S.A.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Duncan brings over 16 years of pharmaceutical and biotechnology industry experience to the Board of Directors. She retired from Intercept Pharmaceuticals, Inc., a biopharmaceutical company, where she served as Chief Financial Officer and Treasurer from May 2009 to June 2016. From 2001 to 2009, Ms. Duncan held various senior leadership roles of increasing responsibility at DOV Pharmaceutical, Inc., a biotechnology company, including Chief Financial Officer and ultimately serving as Chief Executive Officer prior to DOV&#8217;s sale in 2010 to Euthymics Bioscience, Inc. Prior to joining DOV, Ms.&#160;Duncan served as Vice President of Corporate Finance&#8201;-&#8201;Global Healthcare at Lehman Brothers Inc. from 1998 to 2001, and as Director of Corporate Finance at SBC Warburg Dillon Read Inc. from 1994 to 1998. She also worked for PepsiCo, Inc. from 1989 to 1992 in its international audit division, and was a certified public accountant in the audit division of Deloitte &amp; Touche LLP from 1986 to 1989. Ms. Duncan received her BBA from Louisiana State University and her MBA from the Wharton School of the University of Pennsylvania.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Pharma Business Leadership and Operations and International Business</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As Chief Financial Officer and Treasurer at Intercept Pharmaceuticals, Ms. Duncan helped lead the operational and strategic plans of this biopharmaceutical company, including managing the buildout of international operations and preparing financial teams for commercial product launch. At DOV Pharmaceutical, Ms. Duncan developed and lead in the execution of strategic plans, restructured several of the company&#8217;s partnerships and led negotiations on licensing transactions.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Finance and Capital Markets</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Duncan&#8217;s gained extensive financing experience serving as Chief Financial Officer for two public biopharmaceutical companies. Through the successful execution of both private and public financings, Ms. Duncan&#8217;s leadership supported operations and strategic plans. Ms. Duncan managed all phases of Intercept&#8217;s initial public offering and following on offerings. Further, while serving as Chief Financial Officer at both Intercept and DOV Pharmaceutical, Ms. Duncan managed the investor relations function and research analyst and investment banking relationships. </span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Ms. Duncan gained extensive M&amp;A experience in her role as Vice President at Lehman Brothers with an emphasis in the healthcare space. While at Lehman, Ms. Duncan reviewed potential merger opportunities, reviewed valuation work product and authored advisory presentations to assist clients in formulating strategic corporate structuring strategies. While serving as Chief Executive Officer of DOV Pharmaceutical, she led the execution of the company&#8217;s sale to Euthymics.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">: As further described in Ms. Duncan&#8217;s biography, the Nominating and Corporate Governance Committee believes that Ms. Duncan has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) pharma business leadership and operations, (ii) finance and capital markets, (iii) international business and (iv) M&amp;A. Ms. Duncan&#8217;s extensive industry and financial experience, including her experience as chief financial officer at public biopharmaceutical companies, combined with her business acumen and experience serving on other public biopharmaceutical boards, provide our Board with valuable expertise, leading the Nominating and Corporate Governance Committee to determine that Ms. Duncan should serve as one of our directors.</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Mahesh Krishnan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> (age 54)</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Director since: 2024</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Board Committees</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Nominating and Corporate Governance Committee</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Medicine and Science, Pharma Business Leadership &amp; Operations, Complimentary Business/Industry Segment Experience, International Business, Finance &amp; Capital Markets, M&amp;A</span></div><div style="padding-left:72pt"><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Recent Past Public Company Board Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">: Chinook Therapeutics, Inc.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mahesh Krishnan, M.D., brings more than 20 years of health care practitioner and biotechnology and health service industry experience to the Board of Directors. Since 2009, Dr. Krishnan has served in various roles at DaVita, Inc., a provider of kidney dialysis services, including service as the co-lead of DaVita Venture Group, the external innovation arm of DaVita, Inc., where he is responsible for strategic partnerships in technology and research and development at DaVita, as well as medical policy in Washington, D.C. Since May 2019, Dr. Krishnan has also served as DaVita&#8217;s Group Vice President of Research and Development and prior to that role, Dr. Krishnan served as DaVita&#8217;s first international Chief Medical Officer from 2015 to May 2019. From 2004 to 2009, Dr. Krishnan served in various roles at Amgen Inc., a multinational biopharmaceutical company, including serving as the Global Development Leader for Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and as Executive Director, Medical Policy for all of Amgen&#8217;s domestic products. From 2000 to 2004, Dr. Krishnan was a practicing nephrologist at Virginia Nephrology Group. He earned his M.D. from Jefferson Medical College at Thomas Jefferson University and his B.S. in pre-medicine from The Pennsylvania State University. He also holds an M.P.H. from Johns Hopkins University and an M.B.A. in health care management from the Johns Hopkins Carey School of Business. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Key Skills and Experience</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">:</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Medicine and Science; and Complementary Business/Industry Segment Expertise</span><span style="color:#008080;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Krishnan served as a practicing nephrologist at Virginia Nephrology Group where he managed daily operations. While at Amgen, he oversaw clinical trial execution for Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and served as the executive director for medical policy and as the executive director for medical affairs. He also served as Vice President, Clinical Research and Publishing, Vice President Clinical Innovation and Public Policy and as Founding International Chief Medical Officer for DaVita during which time he was involved in a wide variety of operational and commercial functions for a premier nephrology health services company. As a Chief Medical Officer for DaVita he gained extensive experience in multi-site and international medical services delivery.</span></div><div><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Pharma Business Leadership and Operations and International Business</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Krishan gained extensive experience in pharma business leadership and operations in his role as executive director, medical affairs at Amgen. While at Amgen, he developed and executed on the medical affairs and marketing plan for Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and negotiated multiple label iterations with the United States (&#8220;U.S.&#8221;) Food and Drug Administration (&#8220;FDA&#8221;). As global development leader for Epogen</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> he also oversaw multiple aspects of the FDA regulatory advisory committee meetings and successfully implemented a large molecule manufacturing change clinical program. At DaVita, Dr. Krishnan served as the international chief medical officer and oversaw clinical, operational and safety performance for DaVita&#8217;s clinical healthcare operations in eleven countries. Dr. Krishnan has also authored two books on pharmaceutical sales training.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">Finance and Capital Markets and M&amp;A</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Krishnan currently serves as group vice president of DaVita Venture Group. In this capacity, he oversees corporate development and mergers and acquisitions. He has executed multiple industry partnerships including through the use of joint ventures, corporate spinouts and the founding of health care services, pharma, medical device and diagnostic companies. He has also overseen fundraising, venture capital investments in industry related companies and worked closely with corporate investor relations for capital market presentations.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Board Service Selection Criteria: </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As further described in Dr. Krishnan&#8217;s biography, the Nominating and Corporate Governance Committee believes that Dr. Krishnan has the relevant background in the following areas which the committee believes are important to service on the Company&#8217;s Board of Directors: (i) medicine and science, (ii) pharma business leadership and operations, (iii) complimentary business and industry experience, (iv) international business, (v) finance and capital markets, and (vi) M&amp;A. Dr. Krishnan&#8217;s extensive industry, financial and M&amp;A experience, including his experience in senior management positions in the biopharmaceutical industry, combined with his experience as a healthcare professional and his business acumen, provide our Board with valuable expertise, leading the Nominating and Corporate Governance Committee to determine that Dr. Krishnan should serve as one of our directors.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_28"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CORPORATE GOVERNANCE</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Independence</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors (or &#8220;Board&#8221;) has determined that, other than Dr.&#160;Torley, our President and Chief Executive Officer, each of Jeffrey W. Henderson, Bernadette Connaughton, Barbara Duncan, Mahesh Krishnan, M.D., Connie L. Matsui, Moni Miyashita, and Matthew L. Posard is an independent director within the meaning set forth under applicable rules of the NASDAQ Stock Market. Dr. Torley does not meet the requirements for director independence because she serves as the President and Chief Executive Officer of Halozyme</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Leadership</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has separated the Chief Executive Officer and Board Chair positions to: (i)&#160;provide a stronger corporate governance structure; (ii)&#160;improve overall Board effectiveness; and (iii)&#160;enhance communication between management and the Board. Mr. Henderson began serving as the non-employee Chair of the Board of Directors in May 2022.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Tenure</span></div><div style="margin-top:6pt;text-align:center"><img src="halo-20250318_g4.jpg" alt="2199023270664" style="height:380px;margin-bottom:5pt;vertical-align:text-bottom;width:613px"/></div><div style="margin-top:4.5pt;text-align:center"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Sessions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our independent directors generally meet in executive session without management present each time the Board holds its regularly scheduled meetings. The Chair of the Board of Directors, acts as the presiding director for such executive sessions of independent directors.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board Meetings and Committees</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors held eleven meetings during the fiscal year ended December&#160;31, 2024. The Board of Directors has three standing committees: (i)&#160;Audit Committee; (ii)&#160;Compensation Committee; and (iii)&#160;Nominating and Corporate Governance Committee. During the last fiscal year, each director attended at least 75% of the total number of meetings of the Board for the period in which they served as a director and the committees of the Board on which such director served during that period. Our standing committees are currently comprised of the following directors:</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.251%"><tr><td style="width:1.0%"/><td style="width:5.873%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:34.240%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.747%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.906%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.067%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:20.933%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Audit Committee</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Compensation <br/>&#160;Committee</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Nominating / Corporate <br/>Governance Committee</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernadette Connaughton</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara Duncan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey W. Henderson</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connie L. Matsui</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Posard</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Chair</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mahesh Krishnan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moni Miyashita</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">X</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley, M.D. Ch.B., M.R.C.P.</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr></table></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Audit Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current members of the Audit Committee are Barbara Duncan (Chair), Jeffrey W. Henderson and Matthew L. Posard. All members of the Audit Committee satisfy the independence requirements set forth under the applicable rules of the NASDAQ Stock Market and Rule 10A-3 of the Exchange Act, and each of them is able to read and fundamentally understand financial statements. Mr. Henderson and Ms. Duncan are &#8220;audit committee financial experts,&#8221; as defined in the rules of the SEC. The Audit Committee operates under a written charter that is available on our website at: www.halozyme.com. The primary purpose of the Audit Committee is to oversee our accounting and financial reporting processes and the functions of the Audit Committee include retaining our independent registered public accounting firm, reviewing its independence, reviewing and approving the planned scope of its annual audit, reviewing and approving any fee arrangements with our independent registered public accounting firm, overseeing its audit work, reviewing and pre-approving any non-audit services that may be performed by the independent registered public accounting firm, reviewing the adequacy of our accounting and financial controls, reviewing our critical accounting policies and reviewing, overseeing risk assessment and management, approving any related party transactions, overseeing the Company&#8217;s cybersecurity strategy, reviewing the Company&#8217;s cybersecurity risks and receiving periodic updates from management regarding cybersecurity. The Audit Committee held five meetings during the fiscal year ended December&#160;31, 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Additional information regarding the Audit Committee is set forth in the Report of the Audit Committee contained in this Proxy Statement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Compensation Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current members of the Compensation Committee are Bernadette Connaughton (Chair), Barbara Duncan and Connie Matsui. All members of the Compensation Committee satisfy the independence requirements set forth under the applicable rules of the NASDAQ Stock Market, and qualify as non-employee directors as defined in Rule 16b-3 under the Securities Exchange Act. The Compensation Committee operates under a written charter that is available on our website at: www.halozyme.com. The primary purpose of the Compensation Committee is to discharge the Board&#8217;s responsibilities relating to compensation and benefits of our executive officers. More specifically, the Compensation Committee reviews and advises the Board on overall compensation philosophy, policies and plans, reviews and approves the salary and annual cash incentive earned by the Chief Executive Officer and other executive officers; approves equity awards to executive officers; approves employment and severance agreements of executive officers; and reviews the compensation of non-employee directors for service on the Board of Directors and its committees. The Compensation Committee held five meetings during the fiscal year ended December&#160;31, 2024.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Nominating and Corporate Governance Committee</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The current members of the Nominating and Corporate Governance Committee are Matthew L. Posard (Chair), Mahesh Krishnan, M.D., and Moni Miyashita. All members of the Nominating and Corporate Governance Committee satisfy the independence requirements set forth under the applicable rules of the NASDAQ Stock Market. The Nominating and Corporate Governance Committee operates under a written charter that is available on our website at: www.halozyme.com. The primary responsibilities of the Nominating and Corporate Governance Committee are to (i)&#160;identify individuals qualified to become Board members; (ii)&#160;select, or recommend to the Board, director nominees for each election of directors; (iii)&#160;develop and recommend to the Board criteria for selecting qualified director candidates; (iv)&#160;consider committee member qualifications, appointment and removal; (v)&#160;recommend applicable corporate governance principles, codes of conduct and compliance mechanisms, and (vi)&#160;provide oversight in the evaluation of the Board and each committee. The Nominating and Corporate Governance Committee held four meetings during the fiscal year ended December&#160;31, 2024.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">With respect to Board membership, the Nominating and Corporate Governance Committee&#8217;s goal is to assemble a Board of Directors that brings a variety of perspectives and skills derived from high quality business and professional experience. </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">There are no stated minimum criteria for director nominees. The Nominating and Corporate Governance Committee also believes it is appropriate for at least one key member of management to participate as a member of the Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Halozyme Board of Directors believes that our Board should have diversity of knowledge base, professional experience and skills, and considers director candidates who bring diversity including age, gender, nationality, race, ethnicity and sexual orientation. When considering whether to recommend any candidate for inclusion in the Board&#8217;s slate of recommended director nominees, including candidates recommended by our stockholders, the Nominating and Corporate Governance Committee will review the candidate&#8217;s integrity, business acumen, age, experience, commitment, diligence, conflicts of interest, existing time commitments and the ability to act in the interests of all stockholders. Once a potential qualified candidate is identified, multiple members of the Nominating and Corporate Governance Committee will interview that candidate. The committee may also ask the candidate to meet with non-committee members of the Board and/or members of management and, if the committee believes a candidate would be a valuable addition to the Board, it will recommend that candidate to the full Board.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of its charter and our Corporate Governance Guidelines, the Nominating and Corporate Governance Committee will consider qualified director candidates suggested by our stockholders. Stockholders may recommend individuals for the Nominating and Corporate Governance Committee to consider as potential director candidates by submitting the candidate&#8217;s name, contact information and biographical information in writing to the &#8220;Halozyme Nominating and Corporate Governance Committee&#8221; c/o Corporate Secretary, 12390 El Camino Real, San Diego, California 92130. The biographical information and background materials of any such candidate will be forwarded to the Nominating and Corporate Governance Committee for its review and consideration. The committee&#8217;s review process for candidates identified by our stockholders is essentially identical to the review process for candidates identified by the committee. In addition to the process discussed above regarding the consideration of the Nominating and Corporate Governance Committee of candidates suggested by our stockholders, our Bylaws contain provisions that address the process by which a stockholder may nominate an individual to stand for election to our Board at our Annual Meeting of Stockholders.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Risk Management</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate Enterprise Risk Management program is reviewed approximately quarterly by the CEO and Halozyme Leadership Team, and annually by the Halozyme Board of Directors. Our Board is responsible for reviewing and assessing business enterprise risk and other major risks facing the Company, and evaluating management&#8217;s approach to addressing such risks. In connection with these reviews, our Board members rely on information from external sources as well as on their individual experiences identifying and managing business enterprise risk for other entities both within and outside of our industry. In addition, the committees of our Board consider and address risk as they perform their respective committee responsibilities. For example, financial risks and cyber security risks are overseen by our Audit Committee and our Compensation Committee periodically reviews our compensation programs to ensure they do not encourage excessive risk-taking. All committees report to the full Board as appropriate, including when a matter rises to the level of a material or enterprise risk.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our senior management team is responsible for day-to-day risk management and regularly reports on risks to our full Board or a relevant committee. Our legal, finance and regulatory areas serve as the primary monitoring and evaluation function for company-wide policies and procedures, and manage the day-to-day oversight of the risk management strategy for our business. This oversight includes identifying, evaluating, and addressing potential risks that may exist at the enterprise, strategic, financial, operational, compliance and reporting levels.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We believe the division of risk management responsibilities described above is an effective approach for identifying and addressing the risks facing our Company, and that the leadership structure of our Board is effective in implementing this approach.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Corporate Responsibility</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Halozyme continues to build a sustainable, environmentally conscious business while fulfilling our mission of bringing disruptive solutions that can significantly improve patient experiences and potentially outcomes for emerging and established therapies. We are driven by our mission and dedicated to our sustainability efforts across our entire ecosystem internally and externally. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please see the discussion under the heading &#8220;Human Capital Management&#8221; in the Business section of our Annual Report on Form 10-K (which accompanies this Proxy Statement) for additional information on our human capital priorities and programs. Further more detailed information about our sustainability efforts are on our website at www.halozyme.com under the section titled &#8220;Responsibility&#8221;. Information on our website is not part of this Proxy Statement.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Cybersecurity</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our corporate Enterprise Risk Management program, which includes information technology and cybersecurity risk, is reviewed approximately quarterly by the CEO and Halozyme Leadership Team, and annually by the Halozyme Board of Directors. Additionally, Halozyme&#8217;s CEO is briefed quarterly and the Audit Committee is briefed periodically, on our cybersecurity program. Our cybersecurity strategy is based on four fundamental areas: policy, procedure, people and technology. Halozyme maintains policies and procedures that describe our employees&#8217; responsibilities for accessing computerized systems, handling data and information, and reporting cybersecurity events in a timely manner. The Board of Directors receives educational updates from outside experts on key emergent topics. All employees and contractors are required to complete formal training on these policies. Halozyme has a well-defined and proven Business Continuity Plan (BCP). The IT Disaster Recovery Plan and the IT Incident Response Plan, which are standalone components of Halozyme&#8217;s BCP, provide the framework and guidance to manage risk. Please see the discussion under the heading &#8220;Cybersecurity&#8221; in the Business section of our Annual Report on Form 10-K (which accompanies this Proxy Statement) for additional information on our cybersecurity risk management, strategy and governance.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Insider Trading Policies and Procedures</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have <ix:nonNumeric contextRef="c-1" name="ecd:InsiderTrdPoliciesProcAdoptedFlag" format="ixt:fixed-true" id="f-5">adopted</ix:nonNumeric> insider trading policies and procedures governing the purchase, sale and/or other dispositions of our securities by directors, officers and employees that we believe are reasonably designed to promote compliance with insider trading laws, rules and regulations and the exchange listing standards applicable to us.  In addition, our insider trading policy requires that the Company comply with all securities laws and regulations when transacting in the securities of the Company. We filed a copy of our insider trading policy as an exhibit to our Annual Report on Form 10-K.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Communications with Directors</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders may communicate with any and all directors by transmitting correspondence by mail addressed as follows: &#8220;Halozyme Board of Directors&#8221; c/o Corporate Secretary, 12390 El Camino Real, San Diego, California 92130. The Corporate Secretary will transmit as soon as practicable such communications to the identified director addressee(s), unless there are safety or security concerns that mitigate against further transmission of the communication as determined by the Corporate Secretary. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Director Attendance at Annual Meetings</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Corporate Governance Guidelines state that all directors shall make every effort to attend the Company&#8217;s Annual Meeting of Stockholders. All eight of our then-serving directors attended our Annual Meeting of Stockholders in 2024.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Code of Conduct and Ethics and Corporate Governance Guidelines</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board has adopted a Code of Conduct and Ethics that applies to all of our employees, officers and directors. The Board has also adopted Corporate Governance Guidelines. Copies of these documents are available on our website at: www.halozyme.com. Amendments to or waivers of our Code of Conduct and Ethics granted to any of our directors or executive officers will be published promptly within four business days on our website, www.halozyme.com.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Please note that the information on our website is not incorporated by reference in this Proxy Statement.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee Interlocks and Insider Participation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">None of the directors who served on the Compensation Committee during 2024 has ever been an officer or employee of ours or had a relationship in 2024 requiring disclosure under applicable SEC regulations. None of our executive officers currently serves, or served during 2024, on the compensation committee or board of directors of any other entity that has an executive officer serving as a member of our Board of Directors or Compensation Committee.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_31"></div><hr style="page-break-after:always"/><div style="min-height:45pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 2</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ADVISORY (NON-BINDING) VOTE </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">ON EXECUTIVE COMPENSATION (SAY-ON-PAY)</span></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Background</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The advisory vote on executive compensation is a non-binding vote on the compensation of our Named Executive Officers, as described in the Compensation Discussion and Analysis (&#8220;CD&amp;A&#8221;) section, the tabular disclosure regarding such compensation, and the accompanying narrative disclosure, set forth in this Proxy Statement. We hold this vote annually. Please read the Executive Compensation and Related Information section of this Proxy Statement for a detailed discussion about our executive compensation programs, including information about the fiscal year 2024 compensation of our Named Executive Officers. Accordingly, as required by Section 14A of the Securities Exchange Act of 1934, as amended, we are asking our stockholders to cast an advisory vote to approve the executive compensation as described in this Proxy Statement. We expect to conduct the next advisory vote on the compensation of our Named Executive Officers at our 2026 Annual Meeting of Stockholders </span></div><div style="margin-bottom:6pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have many compensation practices that ensure consistent leadership, decision-making and actions without taking inappropriate or unnecessary risks. These compensation practices are discussed in detail in the Compensation Discussion and Analysis section of this Proxy Statement and have the following objectives:</span></div><div style="padding-left:60.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Properly align the interests of our stockholders with those of our executive leadership team;</span></div><div style="padding-left:60.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reward actions and achievements that are consistent with the short- and long-term goals of Halozyme&#8217;s business strategy; and</span></div><div style="padding-left:60.75pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Remain competitive to attract, retain and motivate employees with relevant experience and skills needed to achieve our business goals. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The vote solicited by this Proposal No. 2 is advisory, and therefore is not binding on the Company, our Board of Directors or our Compensation Committee, nor will its outcome require the Company, our Board of Directors or our Compensation Committee to take any action. Moreover, the outcome of the vote will not be construed as overruling any decision by the Company, the Board of Directors or the Compensation Committee. However, our Board of Directors, including our Compensation Committee, values the opinions of our stockholders and, to the extent there is any significant vote against the Named Executive Officer compensation as disclosed in this Proxy Statement, we will consider our stockholders&#8217; concerns and evaluate what actions, if any, may be appropriate to address those concerns.&#160;</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholders will be asked at the Annual Meeting to approve the following resolution pursuant to this Proposal No. 2: </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RESOLVED, that the stockholders of Halozyme Therapeutics, Inc. approve, on an advisory basis, the compensation of the Company&#8217;s Named Executive&#160;Officers,&#160;disclosed pursuant to&#160;Item 402 of Regulation S-K in the Company&#8217;s Definitive Proxy Statement for the 2025 Annual Meeting of Stockholders</span><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Approval of this resolution requires the affirmative vote of a majority in voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the matter. Abstentions will be treated as votes &#8220;against&#8221; the proposal. Broker non-votes will have no effect on the outcome of the vote. </span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Recommendation</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board of Directors believes that the compensation of our Named Executive Officers, as described in the Compensation Discussion and Analysis and the tabular disclosures and accompanying narrative disclosures under the heading &#8220;Executive Compensation and Related Information&#8221; is appropriate for the reasons stated above. </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Therefore, the Board of Directors unanimously recommends a vote &#8220;FOR&#8221; approval of the compensation for our Named Executive Officers.</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">19</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_37"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PROPOSAL NO. 3</span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">RATIFICATION OF SELECTION OF </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee of the Board of Directors of Halozyme has selected Ernst &amp; Young LLP as the independent registered public accounting firm to audit the consolidated financial statements of Halozyme for the fiscal year ending December 31, 2025. Ernst &amp; Young LLP has acted in such capacity since its appointment on June 28, 2006. A representative of Ernst &amp; Young LLP is expected to be present at the Annual Meeting of Stockholders, with the opportunity to make a statement if the representative desires to do so, and is expected to be available to respond to appropriate questions. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholder ratification of the selection of Ernst &amp; Young LLP as our independent registered public accounting firm is not required by our Bylaws or otherwise. However, the Board of Directors is submitting the selection of Ernst &amp; Young LLP to the stockholders for ratification as a matter of good corporate practice. If the stockholders fail to ratify the selection, the Audit Committee will reconsider whether or not to retain that firm. Even if the selection is ratified, the Audit Committee in its discretion may appoint a different independent registered public accounting firm at any time during the year if it determines that such a change would be in the best interests of the Company and its stockholders.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Vote Required</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The affirmative vote of a majority in voting power of the shares present in person or represented by proxy at the meeting and entitled to vote on the matter shall ratify the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025. Abstentions will be treated as votes &#8220;against&#8221; the proposal. Broker non-votes will have no effect on the outcome of the vote.</span></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Board of Directors Recommendation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">The Board of Directors unanimously recommends a vote &#8220;FOR&#8221; the ratification of the selection of Ernst &amp; Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025.</span></div><div style="margin-top:12.6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PRINCIPAL ACCOUNTING FEES AND SERVICES</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth the aggregate fees billed to Halozyme for the fiscal years ended December&#160;31, 2024 and 2023 by Ernst &amp; Young LLP:</span></div><div style="margin-top:5pt;padding-left:11.25pt;padding-right:11.25pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:73.251%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.868%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.045%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.090%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.046%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fiscal 2023</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit Fees </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510,719&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558,350&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Audit Related Fees</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Tax Fees</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">All Other Fees </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,510,719&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 0;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,558,350&#160;</span></td><td style="background-color:#cceeff;border-bottom:3pt double #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Audit Fees consist of fees billed for professional services rendered for the audit of the Company&#8217;s consolidated annual financial statements, including the audit of internal control over financial reporting and review of the interim consolidated financial statements included in quarterly reports and services that are normally provided by our independent registered public accounting firm in connection with statutory and regulatory filings or engagements.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">All Other Fees consist of fees for products and services other than the services reported above.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee&#8217;s policy is to pre-approve all audit and permissible non-audit services provided by our independent registered public accounting firm. These services may include audit services, audit-related services, tax services and other services. Pre-approval is generally provided for up to one year and any pre-approval is detailed as to the particular service or category of services. The independent registered public accounting firm and management are required to periodically report to the Audit Committee regarding the extent of services provided by the independent registered public accounting firm in accordance with this pre-approval policy. The Chair of the Audit Committee is also authorized, pursuant to delegated authority, to pre-approve additional services on a case-by-case basis, provided that such approvals are communicated to the full Audit Committee at its next meeting. All of the services of Ernst &amp; Young LLP for 2024 and 2023 described above were pre-approved by the Audit Committee.</span></div><div style="height:85.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">20</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_40"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">REPORT OF THE AUDIT COMMITTEE</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee oversees the Company&#8217;s financial reporting process on behalf of the Board of Directors and is comprised solely of independent directors as defined by the Nasdaq listing standards and Rule 10A-3 of the Securities Exchange Act of 1934. The Audit Committee is governed by a charter which describes in greater detail the full responsibilities of the Audit Committee. The Company&#8217;s management has the primary responsibility for the consolidated financial statements, for maintaining effective internal control over financial reporting, and for assessing the effectiveness of internal control over financial reporting. In fulfilling its oversight responsibilities, the Audit Committee reviews the consolidated financial statements, internal control over financial reporting, audit matters and reports from management. In connection with these reviews, the Audit Committee meets with management and the independent registered public accounting firm (Ernst &amp; Young LLP) at least once each quarter. These meetings include, whenever appropriate, executive sessions in which the Audit Committee meets separately with the independent registered public accounting firm, internal auditors, management personnel and legal counsel. The meetings of the Audit Committee are designed to facilitate and encourage communication among the Audit Committee, the Company, the Company&#8217;s internal audit function and the independent registered public accounting firm. The Audit Committee is directly and solely responsible for the appointment, compensation, retention, and oversight of the independent registered public accounting firm. The Audit Committee regularly considers the independence, qualifications, audit and non-audit fees and services, and performance of the independent registered public accounting firm.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee has reviewed and discussed with the independent registered public accounting firm, which is responsible for expressing an opinion on the conformity of the audited consolidated financial statements with U.S. generally accepted accounting principles, its judgments as to the quality, not just the acceptability, of the Company&#8217;s accounting principles and such other matters as are required to be discussed by the applicable requirements of the Public Company Accounting Oversight Board (PCAOB) and the Securities and Exchange Commission, and other applicable regulations. In addition, the Audit Committee reviewed and discussed with Ernst &amp; Young LLP matters related to its independence, including a review of non-audit services and the written disclosures and the letter from Ernst &amp; Young LLP to the Audit Committee required by the PCAOB regarding its communications with the Audit Committee concerning Ernst &amp; Young LLP&#8217;s independence. The Audit Committee concluded that Ernst &amp; Young LLP is independent from the Company and its management.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Audit Committee discussed with the Company&#8217;s independent registered public accounting firm the overall scope and plans for their respective audits. The Audit Committee has met the independent registered public accounting firm, with and without management present, to discuss the results of their examinations; their evaluations of the Company&#8217;s internal control, including internal control over financial reporting; the critical audit matters addressed during the audit; and the overall quality of the Company&#8217;s financial reporting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Committee also reviewed and discussed with management and the independent registered public accounting firm the Company&#8217;s audited consolidated financial statements and related schedule, the results of management&#8217;s assessment of the effectiveness of the Company&#8217;s internal control over financial reporting and the independent registered public accounting firm&#8217;s audit of internal control over financial reporting for the year ended December&#160;31, 2024. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In reliance on the reviews and discussions referred to above, the Audit Committee recommended to the Board of Directors, and the Board of Directors has approved, that the audited consolidated financial statements and management&#8217;s assessment of the effectiveness of the Company&#8217;s internal control over financial reporting be included in the Annual Report on Form 10-K for the year ended December&#160;31, 2024 filed by the Company with the Securities and Exchange Commission. </span></div><div style="margin-top:12pt;padding-left:252pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">AUDIT COMMITTEE</span></div><div style="margin-top:6pt;padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Barbara Duncan (Chair)</span></div><div style="padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Jeffrey W. Henderson</span></div><div style="padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Matthew L. Posard</span></div><div style="padding-left:252pt;text-align:justify"><span><br/></span></div><div style="height:126pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">21</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_43"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">EXECUTIVE COMPENSATION AND RELATED INFORMATION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">COMPENSATION DISCUSSION AND ANALYSIS</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Summary</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee oversees the compensation program for the Company&#8217;s executive officers. In this role, the Compensation Committee reviews and approves all compensation decisions relating to our executive officers listed in the table below (referred to in this proxy statement as our &#8220;Named Executive Officers&#8221; or &#8220;NEOs&#8221;).</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our NEOs for 2024 are:</span></div><div style="text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.567%"><tr><td style="width:1.0%"/><td style="width:36.691%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.577%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:60.332%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Principal Position</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">President and Chief Executive Officer </span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Financial Officer</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Legal Officer</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Senior Vice President, Chief Technical Officer</span></td></tr></table></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Executive Compensation Highlights</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our executive compensation program ties a substantial portion of each executive&#8217;s overall compensation to the achievement of key strategic, financial and operational goals and aligns the interests of executive officers with stockholders by annually awarding long-term equity-based incentives (&#8220;LTI&#8221;), in the form of time-vesting restricted stock units (&#8220;RSUs&#8221;), performance-vesting stock units (&#8220;PSUs&#8221;) and stock options. Consistent with this approach, the compensation of our NEOs for 2024 featured:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Total Revenue from Existing Sources</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, New Revenue</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, and Adjusted EBITDA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> growth performance goals were established for the threshold, base and maximum targets under our 2024 annual cash incentive program. Actual Total Revenue from Existing Sources attainment was $957.5 million, a 16% increase over prior year which was 200% to target, New Revenue attainment was $27 million, which was 71.3% to target, and Adjusted EBITDA was $601.4 million a 41% increase over prior year and 200% to target. Actual cash payouts under the 2024 annual cash incentive program ranged from 95% to 189% of target, with the cash payouts driven by a corporate performance factor under the program of 157.8%.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a compensation package more heavily weighted toward long-term equity-based incentive compensation than salary and shorter-term annual cash incentives in order to emphasize the focus on our long-term performance and stockholder value,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">long-term equity-based incentives that were heavily weighted toward performance &#8211; in addition to the value of all awards being dependent on our stock price, the annual awards granted in 2024 consisted of 50% PSUs which are subject to performance-based vesting conditions, 15% stock options, which have value only if our stock price increases after the date of grant of the awards, and 35% RSUs, the value of which depends on our future stock price when the awards vest,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">stock ownership and stock retention guidelines, encouraging executives to maintain a meaningful ownership position in the Company, focus on our long-term performance and discourage unreasonable risk-taking,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a recoupment (or &#8220;claw back&#8221;) policy covering certain compensation elements in the event of an accounting restatement due to material noncompliance with any financial reporting requirements,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a practice of not including tax gross-ups in ongoing compensation arrangements,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">no &#8220;single trigger&#8221; provisions in executive and employee change-in-control agreements and arrangements (i.e., payout or vesting is not triggered automatically upon a change-in-control), and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">no material perquisites.</span></div><div style="text-align:justify"><span><br/></span></div><div style="border-bottom:1pt solid #000000;margin-bottom:5pt;margin-top:10pt;opacity:1;width:150pt"></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:112%;position:relative;top:-3.5pt;vertical-align:baseline">1</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> We use &#8220;Total Revenue from Existing Sources&#8221; in this Compensation Discussion and Analysis (&#8220;CD&amp;A&#8221;) to mean the Company&#8217;s total revenue for the year excluding New Revenue.  We use &#8220;New Revenue&#8221; in this CD&amp;A to mean the Company&#8217;s revenue for the year derived from new collaborations, milestones, and nominations that were not in the Company&#8217;s base financial plan for the year and were the result of new opportunity creation.  We use &#8220;Adjusted EBITDA&#8221; in this CD&amp;A to refer to the Company&#8217;s earnings for the year excluding interest, taxes, depreciation and amortization, and excluding one time items, if any, such as changes in contingent liabilities, inventory adjustments, and impairment charges that we feel are not reflective of our core operating performance.  Total Revenue from Existing Sources and Adjusted EBITDA do not include revenue we received during the year resulting from the issuance of the European patent we were granted in June 2024 covering ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"> manufacturing methods which prevented the reduction in the royalty rate on sales of DARZALEX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:112%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">SC in the European countries where it is validated.  This additional revenue was not included at the time the corporate goals were established as it was dependent upon patent issuance, and it was determined that if a patent was issued,  the incremental revenue would be excluded from the performance measurement.  </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">22</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stockholder Engagement</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board and the Compensation Committee value the input of our stockholders regarding the Company&#8217;s governance practices and the design and effectiveness of our executive compensation program. Halozyme conducts regular outreach to our stockholders to build relationships and solicit feedback on these topics.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our stockholders are provided with an opportunity to cast an advisory vote on our executive compensation program every year through the &#8220;say-on-pay&#8221; proposal. At our 2024 annual meeting of stockholders, our stockholders approved, on a non-binding, advisory basis, the compensation paid to our NEOs described in our 2024 proxy statement. Approximately 97.9% of the votes cast on the matter were voted in favor of this &#8220;say-on-pay&#8221; proposal. The Compensation Committee considered the voting results and high level of stockholder support of the prior year when establishing our executive compensation programs for fiscal 2025.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">When making future compensation decisions for our executive officers, the Compensation Committee will continue to consider the opinions that stockholders express through our stockholder engagement program and through our annual &#8220;say-on-pay&#8221; advisory votes.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2024 Business Highlights</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Halozyme&#8217;s strong financial and operating performance in 2024 was supported by internal corporate developments and significant growth and advancements with our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> collaboration partners. The key developments and achievements in 2024 include:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Strong stockholder return, with the per share price of our common stock up 28% during 2024 (from NASDAQ closing price of $37.39 on January 2, 2024 to a NASDAQ closing price of $47.81 on December 31, 2024) and up 223% over five years (from a NASDAQ closing price of $14.80 on January 2, 2019 to a NASDAQ closing price of $47.81 on December 31, 2024).</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Reported record total revenues of $1,015.3 million, which increased 22% from $829.3 million in 2023.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Revenues from royalties of $571 million which increased 27% from $447.9 million in 2023 driven primarily by continued sales uptake of DARZALEX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> subcutaneous (&#8220;SC&#8221;) from Janssen and Phesgo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> by Roche in all geographies, and the prior year launch of VYVGART</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Hytrulo by argenx.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">In June 2024, the Company completed the $250 million Accelerated Share Repurchase (&#8220;ASR&#8221;) that was initiated in November of 2023, resulting in a total repurchase of 6.5 million shares at an average price of $38.35 per share which concluded our December 2021 share repurchase program resulting in a total of 19.1 million shares repurchased over the three-year period at an average price per share of $39.31.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">The Company announced the issuance of a new European patent covering the ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> rHuPH20 product obtained from our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> manufacturing methods that we provide to our licensees. The newly granted patent maintains the original royalty rate on sales of DARZALEX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174; </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">SC in 37 European countries until expiration of the patent in March 2029.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">argenx expanded its global collaboration and license agreement nominating four additional targets that provides them exclusive access to our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> drug delivery technology for a total of six targets. Under the terms of the expanded exclusive agreement, we received upfront payments of $7.5 million per target nomination for a total of $30.0 million. argenx is obligated to make future milestone payments of up to $85.0 million per new nominated target, subject to achievements of specified development, regulatory and sales-based milestones. We are also entitled to receive royalties on net sales of commercialized products with our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> technology.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">ViiV expanded its global collaboration and license agreement providing ViiV the ability to exclusively access our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> drug delivery technology for one additional undisclosed target.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">In December 2024, the Company initiated a $250 million ASR under the February 2024 Board of Directors approved $750 million share repurchase authorization.  </span></div><div><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Partner Regulatory Submissions/Approvals</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">argenx received regulatory approval in Japan for VYVDURA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (efgartigimod alfa and hyaluronidase-qvfc) co-formulated with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of adult patients with generalized myasthenia gravis including options for self-administration.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">23</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">argenx announced the U.S. Food and Drug Administration (&#8220;FDA&#8221;) approved VYVGART</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Hytrulo with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of chronic inflammatory demyelinating polyneuropathy, and completed the regulatory submissions of VYVGART</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SC for chronic inflammatory demyelinating polyneuropathy in Europe, during the second quarter of 2024.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">argenx announced the National Medical Products Administration approved the Biologics License Application for efgartigimod SC for generalized myasthenia gravis in China.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">argenx announced the Ministry of Health, Labour and Welfare in Japan approved VYVDURA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of patients with chronic inflammatory demyelinating polyneuropathy.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">Zai Lab Limited (argenx commercial partner for China) announced the National Medical Products Administration approved VYVGART</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Hytrulo for the treatment of patients with chronic inflammatory demyelinating polyneuropathy.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">Takeda received FDA and European Commission approval for HYQVIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of chronic inflammatory demyelinating polyneuropathy in adults with stable chronic inflammatory demyelinating polyneuropathy.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">Takeda announced Health Canada approved HYQVIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a replacement therapy for primary humoral immunodeficiency and a secondary humoral immunodeficiency in pediatric patients two years of age and older.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">Takeda submitted a New Drug Application in Japan seeking approval for HYQVIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for treatment of chronic inflammatory demyelinating polyneuropathy/Multifocal Motor Neuropathy.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Takeda announced the Ministry of Health, Labour and Welfare in Japan approved HYQVIA</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SC with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for patients with agammaglobulinemia or hypogammaglobulinemia disorders characterized by very low or absent levels of antibodies and an increased risk of serious recurring infection caused by primary immunodeficiency or secondary immunodeficiency.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Janssen announced the submission of a Biologics License Application to the FDA for amivantamab SC co-formulated with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> also for patients with epidermal growth factor receptor-mutated non-small cell lung cancer and received priority review but subsequently received a Complete Response Letter.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">Janssen announced the submission of a marketing authorization application to the European Medicines Agency for the SC formulation of RYBREVANT</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (amivantamab) with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of patients with epidermal growth factor receptor-mutated non-small cell lung cancer.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Janssen announced the European Commission approved DARZALEX</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SC for the treatment of patients newly diagnosed with multiple myeloma who are eligible for autologous stem cell transplant in combination with bortezomib, lenalidomide, and dexamethasone.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">Janssen announced the submission of a supplemental Biologics License Application to the FDA for approval of a new indication of DARZALEX FASPRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in combination with bortezomib, lenalidomide, and dexamethasone for the treatment of adult patients with newly diagnosed multiple myeloma for whom autologous stem cell transplant is deferred or who are ineligible for autologous stem cell transplant.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">Janssen announced the FDA approved DARZALEX FASPRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for an additional indication in newly diagnosed multiple myeloma patients who are eligible for autologous stem cell transplant in combination with bortezomib, lenalidomide, and dexamethasone.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Janssen announced the submission of regulatory applications to the FDA and European Medicines Agency seeking approval of a new indication for DARZALEX FASPRO</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> in the U.S. and DARZALEX SC in the European Union (&#8220;EU&#8221;) as a monotherapy for the treatment of adult patients with high-risk smoldering multiple myeloma.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Roche received European Commission marketing authorization for TECENTRIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SC for all approved indications of TECENTRIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> IV for multiple cancer types.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.46pt">Roche announced the approval of OCREVUS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ocrelizumab) SC for the treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis by the Medicines and Healthcare products Regulatory Agency in Great Britain.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">Roche announced the European Commission granted marketing authorization in the EU of OCREVUS</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (ocrelizumab) SC for the treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">24</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">Roche announced the FDA approved OCREVUS ZUNOVO&#8482; with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> as a twice a year ten-minute SC injection for the treatment of relapsing multiple sclerosis and primary progressive multiple sclerosis.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">Roche announced the FDA approved TECENTRIQ HYBREZA&#8482; with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for all approved adult indications of intravenous TECENTRIQ</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and was made available to patients.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">Roche's MabThera</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> SC was approved by the China National Medical Products Administration to treat diffuse large B-cell lymphoma.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Courier New',monospace;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.8pt">Bristol Myers Squibb announced the FDA approved Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Qvantig (nivolumab and hyaluronidase-nvhy) with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for SC use in most previously approved adult, solid tumor IV Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (nivolumab) indications.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">Bristol Myers Squibb announced the European Medicines Agency validated its Extension Application for the SC formulation of Opdivo</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> (nivolumab) co-formulated with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">.</span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Partner Clinical Advancements</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">ViiV initiated a Phase 1 study of VH4524184 with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> to evaluate the safety, tolerability, and pharmacokinetic measures in healthy adults.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">argenx initiated two registrational studies evaluating efgartigimod with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> administered by pre-filled syringe in subjects with thyroid eye disease.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">Acumen initiated a Phase 1 study of sabirnetug (ACU193) co-formulated with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> for the treatment of early Alzheimer's disease.</span></div><div style="margin-top:3pt;padding-left:72pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#9702;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.75pt">argenx initiated two studies evaluating VYVGART</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Hytrulo with ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, a Phase 3 study for adult patients with ocular myasthenia gravis  and a Phase 2 study for kidney transplant recipients with antibody mediated rejection.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2024 CEO Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In 2024, the total target annual cash compensation for our CEO, Dr. Helen I. Torley, was $1,824,000 ($960,000 in base salary plus $864,000 in target annual cash incentive opportunity). Dr. Torley&#8217;s base salary was increased for 2024 by 4.3% as a result of the Compensation Committee&#8217;s assessment of her contribution to Halozyme&#8217;s performance during 2023 and its review of base salary paid to other peer group CEOs. See Competitive Peer Group below. Dr. Torley&#8217;s target annual cash incentive opportunity for 2024 (assuming achievement of the corporate goals at 100%) was 90% of her base salary, which was the same percentage of her base salary as her target annual cash incentive opportunity for 2023. The Compensation Committee believes this target annual cash incentive was appropriate based on her level of experience, the Compensation Committee&#8217;s review of the annual cash incentive target for other peer group CEOs, and the Compensation Committee&#8217;s belief that significant portions of total annual cash compensation should be tied to achievement of specified goals. As discussed in more detail below in this CD&amp;A, the annual cash incentive she earned for 2024 was $1,363,392 which represents approximately 157.8% of her target annual cash incentive opportunity. As CEO, Dr. Torley is the only NEO whose annual cash incentive is determined solely based on the performance of the Company.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dr. Torley also received a LTI award during 2024 that had a grant date fair value of approximately $10,400,000, comprising the most significant element of her 2024 compensation opportunity. This award was granted based on the Compensation Committee&#8217;s assessment of her contribution to Halozyme&#8217;s performance during 2023, its review of LTI compensation paid to other peer group CEOs and the desire to link a significant portion of her compensation opportunity to Halozyme&#8217;s long-term performance. The Compensation Committee approved a mix of 50% PSUs (at target), 15% stock options and 35% RSUs for Dr. Torley, and the same mix for the annual LTI awards for each of the other NEOs, to emphasize Halozyme&#8217;s long-term stock price performance and to promote retention. The LTI award mix placed a particular emphasis on performance as the 50% allocation of Dr. Torley&#8217;s total LTI award to PSUs represented a significant increase over the 28.75% allocation to PSUs in 2023. The PSUs granted to Dr. Torley and the other NEOs in 2024 cliff vest aftter three years.  One-half of the PSUs vest based on our relative total shareholder return (&#8220;TSR&#8221;) measured against an applicable subset of companies in the NASDAQ Biotechnology Index over a three-year performance period and the remaining one-half of the PSUs vest based on new collaboration deals and nominations during 2024 as described in more detail under &#8220;LTI Compensation&#8221; below. The stock options have a maximum term of ten years and vest 25% on the one-year anniversary of the date of grant with the remaining 75% vesting monthly over the following three years, while RSUs vest in 25% annual installments over a four-year period following the grant date, in each case subject to continued employment.</span></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Halozyme&#8217;s Executive Compensation Program</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The principal elements of our executive compensation program are base salary, an annual cash incentive opportunity and an annual LTI award opportunity. The LTI awards for 2024 consisted of stock options, RSUs and PSUs.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">25</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:84.986%"><tr><td style="width:1.0%"/><td style="width:2.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.258%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:2.141%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:44.931%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">What We Do</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">What We Do Not Do</span></td></tr><tr style="height:8pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Pay annual bonus based on the achievement of Company financial and strategic goals, and in the case of NEOs other than the CEO, individual performance, and contribution in achieving those goals</span></div><div style="text-align:justify"><span><br/></span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No guaranteed annual bonus payouts</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">Grant PSUs as significant portion of annual LTI awards for all executive officers </span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No severance payments or benefits for executives who voluntarily terminate their employment</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cap the annual bonus plan payout</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No buyback of stock awards or repricing of stock options without shareholder approval</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Prohibit executive officer hedging and pledging of Company stock</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">No executive single-trigger change in control benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maintain an executive officer recoupment (&#8220;claw back&#8221;) policy for accounting restatements</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No material perquisites </span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Maintain robust stock ownership and retention guidelines for all executive officers</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:115%">No supplemental executive benefits</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Wingdings',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#252;</span></div><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Conduct an annual comprehensive compensation program risk assessment</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#215;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">No tax gross-ups in ongoing compensation arrangements</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Detailed Discussion and Analysis</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This CD&amp;A describes the material elements of 2024 compensation for our NEOs. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee makes all decisions relative to the compensation of all executive officers (including the CEO). Except as otherwise noted in this CD&amp;A, the Compensation Committee&#8217;s executive compensation determinations are subjective and the result of the Compensation Committee&#8217;s business judgment. Additional details regarding the role and responsibilities of the Compensation Committee are provided below.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Executive Total Rewards Philosophy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee periodically reviews its total rewards philosophy for executive officers to confirm our programs continue to meet the objectives of:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">supporting Halozyme&#8217;s short- and long-term business strategy,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">anchoring to market-based principles and being tailored to Halozyme&#8217;s culture, and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">aligning the interests of the executive officers with the long-term interests of Halozyme stockholders.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">26</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 compensation for our NEOs consisted of three primary elements, each having a specific purpose as described below:</span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.126%"><tr><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.900%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Compensation Element</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Purpose</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Base Salary</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Provides a fixed amount of cash compensation for services rendered based on individual performance, job scope, experience and competitive market for talent</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Annual Cash Incentive</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Motivates and rewards fiscal year contribution to company performance against pre-established financial and operational goals and objectives </span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Long-term Incentives</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Align compensation with the creation of stockholder value (as the value of equity awards generally, and stock options in particular, depends on stock price)  and, in the case of PSUs, the achievement of relative total shareholder return goals and other performance objectives we consider important to our long-term success</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Increase executive stock ownership and alignment with stockholder interests.</span></div><div style="padding-left:13.5pt;text-indent:-13.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8226;    Serve as a key retention device</span></div></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition, our NEOs are eligible to receive severance payments and benefits in connection with a qualifying termination of employment under our executive Change-in-Control Agreements and our severance policy for covered terminations unrelated to a change in control, each as described in more detail below. We also provide our NEOs with the same package of benefits that are provided to substantially all our full-time employees, including Company matching contributions to a 401(k) plan, health insurance, group term life insurance, and disability income insurance. From time to time, we may also provide relocation assistance in connection with the recruitment of an employee with needed skills and experience. No material perquisites or supplemental executive benefits were provided to our NEOs in 2024. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As shown below, the majority of our NEOs&#8217; target total direct compensation for 2024 (base salary, target annual cash incentive, and LTI awards, taken into account at their fair value on the grant date) was variable (target annual cash incentive and LTI awards), with the single largest component (LTI awards) based on Halozyme&#8217;s stock price performance. </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">27</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:center"><img src="halo-20250318_g5.jpg" alt="CEO CDA Chart 2024.jpg" style="height:280px;margin-bottom:5pt;vertical-align:text-bottom;width:659px"/></div><div style="margin-top:6pt;text-align:center"><img src="halo-20250318_g6.jpg" alt="NEOs CDA Chart 2024.jpg" style="height:280px;margin-bottom:5pt;vertical-align:text-bottom;width:659px"/></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Base Salary</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee determines base salaries for NEOs each year based upon the following factors (with no specific weight applied to each factor):</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the scope and complexity of the NEO&#8217;s responsibilities, </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">a review of external market practices (a more detailed description of the methodology used to assess external market practices is provided below),</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the NEO&#8217;s experience, </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">internal pay equity, and</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">the CEO&#8217;s evaluation of the NEO&#8217;s performance and contribution to the short- and long-term success of Halozyme (in the case of the CEO, the evaluation is done in executive session by the Compensation Committee with input from the other independent members of the Board of Directors). </span></div><div style="margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As reflected in the table below, 2024 annual base salary levels were increased by 4.3% for the CEO, between 3.3% and 6.0% for the other NEOs. The base salary increases for our NEOs were approved by the Compensation Committee after taking into account the base salaries paid to peer group executives holding similar positions and other factors described above.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">28</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.322%"><tr><td style="width:1.0%"/><td style="width:60.438%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.966%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.554%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.968%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Executive Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023 Base Salary ($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024 Base Salary ($)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">% Increase</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">920,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.3%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">546,188</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568,188</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.0%</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder </span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">546,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">579,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">6.0%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">538,200</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">556,200</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3.3%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Annual Cash Incentive</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NEOs participate each year in the Employee Bonus Plan (&#8220;EBP&#8221;). The actual cash incentive paid to each NEO with respect to 2024 was determined based on each NEO&#8217;s target annual cash incentive opportunity and based on the performance of Halozyme as measured by the level of achievement of six metrics, of which three are tied to financial performance and have a combined 80% weighting and three are tied to operational performance and have a combined 20% weighting (&#8220;Corporate Performance&#8221;). As CEO, Dr. Torley is responsible for overall corporate performance, and accordingly, her EBP incentive opportunity is based entirely on the attainment of objective, pre-established corporate performance goals without applying an individual performance adjustment. For the other NEOs, the Compensation Committee may modify final payouts based on individual performance during the year relative to the level of achievement of personal goals (&#8220;Individual Performance Factor&#8221;), and the NEO must achieve at least 60% of his/her individual performance objectives in order to be eligible for a cash incentive payment. In all events, an NEO&#8217;s total payout cannot exceed two times the target cash annual incentive opportunity for the NEO. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee sets each NEO&#8217;s target annual cash incentive opportunity as a percentage of the NEO&#8217;s base salary taking into account the same factors as are considered in NEO base salary determinations. As shown in the chart below, no changes were made to target annual cash incentive opportunities for the NEOs in 2024 (as a percentage of base salary).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:88.980%"><tr><td style="width:1.0%"/><td style="width:59.426%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.283%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.573%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.289%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Executive Officer</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">2023 Target Bonus</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(% Salary)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">2024 Target Bonus</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">(% Salary)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">2024 Target Bonus ($)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Helen I. Torley</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">864,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Nicole LaBrosse</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">284,094</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Mark Snyder</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">289,500</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Michael J. LaBarre</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">278,100</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Corporate Performance.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Corporate goals were established by the Compensation Committee (with input from the full Board of Directors) to tie the compensation of our NEOs to the Company&#8217;s achievement of annual operating objectives that were viewed as long-term drivers of sustainable value creation. EBP funding ranges between 0% and 200% for each of the six metrics. The Board of Directors approved the threshold, target, and maximum goals/level of performance for each metric. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The 2024 EBP focused on achievement of key financial and strategic objectives that resulted in (i) growth in Total Revenue from Existing Sources, (ii) New Revenue, (iii) increased Adjusted EBITDA and (iv) certain other operational goals as identified in the table below. The Compensation Committee is responsible for certifying actual performance relative to these goals following completion of the fiscal year. After reviewing the Company&#8217;s performance results in 2024, the Compensation Committee determined the corporate performance factor under the 2024 EBP was achieved at 157.8% of the targeted level for the NEOs (see table below). We used growth in revenues and Adjusted EBITDA as financial performance measures under the 2024 EBP because they are common metrics used to measure performance and widely understood by investors. </span></div><div><span><br/></span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">29</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.867%"><tr><td style="width:1.0%"/><td style="width:13.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.124%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.125%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Corporate Goal</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Weight</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Threshold 50%</span></div></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Target  100%</span></div></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Maximum 200%</span></div></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Actual Result</span></td><td colspan="3" style="background-color:#00497f;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EBP Funding</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Total Revenue from Existing Sources </span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40%</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$865.0M</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$897.0M</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$935.0M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$957.5M</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">80%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">New Revenue</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">25%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$10M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$50M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$75M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$27M</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17.8%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Adjusted EBITDA</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$495M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$561M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$586M</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">$601.4M</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Demonstrate operational excellence through achievement of key performance metrics related to production and release</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3 of 5</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4 of 5</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5 of 5</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Achieved 4 KPIs</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Achieve new patent filings</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#160;</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6</span></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Achieve HVAI clinic readiness</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5%</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Achieved between May 1 and June 1</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Achieved between April 2 and April 30</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Achieved on or before April 1</span></div></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Achieved on March 19 2024</span></div></td><td colspan="3" style="border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10%</span></td></tr><tr><td colspan="18" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">TOTAL CORPORATE PERFORMANCE FACTOR</span></td><td colspan="3" style="border-bottom:1pt solid #000;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.8%</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">    </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Individual Performance Factor.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Compensation Committee believes the actual payout to each NEO (other than for Dr. Torley whose payout, as noted above, is based entirely on the attainment of objective, pre-established corporate performance goals) should also reflect the executive&#8217;s:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">performance relative to individual goals and objectives established for the year,</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">contribution toward achieving the Corporate Performance results, and </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">demonstration of living Halozyme&#8217;s Leadership Attributes and Corporate Values during the year.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighing Ms. LaBrosse&#8217;s accomplishments and other factors, the Compensation Committee supported the CEO&#8217;s recommendation and awarded her an individual performance factor of 120%. The Compensation Committee noted that:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Ms. LaBrosse successfully led several strategic initiatives and activities, including financial transactions (including completion of the $250 million ASR in the second quarter of 2024, and the initiation of the $250 million ASR in December 2024), continued actions to optimize taxes, further evolution of our cybersecurity readiness and multiple strategic financial analyses related to capital allocation and deployment.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighing Mr. Snyder&#8217;s accomplishments and other factors, the Compensation Committee supported the CEO&#8217;s recommendation and awarded him an individual performance factor of 120%. The Compensation Committee noted that:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Mr. Snyder played a key leadership role in successful issuance of a new European ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> rHuPH20 product obtained from our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> manufacturing methods that we provide to our licensees that resulted in maintenance of a key royalty revenue stream at the original rate, extending the time to royalty rate step down from 2024 to 2029. In addition, he oversaw the submission of multiple new patent applications related to Halozyme&#8217;s drug delivery technologies.  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Weighing Dr. LaBarre&#8217;s accomplishments and other factors, the Compensation Committee supported the CEOs recommendation and awarded him an individual performance factor of 60%. The Compensation Committee noted that:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">While Dr. LaBarre played a key role in the successful accomplishment of the HVAI clinic readiness goal and helped identify innovations that supported multiple new patent applications, full progress related to an internal revenue goal was not accomplished.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below illustrates the 2024 cash incentive calculation for each NEO based on the following formula (also reflected in the &#8220;Non-Equity Incentive Plan Compensation&#8221; column of the Summary Compensation Table). </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">30</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><img src="halo-20250318_g7.jpg" alt="slide1b05.jpg" style="height:97px;margin-bottom:5pt;vertical-align:text-bottom;width:636px"/></div><div style="margin-top:11pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:33.124%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.659%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.648%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.065%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.734%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.734%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.468%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.996%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Named Executive Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Annualized Base Salary<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Target<br/>%</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Annualized<br/>Target Amount<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Corporate Performance Factor</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Individual Performance Factor</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Final Payout<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(1)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">960,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">864,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.8%</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">N/A</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,363,392&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">568,188</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">284,094</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">537,960&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">579,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">289,500</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.8%</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">120%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">548,197&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">556,200</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">278,100</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">157.8%</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">263,305&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="text-indent:22.5pt"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">As noted above, Dr. Torley&#8217;s payout is based entirely on the attainment of objective, pre-established corporate performance goals without applying an individual performance factor.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">LTI Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">All grants of LTI compensation are made under our stockholder-approved equity incentive plan. The Compensation Committee utilized three vehicles to deliver LTI awards to NEOs during 2024:</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Stock Options</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">are strongly aligned with stockholder interests because they deliver value to the NEO only if the value of our stock at the time of exercise exceeds the stock price on the day of grant. As a result, the Compensation Committee believes stock options encourage executives to focus on the decisions and behaviors required to support long-term sustainable increases in our stock price.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Time-vesting RSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">provide a counterbalance to the more uncertain value associated with stock options and PSUs while still maintaining alignment with the interests of our long-term stockholders, as the value of RSUs fluctuates (up or down) with changes in our stock price. As a result, the Compensation Committee believes time-vesting RSUs encourage executives to make decisions consistent with the long-term interests of our stockholders and help support retention.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stock options and time-vesting RSUs granted to our NEOs in 2024 generally vest over a four-year period subject to continued employment.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">PSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> help link our equity incentive program to achievement of specific performance goals established by the Compensation Committee</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> The Compensation Committee believes that the grant of PSUs furthers our executive compensation philosophy to tie achievement of company performance with executive compensation, aligns the interests of executive officers with our stockholders and encourages long-term performance.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PSUs granted to the NEOs in 2024 are eligible to cliff vest after a three-year period following the grant date provided they are earned based achievement of the applicable performance goals. The NEOs were granted two types of PSU awards for 2024: PSUs that are eligible to vest based on our relative TSR over a three-year performance period (&#8220;Relative TSR PSUs&#8221;), and PSUs that are eligible to vest based on new collaboration deals and nominations during 2024 (&#8220;Deal/Nomination PSUs&#8221;).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Relative TSR PSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. To determine the vesting of Relative TSR PSUs, our TSR performance is measured against the component companies of the NASDAQ Biotechnology Index (excluding companies that had not been listed or traded on a national securities exchange for at least three consecutive years as of October 31, 2023, those that had gross revenue of less than $100 million for the period of four consecutive calendar quarters ending with the last fiscal quarter for which there were publicly disclosed financial results as of October 31, 2023, and those that cease to be publicly-traded during the applicable performance period other than due to insolvency). </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">One-third of the target Relative TSR PSUs are earned based on performance over three discrete performance periods each beginning on the grant date of the awards, with one performance period ending December 31, 2024, one performance period ending December 31, 2025, and one performance period ending December 31, 2026. For purposes of these awards, TSR for Halozyme and the applicable subset of component companies is based on a 20-trading day average trading price beginning on the PSU grant date and a 20-trading day average trading price ending on the last day of the applicable performance period. Dividend equivalents, if any, will be accrued as additional stock units and delivered with earned shares at vesting. The potential vesting percentages for the 2024 Relative </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">31</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">TSR PSUs, as determined for each performance period and to be applied to the target number of PSUs allocated to that performance period, are as follows (with the percentage determined by linear interpolation for performance between the 25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and 75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> percentiles):</span></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </span></div><div style="margin-bottom:1pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:55.785%"><tr><td style="width:1.0%"/><td style="width:28.529%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:45.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.605%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Maximum</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">75</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:107%;position:relative;top:-4.2pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Percentile or Higher</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">150%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Target</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">50</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:107%;position:relative;top:-4.2pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Percentile</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">100%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Threshold</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:107%;position:relative;top:-4.2pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Percentile</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">50%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Below Threshold</span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">&lt; 25</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:107%;position:relative;top:-4.2pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%"> Percentile</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">0%</span></td></tr></table></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Relative TSR PSUs eligible to vest based on performance become vested on the third anniversary of the grant date of the award following certification of performance results and subject to continued employment through the vesting date. The three-year cliff vesting schedule serves as an additional retention incentive and incentive for stock price performance for the entire three-year period covered by the Relative TSR PSUs to support long-term alignment with our stockholders.</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Deal/Nomination PSUs</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. Performance for the  Deal/Nomination PSUs is measured based on the number of &#8220;points credited&#8221; for new Company deals and nominations, with points earned based on the occurrence of the following events in 2024: (a) a new collaboration deal signed by the Company for SVAI (2.5ml or less, does not include ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">) (an &#8220;SVAI Deal&#8221;), (b) a new collaboration deal signed by the Company to add HVAI to an existing nominated target (a &#8220;HVAI Deal Added to Existing ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Target&#8221;), (c) a new target nomination under an existing collaboration for any delivery offering by the Company (SVAI, HVAI, or ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> only) (a &#8220;New Nomination&#8221;), and (d) a new collaboration deal signed by the Company for ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> on its own, or ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> with HVAI (a &#8220;New ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> +/- HVAI Deal&#8221;). </span></div><div style="margin-bottom:1pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The total number of points credited for 2024 is then used to determine the vesting percentage of the Deal/Nomination PSUs, to be applied to the target number of PSUs for the award, as follows (with the percentage determined by linear interpolation if the number of points credited is between 5 and 20):</span></div><div style="margin-bottom:1pt;margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.696%"><tr><td style="width:1.0%"/><td style="width:57.990%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:39.810%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Deal/Nomination Points Credited for 2024</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Vesting Percentage</span></div></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">Less than 5</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">0%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">5</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">50%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">10 (&#8220;target&#8221;)</span></div></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">100%</span></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">15</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">150%</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="padding-left:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">20 or more</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:107%">200%</span></td></tr></table></div><div style="margin-bottom:1pt;margin-top:6pt;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Deal/Nomination PSUs eligible to vest based on performance become vested on the third anniversary of the grant date of the award, subject to continued employment through the vesting date. The three-year cliff vesting schedule serves as an additional retention incentive and incentive for stock price performance for the entire three-year period covered by the Deal/Nomination PSUs to support long-term alignment with our stockholders.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">2024 Annual LTI Awards</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2024, the Compensation Committee awarded annual LTI compensation for the NEOs based on the grant date value the Committee determined appropriate considering their assessment of annual equity award grants to peer group executives holding similar positions, and taking into account their assessment of the executive&#8217;s experience, expected contribution to the long-term success of the Company, and skill-set relative to industry peers at biopharmaceutical companies (with no specific weight applied to each factor). The Compensation Committee also determined that the annual award value for each NEO would be allocated 50% PSUs (at target), 15% in stock options and 35% in RSUs. A greater weight was placed on PSUs in the NEOs&#8217; equity award mix for 2024 as compared to 2023 (50% for 2024 compared to 28.75% for Dr. Torley and 25% for the other NEOs for 2023) to increase the performance-based portion of their overall LTI award. Accordingly, the Compensation Committee awarded the following LTI values to our NEOs in 2024:</span></div><div style="margin-top:11pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.801%"><tr><td style="width:1.0%"/><td style="width:42.218%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.827%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.262%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.534%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.267%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option Awards<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">RSUs <br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">PSUs <br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:justify;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,560,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,640,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,200,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,400,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">465,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,085,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,550,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,100,000</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> </span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">487,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,137,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,625,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,250,000</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">330,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">770,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,100,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,200,000</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For each NEO, half the target PSU value was awarded in the form of Relative TSR PSUs and half the target PSU value was awarded in the form of Deal/Nomination PSUs. For each NEO, the LTI value allocated to an award was converted into a number of shares based on (i) in the case of RSUs and the target number of Deal/Nomination PSUs, the closing price of our stock on the grant </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">32</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">date, and (ii) in the case of options and the target number of Relative TSR PSUs, the per-share fair value of the award on the grant date awards as determined under applicable accounting rules, and rounding up to a whole share. The grant date fair value of the options was determined using the Black-Scholes option valuation methodology. The grant date fair value of the Relative TSR PSUs was determined using a Monte Carlo simulation. Differences between the LTI values approved by the Compensation Committee, as shown above, and the actual grant date fair values of the awards as included in the executive compensation tables following the CD&amp;A are due to the rounding of fractional share interests in accordance with the methodology approved by the Compensation Committee.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">June 2024 RSU Award for Mark Snyder</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the awards discussed above, on June 12, 2024 the Company awarded Mr. Snyder a grant for approximately $1,000,000 in RSUs to recognize Mr. Snyder&#8217;s significant contributions to the Company&#8217;s issuance of a new European patent covering the ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.47pt;font-weight:400;line-height:120%;position:relative;top:-3.48pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> rHuPH20 product obtained from our ENHANZE</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">&#174;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> manufacturing methods that we provide to our licensees that resulted in maintenance of a key royalty revenue stream at the original rate. One-fourth of these RSUs are scheduled to vest on the first anniversary of the grant date and then one-fourth on each anniversary of the grant date thereafter.  </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">PSU Award Vesting</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee has determined that, as to the one-third of the Relative TSR PSUs awarded in 2024 that correspond to a performance period ended December 31, 2024, 131.18% of such PSUs are eligible to vest based on our relative TSR measured against the applicable subset of component companies of the NASDAQ Biotechnology Index for that period (our TSR for that period was 17.6% and this placed us at the 65.59</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> percentile against the comparison group of companies for that period). In addition, the Compensation Committee determined that, as to the Deal/Nomination PSUs awarded in 2024, 5 new nominations had occurred during 2024, resulting in 15 points being credited for such deals and nominations as described above and, accordingly, that 150% of such PSUs are eligible to vest. The PSUs subject to each of these Relative TSR PSU and Deal/Nomination PSU awards remain unvested, with vesting subject to continued employment through the third anniversary of the grant date of the awards.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We awarded PSUs to each of the NEOs in 2022 and 2023 that are similar to the Relative TSR PSUs awarded in 2024 described above. The Compensation Committee has determined that, as to the one-third of the PSUs awarded in 2022 that correspond to a three-year performance period ended December 31, 2024, 150% of such PSUs are eligible to vest based on our relative TSR measured against the applicable subset of component companies of the NASDAQ Biotechnology Index for that period (our TSR for that period was 37.7% and this placed us at the 77.92</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">nd</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> percentile against the comparison group of companies for that period). The PSUs vested on the third anniversary of the grant date of the awards. The Compensation Committee has also determined that, as to the one-third of the PSUs awarded in 2023 that correspond to a two-year performance period ended December 31, 2024, 124.14% of such PSUs are eligible to vest based on our relative TSR measured against the applicable subset of component companies of the NASDAQ Biotechnology Index for that period (our TSR for that period was 5.2% and this placed us at the 62.07</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:120%;position:relative;top:-3.5pt;vertical-align:baseline">th</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> percentile against the comparison group of companies for that period). These PSUs remain unvested, with vesting subject to continued employment through the third anniversary of the grant date of the awards.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Competitive Peer Group</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee annually selects a group of peer companies against which Halozyme benchmarks the competitiveness of executive pay levels and program design (referred to in this CD&amp;A as our &#8220;peer group&#8221; or &#8220;peer companies&#8221;). The peer group companies are identified based upon the Compensation Committee&#8217;s assessment of each company&#8217;s similarity with Halozyme with respect to science/business model, revenue, and market capitalization. The peer group is reviewed annually by the Compensation Committee. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2024 compensation decisions, the Compensation Committee utilized proxy data from the following companies, listed below. The Compensation Committee&#8217;s objective in selecting this peer group was to include a group of similar-sized public companies in the life sciences sector, with an emphasis on pharmaceutical and biotechnology companies with commercialized products. Targeted companies generally had revenues and market capitalization between 0.25x to 4.0x Halozyme&#8217;s size at the time of the analysis with Halozyme near the median on both measures.</span></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:85.537%"><tr><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.233%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:32.234%"/><td style="width:0.1%"/></tr><tr><td colspan="9" style="background-color:#00497f;border-left:1pt solid #000;border-right:1pt solid #000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><div style="text-align:center"><span style="color:#ffffff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">2024 Peer Group</span></div></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Acadia Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Alkermes</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Alnylam Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Amicus Therapeutics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">BeiGene</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">BioMarin Pharmaceutical</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Blueprint Medicines</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Exelixis</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Insmed</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ionis Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ironwood Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Ligand Pharmaceuticals</span></div></td><td colspan="3" style="border-bottom:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Neurocrine Biosciences</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">PTC Therapeutics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Sarepta Therapeutics</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Ultragenyx Pharmaceuticals</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">United Therapeutics</span></div><div><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div></td></tr></table></div><div style="text-align:justify;text-indent:22.5pt"><span><br/></span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">33</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following changes to the peer group were made for 2024: </span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">BeiGene, Insmed, and PTC Therapeutics were added to the group based on the Compensation Committee&#8217;s assessment of the criteria noted above.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Agios Pharmaceuticals was removed from the group based on the Compensation Committee&#8217;s assessment that it no longer met the revenue and market capitalization criteria.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Independent Compensation Consultant</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee retains F.W. Cook &amp; Co., Inc. (&#8220;FW Cook&#8221;) as its independent compensation consultant to provide advice and counsel on matters related to our executive and non-employee director compensation program and FW Cook provides no other services to Halozyme. In 2024, FW Cook provided recommendations regarding the composition and selection of Halozyme&#8217;s peer group companies to be used with respect to 2024 and 2025 executive compensation decisions, performed a review of compensation levels and practices for similar executive positions at the peer group companies, advised regarding the compensation mix and levels for the NEOs, advised on the design and implementation of our annual LTI awards, reported on executive compensation trends and developments, and advised on the compensation arrangements for our non-employee directors. FW Cook reports directly to the Compensation Committee and regularly attends meetings of the Compensation Committee, as requested. The Compensation Committee assessed the independence of FW Cook pursuant to applicable rules and regulations of the SEC and NASDAQ and concluded that the engagement of FW Cook did not raise any conflicts of interest during fiscal 2024 and currently does not raise any conflicts of interest.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Risk Assessment</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our Compensation Committee, with assistance from its independent compensation consultant and with input from members of management, annually reviews our compensation programs, policies and practices to determine whether they encourage risk-taking that could have a material adverse effect on the Company. As part of this review, the Company evaluates the primary components of its compensation programs to identify whether those components properly balance compensation opportunities and risk. Our Compensation Committee considers various factors, including the following:</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s pay philosophy provides an effective balance in cash and equity award mix, short- and long-term performance periods, financial and non-financial performance, formulas and discretion.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s compensation programs include an appropriate mix of short- and long-term goals and incentives.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Compensation Committee has the discretion to make positive and negative adjustments to payouts under the Company&#8217;s compensation plans.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Policies are in place to manage or mitigate risk, such as stock ownership guidelines, vesting periods on equity awards, insider-trading prohibitions that also restrict hedging and pledging, recoupment policy and provisions, and independent Compensation Committee oversight.</span></div><div style="margin-top:6pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">The Company&#8217;s design and oversight principles also apply to its broad-based employee compensation plans.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Based on this review and with input from its independent compensation consultant, the Compensation Committee concluded that the risks arising from the Company&#8217;s compensation programs, policies and practices, for both our executive officers and our other employees, are not reasonably likely to have a material adverse effect on Halozyme.</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">34</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Other Compensation Matters</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Stock Ownership and Retention Guidelines</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We maintain stock ownership guidelines for our executive officers which stipulate that the CEO is required to own shares of Halozyme common stock with value equal to no less than six times the CEO&#8217;s current base salary and that all other executive officers are required to own shares of Halozyme common stock with value equal to no less than two times the officer&#8217;s current base salary. Certain other officers designated by the Compensation Committee are expected to own shares of Halozyme common stock with value no less than one times the officer&#8217;s current base salary. Each executive officer is expected to comply with the guidelines within five years of appointment as an executive officer, and has three years to comply with any incremental ownership required as a result of a promotion or other increase in applicable ownership multiple. Share ownership that counts for purposes of satisfying the applicable guideline level of ownership includes fully-owned shares (including shares held in trust and by immediate family members), vested but deferred shares, shares held in retirement accounts, and unvested stock units that are subject to time-based vesting only. Stock units subject to unsatisfied performance-based vesting conditions and unexercised stock options are not counted when evaluating compliance. Each executive officer is required to: (i) hold at least 50% of all net shares (after shares withheld or sold to pay tax obligations) of RSUs and PSUs that vest; and (ii) hold at least 50% of the underlying net gain (i.e., not including shares sold to pay the exercise price or to satisfy tax obligations) in shares of the Company&#8217;s common stock as a result of stock option exercises, until the executive officer comes into compliance with the stock ownership guidelines. The Compensation Committee annually reviews the progress executive officers are making toward achieving compliance with these guidelines and has determined that all of our NEOs have achieved their specific ownership levels as of February 1, 2025.</span></div><ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgMnpiDiscTextBlock" id="f-6" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Award Grant Practices</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee&#8217;s practice is to grant annual equity awards to executive officers at its first meeting in <ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgPredtrmndFlag" format="ixt:fixed-true" id="f-7">February each year</ix:nonNumeric>, which is generally scheduled well in advance. Additionally, the Compensation Committee retains discretion to grant other equity awards from time to time when and as Compensation Committee may determine to be appropriate.  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgMethodTextBlock" id="f-8" escape="true">However, the timing of the grant of a Company equity award may be changed to satisfy the Company&#8217;s policy on the timing of equity award grants. The Company&#8217;s policy on the timing of equity award grants generally provides that if the Company files its Annual Report on Form 10-K, a Quarterly Report on Form 10-Q, or a Current Report on Form 8-K that contains information that would (but for such public disclosure) be material nonpublic information in respect of the Company with the Securities and Exchange Commission (any such filing by the Company with the Securities and Exchange Commission, a &#8220;Disclosure Event&#8221;) on, or on the business day immediately preceding, the intended date of grant of an equity award, the date of grant of such award will (unless otherwise provided by the Compensation Committee) be the second full trading day following the Disclosure Event. In addition, the policy generally provides that if, on the date of grant of an equity award, the Compensation Committee believes that the Company will have a Disclosure Event within the following four full business days, the date of grant of the award will (unless otherwise provided by the Compensation Committee) occur on the second full trading day following the Disclosure Event.</ix:nonNumeric> Any equity awards approved pursuant to any delegated authority to approve equity award grants and other than by the Compensation Committee are generally subject to these same timing provisions. Equity awards granted to members of the Board of Directors in accordance with our non-employee director compensation program are not subject to these timing provisions.</span></div><ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgHowMnpiCnsdrdTextBlock" id="f-9" escape="true"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The release of material nonpublic information is <ix:nonNumeric contextRef="c-1" name="ecd:AwardTmgMnpiCnsdrdFlag" format="ixt:fixed-false" id="f-10">not taken into account</ix:nonNumeric> in determining the timing and terms of equity award grants (other than, as to the timing of such awards, to satisfy the equity award grant timing policy discussed above), and the Company <ix:nonNumeric contextRef="c-1" name="ecd:MnpiDiscTimedForCompValFlag" format="ixt:fixed-false" id="f-11">does not time</ix:nonNumeric> the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.</span></div></ix:nonNumeric></ix:nonNumeric><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Control Agreements</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into Change in Control Agreements with our executive officers. We believe that the occurrence or potential occurrence of a change in control transaction creates uncertainty regarding the continued employment of our executive officers. This uncertainty results from the fact that many change in control transactions are common in our industry and often result in significant organizational changes, particularly at the senior executive level. We provide additional severance protections under the Change in Control Agreements to help ensure that executives can objectively evaluate change in control transactions that may be in the best interest of stockholders despite the potential negative consequences such transactions may have on them personally and to encourage executives to remain employed with the Company during an important time when their prospects for continued employment following the transaction are often uncertain. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Non-Change in Control Severance Policy</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee has approved a Company-wide severance policy, outside of a change in control context, that is also applicable to our executive officers. We believe that such severance protections are only appropriate in the event an executive is involuntarily terminated without cause and that these severance benefits are appropriate in light of severance protections available to executives at our peer group companies, and are an important component of each executive&#8217;s overall compensation as they help us to attract and retain our key executives who could have other job alternatives that may appear to them to be more attractive absent these </span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">35</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">protections. Despite the establishment of the severance policy, however, the Board of Directors or Compensation Committee retains the right to amend, alter or terminate the severance policy at any time.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Incentive Compensation Recoupment (&#8220;Clawback Policy&#8221;)</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In accordance with SEC and NASDAQ requirements, the Board has adopted an executive compensation recovery policy regarding the adjustment or recovery of certain incentive awards or payments made to current or former executive officers in the event that we are required to prepare an accounting restatement due to material noncompliance with any financial reporting requirement under the securities laws. In general, the policy provides that, unless an exception applies, we will seek to recover compensation that is awarded to an executive officer based on the Company&#8217;s attainment of a financial metric during the three-year period prior to the fiscal year in which the restatement occurs, to the extent such compensation exceeds the amount that would have been awarded based on the restated financial results.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Hedging and Pledging Restrictions</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company&#8217;s Insider Trading Policy prohibits the pledging of Company securities as collateral and entering into transactions to hedge the value of Company securities owned by executives subject to the policy. Under the policy all directors and employees (including officers), or their designees, are prohibited from purchasing financial instruments (including prepaid variable forward contracts, equity swaps, collars and exchange funds) or otherwise engage in transactions, that hedge or offset, or are designed to hedge or offset, any decrease in the market value of Halozyme&#8217;s equity securities that are either (i) granted to the employee or director by Halozyme as part of the compensation of the employee or director or (ii) held, directly or indirectly, by the employee or director.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Tax Deductibility of Executive Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Section 162(m) of the Internal Revenue Code generally disallows a tax deduction to public companies for compensation in excess of $1 million paid to a company&#8217;s chief executive officer and certain current and former executive officers. As a result, we expect that compensation paid per year to our NEOs and certain former executive officers in excess of $1 million generally will not be deductible, subject to limited exceptions. The Compensation Committee generally seeks to preserve tax deductions for executive compensation where available but may make compensation decisions based on other factors when it believes doing so is in the best interest of the Company and its stockholders. </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation Committee Report</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We, the Compensation Committee of the Board of Directors of Halozyme Therapeutics, Inc., have reviewed and discussed the Compensation Discussion and Analysis contained in this Proxy Statement with management. Based on such review and discussion, we have recommended to the Board of Directors that the Compensation Discussion and Analysis be included in this Proxy Statement.</span></div><div style="margin-top:6pt;padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">THE COMPENSATION COMMITTEE</span></div><div style="margin-top:6pt;padding-left:252pt;text-align:justify"><span><br/></span></div><div style="padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Bernadette Connaughton (Chair)</span></div><div style="padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Barbara Duncan</span></div><div style="padding-left:252pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Connie Matsui</span></div><div style="height:40.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">36</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_46"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024 Summary Compensation Table </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information concerning the compensation earned during the fiscal years ended December&#160;31, 2024, 2023 and 2022 by each individual who acted as our principal executive officer, our principal financial officer, and our other most highly compensated executive officers during the fiscal year ended December&#160;31, 2024. </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"/><td style="width:18.929%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.163%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.530%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.917%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.525%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.157%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.496%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.384%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.536%"/><td style="width:0.1%"/></tr><tr><td colspan="51" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024 SUMMARY COMPENSATION TABLE</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Name and Principal Position</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Year</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Salary<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Bonus<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Stock <br/>Awards<br/>($)(1)(3)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option Awards<br/>($)(2)(3)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Non-Equity <br/>Incentive Plan <br/>Compensation<br/>($)(4)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">All Other <br/>Compensation<br/>($)(5)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Total<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">960,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,840,059</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,560,006</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,363,392</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,964</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,741,421</span></td></tr><tr style="height:15pt"><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">President and<br/>Chief Executive Officer</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">920,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,200,011</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,800,007</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">883,476</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,364</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,820,858</span></td></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">871,732</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,950,040</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,300,008</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">557,909</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,289</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,696,978</span></td></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">568,188</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,635,082</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">465,006</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">537,960</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,040</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,218,276</span></td></tr><tr style="height:12pt"><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President,<br/>Chief Financial Officer</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">546,188</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,800,055</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,200,001</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">291,391</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,784</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,849,419</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">467,836</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,200,030</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">800,012</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">200,997</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,228</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,683,103</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:5pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">579,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"><div style="text-align:center"><span><br/></span></div></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,762,579</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">487,517</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">548,197</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,572</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,394,865</span></td></tr><tr style="height:23pt"><td colspan="3" rowspan="2" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President, General Counsel, Chief Compliance Officer and Corporate Secretary</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">546,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,620,053</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,080,003</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">349,549</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,322</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,612,927</span></td></tr><tr style="height:23pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">525,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,750,044</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,250,007</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">198,450</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,701</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,740,202</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">556,200</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,870,112</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">330,010</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">263,305</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,814</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,038,441</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Senior Vice President, Chief Technical Officer</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">538,200</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,440,042</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">960,005</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">287,130</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,564</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,243,941</span></td></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">520,000</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,440,041</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">960,002</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">187,200</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16,037</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,123,280</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:3pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">This column represents the grant date fair value of stock awards granted to the NEOs in fiscal years 2024, 2023 and 2022, in accordance with the Financial Accounting Standards Board&#8217;s (&#8220;FASB&#8221;) Accounting Standards Codification (&#8220;ASC&#8221;) Topic 718. Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeiture related to service-based vesting conditions. For additional information on the valuation assumptions used by us in calculating these amounts refer to Note 9 of the Notes to Consolidated Financial Statements, filed as part of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2024 filed with the SEC on February&#160;18, 2025. Stock awards granted to executive officers consist of RSUs and PSUs. A portion of the amounts reported in this column for each NEO for each fiscal year reflect the grant-date fair value of PSUs granted to the executives during that fiscal year. In accordance with applicable SEC rules, these amounts were determined based on the probable outcome (determined as of the date of grant of the awards) of the performance-based conditions applicable to the awards.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%"> </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For these purposes, the grant date fair value for the Deal/Nomination PSU awards granted to each of the NEOs was determined based on the &#8220;target&#8221; vesting level applicable to the award (which we considered to be the probable outcome as of the date of grant of the awards) and the grant date fair value for the Relative TSR PSU awards granted to each of the NEOs was determined based on a Monte Carlo simulation pricing model (which probability weights multiple potential outcomes) as of the date of grant of the awards. The significant assumptions used in the Monte Carlo simulation pricing model were as follows:</span></div><div style="margin-top:6pt;padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:73.245%"><tr><td style="width:1.0%"/><td style="width:43.810%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.798%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.265%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.798%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.265%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.798%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.266%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2023</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">2022</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected volatility</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.08%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">39.38%</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.52%</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Risk-free interest rate</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.28%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4.27%</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1.71%</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt 2px 7pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Expected dividend yield</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">37</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table presents the aggregate grant-date fair value of these performance-based awards granted in fiscal years 2024, 2023 and 2022 included in the &#8220;Stock Awards&#8221; column for those years and the aggregate grant-date fair value of these awards assuming that the highest level of performance conditions was achieved.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.099%"><tr><td style="width:1.0%"/><td style="width:13.952%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.759%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.396%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.759%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.765%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Aggregate Grant Date Fair Value of Performance Awards (Fiscal 2024)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Aggregate Grant Date Fair Value of Performance Awards (Fiscal 2023)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Aggregate Grant Date Fair Value of Performance Awards (Fiscal 2022)</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Based on Probable Outcome as of the Grant Date<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Based on Maximum Performance<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Based on Probable Outcome as of the Grant Date<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Based on Maximum Performance<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Based on Probable Outcome as of the Grant Date<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:112%">Based on Maximum Performance<br/>($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">5,200,043</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">9,100,073</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">2,875,010</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">4,312,515</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">2,062,529</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">3,093,794</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,550,062</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">2,712,603</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">750,028</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,125,043</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">500,013</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">750,020</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,625,071</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">2,843,875</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">675,049</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,012,574</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">500,013</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">750,020</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,100,081</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">1,925,138</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">600,011</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">900,016</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">600,008</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:112%">900,012</span></td></tr></table></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">This column represents the grant date fair value of stock options granted to the NEOs in fiscal years 2024, 2023 and 2022, in accordance with FASB ASC Topic 718. Pursuant to SEC rules, the amounts shown exclude the impact of estimated forfeiture related to service-based vesting conditions. For additional information on the valuation assumptions used by us in calculating these amounts refer to Note 9 of the Notes to Consolidated Financial Statements, filed as part of our Annual Report on Form 10-K for the fiscal year ended December&#160;31, 2024 filed with the SEC on February&#160;18, 2025. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The amounts reported in the Summary Compensation Table for stock awards and option awards may not represent the amounts that the NEOs will actually realize from the awards. Whether, and to what extent, an NEO realizes value will depend on stock price fluctuations and the NEO&#8217;s continued employment. To see the exact share amounts and the value of awards made to the NEOs in fiscal 2024, see the 2024 Grants of Plan-Based Awards table below. Additional information on all outstanding awards is reflected in the Outstanding Equity Awards at December&#160;31, 2024 table.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Performance-based bonuses are generally paid pursuant to our annual incentive plans and reported as Non-Equity Incentive Plan Compensation. The performance-based bonuses represent amounts earned during each respective fiscal year based on applicable performance levels for such fiscal year, regardless of whether part or all of such amounts were paid in a subsequent fiscal year. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The table below lists the amounts set forth in this column which consist of other compensation including (i) Company contributions to Halozyme Therapeutics, Inc. 401(k) plan, and (ii) Company payments for group term insurance premiums.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span><br/></span></div><div style="margin-top:6pt;padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:69.152%"><tr><td style="width:1.0%"/><td style="width:25.538%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:18.350%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.487%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:19.195%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.702%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.322%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">401(k) Plan Company Matching Contributions ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Payout of Accrued Paid Time Off ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Other Compensation ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:115%">Total ($)</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">14,400</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">3,564</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">17,964</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">11,500</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">540</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">12,040</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">15,250</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">2,322</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">17,572</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">15,250</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">&#8212;</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">3,564</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:115%">18,814</span></td></tr></table></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">38</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_49"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2024 Grants of Plan-Based Awards </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain summary information with respect to plan-based awards granted during the fiscal year ended December&#160;31, 2024 to our NEOs:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.783%"><tr><td style="width:1.0%"/><td style="width:7.510%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.159%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.754%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.416%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.857%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.546%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.754%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.791%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.603%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:5.546%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.301%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.404%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.791%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.555%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.219%"/><td style="width:0.1%"/></tr><tr style="height:30pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated Future Payouts Under <br/>Non-Equity Incentive Plan Awards(1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="15" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Estimated Future Payouts Under<br/>Equity Incentive Plan Awards (2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">All Other Stock Awards: Number of Shares or Units(#) (3)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">All Other Option Awards: Number of Securities Underlying Options(#) (4)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Exercise or Base Price of Option Awards<br/>($/Sh)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" rowspan="2" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:100%">Grant Date Fair Value of Stock and Option Awards($) (5)</span></td></tr><tr style="height:26pt"><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Grant Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Threshold<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Target<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maximum<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Threshold<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Target<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Maximum<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="6" rowspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Helen I. <br/>Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">864,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,728,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">89,744&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">3,640,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,596&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">53,192&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">79,788&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,600,025&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">32,052&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">64,103&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">128,206&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2,600,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">93,002&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,560,006&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">284,094&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">568,188&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">26,751&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,085,021&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">7,928&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">15,856&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">23,784&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">775,041&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">9,554&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,108&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">38,216&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">775,020&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,722&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40.56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">465,006&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="6" rowspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">289,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">579,000&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6/12/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,137&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,000,003&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">28,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">1,137,505&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">8,312&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">24,934&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">812,532&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">10,017&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">20,033&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40,066&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">812,538&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">29,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">487,517&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr style="height:15pt"><td colspan="6" rowspan="2" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">n/a</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">278,100&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">556,200&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">18,985&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">770,032&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">5,627&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">11,253&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">16,880&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">550,047&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">6,781&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">13,561&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">27,122&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">550,034&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">19,674&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">40.56&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="padding:0 1pt"/><td colspan="2" style="padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:400;line-height:100%">330,010&#160;</span></td><td style="padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">For a description of the elements of the annual incentive plan applicable to our NEOs, refer to &#8220;Compensation Discussion and Analysis - Elements of Executive Compensation for 2024&#8221; in this proxy statement. The actual amount of cash paid to each NEO pursuant to the incentive plan established for 2024 is set forth in the Summary Compensation Table under the heading, &#8220;Non-Equity Incentive Plan Compensation.&#8221; </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The PSU awards to our NEOs were granted on February 23, 2024. The first award listed in these columns for each NEO vests based on our relative TSR measured against the applicable subset of component companies in the NASDAQ Biotechnology Index over a three-year performance period, subject to the NEO&#8217;s continued employment through the third anniversary of the grant date. The second award listed in these columns for each NEO vests based on new collaboration deals and nominations during 2024, subject to the NEO&#8217;s continued employment through the third anniversary of the grant date. For more information on these awards, see &#8220;LTI Compensation&#8221; in the &#8220;Compensation Discussion and Analysis&#8221; above.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The RSU awards to our NEOs were granted on February 23, 2024 and vest one-fourth on each anniversary of the date of grant.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The option awards to our NEOs were granted on February 23, 2024 and vest one-fourth on the first anniversary of the date of grant and then 1/48 of the shares monthly over the three-year period thereafter.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These amounts represent the grant date fair value of stock awards granted to our NEOs in fiscal year 2024 in accordance with the FASB ASC Topic 718. For information on the assumptions used in the accounting fair value computations, see footnotes (1) through (3) to the Summary Compensation Table above.</span></div><div style="margin-top:3pt;text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">39</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_52"></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Outstanding Equity Awards at December&#160;31, 2024 </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain information with respect to the value of all unexercised options and unvested stock awards previously awarded to our NEOs as of December&#160;31, 2024:</span></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.526%"><tr><td style="width:1.0%"/><td style="width:6.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.845%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.640%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.910%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.845%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.386%"/><td style="width:0.1%"/></tr><tr><td colspan="51" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Outstanding Equity Awards at December&#160;31, 2024</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="21" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Option Awards</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="18" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Stock Awards</span></td></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Grant Date</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of Securities <br/>Underlying Unexercised <br/>Options (#) Exercisable</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of Securities <br/>Underlying Unexercised <br/>Options (#) Unexercisable (1)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Option <br/>Exercise <br/>Price<br/>($)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Option <br/>Expiration <br/>Date</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Number of Shares <br/>or Units of Stock <br/>That Have Not Vested (#)(2)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Market Value <br/>of Shares <br/>or Units of Stock <br/>That Have Not Vested <br/>($)(3)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity Incentive Plan Awards: <br/>Number of Unearned Shares, <br/>Units or Other Rights <br/>That Have Not Vested (#)</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:700;line-height:100%">Equity Incentive Plan Awards: <br/>Market or Payout Value of <br/>Unearned Shares, Units or <br/>Other Rights That Have Not Vested <br/>($)(3)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/3/2016</span></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">376,569&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8.11&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/3/2026</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2017</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">251,923&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.07&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2018</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">201,552&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">250,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">266,051&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">86,378&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,756&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,092&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">625,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">182,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">74,973&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">42,018&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,008,881&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">71,810&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,433,236&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">88,623&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">104,737&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2033</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">50,624&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,420,333&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">31,364&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,499,513&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,008&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">956,582&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">93,002&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/23/2034</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">89,744&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,290,661&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">23,260&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,112,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">46,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,224,073&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">96,155&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,597,171&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2017</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,271&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.07&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/22/2027</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/1/2017</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12.49&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8/1/2027</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2018</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,813&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18.41&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/14/2028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2019</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,597&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.65&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2029</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2020</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,285&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.98&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2030</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2021</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,411&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">540&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.84&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,254&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">59,954&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">44,139&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,176&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.36&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">10,186&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">486,993&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,409&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">832,324&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,985&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">33,076&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2033</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,987&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">764,338&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">8,184&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">391,277&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,219&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">249,520&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">27,722&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.56&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/23/2034</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,751&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,278,965&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,935&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">331,562&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">13,866&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">662,933&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,662&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,370,330&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1/3/2022</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">60,623&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,519&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">41.06&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1/3/2032</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">15,222&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">727,764&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">17,409&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">832,324&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">25,187&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,768&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2033</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">687,890&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,365&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">352,121&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,698&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">224,611&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">29,064&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/23/2034</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">28,045&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,340,831&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,269&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">347,531&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">14,538&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">695,062&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">30,050&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,436,691&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6/12/2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,137&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">962,750&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="height:29.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:40.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:8pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:97.526%"><tr><td style="width:1.0%"/><td style="width:6.777%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.313%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.112%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.311%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.845%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:4.640%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.910%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.467%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:6.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.334%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.379%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.845%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:2.336%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.386%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2019</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,352&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">16.65&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/12/2029</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2020</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,608&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19.98&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/10/2030</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2021</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,339&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">972&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.84&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/15/2031</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,386&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">161,885&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2022</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">52,966&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">21,811&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">34.36&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2032</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,224&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">584,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,891&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">998,799&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,388&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">26,461&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">49.26&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2033</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,789&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">611,442&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,547&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">313,012&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/16/2023</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,175&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">199,607&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">19,674&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">40.56&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/23/2034</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">18,985&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">907,643&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,921&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">235,273&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,842&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">470,546&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2/23/2024</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,342&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">972,551&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Each option grant vests at the rate of one-fourth of the underlying shares on the first anniversary of the date of grant and one-forty-eighth of the shares each month thereafter. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Each RSU grant vests at the rate of one-fourth of the total number of stock units subject to the award on each of the first four anniversaries of the grant date. Reflects the number of outstanding and unvested RSUs subject to the award. </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These values are computed by multiplying the closing trading price of our common stock on NASDAQ on December&#160;31, 2024, the last trading date in fiscal year 2024, of $47.81 by the number of shares or stock units, as applicable, set forth in this table.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2022 Relative TSR PSU awards corresponding to the performance periods ending in 2022, 2023 and 2024. Reflects the number of stock units subject to the awards that are eligible to vest on the third anniversary of the grant date based on actual performance for the completed performance periods.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2023 Relative TSR PSU awards corresponding to the performance periods ending in 2023 and 2024. Reflects the number of stock units subject to the awards that are eligible to vest on the third anniversary of the grant date based on actual performance for the completed performance periods.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2023 Relative TSR PSU awards corresponding to the performance period ending in 2025. Reflects the maximum number of stock units (124.14% of the target number of stock units) corresponding to this portion of the award that are eligible to vest on the third anniversary of the grant date because, had the performance period ended at the end of 2024, the performance level would have exceeded the target level.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2024 Relative TSR PSU awards corresponding to the performance period ending in 2024. Reflects the number of stock units subject to the awards that are eligible to vest on the third anniversary of the grant date based on actual performance for the completed performance period.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These are the portions of the 2024 Relative TSR PSU awards corresponding to the performance periods ending in 2025 and 2026. Reflects the maximum number of stock units (131.18% of the target number of stock units) corresponding to this portion of the award that are eligible to vest on the third anniversary of the grant date because, had the performance period ended at the end of 2024, the performance level would have exceeded the target level.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">These entries reflect the number of stock units subject to the 2024 Deal/Nomination PSU awards that are eligible to vest on the third anniversary of the grant date based on actual performance for the completed performance period (which was 2024).</span></div><div style="margin-top:3pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify"><span><br/></span></div><div style="height:29.7pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">41</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_55"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Option Exercises and Stock Awards Vested </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth certain information with respect to the exercise of stock options and vesting of stock awards by our NEOs during the fiscal year ended December&#160;31, 2024: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.760%"><tr><td style="width:1.0%"/><td style="width:19.052%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:26.228%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.632%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.021%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.503%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.632%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.505%"/><td style="width:0.1%"/></tr><tr><td colspan="30" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Option Exercises and Stock Awards Vested During Fiscal Year 2024</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Option Awards</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Awards</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Shares Acquired <br/>on Exercise<br/>(#)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value Realized <br/>on Exercise<br/>($)(1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of <br/>Shares Acquired <br/>on Vesting<br/>(#)(2)</span></td><td colspan="3" style="border-top:1pt solid #000000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Value Realized <br/>on Vesting<br/>($)(3)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">110,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,734,734&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">115,038&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,125,075&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,000&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,040,109&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,178&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">510,061&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,407&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">445,457&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">194,669&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,040,218&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">30,374&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,089,286&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The value realized on exercise is based on the difference between the closing trading price of Halozyme common stock on the date of exercise and the exercise price of each option.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The amounts in this column represent the number of RSU or PSU shares that vested. The actual number of shares issued was the number of shares vested reduced by the number of shares withheld to satisfy applicable tax withholding obligations.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The value realized on vesting is based on the closing trading price of Halozyme common stock NASDAQ on the vest date.</span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">42</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_58"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Potential Payments Upon Termination or Change in Control </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This section describes the benefits that may be provided to our NEOs upon certain terminations of their employment with the Company.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Termination Prior to Change in Control</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Under our severance policy, if an executive officer&#8217;s employment is terminated by the Company without cause, the executive officer is entitled to receive cash severance equal to one times the executive officer&#8217;s then-current annual base salary (in the case of the CEO, one and one-half times the sum of (a) the CEO&#8217;s then-current base salary plus (b) the CEO&#8217;s target annual cash incentive amount), plus a pro-rated portion of the executive&#8217;s target annual cash incentive for the year of termination. Cash payments under the severance policy will normally be made in a lump sum payment, and will be conditioned upon the receipt of a release of claims from the executive officer. In addition to cash severance payments, the Company will also pay certain costs for the executive to continue healthcare coverage over the applicable severance period, and the executive&#8217;s vested options will remain exercisable for one year following the termination date (or, if earlier, until the expiration date of the option).</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The PSU awards granted to our NEOs provide that if the executive&#8217;s employment is terminated by the Company without cause or by the executive for good reason and the executive provides a release of claims, any PSUs credited based on performance during a performance period that has already been completed will fully vest on the executive&#8217;s termination, and PSUs subject to a performance period that has not yet been completed will remain outstanding and eligible to vest based on performance during that period, subject to pro-ration to reflect the executive&#8217;s employment during the performance period. If the executive&#8217;s employment terminates due to the executive&#8217;s death or disability, any PSUs credited based on performance during a performance period that has already been completed will fully vest on the executive&#8217;s termination, and the target number of PSUs for the next performance period scheduled to be completed after the termination date will vest pro-rata based on the executive&#8217;s employment during that performance period. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the benefits that would be provided to each of the NEOs assuming the NEO was terminated by us without cause (prior to a change in control of the Company) on December&#160;31, 2024 and executed a release of claims in a form satisfactory to the Company: </span></div><div style="margin-top:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024 Potential Payments Upon Termination Without Cause Prior to Change in Control</span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.906%"><tr><td style="width:1.0%"/><td style="width:17.040%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:29.845%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.942%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.019%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.637%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.409%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.643%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lump Sum <br/>Severance <br/>Payment ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Post-<br/>Termination <br/>Healthcare ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity Awards ($) (1)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,304,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">29,939&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,641,982&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">12,975,921&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">852,282&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">34,651&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,925,496&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,812,429&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">868,500&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">42,570&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,968,668&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,879,738&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">834,300&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,395&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,519,637&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,355,332&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Amounts shown in this column reflect the market value of unvested PSUs that would have accelerated if the NEO was terminated without cause (or resigned for good reason) as described above on December&#160;31, 2024. Values were derived using the closing trading price of our common stock on NASDAQ on December&#160;31, 2024, the last trading date in fiscal year 2024, of $47.81. The number of accelerated PSUs for performance periods ending on or before December 31, 2024 was determined based on our actual performance through the end of the applicable performance period. We did not include any amount for the PSUs allocated to performance periods ending after December 31, 2024 because the number of PSUs that will vest with respect to those periods is not known as it will depend on our future performance (the maximum value of those PSUs at December&#160;31, 2024 was $1,471,145 for Dr. Torley, $415,278 for Ms. LaBrosse, $411,264 for Mr. Snyder, and $309,439 for Mr. LaBarre. These amounts were calculated solely for purposes of this disclosure, and there can be no assurance that the value actually realized by the executive for these awards (if any) will be equal to the value shown in this column.</span></div><div style="text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">43</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table below presents the benefits that would be provided to each of the NEOs assuming the NEO&#8217;s employment terminated due to death or disability (prior to a change in control of the Company) on December&#160;31, 2024:</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024 Potential Payments Upon Termination Due to Death/Disability Prior to Change in Control</span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:59.502%"><tr><td style="width:1.0%"/><td style="width:28.138%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:48.777%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.765%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.820%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity Awards ($) (1)</span></div></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">11,536,006&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,173,268&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,208,991&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,707,320&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/></tr></table></div><div style="margin-top:7pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Amounts shown in this column reflect the spread value of unvested equity awards that would have accelerated if the NEO&#8217;s employment terminated due to death or disability on December&#160;31, 2024. Please see the note to the 2024 Potential Payments Upon Termination Without Cause Prior to Change in Control table above for the calculation of these amounts. The number of accelerated PSUs for performance periods ending on or before December 31, 2024 was determined based on our actual performance through the end of the applicable performance period, and the number of accelerated PSUs for the performance period ending December 31, 2025 represents the target number of PSUs allocated to such period (pro-rated for the executive&#8217;s period of employment). These amounts were calculated solely for purposes of this disclosure, and there can be no assurance that the value actually realized by the executive for these awards (if any) will be equal to the value shown in this column.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Change in Control</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We have entered into Change in Control Agreements with each of our executive officers. The Change in Control Agreements provide for cash severance, continued healthcare coverage and accelerated vesting of equity awards if the executive is terminated without cause, resigns for good reason, or is terminated due to death or disability (as such terms are defined in the Change in Control Agreements), in each case on or within 12 months following a change in control transaction. The cash severance, to be made in a lump sum payment, will equal: a multiple (two times for the CEO and one-and-one-half times for the other executive officers) of the sum of (i) the executive&#8217;s then-current annual base salary; and (ii) the amount of the executive&#8217;s target annual cash incentive opportunity (based on the target percentage of annual base salary) in respect of the year the termination of employment occurs. The Company will also make a cash lump sum payment intended to provide the executive officer sufficient amounts to pay expected heath care premiums under the Company&#8217;s group health plans for 18 months after termination of employment (24 months in the case of the CEO). In addition, the Change in Control Agreement provides that the executive&#8217;s outstanding and unvested equity awards granted by the Company will be fully vested upon the executive&#8217;s termination (with equity awards that are subject to performance-based vesting to accelerate based on the greater of (x) the target performance level for the applicable portion of the award and (y) the actual performance level achieved for the applicable portion of the award through the executive&#8217;s termination date). However, the PSU awards granted to the NEOs provide that if a change in control occurs, any performance period then in progress will terminate and the number of PSUs to be credited under the award will be determined based on (i) as to the Relative TSR PSUs, performance through the change in control and (ii) as to the Deal/Nomination PSUs, the greater of performance through the change in control or the target performance level for the award. Such credited PSUs will remain subject to time-based vesting through the third anniversary of the grant date, subject to accelerated vesting if the credited PSUs are not assumed by the acquiring company or if within two years after the change in control the executive&#8217;s employment is terminated by the Company without cause, by the executive for good reason, or due to the executive&#8217;s death or disability. An executive officer will not be entitled to severance benefits under our severance policy described above if the executive is entitled to severance benefits under the executive&#8217;s Change in Control Agreement. The Change in Control Agreements also provide that if an executive officer&#8217;s severance benefits would be subject to the parachute payment taxes of Sections 280G and 4999 of the Internal Revenue Code of 1986, as amended, and a reduction in benefits to avoid such taxes would put the executive in a better after-tax position, then the executive&#8217;s benefits will be reduced to the extent necessary to avoid such taxes.</span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">44</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Assuming a change in control took place on December&#160;31, 2024 and each of the NEOs was terminated without cause, resigned for good reason or was terminated due to death or disability in each case on December&#160;31, 2024, the NEOs would have received the following benefits as a result of such terminations:</span></div><div style="margin-top:6pt;text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:120%">2024 Potential Payments Upon Change in Control Termination</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.321%"><tr><td style="width:1.0%"/><td style="width:22.366%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:22.366%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.169%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.026%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.169%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.169%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.566%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.177%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Equity <br/>Awards ($) (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Lump Sum <br/>Cash Severance ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Post-<br/>Termination <br/>Healthcare ($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total ($)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">24,851,043&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,648,000&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">89,807&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">28,588,850&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,873,650&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,278,423&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">77,962&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,230,035&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,970,244&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,302,750&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">95,791&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,368,785&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5,891,211&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">1,251,450&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,142&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7,145,803&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:left;vertical-align:bottom"/></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Amounts shown in this column reflect the value of the unvested equity awards that would have accelerated if the NEO&#8217;s employment terminated in the circumstances described above on December&#160;31, 2024 in connection with a change in control. Please see the note to the 2024 Potential Payments Upon Termination Without Cause Prior to Change in Control table above for the calculation of these amounts. The number of accelerated PSUs was determined based on our actual performance through December&#160;31, 2024 (or, if greater, the target performance level in the case of Deal/Nomination PSUs). These amounts were calculated solely for purposes of this disclosure and there can be no assurance that the value actually realized by the executive for these awards (if any) will be equal to the value shown in this column. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:112%">CEO Pay Ratio </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For 2024, Dr. Torley&#8217;s total compensation was $12,741,421, as shown in the Summary Compensation Table above. The total compensation for our median employee (excluding the CEO) in 2024 was $220,881. Therefore, Dr. Torley&#8217;s total compensation for 2024 was 58 times that of the median employee&#8217;s total compensation in 2024. The Company believes the pay ratio reported above is a reasonable estimate calculated in a manner consistent with SEC rules based on our payroll and employment records, as well as the methodology described below.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation elements that were considered in the identification of the median employee were annualized base pay, target cash bonus opportunity and target long-term incentive award grant date fair value for 2023 for all employees, excluding the CEO, as of December 31, 2023. The total number of our employees as of December 31, 2023 (excluding the CEO) was 382. We used this population to determine the median employee. The total compensation for the median employee used in reporting the pay ratio in the preceding paragraph was calculated according to the requirements of the Summary Compensation Table.</span></div><div><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">45</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_61"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Pay Versus Performance</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following summarizes the relationship between our CEO&#8217;s, and our other Named Executive Officers&#8217;, total compensation paid and our financial performance for the years shown in the table (in this discussion, our CEO is also referred to as our principal executive officer or &#8220;PEO&#8221;, and our Named Executive Officers other than our CEO are referred to as our &#8220;Non-PEO NEOs&#8221;): </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="ecd:PvpTableTextBlock" id="f-12" escape="true"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"/><td style="width:7.048%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.714%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.540%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.011%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:9.862%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.196%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:10.751%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.788%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.392%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.640%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:7.650%"/><td style="width:0.1%"/></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024 Pay-Versus-Performance Table</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Value of Initial Fixed $100 Investment Based on:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year (1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Summary of Compensation Table for PEO ($) (2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation Actually Paid to PEO ($) (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Summary Compensation Table Total for Non-PEO NEOs ($) (2)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Compensation Actually Paid to Non-PEO NEOs ($) (3)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shareholder Return ($) (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"/><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Peer Group Total Shareholder Return ($) (4)</span></div></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Millions) ($) (5)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue (Millions) ($) (6)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-13">12,741,421</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-14">20,745,724</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-15">4,217,194</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-16">6,315,696</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-17">269.66</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-18">118.20</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-19">444.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="-5" name="ecd:CoSelectedMeasureAmt" format="ixt:num-dot-decimal" scale="6" id="f-20">1,015.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-21">11,820,858</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(<ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" sign="-" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-22">3,608,264</ix:nonFraction>)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-23">3,568,762</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-24">160,639</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-25">208.46</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-26">118.87</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-27">281.6</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-2" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-28">829.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-29">9,696,978</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-30">22,817,187</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-31">2,415,581</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-32">3,154,512</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-33">320.93</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-34">113.65</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-35">202.1</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-3" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-36">660.1</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-37">7,453,294</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-38">5,992,078</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-39">2,398,657</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-40">591,581</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-41">226.79</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-42">126.45</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-43">402.7</ix:nonFraction></span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-4" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-44">443.3</ix:nonFraction></span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-45">6,518,876</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-46">24,374,731</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-47">1,812,287</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-48">4,356,681</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="2" name="ecd:TotalShareholderRtnAmt" scale="0" id="f-49">240.89</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="2" name="ecd:PeerGroupTotalShareholderRtnAmt" scale="0" id="f-50">126.42</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="us-gaap:NetIncomeLoss" scale="6" id="f-51">129.0</ix:nonFraction></span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-5" decimals="-5" name="ecd:CoSelectedMeasureAmt" scale="6" id="f-52">268.0</ix:nonFraction></span></td></tr></table></div></ix:nonNumeric><div style="text-align:center;text-indent:22.5pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><ix:nonNumeric contextRef="c-1" name="ecd:NamedExecutiveOfficersFnTextBlock" id="f-53" continuedAt="f-53-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"><ix:nonNumeric contextRef="c-2" name="ecd:PeoName" id="f-54"><ix:nonNumeric contextRef="c-3" name="ecd:PeoName" id="f-55"><ix:nonNumeric contextRef="c-5" name="ecd:PeoName" id="f-56"><ix:nonNumeric contextRef="c-4" name="ecd:PeoName" id="f-57"><ix:nonNumeric contextRef="c-1" name="ecd:PeoName" id="f-58">Helen I Torley</ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric></ix:nonNumeric> was our CEO for each of the five years included in the table above. For 2020, our Non-PEO NEOs were Elaine D. Sun, Laurie D. Stelzer, Masaru Matsuda, and Michael J. LaBarre. For 2021, our Non-PEO NEOs were Elaine D. Sun, Masaru Matsuda, and Michael J. LaBarre. For 2022, our Non-PEO NEOs were Nicole LaBrosse, Elaine D. Sun, Mark Snyder, and Michael J. LaBarre. For 2023 and 2024, our Non-PEO NEOs were Nicole LaBrosse, Mark Snyder, and Michael J. LaBarre. Ms. Sun commenced employment with Halozyme on March 2, 2020 and separated employment from Halozyme on February 2, 2022. Mr. Matsuda separated employment from Halozyme on December 31, 2021. Ms. LaBrosse was appointed to Halozyme&#8217;s Chief Financial Officer on February 2, 2022 and Mr. Snyder commenced employment with Halozyme on January 3, 2022.</span></ix:nonNumeric></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"><ix:continuation id="f-53-1">See the Summary Compensation Table above for detail on the Summary Compensation Table total compensation for our CEO for fiscal year 2024, 2023 and 2022. The 2020 and 2021 total compensation for our CEO is disclosed in our proxy statement filed with the SEC in calendar years 2021 and 2022, respectively. The average compensation for the Non-PEO NEOs for 2024 was calculated in the Summary Compensation Table above. The average compensation for the Non-PEO NEOs for each of fiscal years 2023, 2022, 2021 and 2020 was calculated from the Summary Compensation Table as disclosed in our proxy statement filed with the SEC in the calendar year immediately following such fiscal year.</ix:continuation> </span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><ix:nonNumeric contextRef="c-1" name="ecd:AdjToPeoCompFnTextBlock" id="f-60" continuedAt="f-60-1" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:AdjToNonPeoNeoCompFnTextBlock" id="f-59" continuedAt="f-59-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">For purposes of this table, the compensation actually paid (&#8220;Compensation Actually Paid&#8221;, or &#8220;CAP&#8221;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#8217;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#8217;s LTI awards granted to the Named Executive Officer:</span></ix:nonNumeric></ix:nonNumeric></div><ix:continuation id="f-60-1" continuedAt="f-60-2"><ix:continuation id="f-59-1" continuedAt="f-59-2"><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the vesting date value of awards which were granted and vested during the same covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,</span></div></ix:continuation></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">46</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-60-2"><ix:continuation id="f-59-2" continuedAt="f-59-3"><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, </span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#8217;s Halozyme LTI awards during the fiscal years covered by the table),</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In making each of these adjustments, the &#8220;value&#8221; of an award is the fair value of the award on the applicable date determined in accordance with FASB&#8217;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.</span></div></ix:continuation><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the Summary Compensation Table Total to Compensation Actually Paid for our CEO for the fiscal year 2024.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.105%"><tr><td style="width:1.0%"/><td style="width:83.344%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.593%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.663%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Reconciliation of Summary Compensation Table Total to Compensation Actually Paid for CEO</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2024 ($)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Summary Compensation Table Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-61">12,741,421</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-6" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-62">10,400,065</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-7" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-63">14,025,875</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-8" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-64">3,744,841</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-9" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-65">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-10" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-66">633,653</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-11" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-67">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Compensation Actually Paid</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:PeoActuallyPaidCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-68">20,745,724</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">47</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-59-3"><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the average of the Summary Compensation Table Total for the Non-PEO NEOs for fiscal year 2024 to the average of the Compensation Actually Paid for the Non-PEO NEOs for fiscal year 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.035%"><tr><td style="width:1.0%"/><td style="width:82.808%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.621%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.171%"/><td style="width:0.1%"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Reconciliation of Average Summary Compensation Table Total to Average Compensation Actually Paid for Non-PEO NEOs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2024 ($)</span></div></td><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Summary Compensation Table Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgTotalCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-69">4,217,194</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-12" decimals="0" sign="-" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-70">3,183,435</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-13" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-71">4,164,663</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-14" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-72">949,818</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-15" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-73">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-16" decimals="0" name="ecd:AdjToCompAmt" format="ixt:num-dot-decimal" scale="0" id="f-74">167,456</ix:nonFraction>&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-17" decimals="0" name="ecd:AdjToCompAmt" format="ixt:fixed-zero" scale="0" id="f-75">&#8212;</ix:nonFraction>&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Compensation Actually Paid</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonFraction unitRef="usd" contextRef="c-1" decimals="0" name="ecd:NonPeoNeoAvgCompActuallyPaidAmt" format="ixt:num-dot-decimal" scale="0" id="f-76">6,315,696</ix:nonFraction></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For similar reconciliations of the Summary Compensation Table Total to Compensation Actually Paid for our CEO and the Non-PEO NEOs for each of fiscal years 2020, 2021, 2022 and 2023, see our proxy statement filed with the Securities and Exchange Commission in the calendar year immediately following such fiscal year.</span></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><div style="padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(4)</span><ix:nonNumeric contextRef="c-1" name="ecd:TotalShareholderRtnVsPeerGroupTextBlock" id="f-78" continuedAt="f-78-1" escape="true"><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock" id="f-77" continuedAt="f-77-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt">Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#8217;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last five years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.</span></ix:nonNumeric></ix:nonNumeric></div><ix:continuation id="f-78-1"><ix:continuation id="f-77-1"><div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><img src="halo-20250318_g8.jpg" alt="CAP vs TSR.jpg" style="height:378px;margin-bottom:5pt;vertical-align:text-bottom;width:668px"/></div></ix:continuation></ix:continuation><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">48</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsNetIncomeTextBlock" id="f-79" continuedAt="f-79-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This column shows Halozyme&#8217;s net income for each fiscal year covered by the table. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last five years against our net income for each of those years.</span></ix:nonNumeric></div><div style="text-align:center"><span><br/></span></div><ix:continuation id="f-79-1"><div style="text-align:center"><img src="halo-20250318_g9.jpg" alt="CAP vs Net Income.jpg" style="height:383px;margin-bottom:5pt;vertical-align:text-bottom;width:669px"/></div></ix:continuation><div style="text-align:center"><span><br/></span></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">(6)</span><ix:nonNumeric contextRef="c-1" name="ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock" id="f-80" continuedAt="f-80-1" escape="true"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.34pt">This column shows Halozyme&#8217;s revenue for each fiscal year covered by the table. We consider revenue to be a the most important financial performance metric in our 2024 executive compensation program because it is used in determining each of our NEO&#8217;s annual 2024 cash incentive. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last five years against our revenue for each of those years.</span></ix:nonNumeric></div><div style="text-align:justify"><span><br/></span></div><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">49</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><ix:continuation id="f-80-1"><div style="text-align:center"><img src="halo-20250318_g10.jpg" alt="CAP vs Revenue.jpg" style="height:382px;margin-bottom:5pt;vertical-align:text-bottom;width:667px"/></div></ix:continuation><div style="text-align:justify"><span><br/></span></div><ix:nonNumeric contextRef="c-1" name="ecd:TabularListTableTextBlock" id="f-81" escape="true"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is an unranked list of the Halozyme financial performance measures we consider most important in linking the compensation actually paid to our Named Executive Officers for 2024 with Halozyme performance.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="c-18" name="ecd:MeasureName" id="f-82">Revenue</ix:nonNumeric> (as used in our 2024 EBP)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"><ix:nonNumeric contextRef="c-19" name="ecd:MeasureName" id="f-83">Adjusted EBITDA</ix:nonNumeric> (as used in our 2024 EBP)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Stock Price (including <ix:nonNumeric contextRef="c-20" name="ecd:MeasureName" id="f-84">relative TSR</ix:nonNumeric>, as used in our PSUs awarded in 2021, 2022, 2023 and 2024 and as described in the Compensation Discussion and Analysis above)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the financial performance measures listed above, we view our <ix:nonNumeric contextRef="c-21" name="ecd:MeasureName" id="f-85">stock price</ix:nonNumeric>, upon which the value of all of our equity awards is dependent, as a key performance-based component of our executive compensation program in order to further align the interests of our senior management with the interests of our stockholders.</span></div></ix:nonNumeric><div style="height:58.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">50</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_64"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:9pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Compensation of Directors </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth information concerning the compensation earned during the fiscal year ended December&#160;31, 2024 by each individual who served as a non-employee director at any time during the fiscal year: </span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:74.853%"><tr><td style="width:1.0%"/><td style="width:16.087%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:16.087%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:14.720%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.743%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:13.548%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.362%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:12.967%"/><td style="width:0.1%"/></tr><tr><td colspan="30" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024 DIRECTOR COMPENSATION</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"/><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Fees Earned <br/>or Paid in Cash<br/>($)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Options<br/>($)(1)(4)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Stock Awards<br/>($)(1)(4)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total<br/>($)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jean-Pierre Bizzari </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline">(2)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,527</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">17,527</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernadette Connaughton</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">70,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,009</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">470,037</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara Duncan</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">85,220</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">485,257</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey W. Henderson</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">144,780</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,009</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">544,817</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mahesh Krishnan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (3)</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">37,473</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">437,510</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connie L. Matsui</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">60,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,009</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">460,037</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moni Miyashita</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">55,000</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,009</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,028</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">455,037</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Posard</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">75,000</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">150,009</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">250,028</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">475,037</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Represents the grant date fair value of restricted stock unit awards granted in fiscal year 2024 in accordance with FASB ASC Topic 718.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Dr. Bizzari did not stand for re-election and his term expired on April 25, 2024.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Dr. Krishnan was elected to the Board on April 25, 2024.</span></div><div style="margin-top:6pt;padding-left:22.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">The aggregate numbers of shares subject to unvested outstanding stock options, unvested restricted stock unit awards and vested stock units deferred under the Equity Deferral Plan (discussed below), held by the non-employee directors as of December&#160;31, 2024 were as follows:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:81.286%"><tr><td style="width:1.0%"/><td style="width:38.288%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.238%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.425%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.778%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.425%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:1.418%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:17.428%"/><td style="width:0.1%"/></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Name</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Number of Option Awards Outstanding (#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate&#160;Number&#160;<br/>of&#160;Unvested Stock Awards <br/>Outstanding <br/>(#)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Aggregate Number of Vested Deferred Stock Awards Outstanding (#)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernadette Connaughton</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,804</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,501</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,271</span></td></tr><tr><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/><td colspan="3" style="display:none"/></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara Duncan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,804</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,501</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">9,253</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey W. Henderson</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,804</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,501</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mahesh Krishnan</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6.5pt;font-weight:400;line-height:100%;position:relative;top:-3.5pt;vertical-align:baseline"> (2)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,804</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,501</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connie L. Matsui</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,804</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,501</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moni Miyashita</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,804</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,501</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Posard</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">8,804</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,501</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,271</span></td></tr></table></div><div style="padding-left:22.5pt"><span><br/></span></div><div style="margin-top:6pt;padding-left:22.5pt;text-indent:-22.5pt"><span><br/></span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">51</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Directors&#8217; Compensation</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The compensation program for our non-employee directors is as follows: </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(1) Annual award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - Immediately following each Annual Meeting, each non-employee director then in office automatically receives (i) an annual restricted stock unit grant having a value of approximately $250,000 (with the number of shares of Company common stock subject to the award equal to $250,000 divided by the closing trading price of the Company&#8217;s common stock on NASDAQ on the date of grant, with any fraction rounded up to the nearest whole share) and (ii) an annual stock option grant with a value of approximately $150,000 (with the number of shares of Company common stock subject to the award equal to $150,000 divided by the per-share value of Company stock options determined based on the valuation method and assumptions then generally used by the Company in valuing its options for financial statement purposes). Subject to acceleration in the event of a change of control of the Company, these annual awards will vest in full on the earlier of (i) the first anniversary of the date of grant or (ii) the date of the next Annual Meeting following the date of the annual grants. All awards granted after our 2021 annual meeting are granted under our 2021 Stock Plan. Vested options granted to our non-employee directors (including the initial option grants described below) generally remain exercisable for three years following the termination of the director&#8217;s service (subject to earlier termination at the end of the term of the option or in connection with a change in control).</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">(2) Initial award</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> - each non-employee director receives an initial restricted stock unit grant and stock option grant upon joining the Board (with the number of shares of Company common stock subject to each award determined in the same manner as for the annual award grants described above); provided that, the grant date value of each award for a director first elected or appointed between Annual Meetings shall be prorated based on the number of full quarters the individual is scheduled to serve as a non-employee director from the date of election or appointment until the next Annual Meeting of the Stockholders such that the recipient will receive a grant of restricted stock units valued at $187,500 and a stock option grant valued at $112,500 for a period of service exceeding three quarters, a grant of restricted stock units valued at $125,000 and a stock option grant valued at $75,000 for a period of service exceeding two-quarters (but no more than three quarters), a grant of restricted stock units valued at $62,500 and a stock option grant valued at $37,500 for a period of service exceeding one quarter (but no more than two quarters), and no award for a period of service of one quarter or less. Subject to acceleration in the event of a change of control of the Company, these initial grants will vest upon the date of the next Annual Meeting following the date of grant. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Our non-employee directors also receive an annual retainer of $50,000 for service on the Board (provided that our Chair of the Board of Directors receives an annual retainer of $125,000), as well as an additional annual retainer for service on any committee of the Board. Non-employee directors who serve on the Audit Committee receive an annual retainer of $15,000, provided that the Chair of that committee receives an annual retainer of $30,000. Non-employee directors who serve on the Compensation Committee receive an annual retainer of $10,000, provided that the Chair of that committee receives an annual retainer of $20,000. Non-employee directors who serve on the Nominating and Corporate Governance Committee receive an annual retainer of $5,000, provided that the Chair of that committee receives an annual retainer of $10,000. Employee directors (including our CEO) do not receive any compensation for service on the Board of Directors.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We also maintain stock ownership guidelines for our non-employee directors which stipulate that each non-employee director is expected to own shares of Halozyme common stock with value equal to no less than five times the non-employee director&#8217;s base annual retainer for service on the Board of Directors. Each non-employee director is expected to comply with the guidelines within five years of election or appointment to the Board of Directors. Share ownership that counts for purposes of satisfying the applicable guideline level of ownership is the same as under our executive stock ownership guidelines, as described in the CD&amp;A above. The same retention requirements apply to a non-employee director whose level of stock ownership does not satisfy the applicable guideline level of ownership as under our executive stock ownership guidelines, as described in the CD&amp;A above.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company also maintains the Halozyme Nonqualified Deferred Compensation Plan (the &#8220;Cash Deferral Plan&#8221;) and the Halozyme Therapeutics, Inc. Directors Deferred Equity Compensation Plan (the &#8220;Equity Deferral Plan&#8221;). Under the Cash Deferral Plan, a non-employee director may elect to defer payment of all or a portion of the director&#8217;s annual cash compensation, deferrals are credited with earnings or losses based on investment fund elections made by the director, and the deferred amounts (as adjusted for such earnings or losses) will be paid to the director (in a lump sum or annual installments over up to five years, as elected by the director) when the director no longer serves on the Board of Directors or an earlier distribution date elected by the director in accordance with the plan. Under the Equity Deferral Plan, a non-employee director may elect (1) to convert all or a portion of the director&#8217;s annual cash compensation into Company restricted stock units awarded under our 2021 Stock Plan and/or (2) to defer the payment of the director&#8217;s annual restricted stock unit award from the Company. If a non-employee director elects to convert all or a portion of the director&#8217;s cash retainers into restricted stock units, the director will be credited with additional restricted stock units on the date the retainers would have otherwise been paid to the director equal to (1) the amount being deferred to the Equity Deferral Plan that would have otherwise been paid to the director </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">52</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">on that date, divided by (2) the average closing price for a share of Company common stock over the period of ten consecutive trading days ending with the last trading day prior to the crediting date. Deferred restricted stock units will be credited with dividend equivalents to preserve the value of the awards if/when the Company were to ever pay a dividend. A non-employee director&#8217;s deferred restricted stock units will be paid in Company common stock (in a lump sum or annual installments over up to five years as elected by the director) when the director no longer serves on the Board of Directors or, if earlier, upon a change in control of the Company.</span></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_67"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">CERTAIN RELATIONSHIPS AND RELATED TRANSACTIONS </span></div><div style="margin-top:6pt;text-align:justify;text-indent:24.75pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to our Code of Conduct and Ethics, our executive officers, directors, and principal stockholders, including their immediate family members and affiliates, are prohibited from entering into transactions which create, or would appear to create, a conflict of interest with us. Our Audit Committee is responsible for reviewing and approving related party transactions. Our Audit Committee shall approve only those agreements that, in light of known circumstances, are in, or are not inconsistent with, our best interests, as our Audit Committee determines in the good faith exercise of its discretion. We are not aware of any related party transactions since the beginning of our last fiscal year that would require disclosure. </span></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">53</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_70"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table sets forth, as of March&#160;4, 2025, certain information with respect to the beneficial ownership of our common stock by (i) each stockholder known by Halozyme to be the beneficial owner of more than 5% of our common stock, (ii) each director and director-nominee of Halozyme, (iii) each executive officer named in the Summary Compensation Table above, and (iv) all directors and current executive officers of Halozyme as a group:</span></div><div style="margin-top:5pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:95.614%"><tr><td style="width:1.0%"/><td style="width:35.444%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:35.444%"/><td style="width:0.1%"/><td style="width:0.1%"/><td style="width:0.564%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:11.744%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:3.028%"/><td style="width:0.1%"/><td style="width:1.0%"/><td style="width:8.076%"/><td style="width:0.1%"/></tr><tr><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Beneficial Owner(1)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Number of Shares <br/>Beneficially <br/>Owned(2)</span></td><td colspan="3" style="padding:0 1pt"/><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Percent(3)</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BlackRock, Inc</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">18,629,818&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(4)</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15.1%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:11.25pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">50 Hudson Yards, New York, NY 10001</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Vanguard Group Inc.</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">13,259,514&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(5)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10.7%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">100 Vanguard Blvd., Malvern, PA 19355</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">State Street Corporation</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">6,635,827&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(6)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.4%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt 2px 12.25pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">One Congress Street, Suite 1, Boston, MA 02114</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Helen I. Torley</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2,505,521&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(7)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.0%</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nicole LaBrosse</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">189,255&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(8)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Michael J. LaBarre</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">321,420&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(9)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mark Snyder</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">136,016&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(10)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Bernadette Connaughton</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">66,962&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(11)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Barbara Duncan</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">35,929&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(12)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Jeffrey W. Henderson</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">53,786&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(13)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Connie L. Matsui</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">203,210&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(14)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Matthew L. Posard</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">90,049&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(15)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Moni Miyashita</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40,947&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(16)</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Mahesh Krishnan</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"/><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">15,305&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">(17)</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">*</span></td></tr><tr><td colspan="6" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Directors and current executive officers as a group (11 persons)</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,658,400&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"/><td colspan="3" style="background-color:#ffffff;padding:0 1pt"/><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2.9%</span></td></tr></table></div><div style="text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:6pt;font-weight:700;line-height:120%">________________</span></div><div style="margin-top:6pt;padding-left:45pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">*&#160;&#160;&#160;&#160;Less than 1%.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(1)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Except as otherwise indicated, the persons named in this table have sole voting and investment power with respect to all shares of common stock shown as beneficially owned by them, subject to community property laws where applicable and to the information contained in the footnotes to this table. Unless otherwise noted, the address for each beneficial owner is: c/o Halozyme Therapeutics, Inc., 12390 El Camino Real, San Diego, CA 92130.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(2)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Under the rules of the SEC, a person is deemed to be the beneficial owner of shares that can be acquired by such person within 60 days upon the exercise of options or warrants and vesting of stock awards.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(3)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Calculated on the basis of 123,533,310 shares of common stock outstanding as of March&#160;4, 2025, provided that any additional shares of common stock that a stockholder has the right to acquire within 60 days after March&#160;4, 2025 are deemed to be outstanding for the purpose of calculating that stockholder&#8217;s percentage beneficial ownership. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(4)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Based on Schedule 13G/A filed by BlackRock, Inc. with the SEC on January&#160;23, 2024. BlackRock, Inc. beneficially owned 18,629,818 shares, with sole voting power over 18,441,079 shares and sole dispositive power over 18,629,818 shares and shared voting and dispositive power over 0 shares, which shares are reported by BlackRock, Inc. as a parent holding company of its subsidiaries. </span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">54</span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(5)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Based on Schedule 13G/A filed by The Vanguard Group with the SEC on February&#160;13, 2024. The Vanguard Group beneficially owned 13,259,514 shares, with sole voting power over 0 shares, shared voting power over 238,774 shares, sole dispositive power over 12,881,335 shares and shared dispositive power over 378,179 shares, which shares are reported by The Vanguard Group as in its own capacity as a financial advisor.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(6)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Based on Schedule 13G filed by State Street Corporation with the SEC on October&#160;17, 2024. State Corporation beneficially owned 6,635,827 shares, with sole voting and dispositive power over 0 shares, shared voting power over 6,127,963 shares and shared dispositive power over 6,635,827 shares, which shares are reported by State Street Corporation as parent holding company of its subsidiaries. </span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(7)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Includes 1,771,802 shares subject to options that may be exercised within 60 days after March&#160;4, 2025.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(8)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Includes 157,355 shares subject to options that may be exercised within 60 days after March&#160;4, 2025.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(9)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Includes 147,664 shares subject to options that may be exercised within 60 days after March&#160;4, 2025.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(10)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Includes 107,527 shares subject to options that may be exercised within 60 days after March&#160;4, 2025.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(11)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Includes 20,175 and 6,501 shares of common stock underlying options and restricted stock units (&#8220;RSUs&#8221;), respectively, that may be exercised or that may vest within 60 days after March&#160;4, 2025.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(12)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Includes 20,175 and 6,501 shares of common stock underlying options and RSUs, respectively, that may be exercised or that may vest within 60 days after March&#160;4, 2025.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(13)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Includes 20,175 and 6,501 shares of common stock underlying options and RSUs, respectively, that may be exercised or that may vest within 60 days after March&#160;4, 2025.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(14)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Includes 20,175 and 6,501 shares of common stock underlying options and RSUs, respectively, that may be exercised or that may vest within 60 days after March&#160;4, 2025.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(15)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Includes 20,175 and 6,501 shares of common stock underlying options and RSUs, respectively, that may be exercised or that may vest within 60 days after March&#160;4, 2025.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(16)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Includes 20,175 and 6,501 shares of common stock underlying options and RSUs, respectively, that may be exercised or that may vest within 60 days after March&#160;4, 2025.</span></div><div style="margin-top:6pt;padding-left:45pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(17)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:5.84pt">Includes 8,804 and 6,501 shares of common stock underlying options and RSUs, respectively, that may be exercised or that may vest within 60 days after March&#160;4, 2025.</span></div><div style="margin-top:6pt;padding-left:9pt;text-align:justify;text-indent:-4.5pt"><span><br/></span></div><div style="margin-top:6pt;text-align:justify"><span><br/></span></div><div><span><br/></span></div><div><span><br/></span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">55</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_73"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">STOCKHOLDER PROPOSALS TO BE PRESENTED AT NEXT ANNUAL MEETING </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholder proposals, including nominations for candidates for membership on our Board of Directors, may be included in our proxy materials for an Annual Meeting so long as they are provided to us on a timely basis and satisfy the other conditions set forth in applicable SEC rules. For a stockholder proposal to be included in our proxy materials for the 2026 Annual Meeting, the proposal must be received at our principal executive offices, addressed to the Secretary, not later than November&#160;18, 2025. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Stockholder business that is not intended for inclusion in our proxy materials may be brought before the 2026 Annual Meeting so long as we receive notice of the proposal as specified by our Bylaws, addressed to the Secretary at our principal executive offices, not later than November&#160;18, 2025, in accordance with the specific procedural requirements in our Bylaws. If the Secretary fails to receive notice of the proposal within such timeframe, any such proposal will be considered untimely. Failure to comply with our Bylaw procedures and deadlines may preclude presentation of the proposal at our 2026 Annual Meeting.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to satisfying the requirements of our Bylaws, including the earlier notice deadlines set forth above and therein, to comply with universal proxy rules, stockholders who intend to solicit proxies in support of director nominees other than our nominees must also provide notice that sets forth the information required by Rule 14a-19 of the Securities Exchange Act of 1934, as amended, no later than March 2, 2026.</span></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_76"></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TRANSACTION OF OTHER BUSINESS </span></div><div style="margin-top:9pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">At the date of this Proxy Statement, the Board of Directors knows of no other business that will be conducted at the 2025 Annual Meeting other than as described in this Proxy Statement. If any other matter or matters are properly brought before the meeting, or any adjournment or postponement of the meeting, it is the intention of the persons named in the accompanying form of proxy to vote the proxy on such matters in accordance with their best judgment.</span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">56</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_79"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="margin-top:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">DELIVERY OF PROXY MATERIALS AND ANNUAL REPORTS </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We may satisfy SEC&#8217;s rules regarding delivery of proxy statements and annual reports by delivering a Notice of Internet Availability of Proxy Materials to an address shared by two or more stockholders. This process is known as &#8220;householding.&#8221; This delivery method can result in meaningful cost savings for us. In order to take advantage of this opportunity, we have delivered only one Notice of Internet Availability of Proxy Materials to multiple stockholders who share an address, unless contrary instructions were received prior to the mailing date. Accordingly, for many stockholders who hold their shares through a bank, brokerage firm or other holder of record (i.e., in &#8220;street name&#8221;) and share a single address, only one Notice of Internet Availability of Proxy Materials is being delivered to that address unless contrary instructions from any stockholder at that address were received. </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">We undertake to deliver promptly upon written or oral request a separate copy of Notice of the Internet Availability of Proxy Materials, proxy statement and/or annual report, as requested, to a stockholder at a shared address to which a single copy of these documents was delivered. If you hold stock as a record stockholder and prefer to receive separate copies of a proxy statement or annual report either now or in the future, please contact our Secretary at 12390 El Camino Real, San Diego, California 92130, or by telephone at (858) 794-8889. If your stock is held by a brokerage firm or bank and you prefer to receive separate copies of a proxy statement or annual report either now or in the future, please contact your brokerage or bank. The voting instruction sent to a street-name stockholder should provide information on how to request (1) householding of future company materials or (2) separate materials if only one set of documents is being sent to a household. If it does not, a stockholder who would like to make one of these requests should contact us as indicated above.</span></div><div style="margin-top:12pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">By order of the Board of Directors,</span></div><div style="margin-top:12pt;padding-left:306pt;text-indent:-45pt"><img src="halo-20250318_g3.jpg" alt="Mark's signature.jpg" style="height:105px;margin-bottom:5pt;vertical-align:text-bottom;width:278px"/></div><div style="margin-top:5.25pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mark Snyder</span></div><div style="margin-top:3pt;padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Senior Vice President, General Counsel, </span></div><div style="padding-left:306pt;text-indent:-45pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">and Corporate Secretary</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">March&#160;18, 2025</span></div><div style="height:135pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">57</span></div></div></div><div id="ie4c4aeb18032482191ecd6127f77fc6d_82"></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><img src="halo-20250318_g11.jpg" alt="Proxy Card 1.jpg" style="height:896px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><hr style="page-break-after:always"/><div style="min-height:49.5pt;width:100%"><div><span><br/></span></div><div><span><br/></span></div></div><div style="text-align:center"><img src="halo-20250318_g12.jpg" alt="Proxy Card 2.jpg" style="height:897px;margin-bottom:5pt;vertical-align:text-bottom;width:684px"/></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>2
<FILENAME>halo-20250318.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:39b8bf14-7331-4741-9722-11882a8adb3b,g:431cca2c-da85-4fa8-92f7-0ac43b2f4488-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:halo="http://www.halozyme.com/20250318" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:dtr-types1="http://www.xbrl.org/dtr/type/2020-01-21" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.halozyme.com/20250318">
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei-sub/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/ecd-sub/2024" schemaLocation="https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20250318_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20250318_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="halo-20250318_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
    </xs:appinfo>
  </xs:annotation>
  <xs:element id="halo_EquityAwardsOptionsAndStockReportedValueMember" abstract="true" name="EquityAwardsOptionsAndStockReportedValueMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" abstract="true" name="EquityAwardsOptionsAndStockOutstandingUnvestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" abstract="true" name="EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockVestedMember" abstract="true" name="EquityAwardsOptionsAndStockVestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" abstract="true" name="EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
  <xs:element id="halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" abstract="true" name="EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" nillable="true" xbrli:periodType="duration" substitutionGroup="xbrli:item" type="dtr-types1:domainItemType"/>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>3
<FILENAME>halo-20250318_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:39b8bf14-7331-4741-9722-11882a8adb3b,g:431cca2c-da85-4fa8-92f7-0ac43b2f4488-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/all" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain"/>
  <link:arcroleRef arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member"/>
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpAdjustmentsOnly"/>
  <link:definitionLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpAdjustmentsOnly" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockReportedValueMember_0f1a5a4b-826f-41e7-aa2a-5952c52eccfc" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockReportedValueMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockReportedValueMember_0f1a5a4b-826f-41e7-aa2a-5952c52eccfc" xlink:type="arc" order="4"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember_9c8160f4-7ebb-497c-bc98-4a49d36c69d1" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember_9c8160f4-7ebb-497c-bc98-4a49d36c69d1" xlink:type="arc" order="5"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember_f0fb856f-4597-4403-aead-321cc1249ecb" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember_f0fb856f-4597-4403-aead-321cc1249ecb" xlink:type="arc" order="6"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockVestedMember_5f23c244-5f41-4d1d-be77-91faf456048c" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockVestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockVestedMember_5f23c244-5f41-4d1d-be77-91faf456048c" xlink:type="arc" order="7"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember_cd6b15cc-3dc1-4372-8f0f-d10479a2a72b" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember_cd6b15cc-3dc1-4372-8f0f-d10479a2a72b" xlink:type="arc" order="8"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember_c01face7-8d15-4049-b36f-623f47732847" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember"/>
    <link:definitionArc xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember_c01face7-8d15-4049-b36f-623f47732847" xlink:type="arc" order="9"/>
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>halo-20250318_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:39b8bf14-7331-4741-9722-11882a8adb3b,g:431cca2c-da85-4fa8-92f7-0ac43b2f4488-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_halo_EquityAwardsOptionsAndStockVestedMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockVestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards, Options and Stock, Vested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockVestedMember" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockVestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockVestedMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockVestedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockReportedValueMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards, Options and Stock, Reported Value [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockReportedValueMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards, Options and Stock, Granted in Prior Years, Vested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards, Options and Stock, Outstanding, Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards , Options and Stock, that Failed to Meet Vesting Conditions [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:type="arc" order="1"/>
    <link:label id="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember_label_en-US" xlink:label="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xml:lang="en-US">Equity Awards, Options and Stock, Granted in Prior Years, Unvested [Member]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:to="lab_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>halo-20250318_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2025 Workiva-->
<!--r:39b8bf14-7331-4741-9722-11882a8adb3b,g:431cca2c-da85-4fa8-92f7-0ac43b2f4488-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="simple" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#PvpDisclosure"/>
  <link:presentationLink xlink:role="http://xbrl.sec.gov/ecd/role/PvpDisclosure" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_ecd_AllAdjToCompMember" xlink:href="https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd#ecd_AllAdjToCompMember"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockReportedValueMember"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockReportedValueMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockVestedMember" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockVestedMember"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockVestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
    <link:loc xlink:type="locator" xlink:label="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:href="halo-20250318.xsd#halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_ecd_AllAdjToCompMember" xlink:to="loc_halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/label"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>halo-20250318_g1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20250318_g1.jpg
M_]C_X  02D9)1@ ! 0$ 2 !(  #_X2!417AI9@  34T *@    @ ! $2  ,
M   !  $   $R  (    4   (2H=I  0    !   (7NH<  <   @,    /@
M$'X<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 #(P,38Z,#,Z
M,#,@,#DZ,S(Z,#0   :0 P "    %   $$:0!  "    %   $#*2D0 "
M S P  "2D@ "     S P  "D(  "    (0  $%KJ'  '   'A@  "*P
M'.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                ,C Q-CHP,SHP
M,R P.3HS,3HR-  R,#$V.C S.C S(# Y.C,Q.C(T #%!,$(U-#1$,3DX,30S
M,T-!0C0R,D0Q1C@Q-S=$1#4X       & 0,  P    $ !@   1H !0    $
M !#, 1L !0    $  !#4 2@  P    $  @   @$ !     $  !#< @( !
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M>2O^% %F&"*WB$4,:QQKT51@#\*DH ** "B@ HH ** "B@ HH ** "B@ HH
M*J:CJ-II5C->WTRPV\2[F=C_ )R?:@#Q+Q1\6-4U*5[?1BUC:9P)!_K7]\_P
M_AS[UY_<7=S=3-+<W$LLC'+/(Y8G\30!UG@/QI>^']9MX)KEWTV9PDL3L2J9
M_B'IC]:^BQR,T <SXS\1_P!A:8(X&'VRXR(_]D=VKQUV9W+NQ9F.22<DF@#J
M/"'A2379_M-R"EA&W)Z&0^@_J:]<M[>*V@2&"-8XT&U548 % $M% !10 44
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MRZ1:W,BC"SK,J@^Y&>?TK-U3PMKVJ&#4+R6.:]\U?W$;!8X8^2<9ZG./_KT
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MX'T'^R-'$\RXNKK#OZJO8?Y]:ZG% "T4 %% !10 44 %% !10 44 %% !10
M44 %% !10 44 %% %>2TCDO8;IMV^%'11GCYL9/U^7]37/:G9_V]XHM;-QFS
MT]1//Z-(?NJ?P&?H: .H I: "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH
M ** "B@ HH 0U7M+1+7SBO+32&1V/<G_  &!^% %FB@ HH ** "B@ HH **
M"B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH ** "B@ HH **
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M 0           0(#! 4&!P@)"@O_Q "U$  " 0,# @0#!04$!    7T! @,
M!!$%$B$Q008346$'(G$4,H&1H0@C0K'!%5+1\"0S8G*""0H6%Q@9&B4F)R@I
M*C0U-C<X.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H.$A8:'
MB(F*DI.4E9:7F)F:HJ.DI::GJ*FJLK.TM;:WN+FZPL/$Q<;'R,G*TM/4U=;7
MV-G:X>+CY.7FY^CIZO'R\_3U]O?X^?K_Q  ? 0 # 0$! 0$! 0$!
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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MCTO2-)M4Q+(TW_HN*&+SIIIO]3#%#++7&E?^6A)5_P Z_;G_ ()C?&+]AO\
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MRE_X+.?M$7O[.G_!/WXVZ[HMX]AXJ\;Z;;_"SPM<V\IM[F"XUZ;['=2PR_\
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M._X?5_L??] KXS?^$3I__P LJ /UVK^7S]K;_E,Q\*_^RR_"?_T;X;K]#?\
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M /@ES^Q1X]T:YTZ/X0P>"+]X/*M?$?@+6K[0M5TX_P#/2*$RR6LA_P"NT,E
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MTYO.L))._E2GS;6;J?)O)L?/BONKJ@ ZM\H[4 E2JC)4YYQTH _B _X)\?\
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MQ_X+?_%$_"[_ ()K_M WMM(%U3QC8Z;\.=-B,OD/<?VSJEG97@7'I9-J$O\
MVQH _P Y#5KVYU'4-0O;J4SW=]J$]Y=3R')FDE8_O*_2K_@D3^RU)^U9^W+\
M'O!U[I_V[P5X-U;_ (6A\0\V_P!IM8M-T&6&\6WN!_SRNK[^SK ^VH&OS);[
MTCG^_P _C7]O?_!M5^RI_P *_P#V>?'G[4&OV?EZ[\=M<_X1WP9+/"#);:#X
M?FEMYIH6Z@W>HM>"4=QI5M0!_30D4=K;Q1(N%AB6,<X"C;UK\*_^"F'_  4O
M/PN?6?V?/@'J\,OQ"FADLO'?C^PF#Q^!>#_Q*]/Y(.I$$^;+TM1_TUS]F^TO
M^"CW[3FH?LQ?LYZYK_A2Y2#X@^,+V/P9X(GDS/\ V9<7D<TEU?"/_IUMH;B6
M,']WYJVX/!K^,B[N[G49;N]O;JYOM4U":2ZN[JYF\^>62;_7233?\]: &7-Q
M=ZC+<WU[=W%[?WTTEU/<7$OVBXEDF_UTDTW_ #UK^H#_ ((V_LGCX>?#:]_:
M(\6Z<(_&'Q+M?L'@J.YB_P!(TGP]%)_Q\1GJ/[0DC6;IS#;VA'WS7X8?L2?L
MS:I^U)\?O"7P[\BY7PE93CQ#\1M3@7R_[/TFTDA^U0^8/]7)=_N[6+'_ "TN
MC+_RRK^W;2='T_0=.TS2M+M;>PTS2K..PL[*TC%O;6T,,8ACCCC P$C7 P/3
M@4 ;BJH'&>OXM2Y=<\+C/ )Z4'AP <_+P!7DWQ@^,'@/X&^!=<^(7Q$URST/
MPYH5JUU=75TX\R5\?NK>WBSNEGE(VQQ1C<Q- 'Q=_P %4/C9I_PC_9.\=Z0;
MJ)?$WQ4M)/AQX=T]G&Z\&HQ,NI2<G.R*R^V'/0RM%'UD%?BY_P $E/V3;OXP
M?&>S^-WB[2Y!\,OA#J<=]I4UQ WV?Q/XBC_>6$<>.0+0F&ZF/:6*V3HYKW"T
M^#?QW_X*V_&^U^+OCRWUGX5?LO\ A:232_!1O&VZG=V!D7SX])@,9BGN+N2(
M?:K[_51>4(OWWV?RZ_H0^&7PU\%?![P5H'P]^'VBPZ#X3\-V*Z?I6G6B?(J#
M;YCR2=7EEE\V6264F22261B2220#U)0%554855P!Z5^>/_!5O_DP7X^?]RO_
M .IEX<K]#QT'TK\\/^"K7_)@OQ\_[E?_ -3+PY0!^9/_  2L_8G_ &9OVD/V
M>?&'CCXS?#7_ (3+Q5I?QBU#PC8ZK_PFGB+PW]GT^+0?#EY%;^397MO%D2ZA
M=_O3$)/WU?IQ_P .I_V!_P#H@G_F4/&7_P MZ^=?^"'7_)J/Q _[.&UC_P!1
MOPC7[,4 ?GC_ ,.I_P!@?_H@G_F4/&7_ ,MZ_#OXM?"'X>_ C_@JW\&?AK\*
MO#I\*>"]'^-WPPN;#1_[8O\ 6O*DO-0T&\NC]JO999GS)-*<>97]:5?R^?M;
M?\IF/A7_ -EE^$__ *-\-T >V?\ !=SQ7J4=G^SEX'AFE31[V[\0>+M0MS)^
MYN[BS_L>SM)?^V,5YJ'_ (&5^Q7[)?PYT/X4_LV_!/P-H-M;V]GI/PYTNZO'
MM^5O;^]M8]0U"Z_[;75U=2_]M:_+3_@N-\)]2\0?##X/_%_3;>2:U^'?B?4/
M#'B,6\/,%OKT=G-:74W_ $RBN=)$7_774HJ^\/\ @GK\?M"^/_[+WPVU2QO(
MV\4>!]"L_AWX]L/. N[34-(M8;/[5+W\N\CBBNXCCI.8^L4E 'W11110!_*[
M_P %,_ &B>!O^"CWPUU31($@E^)5OX/^(&MVT$8BA6\_MZ\TF60_]=1HL,O_
M %UFDK]]OVY_^3.OVEO^R-ZY_P"D,E?SA?MT_'/0_CK_ ,%#?"VI>&+NWU3P
MU\.O%'AOX4Z/J]O,)X=2_LW6OMFH2Q8XDC^VZAJ$44HXEBABD&17]'O[<_\
MR9U^TM_V1O7/_2&2@#\OO^"']^=,^"/[1&JM$9/L'C*SOO('#2^3H\TWEU\M
M_P#!&[PQ;?%']K3XG_&'QG)_;'B?POX2U#Q18W%P?/G&L:]J'DWFH?\ 73RI
MM1B_[?*^K/\ @AG;0WOP>^/]E<()K>[\>6%O<J?^6JS:9+YGY[J^/O\ @G;X
MEE_8X_;\\=? ;XDSG2+?Q9=7GPA&H:A^X@_M"&^AN_#UUYN.8M1\KRH1_P!1
M>&@#^J:BBB@#X _X*9?#71OB7^QA\9X]0@MGU#P-H\?Q)\.W\D>Z?3+S1Y/.
MEDA]#-:M?VOTO)*^5O\ @B!XRO=9_9M^(/A"[EGG3P7\6[B33#+_ *FSMM2T
MVRF,,/M]IAO)?^WNO7O^"MGQ[TCX2?LI>)? R7@'C3XU_P#%$>'K"*7$PT_S
M89=;O91_SR%MFUSQ^]U*'K7)_P#!';X;77PU_9$N_''B41Z6GQ,\9ZAX[MKG
M49H]/@ATBSM8--ADF_YYQ^98:A-F7_EE-')Q0!]=_MG_ +3^B?LH? WQ#\2+
MW[/=>*KO_BG/AWX?N.!KNL3Q3&U\S!_X]X1')=3'_GG"8Q^\DC!_('_@DS^R
M_K?Q7\?^(_VVOC*MSKD\?B6_E^'UWJZ_:)_$WB"::;^UO$$W_/3[+)+-#$<<
M74TW26VKP+XN^+?%W_!53]N#0_AQX#O=1M?@YX/GN-,T*_6/,&@>'[2:'^VO
M$TD/_/349?)$(E_Z<(I:_I^\!>"/#?PW\&^%_ 7A#3(=$\+^#]'@T'0]-ME\
MM8+>WC\J'=@G?(>LDC<R2$R$Y- '<5_-+_P5N^%GB#X!_M(_"S]K[X:J=+N/
M$^J6=UJ-_##_ *%IOBOPYY,UG--_U^6,,7[K_EK_ &;=?\]*_I:KY/\ VS_@
M!;_M,?LY?$7X7I;1/XCN-+_X2'P)<2DJ;/7-._?:?^\Z1^<1):2G_GC>2T >
MK_!/XJ^'OC?\*/ 'Q:\*N/[$\=^&;?7H+;S?-FTR>4;;RQF_Z;6EQ'-:R_\
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M_CVN8C)Q>#RO]=*89H_,DBB_JTIA&[Y& 93ZB@#\$/!__!=3P)-HB?\ "=_
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MXGPU^SM^S]X,O8]2\'_ SX.^$M2BD\Z+4?#7PPT70KV.2/\ Y:>=;VT;?RH
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M/MY+.WU[4KN41B:.%^0D5K#9VP'I:COT^NZ** "BBB@ HHHH **** "BBB@
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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K HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>halo-20250318_g10.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20250318_g10.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %^ IL# 2(  A$! Q$!_\0
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M2T4 )^%'X4M% "?A1^%+10 GX4?A2T4 )^%'X4M% "?A1^%+10 GX4?A2T4
M)^%'X4M% "?A1^%+10 GX4?A2T4 )^%'X4M% "?A1^%+10 GX4?A2T4 )^%'
MX4M% "4M)2T %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M862:ZO/#"6UK8&2,F*:&=,^:@)!RX ('0YS7O&O? OPWXD\<7OB>]^UFYO\
M36TN^LTE46UW"1C,@V[MP^4@JPP40]165X-_9PT+P7K&G7T.M^)-2ATQF:PT
M_4M3,EI:D@@F.,*N.#W)]:"N9'D^C_'KQEXB\%^#_#\&HBV\?7GB.72-1NC;
MQ$K%$P:5_*V;1A9(QD#^!CG/%8&H_M!?%7Q-K.MZEX7L];EL;'46MK72]/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %(:6D/:@""YGCMH9)I9%CBC4N[.<!0.I)[5P_@_
MXM:7XLU?4X(D>VL+>+SK/49UDCBO8E \YT+HHPC$ X8]0>AKK]<BCN-)O8YK
M:2\BDA</;QD!I5VG*#) R1QR1UZBO!OALSZ7XCETK0Y]7UKX=Q6,ZW]KK.G.
M6M)@2# FZ,/(<#:8@&QD]2>..K4G3G%+;^OP/-Q-:=*K!+X7^?\ D>N:5\5/
M"VM:'JNL6>LPR:7I<K175TP98T90"<$@;A@C!7(.1C-,T_XL>%=2M-1N5U5;
M:/3HUENOMT,EJT2,,JQ655.&R,'&#GBO!O\ A']2UCX??%'1[#1=3@N+[5WU
M&Q@FTV:W2:W66)@$+H%R0IPGWNN!79:19QZQ\1?$/BV]T;44\/C2[6T$-YI4
MQFEG$BN"L&PNVPA?F"X!&0>,CFCB:ONZ?GYG#'&XF2C[JN]]_/7\#T?_ (6Q
MX7_X12R\2#47DTB^G^S6\R6LS/))N9-HC";\[E(Z<XK=T37;;Q!9FZM$NDB#
M%,7EI+;/D8/W)55L<]<8ZUX#\/\ 08+SX(Z!HVN67B+2+O2+_P"UR?9-+E\V
M!_.F>)@C0MYB],A%;&Y=V!DCM?A[XR\2V6F$>(=,UC4XKW6)+73KK^SUBG2V
MSA)KF,!?+7.>2H/&<8(SM3K3;2FM_P"F=%'&3E*/M%HUTZ/K?]#K[#XH^&M2
MUZ'1H-09KZ<2&#?;RI'/Y?WS%(RA) /]DGI2^$OBAX9\<PW\NBZJMY%8_P#'
MP[121"/.>?G49'RGD>E>8:K:ZGK?Q:\-ZG:V6M:C);O=+<Q:S8&&WTM&QDPR
M(B([$94'=+D=^,UYGH?@7QAHWA?18],TC4+>?Q!;W&B:F)+=U>UC-T669QMX
M^1Y!EN,'K6$L56A+2.GH<M3'XBG-)0YE=_=T_P""?4/@CXA:#\0K6YN- OOM
MT-M((Y6,4D>&(R/OJ,Y'/%=-WKR3X$>&[GPOJ/C:V>PGL+(ZL19B:)D5XEC5
M0R$CYEXZCBO6AUKMH3G4@I35F>MA*E2M1C.JK2ZCJ***Z3L"BBB@ HHHH **
M** "BBB@!*6DI: "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBD)Q0 M%-WCUHWKQS0 ZBF[A_D4;P><T .H
MINX4;Q0 ZBDW"@,#0 M%)FC(I +2&C=29S]:8",N5Q5.QTFTTSS_ +':0VHF
ME:>7R4"[Y&.6=L=23U/4U=Z]:,TK$V5[M#-J\ +Q1M&#QQ1)+'"A9G"J!DDG
MBN"\3_';P+X561;SQ#:R2IP8;0^>X/H0F<'ZXK.=2G35YNQC4K4J*O4DEZV.
M\VC;C[IH50R]!S_G-?!OCK]H+Q7KOC:ZU31];O=/TZ.4_8K:%BD8C4G:73.U
MB<9.[=UQTP*^X/"E]=ZIX;TN[OX?LU_<6L4D\&"/+D* LN#SP21S7'A<;#%2
ME&"V/-P&9TL?.<*:?N_B:GE^U)Y>5Y&:?S1BO0LCV1JKANG%/H%%,8M%%% !
M1110 4444 %%%% !1110 E+24M !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 44F:* %HI** %HHI,T +12;ATHH 6BBB@ IKTZF2 LO% 'EWQW\
M<7GA'0;&WMYO[-M=6F:SN=:99'%A&RG]X-A!#_W3G@BN>\0?%75?!N@^&%.I
MZ5-IUPL\<_B@0RWMLWE@B,;4D#"1\<Y8X8, 6Q7HGQ"M_%/]DQS^%W@FO8W"
M/87<*O%.CLJL22Z%2@RPPW.",$D8X+2?V</[!_LB?3]:A:[LUN1(E]IXGM7\
M_P"_LB61/+X^7ACQUSSGRZT:_._9?U_7R/ Q4<6ZLO87=UZ6_P _P9/J7Q(\
M7CX0VWC!;?2='DBT[[7-#>)),9Y"<*J*KIY:L-K#+.<R!2!MR<_5/C5XCNEU
M"33++3[#^RM"AUFZM]11Y&F+H',:%77;M&X%B&YP,>MM/V?+VTTOPUIEOXDB
MFTO15\S[#J-@TT,]R79VE95F3@%OE0Y"^Y.:VO&WP?NO'\,4.K7FB,#$L$UV
MFAAKL)N)<0RO,PCR"0,JVTDGFIY<0UO_ ,$F4,=)75T[+JM7W\CISXH>]\ 6
M^OVTEGI[75G%=+)J4A6"W#J#N<C&0H).,KNQC<N=P\DO?CQXEMO"/B"^MX=+
MU!K'5H;"SU6**1;2\5SABJ[R?E/<.1R/3GU"W\'Z[IHN(-,\2K::9'!;PZ;8
MM8(Z6GE@ AFW!I%8#!&5(!X(/-<9JW[/<NN0Z]->:_&=5UB]M;JXGM[#RX%6
M#[J+'YA))R<LSGMQQS558B22IJS^1IB8XR<$J5T[:[??N9>O_M :E;_#K2-0
MTZSM&\37'VD7=K.C&*$VR,UP2H8,.5& 3_&.O?V/PAJTVN^%=&U*X5$GO+.&
MXD6,$*&= Q R>G)KS6Y_9YMI-=\9:C%JS1KKUI-;PP/!N%F\H7S9%^?YBQ7/
M 4XXSQ7?Z?-IWP_\)Z;::GJMM;V]C;1VQNKF185;8H7/)XSC/7O5T%74VZST
MM_7WEX7ZU&<I8MZ6^6G7YG1YI-WI7D'B;]J3P'H+-%;WTVM7"G'DZ=$7_)CA
M3^!KFO\ A=7Q+\;?)X0\ /:0-]V\U1B%8>H#%!^1:KEC:"?+%W?EJ:3S/#1?
M+&7,^T5?\CZ$W!>2?S-<[XE^(OAGP@I;6-;LK!L9\N:8"0_1/O'\!7CJ_!OX
MH^.&W>*_'K:;;M]ZTTD, 1W4[=@_/=^-='X;_93\"Z$PEN[2XUNXSDRW\Q()
M]U7:#^(-1[;$5/X=.R_O/]$1]9QE;^#1Y5WD[?@KLR]8_:R\._:C9^&]+U/Q
M->-_JUMH"BO^?S_DAJB?%7QP\=\:5H%CX0LWY6>^(:5?J&R?_(=>Y:/X;TOP
M[;BWTS3[:P@_YYVT*QK^0%:.W':CZO6J?Q:C^6G_  0^J8FK_&K->4=/QU9\
M^Q?LRZWXL82^-_'6I:J&Y:TM3LC!]BV1^2BN]\-?L^> _"NQ[?P_;W=PN/W]
M^3<-GU&_('X 5Z-S05S6D,'1@[\MWYZ_F;4\MPM)\W+=]WJ_Q,6Z\%Z'>7EM
M=S:-8SW=K@6\\MLC/%@Y&UB,K^%;$:[3CI@8XIWX4#-=48QC\*L=\81@[Q5A
MU%%%6:!1110 4444 %%%% !1110 4444 %%%% "4M)2T %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M6$&4_5SEC^)KI57G&./;BG\^E %=L8Q@K15CU(4XTU:"L@'ZTM%%6:!1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 E+24M !1110
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!*6DI: "BBB@ HHHH ****
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MO")M6U:RTV,]&NIUCS],GFO$_P#A6OQC\<'/B#QI%X>M6Y^SZ6#O4>A*;/\
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M#:Q6\:I%&L2*,!5& ![5*O6G8HQ7I+31'M)):(6BBBF,**** "BBB@ HHHH
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MW[R[/60'?E?HN!UXKHM(\!Z%HWBC4?$-E8B#6+^&.WN9UE<ATC&$7:3M&!Z
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M_P#TH>N,K^C,'_N]/_"OR/Y1QO\ O57_ !/\PHHHKL.-!7Z:_L8_\FZ>%O\
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M%%% !1110 4444 %(W2EI* &'WZ5'\FX$D"I6Z<=:^*O^"BW^N\ Y]+_ /\
M;:O0R_!_7L5##J5K]3R,UQW]FX2>*<>;EZ'VGYB?WU_.E\U/[Z_G7XP\>M'X
MU]W_ *F/_G__ .2_\$_.O]?E_P! _P#Y-_P#]GO.3^^/SH\U/[Z_G7XP_C11
M_J6_^?\ _P"2_P#VP?Z_+_H'_P#)O^ ?LZK*V1NS^-/6OSY_X)^\_&C5O^P#
M-_Z46]?H,.M?%9I@'EF)>&<N:R6NV_WGW^2YG_:V$6*4.6[:M>^PZBBBO)/=
M"BBB@ HHHH **** "BBB@ HHHH **** $I:2EH **** "BBB@ HHHH ****
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MM?\ CWC^@K\83W/:OV7BOK>'[-!)/''-,I\N-F 9\#)P.^!7Y?QHTIT&_/\
M0_8. ]J_R+E%)N%&X>M?FUT?K8M%-W@=Z-Z^M%T ZBDW"EI@%%%% !1110 4
M444 %%)FB@!:**2@!:2BB@!*^*?^"C'_ !\> ?I?_P#MM7VM7Q3_ ,%&/^/C
MP#]+_P#]MJ^BX=_Y&=+U?Y'R7%7_ "**OR_,^-****_=C^<0HHHH] /IG_@G
M\<?&;5S_ -0&?_THMZ^[M!\6:=XBNKZ&RF65K-PC,KHP;(R&7:3QVSZ@^E?
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MK5A<7TMG%>6\EW$,R0)*"Z=.JYR.H_,4MKK%C>7DUI!>0374/^LACD4NG^\
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M8XP*39R.!^=?,W_"X/%__07/_@/%_P#$4?\ "X/%_P#T%S_X#Q?_ !%?G?\
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M<75U<7,EU#=R7+,@=VCX12 H4*/0#O67_P +BM/^@!KO_@(/_BZ7_A<5G_T
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M+$1L';@=@,DGV S4RC)*]@YX]S@?^$1N_$'BKSYM/M=(>Q9TN+VU# WV]!R
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MRR3 8*\<XZ<XX KOU7'/M7-'XB:$ 29KL#J2=/N/_C=;G]KV(R#>6X/O*O\
MC7HX*CA\/'DP[T];C2L6J^*?^"C'_'QX!^E__P"VU?9?]KV/_/[;_P#?U?\
M&OD3]O;P_JGC";P2=!TV[UL6XO?._LV!KCRMWV?;NV XS@XSUP?2OLL@E&GF
M5*4G97_0^7XGISJ955A!7>GYGQ)174_\*K\:_P#0GZ]_X+)__B:/^%5^-?\
MH3]>_P#!9/\ _$U^V_6\/_S\7WH_GOZCBO\ GU+[F<M174_\*K\:_P#0GZ]_
MX+)__B:/^%5^-?\ H3]>_P#!9/\ _$T?6\/_ ,_%]Z#ZCBO^?4ON9TW[/?\
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M ]".:_I$]$=1113$%%%% !1110 4444 )2TE+0 4444 %%%% !1110 4444
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MHH 2EI*6@ HHHH **** "BBB@ HHHH **** "BBB@ HHI* %HI,BB@!:***
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M)X5CQP*\U7XV:A=Z2)K#PU#=7EO8WNH:A;OJ6U(X[:=X"(9!$PF9VC<ID(I
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MSZ'W#UHW#UKP33_@LM]'HEE<^'[^71+=-4:2QU[[!MA>9(?+5(;4B((65V
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M6RT@(,BO"-T><^7M8A237KGB[=:_$KP)=RA5M6^W6GF/@!9GB5T ]RL4@_\
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M3@C# 'W!Q@@@C((->7>#]%\1VOPC\16&GV$]OK=U*\-JEP/)*!XXT,OSD9"
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M$[Q)N$D<TA!7#%B1EF(KD]6^$/B?4-+N;>W\.-::V(-1CU'6DNH%.L^=)^Y
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5110 4444 %%%% !1110 4444 ?_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>halo-20250318_g11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20250318_g11.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+Z17AI9@  34T *@    @ ! $[  (
M   0   !2H=I  0    !   !6IR=  $    @   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1V5T87-E=R!997-E9V%T   %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,V.   DI(  @    ,V.   ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
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M.@#5HHHH **** "BBB@ HHHH **** "L1O\ DJ>B_P#8%U'_ -'V5;=8C?\
M)4]%_P"P+J/_ */LJ .NHHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MP''V>$9'J,@CZ@T:]%)-IT2PHTC"]M6(49( N(R3]  2?84 :5%%% !1110
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M0?\ P60__$T?\*]\%_\ 0H:#_P""R'_XFNBHH YW_A7O@O\ Z%#0?_!9#_\
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M5'_"PO!?_0WZ#_X,X?\ XJ@#HJ*YW_A87@O_ *&_0?\ P9P__%4?\+"\%_\
M0WZ#_P"#.'_XJ@#HJ*YW_A87@O\ Z&_0?_!G#_\ %4?\+"\%_P#0WZ#_ .#.
M'_XJ@#HJ*YW_ (6%X+_Z&_0?_!G#_P#%4?\ "PO!?_0WZ#_X,X?_ (J@#HJ*
MYW_A87@O_H;]!_\ !G#_ /%4?\+"\%_]#?H/_@SA_P#BJ .BHKG?^%A>"_\
MH;]!_P#!G#_\51_PL+P7_P!#?H/_ (,X?_BJ .BHKG?^%A>"_P#H;]!_\&</
M_P 51_PL+P7_ -#?H/\ X,X?_BJ .BHKG?\ A87@O_H;]!_\&</_ ,51_P +
M"\%_]#?H/_@SA_\ BJ .BHKG?^%A>"_^AOT'_P &</\ \51_PL+P7_T-^@_^
M#.'_ .*H Z*BN=_X6%X+_P"AOT'_ ,&</_Q5'_"PO!?_ $-^@_\ @SA_^*H
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M ,51_P +"\%_]#?H/_@SA_\ BJ .BK$;_DJ>B_\ 8%U'_P!'V50?\+"\%_\
M0WZ#_P"#.'_XJJNE^(=%U[XIZ7_8>KV&I>1HM_YOV.Y2;R\SV>-VTG&<'&?0
MT 7/!G_($O/^PUJG_I?/705S_@S_ ) EY_V&M4_]+YZZ"@ HHHH **** "BB
MB@#+^'W_ "*\_P#V&-4_]+[BNGKF/A]_R*\__88U3_TON*Z>@ HHHH ****
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M4*-N7; HVGU'/7BI9_V7+6ZC\NZ\9ZK,@.=LD089]<%J ,;_ (:X?_H2U_\
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M)R< <=30!+1110!E_#[_ )%>?_L,:I_Z7W%=/7,?#[_D5Y_^PQJG_I?<5T]
M!1110 4444 %%%% !1110 5R*_\ )4]:_P"P+IW_ */O:ZZN17_DJ>M?]@73
MO_1][0!MT444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &(W_)4
M]%_[ NH_^C[*NNKD6_Y*GHO_ &!=1_\ 1]E774 %%%% !1110 4444 %%%%
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M^$&@7NJ74-I;1:;"7EF<*H^4=S7-7/Q&\0^.+B33OA5IA^SJ=DNO7Z%(8_\
M<4CD_4$_[/>I&=+\2;WP3;>'3'X^^S20."886&Z9F]8P/F!]Q@#N:X7X1V7C
M6+5&DT[[39^"F;-O;ZV?,G,?;RP,%?\ T'_>KK?"WPGTO1[_ /MGQ#<2^(]>
M<[GOK[Y@A[;$.0,=B<D=L=*[Z@ KQ3XTZ9>^(=;L]/D\>^&-#LK.2&^ALM3N
M$CF$R[P'YY*D,>.E>UUYA\1HOA5/JTT/C>;2X-:DM0J2W08R1J00C8'7!R:
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M):1*Z,,%2$&01V->5^(?'WB&VL[OQ\MG<6GA_0'VP6'G@QZ_#.XCBG$FW]V
M'60#:V>!D=:];TV\_M#2K2]V>7]HA279G.W<H.,]^M %FBBB@#C/!G_($O/^
MPUJG_I?/705S_@S_ ) EY_V&M4_]+YZZ"@ HHHH **** "BBB@#+^'W_ "*\
M_P#V&-4_]+[BNGKF/A]_R*\__88U3_TON*Z>@ HHHH **** "BBB@ HHHH *
MY%?^2IZU_P!@73O_ $?>UUU<BO\ R5/6O^P+IW_H^]H VZ*** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MCX3^*7Q-TC3].N/#VD:=#:2><Y341(TDFTKD$@;5P3QS]>* -'_AJGP/_P!
MS7__  &A_P#CM3_LRW"W?P_URXC!"3:_<2*&Z@&*$\UXW_PS5\1/^?2P_P#
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M/LZRRD$#G)D QT&.,5S\?BS6I?(B?7;J2[U33H;N"VL8K??#/*V4A0M&PV%
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M_P"2IZ+_ -@74?\ T?95UU<BW_)4]%_[ NH_^C[*NNH **** "BBB@ HHHH
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MX>TC5-5CN=.&J!1&3;2RPJQ?8H,ZIL 8XVEBN01Q3_\ A9WA3;*POKEA%-)
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MY_V&M4_]+YZZ"N?\&?\ ($O/^PUJG_I?/704AA1110 4444 %%%% &7\/O\
MD5Y_^PQJG_I?<5T]<Q\/O^17G_[#&J?^E]Q73T %%%% !1110 4444 %%%%
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M#' Q@>?Z/;>+]:T./49;O4=6M?/DM8ETS4C;M-'"ICBN=Y=00S[G;!^8%>&
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M5_=BY/F^8F\&<F-1E@'P =Q7/S>F>+;;5;O11'H;2K<^:I)BE\L[><\Y'M7
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M+1X8!#T).&S@#CK7/67Q1UW6/$BZ1HT^DS)<3QK!>RV3!41DF9E:-;AB74Q
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M=[<V<T[W)M)$DU-Y3))AI-MSF0^9]TD"7=@D8ZU;AM_A_J&G1Z7;^(H[JUN
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MYR>1STK2TF7P#X9:]O=-UC3+4*PM+AY-5WI 5+,(<.Y$>,N0@QCGCBJTM?\
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MMS2+#4O(T6P\K[9;)-Y>9[S.W<#C.!G'H* .LHKG?^%>^"_^A0T'_P %D/\
M\31_PKWP7_T*&@_^"R'_ .)H Z*BN=_X5[X+_P"A0T'_ ,%D/_Q-'_"O?!?_
M $*&@_\ @LA_^)H Z*BN=_X5[X+_ .A0T'_P60__ !-'_"O?!?\ T*&@_P#@
MLA_^)H Z*BN=_P"%>^"_^A0T'_P60_\ Q-'_  KWP7_T*&@_^"R'_P")H Z*
MBN=_X5[X+_Z%#0?_  60_P#Q-'_"O?!?_0H:#_X+(?\ XF@#HJ*YW_A7O@O_
M *%#0?\ P60__$T?\*]\%_\ 0H:#_P""R'_XF@#HJ*YW_A7O@O\ Z%#0?_!9
M#_\ $T?\*]\%_P#0H:#_ ."R'_XF@#HJ*YW_ (5[X+_Z%#0?_!9#_P#$T?\
M"O?!?_0H:#_X+(?_ (F@#HJ*YW_A7O@O_H4-!_\ !9#_ /$T?\*]\%_]"AH/
M_@LA_P#B: .BHKG?^%>^"_\ H4-!_P#!9#_\31_PKWP7_P!"AH/_ (+(?_B:
M .BHKG?^%>^"_P#H4-!_\%D/_P 31_PKWP7_ -"AH/\ X+(?_B: .BHKG?\
MA7O@O_H4-!_\%D/_ ,31_P *]\%_]"AH/_@LA_\ B: .BHKG?^%>^"_^A0T'
M_P %D/\ \31_PKWP7_T*&@_^"R'_ .)H Z*BN=_X5[X+_P"A0T'_ ,%D/_Q-
M'_"O?!?_ $*&@_\ @LA_^)H Z*BN=_X5[X+_ .A0T'_P60__ !-'_"O?!?\
MT*&@_P#@LA_^)H Z*BN=_P"%>^"_^A0T'_P60_\ Q-'_  KWP7_T*&@_^"R'
M_P")H Z*BN=_X5[X+_Z%#0?_  60_P#Q-'_"O?!?_0H:#_X+(?\ XF@#HJ*Y
MW_A7O@O_ *%#0?\ P60__$T?\*]\%_\ 0H:#_P""R'_XF@#HJ*YW_A7O@O\
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MVON!2N[>2?WA1114E!1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MC4(3,N8RN4R <\\8KFGL/!GFRW+>(=<>5)8VNBMJS-J3K<;T8*(/W@$G'[@
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M>.:76/A9H6MZP^HWTDLDK3M,$EM[:=%W!0RA98GP#L4Y^\.<$ XIJUT^EO\
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MGE7,Y=SRG6_A?JMS&++1X-#MK**[>YM&V!)+/+JP"9A?:#@@A"A!YR>E2_\
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M45'!<0W4*S6LT<T39VO&P93@XX(]ZDH ***:TB*RJS*&<X4$\MWXH =1110
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M[K3IHM,MH)))+A9KAHO/GD4,TQ=2T<* $EEW,%))7K26OQ,U6:]BA>71S&&
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M4JBCY_U_PWZ'F^MW/BCPU9W*^(;C6+.UNOM)TRW75RDRR^3'Y>93<2%\-O\
MW?F,6+ JA PO8>&M%^(,6OW5Q?:JT(=&\M[N W-LZD@H-HNU(95&#MB3))RS
M]3S=CXP\3V\VGRR/=WKZ!9W%K<0>8V-0N!"TBNW/S8C6)N>\C=,9K8L/B3XI
MU"S^T6\&DR1P6MU=.T:K,;H1^4%"""XE$9S(P.6<_+G S@:7M)KJE^&NOW*_
MI;L1SJ45_6NGZZ>H:1'XJN[C5[NUAU.^$=Q?P2;]5,<-SB?;&D">;NB9<-SE
M.,#<<Y4L-#\=QZ?Y=\FJRVRSL6MHM3V7$D!=2$60SL5<#/)EZ C=@BGW7Q1U
M>WO-/M[-]&U6*=ROVZV98;>[.Y1Y<;33H P!_@,W3IU IWGQ,UF"ZN+Z*6QF
M9(?+DM(UP--)FVG[0))D0N !R6B&&[#!.6BE%_+[OZ_KJY-2YO6_WOOY?UY=
M%=Z)XGB^%=CIVE":WU*.4-<1"?=*T>]BRAUECRQ!'(E3O\PJG;^&/%LDMM<7
M>H:LTL*62*!>F!<>:_G[HEF=681E1DLY. 02:FT[XA:K/XCT"TU!=-A@U2W5
MO*MI8;B9G)8;ODN,K&0 =RK*.2"PQFJWCJ\UV#Q)?:;I%W>QE[5-7B,4SC(M
MU</"#T56<0 CH0S>]4TEOW_+?Y6N_05N9671?GM^.G_ ,Z7P_P#$J71HS<W=
MYYT=P('B@NM\DD4<81)AMN(1EGW.P,@Z@,K8Q5M_#GC.":7RQ?R22R.\$]M>
MI;I'.2O[Z>,28=" ?D^?'/R\@U5/Q(U#2=.TF:"\BN9=6G%X;6\@)?[-/<%8
MRCF9<!$VY54?'&0H.:Z[P=XOO];NKN'6H;:P-I(M@05:,SW@#-*(]S?,FT*0
M!D_>Y.*:3YN;K_PU_P ;?/\  DHR5NG3YWM^&NO3YWXJTT_QOJN@/=:/+JJ+
M(S"X-SJ!E-YB8X, $Z&(!!@C?$3Z\9/97^G^*U^&5M'IT\T_B&V,<JB5Q"TN
M'R8W(E<?<R.7;.,DDUA>(M5A@^*4]MJ&J6=O&D5J8H;OQ7<:81DON*01@K+G
M ZXSP*KK\0M4?4+N[;4-,C\N ))"R2>7I>ZX"$W*^9\S*O)/R<'L.3$;64.[
M_+^O1#TBW)]/UT_KJ49O"OQ-C58CJNH2P0S-;H\=SYDKHJKY5P1]HA!.2^X,
MQS@91N,=QXM\.ZCK?]D^5)=>9:P3F2:UN3:OYIBPG*L" 7[ X]>*X^Q^*WB.
M]U2QLH+32YC<221I*&2)+L">2/=%YMPK?*J!BJK(3G'RY!I+'XN>(;Y'8:1;
M1*;1KM6>*3"1IB*0M\W\,VX\?P+Z\U4O>BU_P_\ 77_AM#2+7EI^/7\O^"R>
M\T7Q_>ZNTMM'?6!6U='D_M-FBGE$8:-@OGD+EUVL!$O4\L":<FA?$.75M)N[
MB\O8(Y6\^>**83?9)&G9VC<?:8U9!&40?+*!@D*IY+W^)VK(VU+C1ITC+?9[
MB.&39K1#*-EK^\.&^8]Y.G3&2-+PKXRFU;Q5.^JZG8PPQVI#6<;-&;.0SA%C
MEW.09.G.%SN  Y!+BTY1M\OE=_C_ );=9T49+T_&R_#\;O?IH>#/^0)>?]AK
M5/\ TOGKH*Y_P9_R!+S_ +#6J?\ I?/6W<M<);L;.*.6;C:DLAC4\\Y8*Q''
ML:9J2T5E?:/$'_0,TW_P8R?_ !BC[1X@_P"@9IO_ (,9/_C% &K165]H\0?]
M S3?_!C)_P#&*T+9KA[=3>11Q3<[DBD,BCGC#%5)X]A0!+1110!E_#[_ )%>
M?_L,:I_Z7W%=/7,?#[_D5Y_^PQJG_I?<5T] !1110 4444 %%%% !1110 5R
M*_\ )4]:_P"P+IW_ */O:ZZN17_DJ>M?]@73O_1][0!MT444 %>>>"F\-K\2
M?&7]D26!OVGC+B"13(0$7S,@'/$A.?>O0ZRAJJ+XL.C"V ;[%]K,X;K\^W;C
M'XYS2Z_?_G^@7T^XX_P=KFOW%UX=?5]6^W)K5G<2O$;>.,0F,KM*E0#R&YSD
M<<8JQH/B+6K_ ,8CP[<7&9=)DN)-2E\I1YT1/^C#I@;E?)*XYC/O72Z=XGT7
M5-1:QL+L23H&*CRG59 IPQC8@*X!X.TG'>L[POXWT_Q!=W%D^+?48KBXB\GR
MWPZQ2LF0Y4*QP 2 21GFJ6]_7^OD$MCG]#\5Z_J'Q'FT^XO;**%+J>&32WFC
M$J0INV2J@3?EOE.2Q4AN *LZ;XKNW^)TVD7.KQW,<DTL<=G:^4X@55R#(N!+
M&>OS'<AXQC-=#8>,O#VI:O\ 8;*]WW9DD@&;>10SQDAT#E0I8;2< YP,].:W
M0BARX4;B,$XY-"TMZ?TPEJV<%;2SVOQGOX+WQ/<0QW%K ]IILODA;CB7<J K
MN.W )*G//S$C J*Z\5ZG%XNDMEU.,72ZI':1Z%Y:;I;5MNZXY'F' +-N!VC&
M",UNVWBJ6]\9W.D0:4KPV<GDS7!N5$T9*!@_DD9\L_=# \GMCFK[^)='C\0)
MI3SL+YF\M<V\FPMC=L\W;LW8YV[L^U"WB_Z_K_,4NID6<VO:EXZUB.'6/)L-
M-N8$%F;9&61&A5G!;&[.3D$'COD<5U]<T?'_ (976#IIU$K=^?\ 9RIMI0OF
M;]F-^W;]["YSC) [C-A_&>@1ZY)I#W^V\BF6"13#($21@"JE]NT$AAC)Y)P.
M:2U2L-[NYP_B_4KQ?BE9:G;V%Q-8>'VAAN+J.9%C@^T'$H=2P9OD:,\ X[XJ
M/X@Z[/)J.H:9>:TFGK#=V*VFF&-";Y&DC9I,D;SALCY2 -O.<UZ$^K%?&$>B
M^0I22Q>Z,N><JZKC'_ OTI+_ ,3:)IVKPZ=?72I=R;0!Y3,J;CA0[@%4W'@;
MB,GIFG':/K^O^:8-ZOY'G_Q/UV<-K.EW>MIID4=M";2Q:-"=1WM\Y!8;CMP!
M\A&.IR#74:Y-KMWXTMM)T;6/[-B_LQ[H_P"C)*'D61%4-N&=N"00"#Z$'FNN
M**Q!902.A(Z4N!G..?6DM+?UT$UN><>//%6O:3XG@T_3KZRTZ/[*DL+W<T<:
M7DQ<J8_G5BP&%^5"&^8<U8^(?BB^\/75@T6KPV$)A>62W0Q>?.X*X5%E&)!R
M<HA5R<8-=\55L;E!P<C(Z4,BMC<H;:<C(Z&A:6'I<X3XA>)[S0X=-GMM7ATV
M&2.221&,23S$!2JH)AM;J<H"&.1@UVUE/]JL+>?YAYL2O\R;#R,\KV/M4K(K
MXWJ&P<C(S@TZCH'8XOQ9K&G:)X\\-7>L7]O86WD7B^;<RB-,D18&2<9IGQ&D
M75OAA>ZCI&I1-;1P?:@R117$5TJ\A3O5@5S@Y'/'6NU9%?[ZAOJ,TNT;=N!C
MTQ0M!W.3\1W.KR>)-!TK2=5;3(KR"Y>>2.".1CL5-NW>I Y;TK U;QGK:_#S
MPYJ4=U!92:DX2\OW9(D@&QB#ND5D3<R@98$<XZD5Z7@9SCD4A12FTJ"OH1Q0
M):(RO"MY>:AX6L+K4Y;>:YECW/+;-NCDY.&!P.HP>..>*S?'UII=UHEL=:UB
MWTF""[25);E8V21P& 0J_#9SG'7BNHZ=*1E5L;E!P<C(Z&B6K".B,3P7//<>
M$+&6ZLXK.0JW[N&'R4*AB%<)_#N&&QVW5NT44V[NXEH@HHHI#"BBB@ HHHH
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M8_907,KCYAYI/W,_-@*#GOCBDM]0>V@L6OW[^/IO#[:1"MG%:K=B^%WEB&)
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M!+S_ +#6J?\ I?/705S_ (,_Y EY_P!AK5/_ $OGKH* "BBB@ HHHH ****
M,OX??\BO/_V&-4_]+[BNGKF/A]_R*\__ &&-4_\ 2^XKIZ "BBB@ HHHH **
M** "BBB@ KD5_P"2IZU_V!=._P#1][775R*_\E3UK_L"Z=_Z/O: -NBBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH *R?$@D.CAH1(6CN[:3,41E90L\;%@@!+8 )P
M/2M:B@#D8KYTT[5(?M6H+]IEF8)_84W[W<.I^3O3(+N=+K39)+[4&6W1@O\
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M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '&>#/^0)>?]AK5/\
MTOGKH*Y_P9_R!+S_ +#6J?\ I?/704 %%%% !1110 4444 9?P^_Y%>?_L,:
MI_Z7W%=/7,?#[_D5Y_\ L,:I_P"E]Q73T %%%% !1110 4444 %%%% !7(K_
M ,E3UK_L"Z=_Z/O:ZZN&U345T7XDZC=7EEJDEO=:391Q2V>EW%TA9)KLLI,2
M, 0)$.#C[PH T;"ZV7>N/=3[8;>[&&D?"Q(+>%CUX R2?Q)K2,L8F6(NHD92
MRH3\Q P"0/0;A^8]:XB[UNUGT[Q#;I::V'U3?Y)/A[4,+FW2/YOW''S*>F>/
MRJ[+XGL7UZUO19:]Y<-M-"P/AW4-Q+M$1C]QT_=G]* -C6KK_B5QR6D__+_;
M1%XG_P"GE$=<C_@2D?4&GP2R'Q5?1%V,:V5LRH3\H)><$@>IVC\AZ5R_]MVO
M]C_9/LFM^9_:7VO/_"/:AC9]K\['^HZ[>/KWQS5V+Q/8IKUU>FRU[RYK:&%0
M/#NH;@4:4G/[CI^\'ZT =0+JW;9MGC/F2-$F''S.N=RCU(VMD=MI]*I02R'Q
M5?1%V,:V5LRH3\H)><$@>IVC\AZ5R\&MVL7V'=::W_H^I7-V^/#VH<I)Y^T#
M]QU_>KGZ'GUNQ>)[%->NKTV6O>7-;0PJ!X=U#<"C2DY_<=/W@_6@#8O[K?=Z
M&]K/NAN+LY:-\K*AMYF'3@C(!_ &M(2QF9H@ZF15#,@/S '(!(]#M/Y'TKB+
M36[6#3O#UN]IK9?2]GG$>'M0PV+=X_E_<<_,PZXX_*KL7B>Q37KJ]-EKWES6
MT,*@>'=0W HTI.?W'3]X/UH V+^ZWW>AO:S[H;B[.6C?*RH;>9ATX(R ?P!K
M06YB>\DM5?,T4:2.N#PK%@ISTY*-^5<5::W:P:=X>MWM-;+Z7L\XCP]J&&Q;
MO'\O[CGYF'7''Y5=B\3V*:]=7ILM>\N:VAA4#P[J&X%&E)S^XZ?O!^M '16^
MIVEU]E\B7?\ :X#<0?*1OC&W+<CC[Z\'GGZUBW5U<+_:FV>0>7K-G$F'/RHW
MV7<H] =S9'?<?6LK2];M;+^QO-M-;/V#36M)=OA[4.7/D\C]QT_=MUQU'%$^
MMVLOV[;::W_I&I6UVF?#VH<)'Y&X']QU_=-CZCGT .W,L8F6(NHD92RH3\Q
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M,-BW>/Y?W'/S,.N./RJ[%XGL4UZZO39:]Y<UM#"H'AW4-P*-*3G]QT_>#]:
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M#WA__P $4_\ \ET ==17([?&_P#T'O#_ /X(I_\ Y+HV^-_^@]X?_P#!%/\
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MWQO_ -![P_\ ^"*?_P"2Z-OC?_H/>'__  13_P#R70!UU%<CM\;_ /0>\/\
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MC?\ Z#WA_P#\$4__ ,ET ==17([?&_\ T'O#_P#X(I__ )+HV^-_^@]X?_\
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M;XW_ .@]X?\ _!%/_P#)=&WQO_T'O#__ ((I_P#Y+H ZZBN1V^-_^@]X?_\
M!%/_ /)=&WQO_P!![P__ ."*?_Y+H ZZBN1V^-_^@]X?_P#!%/\ _)=&WQO_
M -![P_\ ^"*?_P"2Z .NHKD=OC?_ *#WA_\ \$4__P ET;?&_P#T'O#_ /X(
MI_\ Y+H ZZBN1V^-_P#H/>'_ /P13_\ R71M\;_]![P__P""*?\ ^2Z .NHK
MD=OC?_H/>'__  13_P#R71M\;_\ 0>\/_P#@BG_^2Z .NHKD=OC?_H/>'_\
MP13_ /R71M\;_P#0>\/_ /@BG_\ DN@#KJ*Y';XW_P"@]X?_ /!%/_\ )=&W
MQO\ ]![P_P#^"*?_ .2Z .NHKD=OC?\ Z#WA_P#\$4__ ,ET;?&__0>\/_\
M@BG_ /DN@#KJ*Y';XW_Z#WA__P $4_\ \ET;?&__ $'O#_\ X(I__DN@#KJ*
MY';XW_Z#WA__ ,$4_P#\ET;?&_\ T'O#_P#X(I__ )+H ZZBN1V^-_\ H/>'
M_P#P13__ "71M\;_ /0>\/\ _@BG_P#DN@#KJ*Y';XW_ .@]X?\ _!%/_P#)
M=&WQO_T'O#__ ((I_P#Y+H ZZBN1V^-_^@]X?_\ !%/_ /)=&WQO_P!![P__
M ."*?_Y+H B\&?\ ($O/^PUJG_I?/705R.F>'_%VE6LL%OXAT5EDNKBZ)DT2
M4G=-,\K#BZ' 9R![8Z]:N?8O&G_0?T'_ ,$<W_R70!T5%<[]B\:?]!_0?_!'
M-_\ )='V+QI_T']!_P#!'-_\ET =%17._8O&G_0?T'_P1S?_ "71]B\:?]!_
M0?\ P1S?_)= '145SOV+QI_T']!_\$<W_P ET?8O&G_0?T'_ ,$<W_R70!>^
M'W_(KS_]AC5/_2^XKIZX/X*ZI-KGPFTW5KM8TGO[F]N95B!"AGO)F( ))QD]
MR:[R@ HHHH **** "BBB@#BOA[_R3'PO_P!@>T_]$I715SOP]_Y)CX7_ .P/
M:?\ HE*Z*@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** .=\<?\ (OVW_88TS_TO@KHJYWQQ_P B
M_;?]AC3/_2^"NBH **** "BBB@ HHHH **** "BBB@ HHHH ***H:OJ]OHEC
M]LO5D\@.JN\:Y\L$XW'V^F: +]%-CD2:-9(G5T<95E.01Z@UA6^GQZEJ^L-=
M7%]^YNUCC6*^FB55\B)L!4<#JQ/3O0!OT5D#0M.,7F"ZU#R\9W_VM<XQZY\R
ME;P_8(N7N-149 R=5N1_[4H UJ*R3H%@K*K7.H@MPH.JW//_ )$H_L"PWA/M
M.H[B,A?[5N<X]?\ 64 :U%9 T'3V=D6YU LF-RC5;G*YZ9_>4)H.GR;MESJ#
M;3M;&JW)P?3_ %E &O160-!TXQ>8+K4#'C._^U;G&/7/F4'0-/50S7.H@$@
MG5;GG/3_ ):4 :]%9)\/V"D!KC406.!G5;GD_P#?R@^'[ ,%-QJ.XC(']JW.
M3_Y$H UJ*R1H%@7*"YU$LO)']JW.1_Y$H70+!BP6YU$E3@XU6YX/I_K* -:B
ML==#TUH?-6[U QX)WC5KC&![^95>:QAT_5=&DLKF]99[ID<27\TJ.GV>5NC.
M0>54_A0!T%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% '$_L^?\D)\/?\ ;S_Z4RUZ37FW[/G_ "0GP]_V\_\ I3+7I- !1110 444
M4 %%%% '%?#W_DF/A?\ [ ]I_P"B4KHJYWX>_P#),?"__8'M/_1*5T5 !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MU5GU"+4=6T=+2WO0(;MI':6QFB5%^SRKDLZ =6 _&@#H**** "BBB@ HHHH
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#G?''_ "+]M_V&-,_]
M+X*Z*N=\<?\ (OVW_88TS_TO@KHJ "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M]*NZCH=MJ=UI\\[RJ^GS>=$$( 8XQ\V1T^F*M:A91ZCIMQ93EECN(VC<H<$
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M4C&/J:Z31+VYU#1;:ZO[=;:XD7+QHX=>O4$$\'K^-86NZ-KMY<12P)I=];M
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MR=M3?[9=WNE><%L9[QBSR8'SD$\E<]*G\?3ZQ;>&YY='GCMHXXV:>;)$@'&
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M!#X#MK.:%KD)X@\IXD.#)A<%0>V:Z73([KPE8Z[JPT^72=-\A1;64T_F$R]
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M10 4444 %%%% '.^./\ D7[;_L,:9_Z7P5T5<[XX_P"1?MO^PQIG_I?!714
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MF.Y(D4]%0ITV =J](U^PTW4-%G36XO-LXE\YUWLOW1G.00:H?V+X9'BCS_\
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M36VECT:[25HQN=!&T9 /?# 9'O1U?]=+"Z'F]C?06=QIMMI%V]XGVX8T.^M
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MSTK8ILE!1112&%%%% !1110 4444 <3^SY_R0GP]_P!O/_I3+7I->;?L^?\
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MQ&UF8UCW;8#+]XAMH&['&3CM2>E_D-=/7_,K>"([M+S5#&M]'I!9/L:7^[S
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M7UA8Z'JMY#;_ -F7L2?;'16W0.ZY##G[N3Z?C6AX7UB^UZWN+^>&.&Q>4K9
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MC3/_ $O@KHJ "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M3+7I- !1110 4444 %%%% '*6_PV\/6EK%;6C:U!!"@CBBB\07ZJB@8"@";
M '&!4G_"OM$_Y^->_P#"BO\ _P"/UT]% ',?\*^T3_GXU[_PHK__ ./T?\*^
MT3_GXU[_ ,**_P#_ (_73T4 <Q_PK[1/^?C7O_"BO_\ X_1_PK[1/^?C7O\
MPHK_ /\ C]=/10!S'_"OM$_Y^->_\**__P#C]'_"OM$_Y^->_P#"BO\ _P"/
MUT]% ',?\*^T3_GXU[_PHK__ ./T?\*^T3_GXU[_ ,**_P#_ (_73T4 <Q_P
MK[1/^?C7O_"BO_\ X_1_PK[1/^?C7O\ PHK_ /\ C]=/10!S'_"OM$_Y^->_
M\**__P#C]'_"OM$_Y^->_P#"BO\ _P"/UT]% ',?\*^T3_GXU[_PHK__ ./T
M?\*^T3_GXU[_ ,**_P#_ (_73T4 <Q_PK[1/^?C7O_"BO_\ X_1_PK[1/^?C
M7O\ PHK_ /\ C]=/10!S'_"OM$_Y^->_\**__P#C]'_"OM$_Y^->_P#"BO\
M_P"/UT]% ',?\*^T3_GXU[_PHK__ ./T?\*^T3_GXU[_ ,**_P#_ (_73T4
M<Q_PK[1/^?C7O_"BO_\ X_1_PK[1/^?C7O\ PHK_ /\ C]=/10!S'_"OM$_Y
M^->_\**__P#C]'_"OM$_Y^->_P#"BO\ _P"/UT]% ',?\*^T3_GXU[_PHK__
M ./T?\*^T3_GXU[_ ,**_P#_ (_73T4 <Q_PK[1/^?C7O_"BO_\ X_1_PK[1
M/^?C7O\ PHK_ /\ C]=/10!S'_"OM$_Y^->_\**__P#C]'_"OM$_Y^->_P#"
MBO\ _P"/UT]% ',?\*^T3_GXU[_PHK__ ./T?\*^T3_GXU[_ ,**_P#_ (_7
M3T4 <Q_PK[1/^?C7O_"BO_\ X_1_PK[1/^?C7O\ PHK_ /\ C]=/10!S'_"O
MM$_Y^->_\**__P#C]'_"OM$_Y^->_P#"BO\ _P"/UT]% ',?\*^T3_GXU[_P
MHK__ ./T?\*^T3_GXU[_ ,**_P#_ (_73T4 <Q_PK[1/^?C7O_"BO_\ X_1_
MPK[1/^?C7O\ PHK_ /\ C]=/10!S'_"OM$_Y^->_\**__P#C]'_"OM$_Y^->
M_P#"BO\ _P"/UT]% ',?\*^T3_GXU[_PHK__ ./T?\*^T3_GXU[_ ,**_P#_
M (_73T4 <Q_PK[1/^?C7O_"BO_\ X_1_PK[1/^?C7O\ PHK_ /\ C];.KZU8
MZ':I<:G*T43N44I$\A)"LQX4$X"JQSTXK$?XD^%8[>*XDU&5(9L^7(UE.%?'
M7!V8.* '?\*^T3_GXU[_ ,**_P#_ (_1_P *^T3_ )^->_\ "BO_ /X_73T4
M <Q_PK[1/^?C7O\ PHK_ /\ C]'_  K[1/\ GXU[_P **_\ _C]=/10!S'_"
MOM$_Y^->_P#"BO\ _P"/T?\ "OM$_P"?C7O_  HK_P#^/UT]% 'G?B_P=I>E
M:/9WEK-JS2QZQIFT7&M7DZ'-] .4DE93P>X.#SU%=C67\0?^17@_[#&E_P#I
M?;UJ4 %%%% ",=JECT S6#HGC"PUVYC@@@NK=YH3-%YZ*!(@;:2-K'H1WQ6Z
MXW1LHZD$5RNA^%)=%\,&*!+<:RT+1&YWLP4%B>"1P #G  R1^-'<#7LO$FFW
M]E>W<4^V"QE>.=WX V]3]/2C3M;.HM"R:9?16\Z[HKB54VL,9!(#%ER.F0*P
M/^$%E@FOK2UO&.G:A9"&4RD&1)%X1@ H!&./6K]M9>(OMND+,]O!:V2LESY4
M[$7(VX4[=HQR,X)IH"]I'B&+6;JXCM;*[6*WE>%[B0($+J<$##%OTK7KEO#'
MAZ[T;4[Z2ZMK5EN+F69+F.=BX5CD*4VX_'-=32Z(.K"BBB@ HHHH *SI=<L8
M=;@TEW?[7.&**(SC &2=W3I6C6)J&CW%UXMTC5(VC$-DDRR*Q.X[U &.*.H=
M#;I&8*I9C@ 9)/:EJ.XA6XMI87R%D0H<>A&*3O;0:W,0>+[(PI=M;72Z;))Y
M:7[*HB)S@'&[<!GC)7%6(?$$=QKUSI=O8W<KVK()IP$$:;EW#JVX_@*PSX8U
M6;PQ#X:F-J+*-U5KQ9#O>)6W !-O#=NN*TM/\-B#Q5J>JW21.L[1&V(8[DVI
MM.1T_G5:7_KR%T.AHHHI %%%% !67J6OV>E3!+M9@@*!Y1&2B;SA<GW([9QW
MK4KG?$.GZQJ.HVBVMO8S:? XE=+B5U+N#P2 O0=0,\GZ4=4'1G14444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M>:$BW11&2C;7)\P&/;A05((.[KAFH:%XCUSP3IOAS^P)M-?3S912WRW,(?\
M=S1%G@(8_*%4MEMIR%&TG("A=VOW7X[Z^6PFW=V\_P#@??OY':7GCKPY8%A<
M:D,K*\1$4,DGS)C?]U3D+N 9N@/!(-7M4\0Z7HVBC5M0N@EBQ0+,B-)NWD!,
M!02<DC&!WKSZXT37++3+"UE\/:A)/I<<ME;:CH=W!'*ZDKM<QNX0HV!O# X9
M<X(YK:\5:-KNJ?#+3K)K9I]6AEL9;F+3Y(XF!CE1I/*+E5! 4XY Z4UJOFON
M;W^[7R"[O]_]?UN:5U\1O"UG:VUQ-J9*76_RA%;2R-E" X*JI*D%AD,!U%;.
MGZU8:JTXL;CS#;[/-!1E*;T#KG('56!_&O*(?"?B:UU2UO6T[Q ;?S;UA]DO
MK07Z"4P%?.=I C9*/]TG"A1736<&MVFL>((W\.:J\&M&'RKM9[0^1_HZ1L9,
MS!LJP.=H;..,TG?DNM[?CV*6^NW_  3?L_'7AN_O8[2TU1))II!%$OEN/-)#
M$%"1AE.UOF&5XQFMB&^MKB\N;6&4/-:E1,@!^0L,C].:\CO_  GXLU.ST.73
MM);3=0\/V<5G&9YHBDLGF1AI4VORBHC,,[2=V,9R*[7X?:%K&B6FJCQ%,US=
MS7OR7+N&:>&.-(XW;'\1"9.><DU2L[_/YV:_.]_^&(YG?;M]_P#7]:EZ7QWX
M=@OM2M)[]XYM+A:>\#6TH6)%ZMNVX/X$YYQ6O::G9WTTD5I<+*\<<<C!<\*X
M)0YZ'(!K@?$FD:[J\WCBVMM!N@FIZ4MM9W#S6X2:1%<8QYFX9WC!91T.<<9T
M_ 7AG4_#6IZU!>J#89ACTV3>"3"H8[" <C87V#/4*.M2KVU_K^M/Q!MWT[O_
M (!I0>/_  S<2WL<>J*&L5E:??#(@ BSYFTE1OVX.=N:UI=7L8)+!);@*VHO
MLM1M/[UMA?'3CY5)YQTKR'_A!_%#QW\$6G:@CDZM_P ?=W;M:NEQYIC\E5<L
MKDLF2P4 %_6NHOCKMU#X=O1X3U6-]!N5DEMGFM"]PIMY(CY>V<C(+ X8KD=,
M]*:VN_+]2G=7MY_A:WWZFY<?$7PO:W,-O)J+M+.N]%BM)I.-[)DE4./F1ASC
MI6QJ^MZ?H5FMSJEQY,;N$0!&=Y&P3M5%!9C@$X /0UYEIOA?Q#H^MVUU-IFN
M-&UC$K_V/>6J 2">:1HY?-D7< )%^[D=>:[;Q7:WW]I:%J]C83:@--N9'FM8
M702%7B9-R[F"D@D<9'!.,]*6O*GU_P""%W?Y+\O\QS_$+PNEQ#"=54F:%)UD
M6&1HU1R0K-(%VIDJP^8CH:U=:US3_#^EMJ.KW'D6JLJ%Q&SDLS!5 502220.
M!7DL?PX\2!M1N7BG\J>")Y-,2ZC6.^5KFXEEMF(.05650#D+GC)&:[WXAZ3?
MZSX.CMM*M+B:=+RTG,-M+''*$29';8SL%#!0<9/44^WK^%Q)N[]/T-;3_%&C
M:I):I87R3/=B0PH%8$^7@.""/E(W+D'!YJP^M:='KB:,]W&NHR0&Y6W)^8Q@
MX+?3)KS?1M$\2:%KECJKZ#J>H6Z3WS"%KFU:\19A#M,K-*J,=R/]UCA=HIVH
M>%?%.L:Y/XH6#[#</<I#'ILJQ&X6UV&)LS+*4_Y:22;1GD#G/%3)NR:73^OT
M^5Q]/Z_K9??8[.#Q[X:N'*PZHI(DCC4F)P)"[A%*$KAU+,!N7(!/)K6L=3L]
M2^T?89A.+:9H)&4':'7[R@]#CH<9P<CJ#7FVH:%XCUSP3IOAS^P)M-?3S912
MWRW,(?\ =S1%G@(8_*%4MEMIR%&TG(':^#;34-+T!=*U.T2%M/8P0S1%=EU&
M/NRA0<J2#\P('S ]1@U=E9_/Y[:_U^C)N[JZ_P"!Y>?K_FB*'X@^&9X[N1=2
M*1V<\=O.\MM+&$D=@JKEE&<DCIZY/%77\4Z)%>SVDNH11S6\<LDH<%0BQ;/,
M)8C&!YB=^_UKA-2\-:QXBT?7=-O/#UU;PWVOVUV!//;XEMQ)$)"-DK$$+&QP
M<'!&,G@8T7PX\73:E#/>E6FL3=21S/(ABO2'MO)65<DXD$))XX89] 9@V[<V
MFG_MJ?YMJW6UEJ.3:>BZ_J_\EKTN>RVMU%>6<5U 6,,R"1"Z%"5(R,A@"/Q%
M9!\:^'AHL6K)J22V<TS01/"CR-)(I(951068C:W '0$]*76'U>^\$W']GV+V
MVK7-KL2W>1"8)'&"2P;:=N2>#SCBN!3P9K'AN%[%M-N-9TZ":*[MKC1Y$L[B
MV?RC$PB1I,$X5203A@[=3Q0[J37];_Y#N[)K^NWXGI7]O:9_PC[ZX+M#IJ0M
M.UP 2 B@DG&,\8/&,\5C0?$CPM<V\DT6H3;8V5</8SJSL<D*BE 7.%)PH)P"
M:IOI.O7WP?U'2[Z OJUS9W,443&-7;=O\L.5PF\J5W$?+NS4%UX:U'1)=#U*
MU;5->-A<-)/:S7$;2(K0LF8]VU>"1P3TSC/2F]&_D%WRI]=?PL=5IWB#2M6F
M6+3;V.X=K=;I0@/,3,5#9QCJK#'48J2+6].FL+J]2[C%K9O+'<2O\JQM&2'R
M3Z$'GI7G_AK2=?\ ">N&]E\.WVHQWED0RV=Q;9MY&NIYC&?,E3.%E497(X-*
M^EZ_-X7\1>'/^$<OD?4+N\G@O6N+;[.5>1I$#8E\P9X4_)QGTYHZ??\ G_E]
MX_\ -?=:[_'3R.RTOQCH.LWJ6>G7XDN7#E86B='PH4DD,H(&&4@GJ#QFHKCQ
MUX;M=0:RFU-!.DGE2*L3L(FW;?G8+A!D$98@$@\\5P>L^%?%?B+Q2FO:5;7&
M@27 BL9&EEC\ZVA$<OF2C8Y&XLRJ,$G@'&*K6_AGQ7IVGB0Z+>#Q!?*[O>6-
MW";=I6FDDV7,;M@QC=D%0S88C@XH6K(N^7S_ *_K\=CV6BJ%K"4UB[E:R:-G
MBB#7/FY6;&[@+G*[<]<#.[OBK]!2=PHHHH&%%%% !1110!S_ (JN[:PDT>ZO
MW5+:*]D:4MTV_9)Z\618M.:[U:\TN2'2M4MKR/3-[;A [*0IQ^GZ]J^@+[3K
M+4X1#J5G;W<2MO"7$2R*&QC.".O)_.J/_")>'/\ H7]+_P# */\ PH6DN8'J
MK&OUZ4444 %%%% !1110!C^*=%F\0:";&TNX[.=;FVN8II83,JM#.DP!0,I(
M)CQPPZUE_P!C>-/^ACT'_P $4W_R77644 <G_8WC3_H8]!_\$4W_ ,ET?V-X
MT_Z&/0?_  13?_)==910!R?]C>-/^ACT'_P13?\ R71_8WC3_H8]!_\ !%-_
M\EUUE% ')_V-XT_Z&/0?_!%-_P#)=']C>-/^ACT'_P $4W_R77644 <G_8WC
M3_H8]!_\$4W_ ,ET?V-XT_Z&/0?_  13?_)==910!R?]C>-/^ACT'_P13?\
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M-?7=K:16_B75+%[=-LDUO':E[DX W/OA90>"?D"CYCQTP :]%<W_ ,(OJ_\
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MU#0=1O;^2XMO%FL:?$^-MM;169C3  X,D#-SC/+'D]AQ0!MT5S?_  B^K_\
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M-0B3.ZVN8K,1OD$<F.!6XSGAAR.XXHU#0=1O;^2XMO%FL:?$^-MM;169C3
MX,D#-SC/+'D]AQ0!MT5S?_"+ZO\ ]#WX@_[\:?\ _(M:7]EW?]@_8/[=U#[3
M_P!!+R[?S_O;NGE>5T^7[G3WYH TJ*YO_A%]7_Z'OQ!_WXT__P"1:LZ?H.HV
M5_'<7/BS6-0B3.ZVN8K,1OD$<F.!6XSGAAR.XXH VZ*Q-0T'4;V_DN+;Q9K&
MGQ/C;;6T5F8TP .#) S<XSRQY/8<56_X1?5_^A[\0?\ ?C3_ /Y%H Z2BLVR
MTN[M=*N+2?7=0O)I=VR]GCMQ+#E<#:$B5#@\C<K<GG(XK-_X1?5_^A[\0?\
M?C3_ /Y%H Z2BN?MO#FJ0744LOC37+E(W#-#+#8A) #DJVVV#8/0X(/H15G5
M=&OM1NEEL_$NJ:4BH%,-G':LC').X^;"[9YQP<<#CKD UZ*YO_A%]7_Z'OQ!
M_P!^-/\ _D6M*RTN[M=*N+2?7=0O)I=VR]GCMQ+#E<#:$B5#@\C<K<GG(XH
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M/%<\?A#XD6\77%U^&36'U.6\EM'.+4++E& <1^83Y>T<\9%3^&/@_J'AW7M
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MV(T^-0<!I.??@UIQ65O#$L:0IM48^Z* ,W_A)[+_ )Y3_P#?*_XT?\)/9?\
M/*?_ +Y7_&M7[/#_ ,\8_P#OD4?9X?\ GC'_ -\B@#*_X2>R_P">4_\ WRO^
M-'_"3V7_ #RG_P"^5_QK5^SP_P#/&/\ [Y%'V>'_ )XQ_P#?(H RO^$GLO\
MGE/_ -\K_C1_PD]E_P \I_\ OE?\:U?L\/\ SQC_ .^11]GA_P">,?\ WR*
M,K_A)[+_ )Y3_P#?*_XT?\)/9?\ /*?_ +Y7_&M7[/#_ ,\8_P#OD4?9X?\
MGC'_ -\B@#*_X2>R_P">4_\ WRO^-'_"3V7_ #RG_P"^5_QK5^SP_P#/&/\
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MV>'_ )XQ_P#?(H RO^$GLO\ GE/_ -\K_C1_PD]E_P \I_\ OE?\:U?L\/\
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M_P#/&/\ [Y%'V>'_ )XQ_P#?(H RO^$GLO\ GE/_ -\K_C1_PD]E_P \I_\
MOE?\:U?L\/\ SQC_ .^11]GA_P">,?\ WR* ,K_A)[+_ )Y3_P#?*_XT?\)/
M9?\ /*?_ +Y7_&M7[/#_ ,\8_P#OD4?9X?\ GC'_ -\B@#*_X2>R_P">4_\
MWRO^-'_"3V7_ #RG_P"^5_QK5^SP_P#/&/\ [Y%'V>'_ )XQ_P#?(H RO^$G
MLO\ GE/_ -\K_C1_PD]E_P \I_\ OE?\:U?L\/\ SQC_ .^11]GA_P">,?\
MWR* ,K_A)[+_ )Y3_P#?*_XT?\)/9?\ /*?_ +Y7_&N4BT"UUSQ;XI>_N=4
MM=2C@ACMM6NK>.-/L5L^ D<BJ/F=CG&<FKO_  @FC_\ /SKG_A07_P#\>H W
MO^$GLO\ GE/_ -\K_C1_PD]E_P \I_\ OE?\:P?^$$T?_GYUS_PH+_\ ^/4?
M\()H_P#S\ZY_X4%__P#'J -[_A)[+_GE/_WRO^-'_"3V7_/*?_OE?\:P?^$$
MT?\ Y^=<_P#"@O\ _P"/4?\ "":/_P _.N?^%!?_ /QZ@#>_X2>R_P">4_\
MWRO^-'_"3V7_ #RG_P"^5_QK!_X031_^?G7/_"@O_P#X]1_P@FC_ //SKG_A
M07__ ,>H WO^$GLO^>4__?*_XT?\)/9?\\I_^^5_QK!_X031_P#GYUS_ ,*"
M_P#_ (]1_P ()H__ #\ZY_X4%_\ _'J -[_A)[+_ )Y3_P#?*_XT?\)/9?\
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MSOP]_P"28^%_^P/:?^B4KHJ "BBB@ HHHH **** "BBB@ KD_&__ !_^%O\
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M?^D-U765R?C?_C_\+?\ 86D_](;J@"W;>+I[=38:7HL^HM: "XD6>.((6^8
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@^E?\_>O?^%#?_\ QZI]WC?_ * /A_\ \'L__P B4;O&_P#T ?#_ /X/9_\
MY$H @_X0?2O^?O7O_"AO_P#X]1_P@^E?\_>O?^%#?_\ QZI]WC?_ * /A_\
M\'L__P B4;O&_P#T ?#_ /X/9_\ Y$H @_X0?2O^?O7O_"AO_P#X]1_P@^E?
M\_>O?^%#?_\ QZI]WC?_ * /A_\ \'L__P B4;O&_P#T ?#_ /X/9_\ Y$H
MTM.L+;2M+M=.L(_*M;2%(((]Q;8BJ%49.2< #D\U9K$W>-_^@#X?_P#![/\
M_(E&[QO_ - 'P_\ ^#V?_P"1* -NBL3=XW_Z /A__P 'L_\ \B4;O&__ $ ?
M#_\ X/9__D2@#;HK$W>-_P#H ^'_ /P>S_\ R)1N\;_] 'P__P"#V?\ ^1*
M-NBL3=XW_P"@#X?_ /![/_\ (E&[QO\ ] 'P_P#^#V?_ .1* -NBL3=XW_Z
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MV^Y-K"BBVA &Z1U:0X )^ZI=NN <58/B'2_$E]<^'KK3KPV]PTMMY[[5BF9
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MG]#6W0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %>7Z1\7-^MZQ;:Q]D86M[)9V=A81RR7D[K(57Y3\AR 3P>,<
MX%>H5R,_P[L)-'>SM[^]MIAJDFJP7<93S+>=V))7*E2/F(P0>#2UO?\ K=?I
M<'\-EO?]'^MB72?B'HNN:U9Z9I:7MQ-=6WVG>+8A(4W.I\PG[A#(5P>^*ZFN
M:\->!M-\*WGVC3YKF1S:+:MYS!M^)'D+G 'S%I&)[>U=+5.W]>O^0E>_W?E_
MF%>?V'Q1MV\3>([75H4M-+TJ)YK:\!+&X2([)^/]E\#BN_8;E(!*DC&1VKSB
M?X*^&H--8Z?;R-?_ &:XBGF:4(^H>:A!$SA3U8@Y X(J'=-OI9_?T^XK?3S7
MW=32/Q4T9=)NK^33M7C6SF6&XB>TQ)$3&),D;NFTYZ\]LU3?XM:787-Z+]9[
MJ)9I#;M86C-M@2**1G?+=A+G(QQQC/7$T?X/W>JZ5='QAJ-W!=SW9F3RYXKB
M18_(6$AW:(*20O!5 5XP<YKHE^$VC*ERHO;[%Q;3VS?,G"RPQ1,1\O4"%2/<
MFJU4G?:WXV7Z_J1&[Y;]]?Z_KH-U?XL:;907KZ7IM_J?V*YAMI7CBVQ[I'5<
M!CSD;NF.3@9[UW44GFPI)L9-ZAMKC#+D="/6N'NOA3IUY<ZE<SZI?&XO(8H8
MI56%3;")U=,80;R&0'+[N.*[B)&CA1'D:1E4 NV,L?4XXIJW+KO_ %_7^8+F
MOK_7]?U8XWQSX]D\(ZQHMI#9"ZCNY=U])G_CUM]RH9/^^Y%_#-4'^+.G:-K6
MNVGB=9;:WL;QX;>ZCMV,;!8%EV%LG,ARY  Z ?CJ>)OAAX=\7ZI=7_B"&2[F
MFM1:P[R,6@&[YH^.&);.3GH*H/\ "6S?4'NCK^K$LYG6-C"R).8!#YN#'R=@
M/!RI)Z5$;I._G^:M^"^]]ARW5OZT_P W]R[DP^)T#:M8VRZ%JOV>[TZ6_P#-
M,(+HJ,!C8"<YSUSW7UX@/Q8TPR+>*)5TZ.SGEN(&MB;E)(Y8X]O#;?\ EIT&
M<Y!!ILOP=TA]&L].AU348$M[>>WD>,Q?OUF<2,&4IM #@$!0!QC&.*=:_"#1
M[:VDB.HZA*9$E5W/E+GS)(Y&("H .8A@ 8 )]JK[7EK^MOPL0^?ETWT^[2YU
M?A[Q#:>)-/DN[*.XA\J=X)8;J(QR1NIY!4_A^=3ZU_R!KCZ#^8IFCZ+!HOVW
M[-)(_P!MNY+M_,(^5GQD# Z<4_6O^0-<?0?S%'1?+[^I:OU\_P#@!HO_ "!K
M?Z'^9J]5'1?^0-;_ $/\S5Z@84444 8GBC_CQA_ZZ?T-;=8GBC_CQA_ZZ?T-
M;= !117,_$:U^U_#C7D\^> +832$P/M+;4)VD^A[XI/0J,>:2CW.FHKR?6=3
MNX_B/HNHPVUR^GZ+';VES<QM'Y41N00ZN"P;O P*J<<Y(%>L572_K_7W69G&
M5_N3^\**XSQQJ]G-):: LN-3>_L9XK=N&F07*,Q3^]M"$MCH,9ZUR+>+->UV
M7Q/IKWE]:"&ROFDV?9/]#,;XB"!2TB[TSGS5!/5,=H<O=;7G^"3_ %+23:7I
M^)[#17ES^#+98_ VEB]F%BLCS-;?8[/RY'$32;F3R-N<\9 ![_>^:M&]U77K
M31_$VM0ZI<W/V&XFM[>Q6"#9&H*X?)4$LH)/S-MP!GN:<FHMKM?\+?YF<9\R
M3[V_%7_(] HKR:T\9>)+C2["6TN)YX=2NY-,M;F5;:23>VQHYRT&Z([5$V=I
MVG:.,YKLOB(WD> -1NF1I?L0CN]JCYF\J19./?Y:;T7-_7]6U*B[NW]=OS.G
MHK@_AYK%[?\ ]M:AXFCBL+YKZ.R:-G 5G6),!<]<ES@=>:Z7Q9_R)FM?]>$_
M_HLU,VX0<O*_X7*IVG))?UT->BO$)O$6N>&!=?:+[#7$T EO-/AMX N+1#&F
M+J4IR< _-N.#M )XW(/%7BGSGO#</+*\LD":488PBNM@)P 0N\MYF1RV,'&.
M].Z][R_X'^9E&::C_>/4Z*\1?Q?<Z8;^\L/$-QJ4-U=VT=UJD'V)7A_T=VV9
MEV0K\X"_-S_#RW-=GX5U'7]=NVO-1U.>S%O9VTKZ>EO$49Y(=S;CM+_>Y 5A
MW'/&"]DWV_RN-23MYG=T5Y!I?C?4[C2@NH>)_(@^W)'>:S&MNT=LIB=MJL8P
MJ9=54K*FY-P!))!K1T;Q-XAO+ZQN;O49%C:>S@>T^S1HDJRHQ9SE=X)PK !A
MCIS1?6WFE]X.:2OZO[O^&/3J***984444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 52U+6=+T:-)-8U*TL$<
MX5KJ=8@Q] 6(S5VN(-C::E\9-034;6&[2#1+<Q+/&'$9::7=@'IG:,_04:MI
M?UM<-HM]K?BTOU.KTW6-,UB%I=(U&TOXU.&>UG650?0E2:N5QD%C::=\7HDT
M^UAM4FT1S(L$80.5F7:2!UQDX^IKLZ%K%2[W_!M?H*_O-=O\D_U"BBB@96O]
M2L=*M3<ZI>V]E #@RW$JQJ#]6(%0:;K^CZTSKH^K6-^8QEQ:W*2[?KM)Q7->
M([6"_P#BGX8MKZ".YMQ97THBF0.N\>4 V#QD!B,^YHUG3;'3?B!X2DTZRM[1
MY)+J-V@B5"R>23M.!R,@''J*2V3?7_-K]!2=CM:***8PJ*ZN[>QMGN+V>*W@
MC&7EE<(JCU)/ J6N-\?Q1W6H^$K6YC66WFUM!+$XW*X$,K#(/!P0#]0*-;I+
MR#HWV3?W*YO:?XGT'5[C[/I6MZ=?38SY=M=QR-CUPI)K4KA_&FD:;IZ:#<V&
MGVMM.FMVH66&%48!FVL,@=P2#[5W%"U3?G;\$_U%?WK>5_S7Z!5'6O\ D#7'
MT'\Q5ZJ.M?\ (&N/H/YB@8:+_P @:W^A_F:O51T7_D#6_P!#_,U>H **** ,
M3Q1_QXP_]=/Z&MNL3Q1_QXP_]=/Z&MN@ HHHH **** "BBB@ HHHH J7&EVE
MWJ-I?7$;23V>XP$R-M0L,%MF=I;&1N(R 2 1DU;HHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ JEJ6LZ7HT:2:QJ5I8(YPK74ZQ!CZ L1FKM<0;&TU+XR:@FHVL-VD&B6YB
M6>,.(RTTN[ /3.T9^@HU;2_K:X;1;[6_%I?J=7INL:9K$+2Z1J-I?QJ<,]K.
MLJ@^A*DU<KC(+&TT[XO1)I]K#:I-HCF18(P@<K,NTD#KC)Q]379T+6*EWO\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M021O/</'O"I& _51M^487/7KN^#/B39>,=9NK"VCME,<1GA,%ZLS&,.4_>H
M#$^0#M.>".>H&W>^$=#U&X>>\L?,D>.&)F\UQE89/,C'#=FY]^^13](\+:1H
M-W<7.E6K0R7'#9GD=5&2VU%9B$7))PH R:J^NOG_ ,#[OZ\LK.VGE^"5_O.
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M&%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M<\<,DT:2RY\M&8!GP,G [X%25PWQ$MWEO-&F6+5V6+[1B32EF,B2&+$>3%R
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M@)EPN<YP%/!STJ*STJ4?"G18-.BUV*]T^YLQ)%+)=I('$L8E!#G+QA=W',8
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M?Q"\,:QJ$5E9:BWVB8[8DGM9H/,;&=JF1%!. 3@<UTM<G\0/^//0SW&N6?\
MZ,KK*%JF_.WX)_J*_O6\K_BU^@51UK_D#7'T'\Q5ZJ.M?\@:X^@_F*!AHO\
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MCI5PLA\264]N\6FO<9B5(-SK&N#(@*G(4]B,T*][/^M4OUO\B.9VO;^K-_\
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M !XP_P#73^AK;K$\4?\ 'C#_ -=/Z&MN@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** (+NRM;^#R;ZVAN8MROY<T8==RG*G
M![@@$'L14]%% #(8(K:+R[>)(DR6VHH49)R3@>I)/XT^BB@"."WAMD*6T,<*
ML[.5C4*"S$ECQW)))/<FI*** (KFUM[VUEMKR".XMYE*212H&1U/4$'@CVIZ
M(D4:QQJJ(H 55&  .P%.HH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *HZU_R!KCZ#^8J]5'6O^0-<?0?S% !HO_(&M_H?YFKU
M4=%_Y UO]#_,U>H **** ,3Q1_QXP_\ 73^AK;K$\4?\>,/_ %T_H:VZ "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M>_X_AN.Z_KS-VBL+6?%MGHNN:?I4UM<SW%]RGD^7\B[@NXAF#-@L,A Q Y(
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M$5E?S3*&/[OY2&;K'L)& 20*GT'X>Z'X<\27>M:=%MN;GS,CR85V>8P=_F5
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MUV5\R:Z*%B%!"@E%7<>3\S98]R:AMO#1/CO4?$-Y' /.LTLH%C=F+("6=W!
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M'"MXZ[(P3NV[E3>5W8^\7*CA<#BKWA>U@LO"FF6UH\DD,5LBJ\D;(S\<L58
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MY5*L3&R$="/,DYR"/EQ6:G@>.R\/W6EV5W)/_:%VDU[<700,Z@J& 6-%7)5
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M/S(]MEB02CRALYPZ@_/OZ8Z<5);>";>SM[-;;5M12XM;N:[%UF%I)&E8M(K
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M?(14*;V*(!$3S][;SP .E06?P[T^ST:]TX:A?R"[,+>>WDJ\30D&,H%C"#!
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M+M\^=VW/8YU+'5]8UFXT^QL/$TYM)KNYBBU6"&W=KR)(U97'[LQGYBRY50"
M>_(Z>UTFPLXFCM[2)%:1Y""N?F9BS'GW)J;[);?\^\7_ 'P*5OZ^?]?KTL2U
ME=::W^78XMO$VJ7OQ O-"M==G5&CN(3$JVXDMW2,%75-C,"3D[G)#=EP,UG3
M^,;W2OASX=FM?$%Y?M.I2\U!9;(RPS+&"(':;9&#N."&_>'!'4YKT7[);?\
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M^7\NX1JPW \?=PN!7=_9+;_GWB_[X%'V2V_Y]XO^^!52U;MI?_,E*W]>5O\
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M$<XZK%M!Q@$L>N*V/LEM_P ^\7_? JM9Z)IU@)A;6J S2M+(SDNS,>^6R?0
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M5C?9+;_GWB_[X%'V2V_Y]XO^^!0!LT5C?9+;_GWB_P"^!1]DMO\ GWB_[X%
M&S16-]DMO^?>+_O@4?9+;_GWB_[X% &S16-]DMO^?>+_ +X%'V2V_P"?>+_O
M@4 ;-%8WV2V_Y]XO^^!1]DMO^?>+_O@4 ;-%8WV2V_Y]XO\ O@4?9+;_ )]X
MO^^!0!LT5C?9+;_GWB_[X%'V2V_Y]XO^^!0!LT5C?9+;_GWB_P"^!1]DMO\
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MZ$C7O^_]A_\ )-'_  DNJ_\ 0D:]_P!_[#_Y)KHJ* .=_P"$EU7_ *$C7O\
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M $)&O?\ ?^P_^2:Z*B@#G?\ A)=5_P"A(U[_ +_V'_R31_PDNJ_]"1KW_?\
ML/\ Y)KHJ* .=_X275?^A(U[_O\ V'_R31_PDNJ_]"1KW_?^P_\ DFNBHH Y
MW_A)=5_Z$C7O^_\ 8?\ R35;4?&MYI6EW6HW_@W7HK6TA>>>3S;%MB*I9C@7
M))P >!S75USOQ"_Y)CXH_P"P/=_^B7H /^$EU7_H2->_[_V'_P DT?\ "2ZK
M_P!"1KW_ '_L/_DFNBHH YW_ (275?\ H2->_P"_]A_\DT?\)+JO_0D:]_W_
M +#_ .2:Z*B@#G?^$EU7_H2->_[_ -A_\DT?\)+JO_0D:]_W_L/_ ))KHJ*
M.8F\875HT#:CX3UJR@FN8;;[1+)9LJ-+(L:$A+AFQN=>@-=/7.^./^1?MO\
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M->_[_P!A_P#)-=%10!SO_"2ZK_T)&O?]_P"P_P#DFC_A)=5_Z$C7O^_]A_\
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M_P"A(U[_ +_V'_R37144 <[_ ,)+JO\ T)&O?]_[#_Y)H_X275?^A(U[_O\
MV'_R37144 <[_P )+JO_ $)&O?\ ?^P_^2:BF\875HT#:CX3UJR@FN8;;[1+
M)9LJ-+(L:$A+AFQN=>@-=/7.^./^1?MO^PQIG_I?!0!T5%%% !1110 4444
M%%%% %74YKF#2KJ6PB\ZY2)FBC/\3 <#\ZX7PKXFU.^U>""[UR*XD>)S<V-S
M:"WDA<#(V$#Y_P 3T&:[O4+-=0TZ>T>22(3(4WQMM9<]P?6N:M?!VH-J=C<Z
MUK?VY-.!%NHM@C$D8RS9)-+JQ]#FC\19O^$"#?VDW]N^;C/V7C;YGKMV?=_S
MFMGQIXHU73=3M[?1&!%K!]LOAL4YCW 8Y''?IS5X^!_^*$_X1O\ M#_EIO\
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MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N=^'O_),?"_\
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M=&\/^'=%U%/LEQ%)=*BVJI))&6#+EC@  [R#D^V*/M7?]?UH+[-D=-574O\
MD&S?0?SJU574O^0;-]!_.D,OZ+_R!K?Z'^9J]5'1?^0-;_0_S-7J "BBB@#G
MO%7_ "Z?\#_]EJ]5'Q5_RZ?\#_\ 9:O4 %%%% 'DOA;XDS:'X/T;2;OP!XX>
M>PL(+:5HM%)4LD:J2"6!QD=P*UO^%N_]4]\>?^"3_P"SK0T[6-:3Q(T&JSO&
M9Y9TMK5[=1!,J[C'Y4RY.[:,L'YX; &*M67B>Z.E6F;5[O4+R^N+:.%G5%4Q
MO)NRP&, (0#C)X]Z.EP>AB_\+=_ZI[X\_P#!)_\ 9T?\+=_ZI[X\_P#!)_\
M9UH+\0B\33+HTPA@ACGNF:908E:5XL ?Q$&,G'3'>J^M_$66S;4+73[&&2YA
MAN3"QNE;:T*ECO5<[>!D#.3W"T#2N[>GXE?_ (6[_P!4]\>?^"3_ .SH_P"%
MN_\ 5/?'G_@D_P#LZZ<^(I+;R(K^SV7$EC->,(Y R@1%,C.!R=X^E5[+Q7/?
MW1%OI,GV:.&&>:X:=0$21-_"]21SD<>V>E#T_KU_R9-]O/\ K]3 _P"%N_\
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M@X_.H3IEB3G[)#_WP* ,K^U;+_GM_P".-_A1_:ME_P ]O_'&_P *U?[+L?\
MGTB_[X%']EV/_/I%_P!\"@#D+31_#=CK']I6YG$P=I$C:XF:&)VSN9(B=B,<
MG) '4^IJ#6-*TV]TR*TTZX6U\JZ>Y!/GAMSEBY5T=70DN3PW3(Q@UVW]EV/_
M #Z1?]\"C^R['_GTB_[X%'2P'$:5X?\ #^GZ$-.G8W/F6Z03R'S%\U5=G'&>
M/F=CUSSR34@\/^%A<-*R2N&\W$3SS&-/-!$@5,[0&W'/'>NS_LNQ_P"?2+_O
M@4?V78_\^D7_ 'P*'KN"T.,GT'PU<VL%O-)>.ENKHC->W)<HX 9"Y;<5.!\I
M..!6E9#1=.#BS'EAXTC8'>V51=JCGT'%=#_9=C_SZ1?]\"C^R['_ )](O^^!
M0!RVE6.@:-,9+ RJ=GE(LDLLBQ)G.Q%8D(N>PQT'8##9_+D\2QZA'>0_9FM6
MMIX7A<LPSD%6!&.?8UU?]EV/_/I%_P!\"C^R['_GTB_[X%&^X'+3V/A^X\.Q
MZ%('&G11QQQQ1R2HR!""F'4A@05'.<\50?PUX8D,+/<ZL98-_ES?VQ?>:H?;
MN7?YF[:=B_+G''2NX_LNQ_Y](O\ O@4?V78_\^D7_? HOK<-M#DUTOPVNEMI
M[(\MN\ZW#^=++([R*0P8NQ+$Y4=3VQTK+/@KP:TT,K?;S);-FU<:E=JUJ,8*
MQ$.#&N#C:N!T]!CT#^R['_GTB_[X%']EV/\ SZ1?]\"@#!LY=,L=/6RBGFEA
M4$?Z3++.[ ]<O(2S=>Y-8]MX<\+VD=Q'"][MGB,'S7UR3#$2"4B.[,2\#A,=
M!V KMO[+L?\ GTB_[X%']EV/_/I%_P!\"@#AO^$5\(_9K>WVW7DP1"$(;VY(
MDB!)$<GS_O$&3A7R #@<<5>M]-\-6EW:W5O J3V;3M!)^\)0S-NDZ]02<X/
M[8KJ_P"R['_GTB_[X%']EV/_ #Z1?]\"G=BLCD]1TKPOJUQ<SZC:QSRW44<,
MS,'!9(W+H..F&.>*?:66A66NW6L6\MT+V[4),SW4[HP'0"-F*#'., 8R<=37
M4_V78_\ /I%_WP*/[+L?^?2+_O@4A[G,QVN@10VL,:82SN&NH!F3Y)6W9;W^
M^W!XY^E4VT+PPUU9W"_:HWLII)X!%>7**LCL6=BJL V2S9R#P2.G%=E_9=C_
M ,^D7_? H_LNQ_Y](O\ O@4!TL<K;Z=X;M;RUNX(%6>T:=X),R$H9FW2=>N2
M<X/ [8J'4M%\,ZOJ;7]^)WF>-(I52ZN$CF122JO&K!' +'A@>M=A_9=C_P ^
MD7_? H_LNQ_Y](O^^!0!QC>'_"SR7#/'(5N!(&B\^;RU\PYD*)G"%N^T#.3Z
MG+->TO3]0T75K729X;*YU6V%M-*\4C)MVE0=@(&X*<9]AG( KMO[+L?^?2+_
M +X%']EV/_/I%_WP*!IV=T8\6I6<4*1^?G:H&=C<X'TI_P#:ME_SV_\ '&_P
MK5_LNQ_Y](O^^!1_9=C_ ,^D7_? H)2LK&5_:ME_SV_\<;_"C^U;+_GM_P".
M-_A6K_9=C_SZ1?\ ? H_LNQ_Y](O^^!0,X5_"7@YY'D:&9I#,UQ&SW5PWV>1
MGWEXLL1$2Q)RF/RJT-%\-"P-H/M 0W/VOS!=7 E$V,%Q(&W@D<'!YR?4UV']
MEV/_ #Z1?]\"C^R['_GTB_[X% ')V6F^'M/U 7EJ9ED4LRHTTSQHS?>8(25#
M'N<9.3ZG.O\ VK9?\]O_ !QO\*U?[+L?^?2+_O@4?V78_P#/I%_WP* ,K^U;
M+_GM_P".-_A1_:ME_P ]O_'&_P *U?[+L?\ GTB_[X%']EV/_/I%_P!\"@#*
M_M6R_P">W_CC?X4?VK9?\]O_ !QO\*U?[+L?^?2+_O@4?V78_P#/I%_WP* ,
MK^U;+_GM_P".-_A1_:ME_P ]O_'&_P *U?[+L?\ GTB_[X%']EV/_/I%_P!\
M"@#*_M6R_P">W_CC?X4?VK9?\]O_ !QO\*U?[+L?^?2+_O@4?V78_P#/I%_W
MP* ,K^U;+_GM_P".-_A1_:ME_P ]O_'&_P *U?[+L?\ GTB_[X%']EV/_/I%
M_P!\"@#*_M6R_P">W_CC?X4?VK9?\]O_ !QO\*U?[+L?^?2+_O@4?V78_P#/
MI%_WP* ,K^U;+_GM_P".-_A1_:ME_P ]O_'&_P *U?[+L?\ GTB_[X%']EV/
M_/I%_P!\"@#*_M6R_P">W_CC?X4?VK9?\]O_ !QO\*U?[+L?^?2+_O@4?V78
M_P#/I%_WP* ,K^U;+_GM_P".-_A1_:ME_P ]O_'&_P *U?[+L?\ GTB_[X%'
M]EV/_/I%_P!\"@#*_M6R_P">W_CC?X4?VK9?\]O_ !QO\*U?[+L?^?2+_O@4
M?V78_P#/I%_WP* ,K^U;+_GM_P".-_A6+JNC^'-9OA=WQN/,*A)5AN)HDG09
MPLJ(0LBC)X8'J1T)KK_[+L?^?2+_ +X%']EV/_/I%_WP* .0UNPTO5;>Z,,J
M175PD2-*ZR$;8W+*!M*E2"S892&!.<\"JF@Z!HVDVCK=3M=7,OGAY2TQ^68K
MO7+,S'[B_,Q)XSD9KNO[+L?^?2+_ +X%']EV/_/I%_WP* .,CT#PO%=13Q+,
MGE21RI&MQ.(Q(BA5?9G!;"@9(YQ4LND>&Y8[R-C.$O9/-E1;F<*)-P?>B[L1
MMN ;*@'/-==_9=C_ ,^D7_? H_LNQ_Y](O\ O@47#8Y73[#P_I;(]H)!(DLD
MPDDEED8NX =B6))) '6BUL/#]GJ9O[<R++O=U0RRF)'?[[+&3M4GN0.Y]3GJ
MO[+L?^?2+_O@4?V78_\ /I%_WP* .;U!K.\O+"[CNO+FLIBZDHQ#*RE64\=P
M<_4"J$/A_P *PW%U+Y4DGVJ-XFCFFFDC1'.75$8E8PQY.T#-=G_9=C_SZ1?]
M\"C^R['_ )](O^^!0!R<.F^'H=/O+,^;-%?1^7<M/-+))(F-H4NQ+8 ) YXR
M>YJ:[MM!OC<FZ7>;J&.&;F0;T0EE''3!8\CUKIO[+L?^?2+_ +X%']EV/_/I
M%_WP*=V'2QS=C%HNFW=S<64DT;73F25#-*T>XG)(C)*J2>25 S5?4M,\.ZM?
M"[O@[R;520+)*B3*IW*LBJ0K@$D@,#U/J:ZS^R['_GTB_P"^!1_9=C_SZ1?]
M\"D!Q=IX;\'V&S['9)#Y:11KM,G"QRF5!U[.2??H<CBI;K1_#5W(\CB:*5Y)
M)&E@GFB<EP XW*0=IVKE>G /6NO_ ++L?^?2+_O@4?V78_\ /I%_WP* ,"T;
M1K%Y&M L9E5$<!6P0@VJ,=!@<5C3>']!%A<VME+)$+J,6TC2R2R[+?=EHT#$
M[01D<=,^P%=Q_9=C_P ^D7_? H_LNQ_Y](O^^!1UN'D9*ZI8JH59< # &P_X
M4O\ :ME_SV_\<;_"M7^R['_GTB_[X%']EV/_ #Z1?]\"@#*_M6R_Y[?^.-_A
M1_:ME_SV_P#'&_PK5_LNQ_Y](O\ O@4?V78_\^D7_? H RO[5LO^>W_CC?X4
M?VK9?\]O_'&_PK5_LNQ_Y](O^^!1_9=C_P ^D7_? H RO[5LO^>W_CC?X4?V
MK9?\]O\ QQO\*U?[+L?^?2+_ +X%']EV/_/I%_WP* ,K^U;+_GM_XXW^%']J
MV7_/;_QQO\*U?[+L?^?2+_O@4?V78_\ /I%_WP* ,K^U;+_GM_XXW^%<[?>&
M/"&IWEU<ZA;O<M>-OFCDGG:)GVA0XBW;%<!1A@ 1CK7;_P!EV/\ SZ1?]\"C
M^R['_GTB_P"^!0!QZ:+X:6UO('-Q,+W9]HDEN9WD<H<H0Y;*D'H5((P/2EAT
M?PY!?)=(UR9%=9"'NIW61U&%=U9B'8# W-D\#T&.O_LNQ_Y](O\ O@4?V78_
M\^D7_? H#I8RO[5LO^>W_CC?X4?VK9?\]O\ QQO\*U?[+L?^?2+_ +X%']EV
M/_/I%_WP* ,K^U;+_GM_XXW^%']JV7_/;_QQO\*U?[+L?^?2+_O@4?V78_\
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M* ,K^U;+_GM_XXW^%']JV7_/;_QQO\*U?[+L?^?2+_O@4?V78_\ /I%_WP*
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
:*** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>halo-20250318_g12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20250318_g12.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+Z17AI9@  34T *@    @ ! $[  (
M   0   !2H=I  0    !   !6IR=  $    @   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1V5T87-E=R!997-E9V%T   %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,U.   DI(  @    ,U.   ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
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M_P#\>J5?^2IZU_V!=._]'WM;= '/_P#"&:;_ ,_WB#_PHK__ ./4?\(9IO\
MS_>(/_"BO_\ X]7044 <_P#\(9IO_/\ >(/_  HK_P#^/4?\(9IO_/\ >(/_
M  HK_P#^/5T%% '/_P#"&:;_ ,_WB#_PHK__ ./4?\(9IO\ S_>(/_"BO_\
MX]7044 <_P#\(9IO_/\ >(/_  HK_P#^/4?\(9IO_/\ >(/_  HK_P#^/5T%
M% '/_P#"&:;_ ,_WB#_PHK__ ./4?\(9IO\ S_>(/_"BO_\ X]7044 <_P#\
M(9IO_/\ >(/_  HK_P#^/4?\(9IO_/\ >(/_  HK_P#^/5T%% '/_P#"&:;_
M ,_WB#_PHK__ ./4?\(9IO\ S_>(/_"BO_\ X]7044 <_P#\(9IO_/\ >(/_
M  HK_P#^/4?\(9IO_/\ >(/_  HK_P#^/5T%% '/_P#"&:;_ ,_WB#_PHK__
M ./4?\(9IO\ S_>(/_"BO_\ X]7044 <_P#\(9IO_/\ >(/_  HK_P#^/4?\
M(9IO_/\ >(/_  HK_P#^/5T%% '/_P#"&:;_ ,_WB#_PHK__ ./4?\(9IO\
MS_>(/_"BO_\ X]7044 <_P#\(9IO_/\ >(/_  HK_P#^/4?\(9IO_/\ >(/_
M  HK_P#^/5T%% '/_P#"&:;_ ,_WB#_PHK__ ./4?\(9IO\ S_>(/_"BO_\
MX]7044 <_P#\(9IO_/\ >(/_  HK_P#^/4?\(9IO_/\ >(/_  HK_P#^/5T%
M% '/_P#"&:;_ ,_WB#_PHK__ ./4?\(9IO\ S_>(/_"BO_\ X]7044 <_P#\
M(9IO_/\ >(/_  HK_P#^/4?\(9IO_/\ >(/_  HK_P#^/5T%% '/_P#"&:;_
M ,_WB#_PHK__ ./4?\(9IO\ S_>(/_"BO_\ X]7044 <_P#\(9IO_/\ >(/_
M  HK_P#^/4?\(9IO_/\ >(/_  HK_P#^/5T%% '/_P#"&:;_ ,_WB#_PHK__
M ./4?\(9IO\ S_>(/_"BO_\ X]7044 <_P#\(9IO_/\ >(/_  HK_P#^/4?\
M(9IO_/\ >(/_  HK_P#^/5T%% '/_P#"&:;_ ,_WB#_PHK__ ./4?\(9IO\
MS_>(/_"BO_\ X]7044 <_P#\(9IO_/\ >(/_  HK_P#^/5I^ ;F>\^&WAJZO
M)I)[B;2;62665RSR,85)9B>223DDU=K.^''_ "2SPI_V!;/_ -$)0!TE%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% '(K_
M ,E3UK_L"Z=_Z/O:VZQ%_P"2IZU_V!=._P#1][6W0 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 5G?#C_ ))9X4_[ MG_ .B$K1K.
M^''_ "2SPI_V!;/_ -$)0!TE%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% '(K_ ,E3UK_L"Z=_Z/O:VZQ%_P"2IZU_V!=.
M_P#1][6W0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 5G?#C_ ))9X4_[ MG_ .B$K1K.^''_ "2SPI_V!;/_ -$)0!TE%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 5P_BW1M,USXB>'[;6M.M-1@72M1D6*[@65
M0PELP& 8$9P2,^YKN*Y/6?\ DIV@_P#8'U'_ -'65 %;_A7O@O\ Z%#0?_!9
M#_\ $T?\*]\%_P#0H:#_ ."R'_XFNBHH YW_ (5[X+_Z%#0?_!9#_P#$T?\
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M% !1110 4444 %%%% !1110 5G?#C_DEGA3_ + MG_Z(2M&L[X<?\DL\*?\
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M9S6R['BEN68,)94/25,$ CKZ4_\ MW6_^A%U[_P(L/\ Y*KL** ./_MW6_\
MH1=>_P# BP_^2J/[=UO_ *$77O\ P(L/_DJNPHH X_\ MW6_^A%U[_P(L/\
MY*H_MW6_^A%U[_P(L/\ Y*KL** ./_MW6_\ H1=>_P# BP_^2J/[=UO_ *$7
M7O\ P(L/_DJNPHH X_\ MW6_^A%U[_P(L/\ Y*H_MW6_^A%U[_P(L/\ Y*KL
M** ./_MW6_\ H1=>_P# BP_^2J/[=UO_ *$77O\ P(L/_DJNPHH X_\ MW6_
M^A%U[_P(L/\ Y*H_MW6_^A%U[_P(L/\ Y*KL** ./_MW6_\ H1=>_P# BP_^
M2J/[=UO_ *$77O\ P(L/_DJNPHH X_\ MW6_^A%U[_P(L/\ Y*H_MW6_^A%U
M[_P(L/\ Y*KL** ./_MW6_\ H1=>_P# BP_^2J/[=UO_ *$77O\ P(L/_DJN
MPHH X_\ MW6_^A%U[_P(L/\ Y*H_MW6_^A%U[_P(L/\ Y*KL** ./_MW6_\
MH1=>_P# BP_^2J/[=UO_ *$77O\ P(L/_DJNPHH X_\ MW6_^A%U[_P(L/\
MY*H_MW6_^A%U[_P(L/\ Y*KL** ./_MW6_\ H1=>_P# BP_^2J/[=UO_ *$7
M7O\ P(L/_DJNPHH X_\ MW6_^A%U[_P(L/\ Y*H_MW6_^A%U[_P(L/\ Y*KL
M** ./_MW6_\ H1=>_P# BP_^2J/[=UO_ *$77O\ P(L/_DJNPHH X_\ MW6_
M^A%U[_P(L/\ Y*H_MW6_^A%U[_P(L/\ Y*KL** ./_MW6_\ H1=>_P# BP_^
M2J/[=UO_ *$77O\ P(L/_DJNPHH X_\ MW6_^A%U[_P(L/\ Y*H_MW6_^A%U
M[_P(L/\ Y*KL** ./_MW6_\ H1=>_P# BP_^2J/[=UO_ *$77O\ P(L/_DJN
MPHH X_\ MW6_^A%U[_P(L/\ Y*H_MW6_^A%U[_P(L/\ Y*KL** ./_MW6_\
MH1=>_P# BP_^2J/[=UO_ *$77O\ P(L/_DJNPHH X_\ MW6_^A%U[_P(L/\
MY*K5\%:?=:1X!\/Z;J$7DW=GIEM!/'N#;'2)589!(."#R#BMNB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "N3UG_ )*=H/\ V!]1_P#1UE765R>L_P#)
M3M!_[ ^H_P#HZRH V:*** "BBB@ HHHH *Q&_P"2IZ+_ -@74?\ T?95MUB-
M_P E3T7_ + NH_\ H^RH ZZBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKD]9_P"2G:#_ -@?4?\ T=95UE<GK/\ R4[0?^P/J/\ Z.LJ -FBBB@ HHHH
M **** "L1O\ DJ>B_P#8%U'_ -'V5;=8C?\ )4]%_P"P+J/_ */LJ .NHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *Y/6?\ DIV@_P#8'U'_ -'65=97
M)ZS_ ,E.T'_L#ZC_ .CK*@#9HHHH **** "BBB@ K$;_ )*GHO\ V!=1_P#1
M]E6W6(W_ "5/1?\ L"ZC_P"C[*@#KJ*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "N3UG_ )*=H/\ V!]1_P#1UE765R>L_P#)3M!_[ ^H_P#HZRH V:**
M* "BBB@ HHHH *Q&_P"2IZ+_ -@74?\ T?95MUB-_P E3T7_ + NH_\ H^RH
M ZZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD]9_P"2G:#_ -@?4?\
MT=95UE<GK/\ R4[0?^P/J/\ Z.LJ -FBBB@ HHHH **** "L1O\ DJ>B_P#8
M%U'_ -'V5;=8C?\ )4]%_P"P+J/_ */LJ .NHHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *Y/6?\ DIV@_P#8'U'_ -'65=97)ZS_ ,E.T'_L#ZC_ .CK
M*@#9HHHH **** "BBB@ K$;_ )*GHO\ V!=1_P#1]E6W6(W_ "5/1?\ L"ZC
M_P"C[*@#KJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N3UG_ )*=H/\
MV!]1_P#1UE765R>L_P#)3M!_[ ^H_P#HZRH V:*** "BBB@ HHHH *Q&_P"2
MIZ+_ -@74?\ T?95MUB-_P E3T7_ + NH_\ H^RH ZZBBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KD]9_P"2G:#_ -@?4?\ T=95UE<GK/\ R4[0?^P/
MJ/\ Z.LJ -FBBB@ HHHH **** "L1O\ DJ>B_P#8%U'_ -'V5;=8C?\ )4]%
M_P"P+J/_ */LJ .NHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y/6?\
MDIV@_P#8'U'_ -'65=97)ZS_ ,E.T'_L#ZC_ .CK*@#9HHHH **** "BBB@
MK$;_ )*GHO\ V!=1_P#1]E6W6(W_ "5/1?\ L"ZC_P"C[*@#KJ*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "N3UG_ )*=H/\ V!]1_P#1UE765R>L_P#)
M3M!_[ ^H_P#HZRH V:*** "BBB@ HHHH *Q&_P"2IZ+_ -@74?\ T?95MUB-
M_P E3T7_ + NH_\ H^RH ZZBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MKD]9_P"2G:#_ -@?4?\ T=95UE<GK/\ R4[0?^P/J/\ Z.LJ -FBBB@ HHHH
M **** "L1O\ DJ>B_P#8%U'_ -'V5;=8C?\ )4]%_P"P+J/_ */LJ .NHHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH *Y/6?\ DIV@_P#8'U'_ -'65=97
M)ZS_ ,E.T'_L#ZC_ .CK*@#9HHHH **** "BBB@ K$;_ )*GHO\ V!=1_P#1
M]E6W6(W_ "5/1?\ L"ZC_P"C[*@#KJ*** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "N3UG_ )*=H/\ V!]1_P#1UE765R>L_P#)3M!_[ ^H_P#HZRH V:**
M* "BBB@ HHHH *Q&_P"2IZ+_ -@74?\ T?95MUB-_P E3T7_ + NH_\ H^RH
M ZZBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KD]9_P"2G:#_ -@?4?\
MT=95UE<GK/\ R4[0?^P/J/\ Z.LJ -FBBB@ HHHH **** "L1O\ DJ>B_P#8
M%U'_ -'V5;=8C?\ )4]%_P"P+J/_ */LJ .NHHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH *Y/6?\ DIV@_P#8'U'_ -'65=97)ZS_ ,E.T'_L#ZC_ .CK
M*@#9HHHH **** "BBB@ K$;_ )*GHO\ V!=1_P#1]E6W6(W_ "5/1?\ L"ZC
M_P"C[*@#KJ*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "N3UG_ )*=H/\
MV!]1_P#1UE765R>L_P#)3M!_[ ^H_P#HZRH V:*** "BBB@ HHHH *Q&_P"2
MIZ+_ -@74?\ T?95MUB-_P E3T7_ + NH_\ H^RH ZZBBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ KD]9_P"2G:#_ -@?4?\ T=95UE<GK/\ R4[0?^P/
MJ/\ Z.LJ -FBBB@ HHHH **** "L1O\ DJ>B_P#8%U'_ -'V5;=8C?\ )4]%
M_P"P+J/_ */LJ .NHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *Y/6?\
MDIV@_P#8'U'_ -'65=97)ZS_ ,E.T'_L#ZC_ .CK*@#9HHHH **** "BBB@
MK$;_ )*GHO\ V!=1_P#1]E6W6(W_ "5/1?\ L"ZC_P"C[*@#KJ*** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "N3UG_ )*=H/\ V!]1_P#1UE765R>L_P#)
M3M!_[ ^H_P#HZRH V:*** "BBB@ HHHH *Q&_P"2IZ+_ -@74?\ T?95MUB-
M_P E3T7_ + NH_\ H^RH ZZBBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M\$U<VN;3N_\ VZW_ +:9I.WR_2-_U.N\.>*O$'B;X/S:]%%86VMM%<^6A5A
MCQNZC(RQ_A]3S7GVG>)/']S:?#687EI=:EJB7;B-KJ6*"X3R04:XP#N9<DX
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M(L1!7+$8.[/!XQ5Q?A=HBWBW'VF^++K;:WM,B8,[+M*_<^YCMU]Z4=$F]_\
M@Q?Z2">J:7]:27ZHYY/B'XEA\?V>EZBFA7.C:K+<06DVE-<220M&A;YY641L
M?EP0O(_"N?\  'CWQEIGAGPG=^((;._T+5KO^SQ=/=2RWWFO(X61RWR[>,8Y
M.!U[5VFD_!KP_HVIV5[::AK3?V?<236=O-?&2&W5U96C1",!3N)_O9Q\U,\/
M_!;P[X=OM.G@O]:O(=-8RVUE>7N^W68DGSO+  #\GI@=\9YIQLK7\@EUM_7]
M:'+Z9XIU34)/!<HN9[9;CQ!J%O/%%=SLLR() H;S'8D< XS@=@*H^&?%_CG5
M]9\#IIEQIT-AJ"WKS0W$MS*7\J5E<LSNSG"%=@+8SG. !CTBQ^&.C6"Z2(;F
M^;^RK^>_@WR)\TDV[<&^3E1N.,8/N:K6OPGT6PM_#Z66H:O ^@3RS6TL5RJ/
M*)'WO')A0&0G@@ <<9I1LM_ZT'+6]OZU?_ *&B?$35]7N?#NEFTM$U:YO;N#
M5D$;[(([8D.R#=D%B8\9)^]WK4\9>)_$-MXAT_PUX*M-.EU>\MY+MIM4=Q;Q
M1(RJ>$^8L2V!CI53P;X1N+?XC>)?%U_ILNF_VCY<5K;3S1NZ@*/,D/ELRKO9
M5X!)^7GTK:\7>!=.\8-:S7%YJ.F7UIN$&H:7<F"XC5L;EW8/RG R"*72+^_^
MON_$75_A_7X'ENO^+_&/B[5_"=CIC6NE>?J-S8ZA:I>W$6^X@SO'FPE6,>WE
M<'[QP<@5TGQSO[VPTCPY'97>NVZ7.K+#.N@2LMW*GEN=J8/S'@<&NHM?AQH5
MC)X?:R^TPC0999K<"4-YSRJ0[2E@2Q.2<Y'-:>O>&++Q%=Z1<7LLZ/I-ZM[
M(64!G"D -D'(PQZ8/O3=K)>?^0=WY/\ 6WZ'CVE^)_&/@_PKJ^J6D&O7-@UY
M9V^FQ>-#_I3/(^V7.TA@O*X)_(UU]WXJ^(3:O#X<TK3_  [+KMO9_;M1EFEF
M%J(VD94CBQ\Y<A>6.!GM79^*/#-GXLTE-.U&6>*%+B*X#0, VZ-PZCD'C(YK
M+\6?#O2_%FH0:A+?:II5]%'Y+76E79MY)H<Y,3D [ESSCK[T-W7]=M/Q%;^O
MGK^'XG)ZC\7=1L_#>C>(DTVV-CJT4MHMJ6/FQ:BI*HA?(4Q$JPS@8QG/-:>J
M^/M7\)WEW;^*(;)S'H!U*![2)U62XC.V6/YF/&63'?!-:5U\*O#-[!;6MS#-
M)86=@]C:V)D'E0!_O2+QN\PC^(D^W4UC>*O -QKM_P"$-'%O?7=CHMPDUSJ]
MY/%F6)1_J2%(9F8JF?D"X&<DT:-V[O\ #7\M_N7J]M?ZZ?GM][ZZ7O'.I:U;
M_ G4=1NIOL&L_P!F++*]BS1>3*0"=AR6&"<=:\L\3>+/$;?#FTT2WUW4(=6T
M22YDU&\AN66:2.)U2+>X;/SB9#SUQ7OOB30+7Q3X;O=$U"2:.VO8O*D> @.!
M[$@C/X&N;OOA-X>O[K7[B22\CEUZWAM[IHY$RJQ8P4RIP3M&<Y!QT%--<S;V
M_JP+2*75?EI<P_%OQ$\2^&M>ADM4T&]T.*XM[6ZBC:XEO4:3 RQ5?+C/S X8
MG/'.6 K'_P"%C>*_"S>.]6\2OIMW9:;?QVEG%&9!Y4C[-F>/]6%8%L MNSCC
M%=9J/P;\/ZEJUY?/?ZS +NXCNGM8+TK;B="I$HCP5+': =V1Z =:O7?POT.^
MU+7+JYN-2>/7-C7-J+HB%)4V[9HP!E9!L7YL]JGI]_Z?\'[Q?\#]?^ >>Z?\
M==5U#P7J5S9)HNH:S87EI#YEJEPEI,D\FT8$H5U88(YR._/2NE3Q/XBT[QXU
MCXA_L>*]B\.2WLCI>W,5FCB<A0=S%0NW&7\O=UP<<5LK\+[!O#1T:_U[Q#J:
M-=Q71N=0U SRAHW#*H++M5<CD!1GUJWXA^'6B>)]7NM0U9KIVNM,.F21)(%3
MRR^_<.,A@P'.<>U-M=//_P!)M^8X^?E_Z5K^!YOJWQ#\67'A/QGI6MM8VVI:
M?I:7MK?Z']IA3:[8X:4!B>/O+QU'8ULWGQ%\3:;XPM--FCT33=(5+=?M.LFY
MC>]WH"6CG5#$#DD;6.25/X;,/P:T..QU*WEU;7+M]4L%L;JXN[T32NBMN5@S
M*<$=,#Y<=L\U9UGX5Z9KNH1RWVN>(OL2JBRZ6FIN+.<+C&Z(_09"D#CI35KK
M^NXG=K^O+];E3XWZIK^D?#.XN_#-W':2^?%'/,7=9%C=PO[MEY#;BHSZ9QSB
ML.+Q=X[T^WO+/1M,T:[B\+VZ?VP]W?7+R7,AC\QE@=RS8"G[TA.?PKT;Q5X7
MLO%WAN;1-1DGAMI6C8M;LJN-CAA@D$=5':L+Q#\*M"\1ZU)J4]WJMD;E%CO[
M>PO6AAU!5& )E'WL#CC'%2M$_7_*WZZ%::7,K0O'OB3Q7X_:PT&VTE-"AM;.
M]FFNA*+CRIHRQ50#M+9[G &#US3O&.K^,+;XO>%M,T2YT^/2;N&:2:&?>&DV
M8\PG;W"L-G;=G/:NLTGPCINB^)-0UFQ,R37\$%N\)*^5&D((0( ,C@]R?PJ+
MQ%X+L?$>M:/JL]YJ%G=Z1*SPO93^7YBMC=&_!RAVC(X^M.5KJPE>SOV7]?F>
M6_#[Q_XNL-'\*MKL=K>Z+JU]/8B\FNI9;TR;Y"K'(P%&W;C)/ Y'2K'@WX^'
MQ+X^MM*F&F"QU*=X;6W@6X^UVQ )5IBR^4P;;T0\;AUP:[JS^&.BV.C:#IL5
MS?-#H5^U_;%Y$+/(2Y(?Y,%?G/  /3FG:#\-]-\-Z\VH:7JVN);99HM);47-
ME"6R25B^I)P20">G2FFN;7;^O^"$M;V_K5_\ J?%OQ'_ &'X2ALX=532;K6+
MN*QCO&G$7V=&.9)0Y(V[4#<YX)%<A8?$S4='^$]W-IEY:^(=3T;5TTL7$TYF
M6\C:4".0NK<ED8?-D\@\'I7I&O>!M$\3Z]8:GK]N-0%A%)'#97*));DOC+LC
M*<M\H .>/2L:\^#_ (7GN[J6QCFTJ&Z:V>6TTY8H82\$F]'"[."3P?4>_-3'
MSZO]5^E_O"6VG];_ / ^XY?6/BGXP\.:7XIAUG2]&_MC1Q:3VZVK2R0R13R;
M=K9*L6'J,#/;UGOOB9XNT.W\56^OZ;H\6I:7ID>IV0M7EDB,;MMV2;MI+ CD
MC:*ZOQ!\,M&\27FK7-]<WT;ZM%;13B&1 %$#[TVY0X)/7.>.F*L:M\/=&UO5
MM3O]1:YD;4]-73)XA( GE!BP*X&0V3USCVHZ>>OY:?B/K]WYJ_ZF<_C?44\<
MIHQCT]+9O#IU4RSLT867>%PSY(6/'4[217!Z[\1_%DGA_P 5:3K+Z=!=PZ-_
M:-CJ&A&YC55\P)C?( 2>?O+QU'T[33O@QX?LI+J2[U+6]5>[TU],F;4;[SBT
M+-G@[05(P -N /3/-1Q?!/04L[N";5]>NWO-/.G37%W>B:1HMX8 %E(7;C
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M9QZ;3S6CK.AVVN+9+=O*@LKR.\C\H@9=#D Y!X]?YT/7E\N7\+7!_:MY_P#
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M6,J[OOP OF<@*<XZBK=[XHU_2/[5M;N+3[RZTNWAU!Y88VA2>V9G#J%9VV2
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M 4444 %%%5M0M9KVPDM[:_N-/E?&VYMEC,B8(/ D5EYQCE3P>QYH LT5S?\
MPB^K_P#0]^(/^_&G_P#R+5G3]!U&ROX[BY\6:QJ$29W6US%9B-\@CDQP*W&<
M\,.1W'% &W16)J&@ZC>W\EQ;>+-8T^)\;;:VBLS&F !P9(&;G&>6/)[#BJW_
M  B^K_\ 0]^(/^_&G_\ R+0!TE%9$6C7T>C363^)=4EN)'#+J#QVOG1#CY5
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M^)=4TI%0*8;..U9&.2=Q\V%VSSC@XX''7-+_ (1?5_\ H>_$'_?C3_\ Y%H
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MTN[M=*N+2?7=0O)I=VR]GCMQ+#E<#:$B5#@\C<K<GG(XH TJ*YO_ (1?5_\
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MO_CE &G_ ,-!_#'_ *&;_P D+G_XW1_PT'\,?^AF_P#)"Y_^-UF?\(_\!/\
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M."#CW% #/^&@_AC_ -#-_P"2%S_\;H_X:#^&/_0S?^2%S_\ &ZT?^%,?#O\
MZ%.P_)O\:/\ A3'P[_Z%.P_)O\: ,[_AH/X8_P#0S?\ DA<__&Z/^&@_AC_T
M,W_DA<__ !NM'_A3'P[_ .A3L/R;_&C_ (4Q\._^A3L/R;_&@#._X:#^&/\
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M_P"%,?#O_H4[#\F_QH SO^&@_AC_ -#-_P"2%S_\;H_X:#^&/_0S?^2%S_\
M&ZT?^%,?#O\ Z%.P_)O\:/\ A3'P[_Z%.P_)O\: ,[_AH/X8_P#0S?\ DA<_
M_&Z/^&@_AC_T,W_DA<__ !NM'_A3'P[_ .A3L/R;_&C_ (4Q\._^A3L/R;_&
M@#._X:#^&/\ T,W_ )(7/_QNC_AH/X8_]#-_Y(7/_P ;K1_X4Q\._P#H4[#\
MF_QH_P"%,?#O_H4[#\F_QH SO^&@_AC_ -#-_P"2%S_\;H_X:#^&/_0S?^2%
MS_\ &ZT?^%,?#O\ Z%.P_)O\:/\ A3'P[_Z%.P_)O\: ,[_AH/X8_P#0S?\
MDA<__&Z/^&@_AC_T,W_DA<__ !NM'_A3'P[_ .A3L/R;_&C_ (4Q\._^A3L/
MR;_&@#._X:#^&/\ T,W_ )(7/_QNC_AH/X8_]#-_Y(7/_P ;K1_X4Q\._P#H
M4[#\F_QH_P"%,?#O_H4[#\F_QH SO^&@_AC_ -#-_P"2%S_\;H_X:#^&/_0S
M?^2%S_\ &ZT?^%,?#O\ Z%.P_)O\:/\ A3'P[_Z%.P_)O\: ,[_AH/X8_P#0
MS?\ DA<__&Z/^&@_AC_T,W_DA<__ !NM'_A3'P[_ .A3L/R;_&C_ (4Q\._^
MA3L/R;_&@#._X:#^&/\ T,W_ )(7/_QNC_AH/X8_]#-_Y(7/_P ;K1_X4Q\.
M_P#H4[#\F_QH_P"%,?#O_H4[#\F_QH SO^&@_AC_ -#-_P"2%S_\;H_X:#^&
M/_0S?^2%S_\ &ZT?^%,?#O\ Z%.P_)O\:/\ A3'P[_Z%.P_)O\: ,[_AH/X8
M_P#0S?\ DA<__&Z/^&@_AC_T,W_DA<__ !NM'_A3'P[_ .A3L/R;_&C_ (4Q
M\._^A3L/R;_&@#._X:#^&/\ T,W_ )(7/_QNC_AH/X8_]#-_Y(7/_P ;K1_X
M4Q\._P#H4[#\F_QH_P"%,?#O_H4[#\F_QH SO^&@_AC_ -#-_P"2%S_\;H_X
M:#^&/_0S?^2%S_\ &ZT?^%,?#O\ Z%.P_)O\:/\ A3'P[_Z%.P_)O\: ,[_A
MH/X8_P#0S?\ DA<__&Z/^&@_AC_T,W_DA<__ !NM'_A3'P[_ .A3L/R;_&C_
M (4Q\._^A3L/R;_&@#._X:#^&/\ T,W_ )(7/_QNC_AH/X8_]#-_Y(7/_P ;
MK1_X4Q\._P#H4[#\F_QH_P"%,?#O_H4[#\F_QH SO^&@_AC_ -#-_P"2%S_\
M;H_X:#^&/_0S?^2%S_\ &ZT?^%,?#O\ Z%.P_)O\:/\ A3'P[_Z%.P_)O\:
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M_AC_ -#-_P"2%S_\;H_X:#^&/_0S?^2%S_\ &ZT?^%,?#O\ Z%.P_)O\:/\
MA3'P[_Z%.P_)O\: ,[_AH/X8_P#0S?\ DA<__&Z/^&@_AC_T,W_DA<__ !NM
M'_A3'P[_ .A3L/R;_&C_ (4Q\._^A3L/R;_&@#._X:#^&/\ T,W_ )(7/_QN
MC_AH/X8_]#-_Y(7/_P ;K1_X4Q\._P#H4[#\F_QH_P"%,?#O_H4[#\F_QH S
MO^&@_AC_ -#-_P"2%S_\;H_X:#^&/_0S?^2%S_\ &ZT?^%,?#O\ Z%.P_)O\
M:/\ A3'P[_Z%.P_)O\: ,[_AH/X8_P#0S?\ DA<__&Z/^&@_AC_T,W_DA<__
M !NM'_A3'P[_ .A3L/R;_&C_ (4Q\._^A3L/R;_&@#._X:#^&/\ T,W_ )(7
M/_QNC_AH/X8_]#-_Y(7/_P ;K1_X4Q\._P#H4[#\F_QH_P"%,?#O_H4[#\F_
MQH I0?'SX9W$Z11^)T#.< R6=PB_BS1@#\37H%K=6][:Q7-G/'<6\RAXY8G#
M(ZGH01P1[UP>H? SX>7^GS6H\.6]J94*B>W9EDC/9E.>H]\CU!KB?V6M3NY/
M#FOZ-/,TMMIMXIM]Q^YO#;@/093./4F@#W>BBB@ KD?BO_R2+Q1_V#)O_037
M75R/Q7_Y)%XH_P"P9-_Z": .6^ O_)$= _[>/_2F6O1*\[^ O_)$= _[>/\
MTIEKT2@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M *R?!W_(;\8?]AJ/_P!(+2M:LGP=_P AOQA_V&H__2"TH ZFBBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH YWQIXI_P"$1T>WO?*LW\^[CMMU]>?988]V?F>38V ,>E<E<?&%HK73I!I^
MDP->07,P>_UG[/#)Y,@3$#^2WF[\[E.%R*] U71[?5_L7VEY%^QW:7<?ED#+
MIG .0>.:HZYX/TOQ%>//J8ED#V$M@T:L ICD9&+=,A@47!!XI+S\_P M/Q#_
M ('YZ_@<^?B7+)I]WJL&AL-+TQ(FU-[BX\N>W+QK(56+80Y177=EE[XS5AO'
MFH2>,+KPU8^'_/O[>)KK<]YLB>WV_NY VP_,S_)MQQ@G)&,S'X<6#(T4FJZK
M);W*1KJ%NTL934"BA0TOR9W$*H.PINQSFIK?X?Z5;>*!XBBGO/[5-P\SW)D7
M=)&R[?(;Y?\ 5  848((SG.<V[7T_K^OR\Q*]OZ_K_@^0O@_QI_PF+W,EIIL
MMO:6JI')-,_S"YQF2';C^#@%L]21CBNHK-T/0K;0+:Y@LWE=;F[FNW,I!(>5
MRS 8 XR>/YFM*DQ]0HHHI %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %?/O[+'_,X_P#7W!_[5KZ"KY]_98_Y
MG'_K[@_]JT ?05%%% !7(_%?_DD7BC_L&3?^@FNNKD?BO_R2+Q1_V#)O_030
M!RWP%_Y(CH'_ &\?^E,M>B5YW\!?^2(Z!_V\?^E,M>B4 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !63X._Y#?C#_L-1_\ I!:5
MK5D^#O\ D-^,/^PU'_Z06E '4T444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %>=^.O%^N:#XAO;;2K>ZNH4\/3W:K;K!_H\JM@3,96
M4E0.PW?[IKT2JT^F6-U,\MS96\TDD)MW>2)6+1'JA)'*GTZ5,DWMY_DQII?A
M^:/)V^)&KCQMHL8NYCI$*6=OJ86P+1R3W$9.YI@FV/:S0_+N7.\\&MF'QCK"
M?#"?5Y;A7O#K$MC]I>-0MO$;TPAR  /D3GGTYSS7<+H&CI9S6B:38K;3N))8
M!;($D88PS+C!(VKR?0>E5[?PCX;M+RXN[7P]I4%S<JRSS1V4:O*&.6#,%RP)
MZYZUHVGT_KM^?R)2:2^1Q.J>(M4TK^W-(DU[4KJ:Q-K]AN[:&U%S=3S!P+8@
MQ&/J%;(0$*<D\9))/X\T;4]!T*]UU+VXUJ,"6]-O"ILY(CYDVQ0@#AD.T9'!
M&>^*[1_!GA>32X]-D\-Z0]A%(98[5K"(Q(YZL$VX!]\5;L]!T?3HK6/3]*L;
M6.S+&V2"V1! 6^]L 'RYR<XZTDTG<'=H\8N/B3XNCU2XTQ;Y/.'B3]W*;=.-
M.%Q]G:/[F,[\#/7#=:[+X=ZKX@UR]NKS5KG6I;9+N\A1G2P6R(2=D55"#[1N
M  Y;C(/M79GP]HK2%VTBP+EBQ8VR9R7$A.<==X#?[PSUJ*S\*>'M.U1]3T_0
M=,M;]RQ:[@LXTE8M][+@9.>_/-":2L_ZT2_3[RI6;=N_^?\ G]UC@?$>I^(]
M%'C>XMO%&H2C1M.2YM(9;>T*J\BN><0@D*5&.?KFJ&L^.O%4NJWEK;1ZII9%
MSI<,=JJ637&)O-\PH27CRVU<;VXQVKUB?2M/NENENK"UF%X@CN1)"K>>HSA7
MR/F R>#ZU!?>&]#U195U/1M/O%FV>:+BU202;,[,Y!SMR<9Z9.*.B^1/1_,\
MO\4^)_$VA,B&_P#$D"0Z6UU*TD.F-)%(9MBO<%5*^4.,^5R!R>]6-0^(6L6W
MQ'TVU^U-_9%HUK::H+>R:2"2>=&^;S]A"!6:' +#(<\&O2+3PWH=A;&WL-&T
M^V@,30F*&U1%,;'+)@#&TDDD=#2Q>'=%@T^6Q@T>PCLYG#R6Z6J"-V&,$J!@
MD;5Y]AZ41=M_ZU?Z ];_ -=OU/)I?$_CM/"NO:_!>WPM;2+4<3745EY*M'*R
MP^0J#S"1MPWFC!]ZZ:PU?7K'4O#<6I76LHFI7[PS)K"6.YU%M(X"&V& -R@\
MG=QZ=>Y;2=.;39=.;3[4V,V[S;4PKY3[B2V5Q@Y)).>I)K/C\%^%H=-FT^+P
MUHZ64[AY;9;"(1R,.A9=N"1V)H3L#5_Q.#M-5\3:I:^%[AO%&H6?]K:I=6<R
MV]O:%3&GVAD9=\+$'$:#.<8'3)S3M&\2Z_KVKZCIMQXD.D1V,E[*EY]G@/F+
M%<-&J-O7;L10"V,,=P^85Z6NEV"1VD:6-LJ61S:J(5 @.TKE!CY?E)'&."15
M:Y\,Z#>1)'=Z)IT\:3M<JDMI&P65CDR $<,3R6ZT:7^\K>/GI^O_  QPUSXP
MU:U^*%C9S:HLNB7#P6T;V,<$T+3/$S%91N\V)F.&5@2NWL<[AO\ CS6]0T7^
MPO[-N/)^UZCY$WR*V]/(E;'(..54Y'/%;LN@Z1/JJ:I-I5D^H1IY:7AMU\Y%
MP1@/C<!R>A[T0:!I-OIME8)I]NUK8 "UCD02>3A2H*ELD'!(SUY/K2>L;?U_
M7]>HFD[^7Z?U_6WB^A?%7Q5-:QVVJR(NH6^A"[N&:!?*D,LL(BN> .!'(VY1
M@95N.E>P: D]NUW:7?B(:W)$RG,D<230AESA_*"J<]1\J\>O6K4>BZ5"Z/%I
MEFC1V_V5&6W4%8?^>0XX3@?+TIEEX=T73K>&#3]'L+2&WE,T,<%JB+'(0074
M <-@D9'.":MM/;^M?Z_X8A)K?^M#1HHHJ"@HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ KY]_98_YG'_K[@_\ :M?05?/O[+'_ #./
M_7W!_P"U: /H*BBB@ KD?BO_ ,DB\4?]@R;_ -!-==7(_%?_ ))%XH_[!DW_
M *": .6^ O\ R1'0/^WC_P!*9:]$KSOX"_\ )$= _P"WC_TIEKT2@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *R?!W_(;\8?\
M8:C_ /2"TK6K)\'?\AOQA_V&H_\ T@M* .IHHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** ///B#;ZOJ7C#0]+T:64&>RO':-=7N-/3<IA"N6A!+%=
MQPI&#D\UR%S<>(=+\4R_VCJMX\5IJMA93ZN-4G6. F"(MNLQ^Z*2,2-Q/!DS
MCC->Y44XOEM_76__  /^!H4W=6\CR"SUR4WUF\^M7O\ PD+:I-'J^G->2!+>
MR!DRWDYVQHJ!"LH4$G'S'=57PA<ZOKVE:_%=Z[K-MJ$5NESH<EQ,R>99(Q:&
M9E#?.S$8DW<E=H/6O::*6RT_K^OU??1=;_U_7^2[' :'=ZC<?!VZUZ\U>>'4
M-6LI+\7 229;(R)E%CC )VH-O"CD@GJ:XWP]XEGN= L8=7U6\@T2/57AU+58
MM8DFA9?(#)Y=W\LB1F0C)+95OEW8.*]QHJFUS-I:,GHE_6IX[H/C'^S/&NF_
MV]XB^SZ$]OJ"V-QJ-[L2ZB6:$0N6<@2'!<*YR2O.3DFF)K@G\4:I#XH\17VG
MZ M_>B"YCOY(%\Y?)\N,2J0>%9RL><,<\'%>RT4K[>2:^]WOZ@U?[[_\#T/'
MM?GN+NT\82)K.M;=.LK":SD6]GM74M&<LR(4P6ZE2H&>PINI74&E?%A](NM9
M\JPAL;-H(M2\7W=DVYI)=Q0 M]H8X&0Y[*,X->QT47UN+ETL>1>#-8-QXBTQ
M=.URZU#49=3U"/5[.34I+A8+=7F\MC$SD0X*QA<!<@]ZH7.OW<7Q3O(%U8F5
M/$,-NMJFNS&?R&BCW*MA_JS'EB3)G(^8@9%>V44)I-/^MT_T_$;5TUW_ .#_
M )_@>?>"H-6;QKK=IJ6L75W9Z _V2T1YF)E$P$N^8G[[*K*BDYZ$]37/^++>
M?2I/&USINJ:PDUC;6DEJK:S=%(VE9M^%,A !P.QQV KV&BEV!ZL\(\3^(==B
MUZ]CUN^CTU%URRBD@3Q!/;6J1M9R,5^TJB,BD@,<)U]>M=3XKU-+;X0V%UIN
MJ0I"]_;(]S!XBGDB*&X <&^_UFSJ"V,@9&.*].HH6B^:?W6_R&]?NM^?^9XI
MI/B"2>UM(=<UJ>V\-?VG=13:C;ZQ-)",(C0QK?961H\LXWDKEEV].#GZMXD\
M6:A8VEEHKZO=2:2MSJ9EMIUB>>W6<K;><6="Z,BN3]XMA3@YKWNBG?L']?C_
M %_6AX?>>(+^\\6SZS:7MW#I$NKV$<>HKJUQY5I')!$^UK0?NF1RVW<3P9,X
MXS6EX,U@W'B+3%T[7+K4-1FU/4(]7LY-2DN%@MU>;RV,3.1#@K&%P%R#WKUZ
MBG=+1+^K+^OZN*5Y'DVMZS=1:WK(;5KR'Q-!J44>CZ6ETZI/;'R^1 #ME4@R
M;G*L5P>1M%:?PMBU.[^WZKJ33SHU[>0QW$NMW,Y8+<NH7[,X\J, +@%23@=L
MFO1J*2=E8;U/#FUV17O'TGQ#>W&MC5-3BO;,:G)+Y%H@GVL82Y$(4K'M8*O.
M!GFJ5CJ^M_;;:_N;^_2T%[ID$FIMK%P4M=]M"[*]K_JW61B5+L<AI,D<9KWZ
MBB+Y?P_#_/\ J^PY/F;?K^/^1X7H&OWTNF^(I;/5DN==A?4/L\8\27%Q=#;,
MX7&GL#&-J#Y2,]%XYK?UEM&N/AOXENO"_BG6;\V-FURDT6KW#+!,(VZ3!LL>
M[1EF52!\J]_5:*+Z"6DK^9Y5K,UOI&JOI^LZYJ>F:?%I23:3(VJ3A[F[9G+@
MR%RTSC]WB)BPP>%/;FXM7\3_ -LK?ZY/>61&HZ=;W5X-5G6.Q=[>%W1K0?NB
MCL2I8_=,F<<9KWFBFI6=_P"M[_\  _X&@=+>7Z+_ (?YGE/@C7;N7XL:OIUQ
MJ=SJ:2?:)%:.[D*6ZK(H6.6VD4>2P!PK*0KC)PW!KU:BBIZ)=@ZM]PHHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH *^??V6/\ F<?^ON#_ -JU]!5\
M^_LL?\SC_P!?<'_M6@#Z"HHHH *Y'XK_ /)(O%'_ &#)O_03775R/Q7_ .21
M>*/^P9-_Z": .6^ O_)$= _[>/\ TIEKT2O._@+_ ,D1T#_MX_\ 2F6O1* "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ K)\'?\
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M.2%''-;&M:1K'B=M5L=.T6ZDL?$6N+._V^.:S7[-!;QY\PF,M'ND0  IEL'
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MGO[K[5/<7@B#EO*CB  C1% "Q+V]:V** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "OGW]EC_F<?^ON#_P!JU]!5\^_LL?\ ,X_]?<'_ +5H
M ^@J*** "N1^*_\ R2+Q1_V#)O\ T$UUU<C\5_\ DD7BC_L&3?\ H)H Q/V?
M/^2$^'O^WG_TIEKTFO-OV?/^2$^'O^WG_P!*9:])H **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH *Y_P <6:W7@W4I#<7EO):VTL\4
MEG>2VS!U1L$M&RDCV.1[5T%,FABN('AN(TEBD4J\;J&5E/!!!ZBIDFXM(J+M
M)-GF&DQ2MIO@O3+C4]5CL];LS<WMR^JSF6><0H5B65G+H#EVPA7[GUK2L=1O
MH_#'C>UCO+B:WTAIH=/O'E9Y<"W5B/-)RQ1RPW$D\<DD5VEQH^F7>EC3+O3K
M2>P"!!:2P*T04=!L(Q@>F*?#IMC;Z:-.M[*WBL1'Y0M4B58@F,;=@&,8[5=3
MWN:W6_\ 7RV)I^[RWUM;^OF>)37GB#0O#?G7%S>6K:AX8NIXGBUZZOV>5(D<
M2MYP4P$9.-F1EL9X%>C>!-)U&R@%UJ=N\1FMTVN?$=YJ._(R24G4*A]USZ5K
MV7@[PSIL5S%IWAS2;2.ZC,5PD%C$@F3^ZP"_,/8T_2O"GA[0;A[C0]!TS39G
M78\EG9QPLRYS@E0"1D=*IR3?]>?^8K>ZEV_X'^1Y1JWB#Q5%HOB=K>4?8H?%
M"0+>'4Y5N(4\Z$>6D8C(V<XQY@X8\>NQX/L]:U*^U'5+D3W%O#JUZBW+^)KU
M614E<*HM OE$#  !;&/RKTA]%TJ2":!],LVBN)OM$T9MU*R2Y!WL,<MD Y//
M JB/!7A4:G_:(\-:.+[S/-^U?8(O-WYSNW[<[L\YSFH^REY?HE^A5]_6_P"?
M^9PD>JZC-^S9::@^HWGVZ2UAWW8N'$Q)F4$^8#NS@XSG-=)H0DTGXAWVA6=W
M>76G+IL5TR7EW)<M!*TC+@22,S891G:3@;>,9K3B\!>#X!*(/"FB1^<ACEV:
M="/,4D$J<+R,@<'TK2TO1M+T.U-MHNFVFG0%MQBM(%B4GUPH S57]YO^OZZD
M]+?U_70\UO-0OCX0UCQ4VJ7T6OV6H30062WCB%2DY2.W, .QBZ[>2I8[\@CC
M'.WGB77=/T/Q!)<ZO>^7>>)A;6;^>VZV9+F,-"K9R$:,G"]/E;UKVJ30=(EU
MA-6ETJQ?4HUVI>-;(9E'H'QN _&B30M(EMI+>72K)X))_M+Q-;H5>7.?,(Q@
MMD [NN:479I_UNO\OZUNY:IV[_Y_YGGWQ/US4-"\:>&;^UO[J"QLH;B[OK>*
M4K'/$KPJV]<X;:KLPSW%8GA7Q;XAM+76!)?M<:GJ&J*]I!?H]QY*/:BX\E(]
MZ 8!QRZ*.3D]#[!>:5I^H-NO["UNF\IX<SPJY\M\;TY'W6P,CH<#-03^'-$N
M59;G1M/F5I4F826J,#(H"JYR/O   'J !26D;?UO<IM?U_7FS@;#XH:I>Z?I
M):RM(KS7K:V?3(SN(:1I-EP#\W(1</QC@UK_ !'FURU;1+C3M3^Q6']JVD5Q
M%"I$MP7G1=I?/"8)R!R?ID'>3PIIZ:]9:DA=5T^)X[.R1(T@MB_#NH50VXCC
MEB/0#)K5N;.VO8T2\MXKA$D65%E0,%=3E6&>A!&0>U5=<REYW^5]ON(ULUY6
M_ B-[9WEO>);W\7^CEHIY(95+6[A<D'J%8 @X/MQ7DFGZAJ-_=0_V;?:N?"6
MJ:G!9Q7ES?R^?<;4E:6:.3(>-'98U 4J.#M !KU:#0].MX]006L3IJ4K2W:/
M&I64LH4[AC!&U0.>O?-5;;P7X7LK2YM;/PWI%O;W:A;B&*PB5)@.@<!<,!GO
M4K_+_@E=+>IYK+K&I:EH?A^"QU'5+CQ3>!DLX(KMDACACG(-W.%P'78 /GW!
MCC R2:W-(U"ZMOB-+-J_G3Q:IJ,]KI[VVMRS1P^5%RKVJ_ND'R,<DE@S<@5U
M][X.\,:E<13ZCX<TF[FA18XI)[&)VC1?NJ"5X [ =*N0Z+I=OJDVIV^FV<5_
M.H66[2!5ED Z!G R1]333L[^OX_U_2T):NK>G]?U^>I=HHHI#"BBB@ HHHH
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M#T..*AOOA#H>HZE=7MU?ZF\EQ#)  9(CY2.@1E5C'NQP"%)(!S@#)!2MI?\
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M]["N,GDYIJW7^M_^!;YW*TO_ %Y?\'\"K=_$G4;/PW>:I+X=B+:9.\6I(-2
M2':B.HC8H#(["1=J[0,Y!(XSJ:/XTGU3QE=:+/I?]GQ1HS6\ETTT<MT%"99$
M:$(R@M@E9&(P..:I7'PKL;B"R3^W=826UO&OFFS;L;B<J%5Y%:$HQ55 7"C'
M7KS6W9^$K>U\2?VS-J.HWLR+(((;J</';^9MW[/E!YVC@DA>BA13TO\ UV_S
M)UM_7?\ R_KOO4445(PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MR-MCV-L:-<%0,;_[RAAM^)_%&J:7\0K>SAU94MV\A8].B2-I9][$.?+=0T@
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M,G'%)OW;O;_+0%\5EN%M\/?#5K>17:64\EQ$H5)KB^GF? 5U )=R2 LK@9Z
M^PQK_P!C:>="71GM4?3U@%N+=\L/+ P%YY/ Z]:P9?B%I:7>G6D8=[B[FBBF
M&QQ%;EXRY!EV;"P&"4R#@YP*L?\ "P/#8MI)VO)T1&0#?8SJTN]MJ&-2F9%9
MN R @DCFF[[/^OZN*Z=F6=/\(:+IDT,]K;2M/!*94GGNI9I"Q0IEG=BS?*2
M"2 .F*FUOPSI/B)8QJ]L\PC22-=D\D1*2+M=2489!'8\< ]0*@TCQCHFN7YL
MM.N9FG"LP6:TFAWA2%?:9% 8J2 P&2IX.#27_C30]-U"6QN;J0W$.%<16TLB
MJY&5C+JI42,,83.XY& <BDVUJQQT=T27_A+1=2DDENK5_.D$7[Z*XDBD3RPP
M0HZ,&0@.PRI!()!S5VSTFQL-)73+6V5;,*RF)B6W!L[MQ.2Q))))R22<US%M
M\0D;X<VWBV\TNXBBN9(Q';0I+*^UY BDCRPW?/"D'^$MD$SZ1\1-&U%IX[UW
MT^6&:Y3]_'((RL#LK'S2@3=M7<4SN /MFFT]4_F%K*Y=L/ _A_3;F"XM;.0S
M6\@DADFNYI6BPC(JJ7<X0+(X"#Y1N.!4$OP[\,S,Y:PF"R',D:7LZI(=YD#,
M@<*Q#,2"1D=L5IZ1XAT[7/._L^2;?!CS(KBVEMY%!SM;9(JMM.#AL8.#@\5F
M67B?4]0>*]M=#631)I3&ET+O]_C<5\WR=F/+XSG?NQSMHN[ZBT:+=QX/T2YT
M^&R>VECB@DDEB:WNI89$9V+/B1&#@,6.1G!Z=*CM/!'AZPU"*\LM/\AXMI2*
M.>00AE7:K^5N\LN% &\KNP.M0?\ "Q/"_P!GEG.HN(H]I#M:S 2JSA%>/Y/W
MJEF4;DW+R.::WQ'\+I;M/-J$L,:I(SM-93Q[#'RZ-N0;7 !.P_-CG&.:%?=#
MV5C4UGPWI>O-"^I02-) &$<L-Q) X5L;EW1LI*G RI.#@9%3Z?H^GZ4\K:=;
M+;^:L:L$)VX10J@#H % '%9?_"=:!]E:<7-R2LPA^SK83FX+E=P AV>81M!;
M(7&.>G-,/Q \-":*,:@[F1(I R6LS(BRDA"[!,("5(^8CG@\T@N3S^"M NM1
MGO;BQ:22XW&2-KB0PLS+L9_*W; Y4D;PN[!ZTR#P-X?MKR"YCLY3)!L*B2[F
M=79  CNK.5D=0  [ L,#GBK]EK^FZC):1V=SYCWEL;J$>6PS&" 2<CY>6 P<
M'KQP:P[7XCZ)+%.UT+RV>*\GM5B^Q3O(XB;#2!53.P<9;&U<@$@\4;?UV#=?
MUZERW\!^&[6Z%Q#IQ$BRK,FZXD81E22 BEL(N6)V* N3TK4M=(L++1QI5O;*
M+%4,8@<EUV'.5^;/'.,= ..E4=7\3VFEV&F7R%;FUU"YCA26-\C:ZDJRX!W9
MP, =<U _CWPXEI#<_;96BE#,3':3.80K%6,JA"80I!!,@4 @YQBBVE@ZW)+'
MP5H.GR)+;6<AD25)$DFNI960H"$4,[$A%W-A!\HR<"M6ZTZUO;JSN+F+?+92
MF6W;<1L8HR$X!Y^5F'.>M9?B#Q5;>'KC2UN8I)H=0E>,/ CRLNV)G!6-%9GS
MMQ@>N:;<^-_#]K9VUU)>N\%S%YZ/#;2RA(_^>DFU3Y:CNS[0,')XHN+<=>^"
M]"O[Y[RXM9EN9)C,\L-W-$S,45""4<94JB K]TX&0:@7X?\ AJ.Q2T@L)((X
MMGE/!=S1R1;$V+MD5PZ_+\O!&1US68?BAI0\/6E^L;27-TD<BV\0>1$6238I
M:94*+GDC=C=CBNCUGQ)I>@M"FI3R+).&,<4-O).Y5<;FVQJQ"C(RQ&!D9-'3
M^NA5VRA%X#T&VODO+*.^M)45%5;;4[F*,A/N@QI($8<G((YR<YR:;H?@NSTR
M.>6_\J[OKG43J4T\,1@0S8VJ53<< +Q@DYY)Y-/7QYX=DOQ9P7[2RLZ1ATMY
M3#O= Z*90NP%E9<9;G.!D\5GZ7\2M*NM+M+O40;62[CB:*VMXYKJ4L\/F[-J
M1<D*#C;G..QXIZK7^N_Z"W7]?UL:L_@O0+JUBMY]/#QPB7RQYK@H97$CD'=D
M'> P/52.,5?TG1K'1+1K?3HW57<R2/+,\TDC'JS.Y+,< #))X %9Q\<>'P;7
M;?.Z7,:2+)';2O'&K'"F1PI6+)X&\KR#5O6?$FEZ"T*ZE/(LDX8QQ0V\D[E5
MQN;;&K$*,C+$8&1DTM@WT)9M$T^>XO9Y;?=)?VZVURV]AYD:[L+UX^^W(P>?
MI5*\\&Z%?R"2XLW$JQ10I-%<RQ21K%NV;'5@RD;W&002&()(J.T\<^';_4DL
M;._,TLD@B1TMY#$7*!POF[=F2I! W<CIFH?$FOZ]H^IV$&FZ-IM[!?SBVBEN
M-3D@82%&<[E$#@+A#R&)YZ4?J"=[V_K^K?@68_!>@16=Q;)IX$5U;+:S#S7R
M\89F&3NSNW2.=WWB3DFLRZ^&>B37UI/"UW#Y4YFG;[;<--.?*:-3YQDWJ0&^
M\#D@8IUG\0M/6\O;+75_L^ZLYV@?RUEFA++$LAQ+Y84'!.%.&(7(':M&^\::
M#IS*EU>2;VCAD6..VED9Q+N\O"JI)+>6V .>.G(IZ[_UKL+?Y?IH,'@;PZMS
M;S1Z?Y7V?9MBBGD2)RARA>,,$D*GD%P2#S40^'OAD&?_ (E\A$\<L3 W<Q")
M*P9U0;\1@LH.%Q@\C%/C\?>&Y'N5^WO']F1W<RVLL88(P5]A90)"K$*0F2&(
M!&>*IV?Q'TBX.H--'=Q):W8MHD6SGDGF/E)(Q\@1^8N-^""O&,G&:-?Z^XHN
M77@+PY>VZ0W5C)(JN[DFZF#/OQO5V#Y=6VC<K$J<#(-(W@;2(1=2:6DUA<SH
MX22*YEVVQ?[S11[]L9)Y)0+D]<U;M/%FB7]M'/9WZS12W"6T;(C'=(Z!U &.
MA5@V>F.<\57\;>)W\'^%IM8CT]]1:.6*,6R2;&??(J<'!Y&[.,<]*-4+?0U[
M_3[;4[%K2^C\V!RI9=Q&2I##D8/4"L^3PCH4ULMO-IZ2PK+/-Y;NS*7GW>:2
M">0V]N#P,\8XK)NOB'86WBRVTHQ V4FFMJ$VHF7"0KC*KC')*Y/7CCKFM33O
M%^BZI.D%M<3).S,HAN;2:W<%5#D%9%4CY3D9ZC)&<&EL"?8DTGPOI6A@?V9'
M<1G>TC,]Y-(TK%0N7+L2^  !NSM &,5)J&B17^JVE\7"O!'+!(A7(FAD W(>
M1CE5.>>A'>DEU^W_ .$;&M:?#<:C!)$)8$MXSOF!Z8#8P#ZG  Y)Q4F@:K_;
MGAS3M5\GR/MUK'<>5NW;-ZAL9P,XSUQ3LW>_0-BE;^"]!M=.:QBLW:W9X'*R
MW,LA)A(,7S,Q/R[5XSCC!XJ72/"FCZ'=O<Z9:O'(R&-=]Q)(L2$Y*1J[$1KG
M!VH .!QQ69K/B^_T"^#ZIHJQZ4[RQQW"7@:8E(WDW&(+@(0C<[R>F5':.R\5
MZ]=O+9MX<MEU/R(;F*%=3W0^5(6 9Y#$"I!0@A4?J,9YP)MZC:LK=#K)X8KF
MWD@N(UEBE4HZ.,JRD8(([BL"'P'X=ACF0V4DZS1&'%U=S3^6F0=L?F.?+&0#
MA-O0>@K E^)SK>:?8?9-(M+^Y,Z2QZGK/V:,/%,(ML3^4QEW-G'RKP.@/%=]
M+,D$#S3NL<<:EG8GA0!DG-+97%UMU,.V\#^'[0NT5E(\LD4L,DTUU++)(LH4
M/N=V+,2(T&220% !%5=:\ :5K%]I]SF6V-I)&9##-(KR1QQRI&@=7!0@S$[A
MSQ^4=S\2-$C6#[*M[<O+=PVYC%A<(ZB4D+(%,>60[6PP&TD8!I_C+QJOA*2T
M1H+1OM"22;[R]^S*VS;^[C.QM\K;OE3C.#R,4]?Z^_\ 4:?3R_!DES\._#%U
M$(I=/D6(P>0\<5W-&LJ99OW@5P)#N9FW-D@DG.>:MR^%K**R5-*BBMKF"6>X
MM99@\R1S3;M[LF\;@=[?+D#GC%0:KXFN;>:SL]'TPW6H74OEK#>N]K&H$?F,
M?,\MMV!@?*&&>,C!QC6OQ&N+T"ZM]&C_ +.@F@M[Z9[W$L$TK!=JQA"'"EER
M2R\'@'%&K]T2\CI?"_AZU\*^&;+1;#F*UCV[MH7>Q.6; X&6).!ZU/H^EKI-
MF\7F>=+-,\\TNW;O=V))QV'. .> *@UKQ/I7A]HUU2:96D5G"P6TL[!%QN=A
M&K%4&1EC@#/6C5O$^DZ)!:37]Q)MO&*VPM[>2=I2%+_*L:L3\H)Z=J&[^\'D
M4[?P#X8M;N*YM])C2:&:XFC<._RO/_K2.?XOT[8JR?"6B'[)FR_X\XX8H/WK
M_(L3;HQUYP1GGKWS3M'\4Z/KT[1:3=F=A$LX/DNBR1MT9&8 ..Q*DX/!P:JZ
MWKVJVGB&RT?0]+L[V>YMIKEGO+Y[946-D7 VQ2$DF0>G2C5-+^M+_EJ)V=[_
M -7_ ,QUIX'\/6-Z+JVL"LRRK+&3/(PB*EB BEB$7+,=J@+DYQ6KI^FVFEV[
MP6,7E1R323LNXMEY'+N>2>K,3CI7/VOQ#T5K"VFU!Y;664-YD<<$DZ0;9&C+
M/(BE5C+*V';:"!GUJ2Y\>Z&EQ+:VM[')<PSI"RRI*B,3,L3;'$9#E6< A<@,
M0&*YR!)_"A[DUOX'\/6MG=VL-BX@O(!;S(US*V8@S,$&6.T NV N,9QT %3V
MWA/1K/63JEO:NMR7:10;B0Q([?>=8BVQ6.3EE4$Y.3R:Y[1/BA8ZG<:L]_;_
M -G6>GNR(\J7'G38E,7^K:!1DN,!49VR<$ \5T\6K_VKH/\ :/AI8+YGR(DN
M9'MU+!L,KG8S(00004R",$"C6W,-K5I[D&N>$=%\22B36+1YF$+VYV7$D0>-
MOO(X1@'7OALX/(YI[>%=%>.-'L5=([E[I59V(\QT9&)!/.5=A@\<]*Y[3/'F
MH26T-[K^F:;IEC+=7%J'BU&:XD+0^;OP@ME'_+%B,L./? .G;?$+PU=NBPWT
MP+R1QCS+*= /,_U;$L@PC'A7.%8\ DT6>P-M;_UT"+X?>&X4G"64^Z=8U,IO
MIS(@C+&/8Y?='MWMC:1@' XJ>W\$^'K:UN;>+3@8[N 6]QYDKN94#,XW%F)+
M;G8[L[B3DGI4^G>*=(U74GL;&YD>=59EWV\D:3*IPQC=E"R $C)0G&1FH;SQ
MIH.GZE+97=W(DL.1(XM96B5@F_890NS?M&=F[=CM2;TU#4IW'@#1OL,Z65LO
MVN2&2,7-_+/=,=^S)<M*'?\ U:8.\$;1@BF^%? =KX?\RXO)S?ZA).\S7&90
M 6C2,@!Y'8_+&O+NQSDY'2K$7C[PY-:RSQWDQ$7E_NS93B6029V&./9ND#8.
M"@(.#Z&I-$\6V>K>&;C79P+.S@FN(V>1CPD4C)O.0",[<XQD9Q3UL[AT0Q/
M7AR)[0QV#*MHD:1Q"YE\MQ'_ *OS$W;9"N!@N&(Q4^D^$-$T/46OM,M9(IS$
M85+7,KK'&2&V(C,51<@$*H ';J:SV^(>D/J&F6EK%?2R7]X;0J]A/$\#>69
M71HPP! &"0!@ELX4D:>K>*]'T.\2VU*YDCE90[>7;2RK$A. \C(I$:D@C<Y
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M Q/V?/\ DA/A[_MY_P#2F6O2:\V_9\_Y(3X>_P"WG_TIEKTF@ HHHH ****
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MWATS26T^UU%_)^W6ETA>++*((XDVGGDMY6<\8W=.*- ^'7]AW>F3_P!J>?\
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M+;]GOKN[\SR,[O/6<;<;N-OG]>^WH,\27/@47$=VAU#'VF*PC)\C[OV9]_\
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MQJ&",.#R5VE>^2*[:BG=V:]/P!/8\3LS\0+L73.NMQ12G^UOGWI)'',Z*;5
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ML=>74+?4;F;6S-_;$<)BEFF,0MC;)O)C)V[=^?F(X;.".:]*HHO[SEZ?G?\
MX!/+[JCVO^*M^&YPGQ(;4Y'LK73UU5$DAF*S6'VDJ)AM\L.+?:_=B"SJG!W9
MXQDZ9/XBGO8)M27Q$-4DLX#9+%&R6HS;?O/M"D"-6\W.0V'^[MXS7J-%3T:_
MK^OT+OJF>2VK7IL+%;L>-?[-#J=7+"X\[S_*Z1;/W_E[_O>7\F=NWY=U%G8>
M*I=)U*]U.37_ #HI;=$C2XE5_LA8>:512 TOE]2 6#9VX8\^M453=W?^OZ_3
M0F*M_7]?\.>*2P:G';7EOIEOXG@M+J]N9;6>1+T2,WE0"+S FV8Y^?!D=5^4
MA\GII:7!XIN+4:O/)KJZDM_8)'#*\R1^6]O )R8>$(W%\DK\I!Q@YKUFBA.R
MMZ?A_GL_(+;_ #_'_(\9*^))/#=M'#/XIMY3)"=<EN[:YF"R;'W^0L;I.5\S
M9GR6V ;=O&\5WNAV.J7?PY^Q7VH7OVZ:"5([N2)K:=,EO+.TN[*0-OWF+<?-
MSD5U-%$G=/I?^O\ AA]4^W]?\.>&--\0M2M=2EEAUZT&H6DU_'&GF(UJ\,4D
M*VZX.07?RY HZ\FM6U\+37'Q&O5N(=>@2:XFN'N(Y[J-"K6L(7;*#A3O#@A2
M#\H!X %>O44-W5O*W]?<@[>M_P"OQ^\XQK75-8^";6NI1W3ZK<Z(4E1MT<S3
M&+H<8(8MU%<IH6CZK9V;:CH2Z[!<2:J$BBO'N55H3:J"TD4O4;U'SN"01P17
MKU%#=Y2??_.__ !ZI+M?\58\[^&L.O1WUR^L:AJ5PK6Z^?%>:?<P*EQGYMKS
MSON[_P"J41],>E4]9TF]L_&.J7P375TJZOH/M[6$URTCQ"W./+6,[L"3:#Y0
MW <=,UZA10]7<25OZ_K_ (<\8BTWQ3-K"79LKY[@?9_LDUU$Q8(LM[Y7F,1]
MX(T6[/(W#=R:L^;XCL['^TM$B\37#:?;QW%]:WWGE[FZ#@2)$K_>&QI#B/\
M=Y";>17KU%%]7_7]?YV*D^9W^7]?EZ-GC6C6GCF!(;;4YM:F.F3I;_:"\O\
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MQE6=LMCC?QNQT&*Y[Q!X]UM[?4($>!+.ZM+M[.YM8WA>,PL%R)&DW.3SG$:
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M1U/=HEI'<PO %M08_-7S8GC,F(@2RJA7)9NV N2*22T^?]?,;V=CUJBO*/\
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M$(5W*!@#++D'7\ ^ [_PKKFJWNHWGV@W;-B1)U(GS(SAW00(P< XRTDAQQD
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MK:,W3QDS-),JO@ <EHP.A/>G)<LG'SM\]R;_ )7_ !L>VT5YEXN\0WUS\,]
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M(^7D5WM%A];!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "OGW]EC_F<?^ON#_VK7T%7S[^R
MQ_S./_7W!_[5H ^@J*** "N1^*__ "2+Q1_V#)O_ $$UUU<C\5_^21>*/^P9
M-_Z": ,3]GS_ )(3X>_[>?\ TIEKTFO-OV?/^2$^'O\ MY_]*9:])H ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KY]_98_P"9Q_Z^X/\ VK7T
M%7S[^RQ_S./_ %]P?^U: /H*BBB@ KD?BO\ \DB\4?\ 8,F_]!-==7(_%?\
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MTXP.>N6^*_A]>^*M4::X\0-%:+O,%MY#MY1>%HFZ2A&'S;AE-P.1NP<5W%%
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M44N_F.+Y9*2Z' /\-)=0AEDU75E^TW%L\$AM+8P*N1"$( D)!7R1D@Y.>"N
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M.*VZ**&[NX+8****0PHHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "OGW]EC_ )G'_K[@_P#:M?05?/O[+'_,
MX_\ 7W!_[5H ^@J*** "N1^*_P#R2+Q1_P!@R;_T$UUU<C\5_P#DD7BC_L&3
M?^@F@#$_9\_Y(3X>_P"WG_TIEKTFO-OV?/\ DA/A[_MY_P#2F6O2: "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MDDEPA'.1A0.P''4\9H6P/<J_L^?\D)\/?]O/_I3+7I->;?L^?\D)\/?]O/\
MZ4RUZ30 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !7S[^RQ_S.
M/_7W!_[5KZ"KY]_98_YG'_K[@_\ :M 'T%1110!RGC%M$2[LYM:TF74C:PRS
MML1'6& ;0[LK$9 RIPH+<<#KG#\:V]K#\&?%S6.AC1X)-/F*H41&E&P_,54G
M'MGGU KM]3T#2-:*'5],M+XHI5?M$*OM!QD#(Z' _*N5^(^DZ?I/P>\5QZ79
M6]HCZ=,66",(&.P\G%"T0,H?L^?\D)\/?]O/_I3+7I->;?L^?\D)\/?]O/\
MZ4RUZ30 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MV?/^2$^'O^WG_P!*9:])KS;]GS_DA/A[_MY_]*9:])H&%%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MK\WPITOQJU_NN&U ,)I7CN&@V@HKLI# E0 ><X-**<EI_6_^7W%M6;_KI?\
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M'P7X:GUO5(KB6V@=$9+959R7<*,!B!U([UM*VY0PZ$9KY#\5G1!H/B)?$?\
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "OGW]EC_F<?^ON#_P!JU]!5\^_LL?\ ,X_]?<'_ +5H ^@J*** "N1^
M*_\ R2+Q1_V#)O\ T$UUU<C\5_\ DD7BC_L&3?\ H)H Q/V?/^2$^'O^WG_T
MIEKTFO-OV?/^2$^'O^WG_P!*9:])H **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** ,>T\,
M6-CXNO\ Q#:O,EUJ,$<-S$&'E/Y>=KXQG=@XSG&.U;%%% =;A1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7 ^)O@]H/B;Q!=:N^H:SID]
M]&(K^/3;SR8[U   LJ[3D8&.,5WU%'F%RKIFFVNCZ5:Z;I\7E6MI$L,,><[5
M48 JU113;;=V"5E9!1112 **** "BBB@ HHHH **** "BBB@ HHHH **** ,
MSQ)H-OXG\.WFBWL]Q!;7D?ERO;L%?;GD D$<C@\=":O6UM#9VD-M;((X84$<
M:+T50, ?E4M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 5\^_LL?\ ,X_]?<'_ +5K
MZ"KY]_98_P"9Q_Z^X/\ VK0!]!4444 %<U\1]/N=5^&7B.RL(C-<S:=,L4:]
M7;8< >YZ5TM% 'AOP"^)/A2S^%MEH6K:W9:7?::\RR)?3K"'#RM(&4L0"/GQ
MC.00>.E>G?\ "Q_!'_0Y>'__  :0?_%5AZ_\#O 'B/5I=2O]#"74S%I6MIWB
M$C'JQ52!GWQSWK,_X9Q^&_\ T";G_P #9?\ XJ@#K_\ A8_@C_H<O#__ (-(
M/_BJ/^%C^"/^AR\/_P#@T@_^*KD/^&<?AO\ ] FY_P# V7_XJC_AG'X;_P#0
M)N?_  -E_P#BJ .O_P"%C^"/^AR\/_\ @T@_^*H_X6/X(_Z'+P__ .#2#_XJ
MN0_X9Q^&_P#T";G_ ,#9?_BJ/^&<?AO_ - FY_\  V7_ .*H Z__ (6/X(_Z
M'+P__P"#2#_XJC_A8_@C_H<O#_\ X-(/_BJY#_AG'X;_ /0)N?\ P-E_^*H_
MX9Q^&_\ T";G_P #9?\ XJ@#K_\ A8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/
M_P#@T@_^*KD/^&<?AO\ ] FY_P# V7_XJC_AG'X;_P#0)N?_  -E_P#BJ .O
M_P"%C^"/^AR\/_\ @T@_^*H_X6/X(_Z'+P__ .#2#_XJN0_X9Q^&_P#T";G_
M ,#9?_BJ/^&<?AO_ - FY_\  V7_ .*H Z__ (6/X(_Z'+P__P"#2#_XJC_A
M8_@C_H<O#_\ X-(/_BJY#_AG'X;_ /0)N?\ P-E_^*H_X9Q^&_\ T";G_P #
M9?\ XJ@#K_\ A8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/_P#@T@_^*KD/^&<?
MAO\ ] FY_P# V7_XJC_AG'X;_P#0)N?_  -E_P#BJ .O_P"%C^"/^AR\/_\
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M_H<O#_\ X-(/_BJY#_AG'X;_ /0)N?\ P-E_^*H_X9Q^&_\ T";G_P #9?\
MXJ@#K_\ A8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/_P#@T@_^*KD/^&<?AO\
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M (6/X(_Z'+P__P"#2#_XJC_A8_@C_H<O#_\ X-(/_BJY#_AG'X;_ /0)N?\
MP-E_^*H_X9Q^&_\ T";G_P #9?\ XJ@#K_\ A8_@C_H<O#__ (-(/_BJ/^%C
M^"/^AR\/_P#@T@_^*KD/^&<?AO\ ] FY_P# V7_XJC_AG'X;_P#0)N?_  -E
M_P#BJ .O_P"%C^"/^AR\/_\ @T@_^*H_X6/X(_Z'+P__ .#2#_XJN0_X9Q^&
M_P#T";G_ ,#9?_BJ/^&<?AO_ - FY_\  V7_ .*H Z__ (6/X(_Z'+P__P"#
M2#_XJC_A8_@C_H<O#_\ X-(/_BJY#_AG'X;_ /0)N?\ P-E_^*H_X9Q^&_\
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MX6/X(_Z'+P__ .#2#_XJN0_X9Q^&_P#T";G_ ,#9?_BJ/^&<?AO_ - FY_\
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M?AO_ - FY_\  V7_ .*H Z__ (6/X(_Z'+P__P"#2#_XJC_A8_@C_H<O#_\
MX-(/_BJY#_AG'X;_ /0)N?\ P-E_^*H_X9Q^&_\ T";G_P #9?\ XJ@#K_\
MA8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/_P#@T@_^*KD/^&<?AO\ ] FY_P#
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MAO\ ] FY_P# V7_XJC_AG'X;_P#0)N?_  -E_P#BJ .O_P"%C^"/^AR\/_\
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
F*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>halo-20250318_g2.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20250318_g2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X2$*17AI9@  34T *@    @ ! $2  ,
M   !  $   $R  (    4   (2H=I  0    !   (7NH<  <   @,    /@
M$'X<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 #(P,34Z,#,Z
M,3D@,#@Z,#8Z,#(   *D(  "    (0  $%KJ'  '   'W@  "'P     '.H
M   (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                         #E&1#(V1C8V140X0C0V
M-40Y.$(X-35#,#!!-#<S,4(Q       & 0,  P    $ !@   1H !0    $
M !#, 1L !0    $  !#4 2@  P    $  @   @$ !     $  !#< @( !
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MH:";5;U?)V1CY8$/!+8Z<4 =7X?TF/0M LM,C.Y;>()N]3W/YUI4 %% !10
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M)I=[!#); )*DRDY7G.,>H)':NW'3F@!:* "D//6@!$547:BA5'0 8%.H **
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M@2&",855'Z_6O.48^-?BJ'7Y]*T-< ]5>7_]?_H- 'J(HH ** "B@ HH **
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
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MHHH **** "BBB@ HHHH **** "BBB@ HHIC]!\K-ST4[?ZB@!]%>8>*OC/\
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M9O=75TR [3J.J2P_,EBJG^I_X<?"[X9_!_PY#X3^%7@#P1\-?"MIM2#P_P"
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(* "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>halo-20250318_g3.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20250318_g3.jpg
M_]C_X  02D9)1@ ! 0$ D "0  #_X0+Z17AI9@  34T *@    @ ! $[  (
M   0   !2H=I  0    !   !6IR=  $    @   "TNH<  <   $,    /@
M   <Z@    $
M
M
M
M
M
M1V5T87-E=R!997-E9V%T   %D ,  @   !0   *HD 0  @   !0   *\DI$
M @    ,P,   DI(  @    ,P,   ZAP !P   0P   &<     !SJ     0
M
M
M
M
M
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M!]W45QGPU^)>D_$CP^+NP98+^$ 7EB6RT#'N.F5/9OPZ@UV= !1110 4444
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M7$Y/F%6SL4CC:'.&."3M&>V* '_M ?$,>&K&'X;>$5%E;0VJ1WK1.<K$4PL
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M,8!.K/%SELC;!N]L$L/=1GAA0!QWQP^,4WCR_&BZ,?)T"TDWJRMDWCX&';T
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M0$@]E51_$10!QEKHL/CKXD6?AC0;IUT]7CL;-PG#I&/WDQ3.5W!993UP6P<
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M@<YQNP,;3@#=QR0,<BNY_90LM:CAUR[E6=-%F"+%O)\MYP3N*CU"X!(]AVX
M/HZBBB@ HHHH **** "N-^*?CF'X?^ KS5MZ_;7Q#91$9,DK=./898Y[+^![
M*OC3]H7QY_PEWQ"DTZR=_P"SM$+VJ ]'F#8D?\P%'LN>] 'E?VF?[2UQYTGG
MLQ9I=YW$GJ<]<G-?7/[/?PN_X1+P\/$6L1,NLZG'A8I(\&VASPO/.6P&/3J!
MVKR3X _"E?&VO?V]K*1R:'I<HW0NNX7,XY$9!&"H&&;U#*,')Q]@T %9U[X>
MT74M1@O]1TBPN[RW $-S/;(\D0SGY6(R.23Q6C10!Y;^T!XRLO#'PVGT^X59
M;K7,VD414-B/CS9,'NJG@]F9#7R7'X0U)O LOBQU6+34NA:(\C!3+(0#A 3E
ML#=G XV_7'>_&G5KKXB_' Z/HI:X%M(FF6J#E=X;YVXSQO+9/HH]*Z7]HG2O
M^$/\"^!?">G/LTZW2=G13_KID$>9",=<RR'_ (&W% 'A::5>OH\FJK;L+&*9
M8&G8@*9""0@S]XX&2!G P3C(JKM8J6"G:" 3C@$__J-=!H.G^(/'6JZ9X7TQ
MC<.6(MX6(2./CYG8@=E7DG)P .>!7TCJ'[,6AW?@[3--M=4FM=2L]SRWBQ!D
MN7?;OW*>1]T!<-QSP: /F_P5X&UOQ[KB:;H-JTF"OGW# ^5;J3C<Y[=^.IP<
M5Z/\1/@+;?#KX=2ZY=ZW+J%^+F.)$B@$<2ACSG)))XZY'^/T3\-/AQIOPU\-
M'3;"0W5S,WF7=XR;6G;M\N3M ' &?7N36AXZ\'VGCOP;>^'[^0PI<A2DZH&:
M)U8,& /TQ[@D=Z /@RPOK:SL;Q9+&.YNY@B0RR\K N26(7NQPH!/ &[CD8W/
MAQI>F:AXQAN/$=S]ET;3$-_?R[2W[M",+@ _>=D3_@7'. ?3_&WP,T_X8?#K
M5?$$VKR:OJ"^7!:DVPACA+R*"^W<Q+!=V#D8)!QD9KPRSLY]0O(K2SC::YG=
M8X844EI79@ J@=R30!Z7>CQ)^T)\4/M%C;O%!E8F'+1Z=;@\,Q) )/+8&"S;
ML 5L?M$^"M/\&-X5M-$M'CL8K*6W69SEI&60N=Q[G,A/XU]"_"OX?V_PY\$P
M:6K++?3'S[V<+C?(1T'^RHX'T)XS6?\ &[P&_CSX=SP6,9?4[!OM5FJ]9& (
M:/\ X$I('OB@";X(7UM??!O0/LDHE%O"T$A (PZ.0>OY_0BN^KX<\"_%3Q9\
M+VN]*T>.WECFFW2V5] YV38VG@%6#< $?[(KZ*^"^I?$+Q+<ZGXA\=R2VEC,
MB0V6G/:>2IQ\WFJ#\P&#C)SNSU^44 >F:UI%GK^AWNDZG'YEI>PM!*O?:PQD
M'L1U!['!KX:\;> O$GPR\1D7D5S;PK.WV#4HCM68 G:RLI^5L#.W.17WE535
M-)T_6]/DL-8L;>^M),;X+F(2(V.0<'N#SGM0!\R> OVG]1TN(6?CJTDU6!5
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M]Q^!8C\*ZR@#COA[\,/#_P -K":'1$EFN+ALS7ER0TKCLN0  H] />NQHHH
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MMDCK_JS7<? WP&? WPYMDOK<PZMJ)^U7H;[R$_<C.0"-J8R.S%N: /1Z***
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !7SE^U;K<;_P#".>'%N%C+N]Y.&8X0?<1B
M!DD<R\X)X..]?1M?(?[4MS'/\6;6./.ZWTF&.3([F25OY,* /?\ X)Z"/#WP
M?T& J1+=6_VR4D]3*=X^F%*C'M7>U!96B6&GV]I"6:.WB6)2QY(48&??BIZ
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "OG?]H/X2>(_%'BRT\0^%-/^WK):K;W44<BJZNK':^&89!# <=-I
M)]:^B** *^GF[.F6IU((MYY*?:!&<J),#=@\9&<U8HHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
L* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@#_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>halo-20250318_g4.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20250318_g4.jpg
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M;U?64ZE.K!3@TT^JU1Z\91G&\7=!1115E!1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M\.>6C)ZCJA.#G*LW[1PMQ;2S>*PV)M&LONEZ=GW7S79?;Y3G$<8E2JZ3_/\
MX/E]Q[11117VY[P4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M?^3Z!1117NGH!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M_L*_% >FCZY_Z;%K\V:_27X>9;]ACXHJ.O\ 9&M_^FQ:_-JO] .'M?#C(?\
MKQ_[<S^-?%7_ )*RMZO] HHHKH/S4**** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH *_2W_@F_P#M2-\;?AF?AUXPU+S?$WAB%8VDE?+WME]V
M.;GEF7A'/^XQ.7K\TJZ_X$_&'Q%\!_BII/Q.\-.S2Z?<#[3;;\+=6[<2PM[,
MN1GL<'J!7T'#6=3R3,HU7\$M)+R[^JW7W=3T<KQTL!BE/[+T?I_P#]D:*RO
MWC3P]\1?!^F^.O"E\+G3M5LTN;24=2C#.".S#H1U!!':M6OZ"A.-2"E%W3U3
M/T:+4DFM@HHHJAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MK^V;\5/VN8?AUXB\,^$M=\/:/HF@IXHTB33[O5I;=6::Z^SR@2+&N5C5F W
M\="!]2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 0:KJ5IHVEW.L7\FR"TMWFG?^ZBJ6)_(&O@[Q5XAO/%GB6_\3:@?
MWU_=R3N,_=W,3@>PZ#Z5]6_M9>+#X8^#MY:0R;9M6F2SCP>=IRS_ (;%8?\
M J^0J_@[Z6G$SQ6?X+(J<O=HP=6:_OU':*?G&,;KRF?M7AAERIX&MC9+6;Y5
MZ1U?WM_@%%%%?R(?J04444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M25^9%?W[PMKX79#_ ->I_P#IQG\=^+/_ "5=7U?Y1"BBBNL_+PHHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /4_V*/B"WPT_
M:B\'>('FV07&JK879)POE7(,!+>RF0-_P&OUMK\0[2[N+"[BOK.9HYH9%DBD
M4\JP.01^-?M'\.?%L/CWX?:%XYMPH36='MKU0O0"6)7Q_P"/5^L>'&+<J%?#
M/HU)?/1_DCZ_AFM>G4I/HT_OT?Y(V:***_3#ZD**** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *CN[F&
MRM9;RX;$<,;.Y] !DU)7-?&/53HOPI\1:BK89=(G5#Z,R%5/YD5Y^;X^.5Y5
MB,;+:E"<W_V[%R_0WPM!XG%0HK[32^]V/B35M1GUC5;G5KD_O+JX>:3G^)F+
M']35>BBO\9JE2=:I*I-W;;;?=O<_K2,8PBHK9!1114#"BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ^@?V8AN^ ?C9/5+G_T
MEK\QJ_3K]EH;_@;XT3U6?_TFK\Q:_OSA37PKR'_KW4_].,_CSQ;_ .2JJ>K_
M "B%%%%=A^7!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %?JI_P3O\ %K>+OV1O"LDTNZ;3H[BPEYZ"*=U0?]^]E?E77Z'?
M\$AO$;7_ ,#/$/AF1]QT[Q.TJ G[J2P18'TW1L?Q-?<>']=TL]</YX-?=9_H
MSWN':G)F'+W37Z_H?65%%%?MA]T%%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ KR']M6W,WPCMI /]5KD+G_ +]RK_[-7KU>9_M<
M61NO@AJ$X&?LUU;2'VS*J?\ LU?G7BYAWBO#'-X+IAZDO_ 8N7Z'O<+U/9\1
M85_WXK[W;]3Y#HHHK_)@_IX**** "BBB@ HHHH **** "BBB@ HHHH ****
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M9=*T%_5WY]E]G=Z[+XG\3^(/&?B"\\5^*]7GO]1OYVFO+RY?<\KGJ2?Z= ,
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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MF#3E8;O.B*YW6QSGC[F?[GW?E"OI_P#81_;NG^#<\7P?^,%V]WX-NW,=K=3
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M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M&O <#8&.<9Q%5,746KZ13^Q#^[_-+>;[1LG_ "%XK>*];,JTLOR^5H+^KO\
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M;PQ1TJ57Y+]7^@4445^HGU84444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 5\>_M3>"/
M^$-^+E[<6\.VUU8"^@P.-SDB0?\ ?88_1A7V%7DG[87@'_A*/APOBBS@W76A
MR^:<#DP/A9!^!VM]%-?AGTA^$'Q7X;UZE&-ZV%?MH][1351?^ .3MU<4?9\"
M9JLLX@A&3M"K[C]7\+^^R]&SY2HHHK_,8_HD**** "BBB@ HHHH **** "BB
MB@ HHKJ/A3\*/$OQ:\2+H>AQ>7#'AKZ^=28[=/4^K'G"]2?0 D>AE659CGF8
MTL!@*3J5JC48QBKMM_U=MZ)7;:2,,3B</@\/*O7DHPBKMOH)\*OA5XE^+/B1
M="T*+9"F&O;YU)CMH_4^I/.%ZD^@!([/]J?]JGP+^Q;X'_X4K\%!!<^,;B -
M/.X60:?O7_CXG[-,PP4C/ &&8;=JNG[57[5G@?\ 8P\$?\*2^"(@N/&%Q &N
M)W"R#3@Z_P#'Q/V>9A@I&> ,,PV[5?\ /+5M6U37M4N=<US49[R\O)VFNKNY
ME+R32,<L[,>68DDDGK7^MGT;OHVY?P'E\<VS:*J8NHM7T2WY(7VA_-+>H^T4
MD?R!XJ^*U?-*TLOR^7+"/X>;_O>7V?\ %LNL:QJOB'5;G7==U*>\O;R=IKN[
MN92\DTC'+.S'EB22235:BBO[/2459'\[-MN["BBBF(**** "BBB@ HHHH **
M** "BBB@ HHHH *^I/V#OV\;KX,74'PB^+M[)=>#[J39:7<N7;2&8\\=6@)/
MS+_#DL.X/RW17!F66X3-<)+#XB-XO[T^Z[/^MCMR_,,5EF*5>@[-?<UV?D_Z
MU/K_ /;N_8/M?"EK/\?_ -GZRCN?#5S']JU72; AUL58;OM,&WAK<@Y('^KS
MD?)]SY$KZ@_8._;QNO@O=0?"/XN7TESX/N9-EG>29=M(9CSQU: D_,O\.2P[
M@[O[=W[!UKX8M9_V@/V?;*.Y\-W,?VK5M(L,.MDC#=]IM]O#6Y!R5'^KSD?)
M]S^,?$KPTQ?#N+EB<+&]-W;26ENKC_[='INO=V^_3PN;X5XS!JS7QPZQ?=>7
M]=TOD*BBBOQ@\\**** "BBB@ HHHH **** "BBB@ KH_A'\.M3^+?Q.T+X:Z
M/N$^LZG%;>8HSY2%OGD/LJ!F/LIKG*^R?^"1_P %/[7\7:U\=]7M,P:1$=-T
M=F7@W,B@S.#ZK$57Z3FO6R/+I9KFM+#+9O7_  K5_A^)V8##/%XN%+HWKZ=3
M[LT'1-,\,Z'9>'-%M5@L]/M([:TA7I'%&H55'T  JW117]&I**LMC]+225D%
M%%%,84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %17]C::I8S:;J$"RP7$3131..'1A@@_4&I
M:*F<(5(.$U=/1I[-=AQ;BTUN?"OQ,\$7?PZ\<ZCX0N]Q%I<$02,/]9$?F1OQ
M4C/OD5@U],?MG?#/^V/#UO\ $G2[?-QIF(;_ &CEK=C\K'_=8_DY/:OF>O\
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M:IJ6MZE<:SK.H37=W=S--=75S*7DFD8EF=F.2S$DDD\DFO\ 6WZ-_P!&[+N
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M8\LQ)))/))J"BBO[*225D?SRVV[L****8!1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M2&O[]TRD"?\ LS'G"]_8 D=+^UQ^UUX-_9%\''X"_ /R9/%3P_Z9>?+(-+#
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M;T' "C^%0!SC)[NOWOA?((9'@+3_ (L]9/\ **\E^+NS]#RG+U@,/9_&]_\
M+Y!1117TQZ@4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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MPF>4+1]VHEK']5W7Y=?/\.S[A_%Y+6O+WJ;>DOT?9_GT.>HHHKZ,^?"BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBI;*RO=2O(M.TZTEN+B>18X(((R[R.QP%51R22< #K0V
MDKL$FV15^FO_  33\ _'SP+\&#'\6]0:+2+MEE\,Z)>1DW5G$<EF8D_NT?(*
MQ$$CD_+G!XK]A_\ X)R6O@=[+XN_'[38[C6E*S:5X=D :.P/59)NSRCJ$^ZG
M4Y;[OV)7Y+QEQ/A<=!X'#)2BGK+?5?R_J^NRT/U/A#AO$X*:QN);C)K2.VC_
M )OT7S>H4445^<GZ"%%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MB%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M>O@LWX^P>'3IX&/M)?S/2*_5_@O-GW.4\#8O$-5,:^2/\JUD_P!%^+\CYO\
MV9/^"9'PQ^$DEOXL^+,T'BO7H\/';R0_\2^T?_9C;F8C^\XQT(0$9KZ?5510
MB*  ,  < 4M%?E^89ECLTK^UQ,W)_@O1;+Y'Z5@<NP66T?98:"BOQ?J]V%%%
M%<)VA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% 'DGQG_8>_9O^.,DVH>)O
M <=AJ<V2VL:&PM;@L?XFVC9(?=U8U\J?%[_@D;\3M >34/@WXTLO$%L,E-/U
M+%I=#T4-S&_U)3Z5^@U%>_EW$^=99:-*JW%?9EJOQU7R:/"S#AO)\RO*K32D
M^L='^&C^:9^,WQ(^!OQ?^$%R;;XE_#G5M'&[:L]U:-Y+G_9E&4?_ ("QKE*_
M<"ZM+6^MGL[ZVCFAE4K)%*@97!Z@@\$5Y-\1?V$_V5OB9YDVL?"2PL+E\G[7
MH>;)P?[V(B$8_P"\IK[;!>(M&22Q=%I]XN_X.WYL^.QGA_53;PM9/RDK?BK_
M )(_)BBOO7QS_P $=O!UT7G^&WQBU&Q/)CMM:L$N0?;?&8R![[37D'C'_@E/
M^U)X==SX>CT'7XQRGV#51$Y'N+A8P#_P(CWKZC"\6\/XKX:ZB_[UX_B]/Q/F
M<3PMGV&WHMK^[:7X+7\#YIHKTCQ3^R!^U!X-9AKGP+\1[5^])9:<UT@^K0;U
M_6N%UGPSXD\.2^1XA\/WU@^<;+VT>(Y^C 5[E'%87$*]*I&7HT_R/&JX7$X=
MVJP<?5-?F4:***W, HHHH ***EL[&]U&X%II]G+/*WW8X8RS'\!S0VDKL$FW
M9$5%=KX;_9O_ &@?%[JOAOX*^*+I6Z2KH<XC_%V4*/Q->D^$O^"9G[77B<HU
M[X'LM&B?I+JVKPC ]2L1D<?BN:\^OFV5X7^+7A'UDK_=>YWT,KS+$_PJ,I>D
M7^=CP&BOMKP/_P $<]6DV3_$GXT6T./]9:Z'IK29^DLK+C_OV:]L^'7_  31
M_92\!>7<7_A&[\17,>")]?OFD7/_ %RC"1D>S*:^?Q?'.0X9/DDZC_NK]79?
M=<]W"\%YYB/CBH+^\_T5V?F7X7\'^+?&^J+H?@SPQJ&K7K_<M--LWGD/_ 4!
M-?0'PG_X)<?M(^/GBN_&5O8^$K!\%I-3F$MP5]5AB)Y]G9*_2'PQX/\ "7@G
M31H_@WPOIVDVB]+73;)((Q_P% !6C7R6/\0L=5O'"4U!=W[S_1+[F?58'@+!
M4K2Q51S?9>ZOU?XH^<_@[_P3%_9O^&AAU'Q5I]SXNU&/#&766 M@W^S;I\I'
MM(7KZ&T[3=.T>QBTO2;"&UMH$"06]M$$CC4= JJ  /85-17Q.-S''9C4Y\34
M<WYO1>BV7R/LL'E^"R^')AZ:BO):OU>[^84445Q'8%%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%
M% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4V:&&XB:"XB61&&&
M1UR"/<&G44 <]J?PD^%6M9_MCX9>'KO/7[3HL$F?^^D-8ES^RW^S3=RF:?\
M9_\ !A8]2OAFU7/N<)UKO**Z(8O%T_AJ27HV<\\)A:GQ4XOU2/.3^R%^RX3G
M_A07A3_P31?X5+#^R?\ LQ0*%3]G_P 'D*>-_AZW;^:'->@T5H\QS![UI?\
M@3_S(6 P*_Y=1_\  5_D<KIOP+^"6C #1_@[X5M,=/LWAZVCQ_WR@KHM.TG2
MM'A^SZ3IEO:QDY,=M"J+^2@58HKGG6K5?CDWZNYO"C2I_!%+T04445F:!111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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MGU(G[H@"7 .[VW%:^EOVG[_3M._9G^(>IZI(@M(? NK27#,?E\L6<I;/MC-
M'SQ\0OVR?B-\?]$_9S\%_L_>+CX)N?CS'?WNI>(4L8;R?2+?3[(7%U;0K,IC
M,K2$Q"1E.-A(&3QTW[*'[0OC_P *^,?CC\%OVFOBI;ZY!\&+ZQN3XZOK&&S>
M;2[RR:[7[0L(6/?$J,&95&[/3/7S/]A7]D?2_C]_P3;^!>I:MXRUSPIXK\'2
MZAJWA+Q5H+QBZL#/?765VS(Z2120L@9&7# +VR#Q/C;X6^"+WQG\1/A);>-?
M$/BGP'X)ED\:_M-^.]3FC-WXJU"T@,UMX?C,2I&L<:1;I(T " !,JPY /IG]
MB;Q?\;/V@]7\0?M:?$'5M3TGPAXH"VWPR\#S (D&D1ME=2N%QDW%R1O'/RQD
M %@PQ]"5\=?#+]M?]J'P[<?!SQG\</A;X"T[X>?&>_M=-\+VGA:>[_M'07NX
M#-IZ7!E_=3*\8 /EK'LY],'[%H **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M_'O@7]FJ7X1_LDC0]%UG3- ATGPC+KLLBVFGHBK$)6,<<C.\<8+J"I#NJAB
M2:Q/A=^QI\-/AI^RA?\ [*45Q<W=AKVB7MIXIUJ1O]+U:ZO8F2[O9&.297+L
M023M 5<X45Z_10!\D_"[]A#]HLZC\*?!?[0/QH\*ZSX&^"E_#>>$;;0-"N+?
M4-5GMH3!9/>O+*T<?DH1Q$#NQ@DYW#ZVHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH *\?_ &Y/C1XW^ OP%N/B#\/I[:/48]3MH%:ZMQ*FQV(;
MY3WXKV"OG/\ X*E_\FG7G_8<LO\ T,UY.>U:M#)L14INTE"336Z=CCS"<Z>"
MJ2B[-)GRO_P]+_:Q_P"@OH?_ ()4_P :/^'I?[6/_07T/_P2I_C7SG17X7_K
M'GW_ $$S_P# F? _VGF'_/V7WGT_X)_X*;_M3:[XSTC1+_5M%,%YJ=O!.%T=
M02CR*IP<\<$U^D-?BW\,?^2D^'O^PY:?^CDK]I*_2> LPQV/HUWB:CG9QM=W
MMHSZ?A[$U\1"HZLG*S6_S"N<\7?&+X1_#_4X=%\>?%/PYHEY<*&M[35]<M[:
M64$X!59'!89XX%+\7?'D/PK^$_BCXGW$ EC\.>';W5'B)P'%O \I'X[,5\9?
M\$[OV&/@+^TC^RS;_M(?M6?#^R\=^-_BA<7FJ:WK6O;Y)8(VGDBBBMVW P*(
MT4@IM(+8!PJ@?H)]&?=L,T5Q$MQ;RJ\;J&1T;(8'D$$=13J^-O\ @D'KGB3P
M?9_%_P#9&UO7[K4[+X1_$>YTSPY<7LI>2/3)'D\F+/H#"[@=O,('  'V30!S
M$WQM^#%M,]O<?%SPQ')&Q5T?7[8%2#@@@OP:WM)UC2=?TZ+6-"U2VO;2==T%
MU:3K)'(,XRK*2",@]*_+/_@GE\/?^"3WB[X%0C]JN[^':^.KCQ/JB7*>)/$?
MV2Y,?VIQ#N4S( "F,'C/%?II\*/A]\./A7\.]*\!?"+0[/3?#=A;?\2BST]R
MT*1.QDRC$G<&+ELY.=V: -'4?%?A;1]8LO#NK>)=/M=0U(N-.L;F\1)KK:,M
MY:,0SX!!.T'&:GU?6-(\/Z9/K>OZK;6-E:QF2YN[R=8HHD'5F=B H]R:^9_^
M"K7[/GB?XI? .T^-?PE5HOB#\(]37Q1X3NH4S(XA*O<6X'5@R1APH^\\"+W-
M>.?M+_M&0?\ !2KPE\$_V3O@Q?R6]O\ %JWA\2?$A[23+:1HUG(1<6['LQNH
M98P3U>W0='H ^_M-U+3M9T^#5](OX;JTNH5EMKJVE#QS1L,JZLI(92"""."#
M4U>)_M$?M2?#W]CO2?!_PC\&_#;4_$WB?Q !IG@/X?\ A>-!-/%;QJ"2SD+!
M;Q(%!=LX'."%8K@_"7]O'Q)J?QRTK]G#]I[]FK6_A3XK\2VDUQX36^UNUU2P
MU<0C=+%'=6WR"95^;81Z D%D# 'T517A'QJ_:R^-WA#XF7_PK^ O[$WC'XAW
M>DP0R:EK#ZG:Z-I0,D:R".&ZNCMG<*PW*H^4G&<YQH_L>?ME:!^UE8^)M)N/
MA]J_@_Q;X)U9=.\7^$];97FL)F#%&61.)(VV. V%)*-QC!(![-17QAX1_P""
MNVJ_%Z:XT7]GK]C7QGXWU?1]3N(?%-GIM[&D.DVZ3M%'(TS1E9)90CNL( .U
M3\W!QZ+\7?VZ?&>C_'G6/V;?V:/V8-9^*7B?PMI]M>>+A;>(;32;32TN$#PQ
MF>Y.))60AM@ X/!)#!0#Z*HKE_@Q\0==^*?PTTWQSXG^&FL^#M0O!,MYX;U]
M4%U921S/$0Q0E65BF]''#(Z-QG%=10 4444 %%%% 'RC_P %#_VO/C)^S;XR
M\.Z)\,;W3XH-2TR6>Z%Y8"8EUDVC!)X&*^=_^'IW[67_ $%]"_\ !*O^-=Q_
MP6*_Y*3X-_[ =Q_Z.%?'-?M7#.2Y1BLBH5:M",I-.[:5WJS\>XCSC-<-G=:G
M2K2C%-62;MLCZ._X>G?M9?\ 07T+_P $J_XU[#^PS^W-\>OCY\>K?X>_$+4-
M+DTV32[F=EM--6)]Z*"OS ].:^$*^CO^"6'_ "=E:?\ 8"O?_05KHSS(\GH9
M/7J4Z$%)0;325T['/DN=9O7S:A3J5Y.+DDTV]5<_3:BBO"_^"DO[16O?LM?L
M8>-/BYX0G$6N0V<5CH<Q4'R;JYF2!90#P3&':0 Y!,>"#7X:?M)Z=XF^-/P<
M\%:XGACQE\6?#.DZE( 8]/U/7K>"=L],1NX8YSQQ72QR)*BRQ.&5@"K*<@CU
M%?!?P1^!O_!(7P%X3L/A5\<?B%\+_&'Q%U.!&\8:WXJ\26]W?7>J2 &<>?)(
M?);S"55%96X&<L23]S^&/#NA^$/#6G>$O#%BMKINEV,-IIULC%EB@C0)&@))
M) 50,DD\4 7JSQXL\+-XE/@Q?$NGG6%M?M+:2+Q/M(ASCS?*SNV9(&[&,FLS
MXM^&?'7C+X<:MX6^&GQ"/A37+^V\FP\1KIJ7;6!+#=(L+D*[;=P&3@$@]J^%
M_P!F_P#9Z\,_LU_\%FI/ WA_Q/KNNW%[\$9=2UK7_$NI-=WNI7LM\BR3RN>
M2$0!5  "CODD _0B>>"U@>YN9DCCC0M))(P"JH&223T '>N?\(?&'X2?$+49
MM'\ _%+PYKEW;*6N+71];M[F2( X)98W)49XYKY:_P""I.I:O\5OBI\#_P!A
MNWUV[L=$^*'BNXG\9FPG:*6YTRQ6.1[;<.BR;W/^]$I[8/"_\%.OV0/@K^R/
M^S[IO[7O[*'P\T_P-XN^&?B'3;JWO]!5H?M=M+<);-#. <3!FECR6RQ7<I)#
ML" ?H%6?H'BOPMXK2YD\+^)=/U);.Y:VNVL+Q)A!,OWHWV$[7'=3R*7POKUM
MXJ\,Z=XHLD*PZE80W42D\A9$#@?D:^+X(X_V _\ @J'*))%LOAK^T9$TF]VV
MP:=XF@RS9)X7SBY]-S70[1< 'VA=>*O"]CK]KX4OO$EA#JE]&\EEILMXBW%P
MB EF2,G<X !)(!QBK]?%O[ >F77[77[4WQ _X*0^*+9WT432>$OA'%.IQ'I=
MNY6>[0'H97SR.C/<+TQ79ZO_ ,%#O'GC?QOXC\,_L@_L@^(OBKIG@_4GT[Q%
MXGM_$-GI5B+N/F6&U:X)-VR9 (0#D@C*LK, ?3]%>0? K]M'X:?'W]G[6OCY
MX4\.^((AX8%]#XE\*RZ:6U:PO;2,O-9^0I.^;&-B@_-N4<'('D?CG_@I=\=/
MA5X7/QB^*O\ P3H\=Z#\.8I8_MOB.Z\06+7]G"[J@DFTU3YD?+#.Y@ 3C- '
MUW17BW[4W[;OPX_9?^!_AO\ :"U/3Y=9\.>)-;TVS@N[2;RQ%;7:-*MV<J2R
M+&I;:!DYQ7-_!O\ ;\UGXB:+XH^*?Q#_ &8_%G@3X;Z'X7G\0:3XV\02*?[5
MLHL,2+95W1.T?[Q%W-O4<=1D ^C:*^9_@M^W7\>?C#J/AGQ3'^P+XQT_X>>+
M[FW71?&?_"16%Q,MO.P$5W<6$;>;# 00[/E@$.X;AC/TQ0 4444 %%%% !7S
M9\6OVG_BKX/^)&L>&-%N[);6RNS' )+,,P7 ZG/-?2=?%/[07_):/$7_ &$6
M_P#017\V?2:XES_ACA/!U\IQ4Z$Y5^5N$G%M>SF[-KI=)GZ#X=Y?@<QS.K#%
M4U-*%TI*^O,CH?\ AL/XT?\ /]IW_@ /\:/^&P_C1_S_ &G?^  _QKRRBOXI
M_P"(M>)O_0XQ'_@V7^9^O?ZL<._] M/_ ,!1]<_LP_%7Q=\5=!U34/%LT#R6
MEVD<)@@" *5R<XZ\UZ?7AG[#/_(J:[_V$8__ $77N=?Z->#.:9CG7AEEN-Q]
M656M.,G*<FW)VJ36K>^B2/P/BW#4,)Q%B*-&*C%-62T2]U!6?H7BSPMXHDNX
MO#7B73]1:PN3;WZV-XDQMIAUCDV$[''=3@UP?[3?P)\:_M#>&M/\ Z%\<];\
M$:))>,WBH^&HD2_U2TV$"UCN6YM06.6=5)8#;T)KYJ_X(P>"_#WPVU?]H?X=
M^$K1X-*T#XUZAIVF023-(T=O SQ1J68EF(15&223U-?IY\X?:7B7Q5X8\%Z/
M+XB\8^([#2=/@QY]]J=XD$,>>FYW(4?B:@\'>/O GQ$TQM:^'_C72==LTD,;
MW>C:E%=1*XZJ6C9@#[9KXQ\<^"?#?[<W_!5SQ!\%_C3:'6/ 7P8\&6EU;^%I
MI&^QWFKWJQ2B>9 <28BFVX/'[I1T+AL[XC_"?P-^P/\ \%,_@MXA_9YT&+PU
MX9^+L>H>'_%OAK3"4LIIH5C,$PBSM1M\\1^4 #RFP!O?< ?>M%>+_P#!0G]H
M_P 9_LD_LB^*_C_\/M'TR_U?0FL!:6NLQ2/;/Y]];V[;UC=&.$E8C##D#.1P
M?9;64SVT<[#!= Q ]Q0!3\2>*_"_@W3?[9\7^)+#2K/S%C^U:E>)!'O;A5W.
M0,GL.]7P01D&O.?VM/V=O#7[5O[//BCX$>)]D::YIS+8W;IG['>(0]O.._R2
MJA('5=R]":^)M)_X*!?$W2_^";-Q\%9HKG_A?%AXC'PJ@TH2?Z6VHL3#'=CG
M.1;AOWAX,\?H: /T0\.>*O"_C"P;5?"7B2PU2U69HFN=.O$GC$B_>0LA(W#N
M.HJ_7SOX3'P2_P""4'[#&C:9XSO)&L/#=G%#=_V;;^9=:WJ\[;G6%"07>65G
MV@D;449(5"1S5U_P4D^)'PQO=$\0?M6?L3^*OAKX)\0ZC#967C&Z\06=^EG)
M-_JS?6\.)+-3WWY(.1@D&@#ZMHKRG]I']HWQM\%[[1?"WPP_9M\6_$?7]>2>
M2UM-!6*WL[6.(H&:ZO)B([?)D4*#DMANF.>._9Z_;OUGXD_'FZ_9<^/7[.^M
M?"_QZFBG5]-TO4-6M]1M=2LP^QGAN8,*[ @\ $?(_P V5(H ^AZ*^5/C!_P5
M#T_X>?M%^,/V3_ W[/'B7QIX\\/R::FB:-HMP@&KK<V0NY96<H1:Q0(R*SMN
MRTBX&,D;OQ(_;Y\1> =!^'?A:U_9B\1ZG\5/B1:3SZ7\,8]2@@ELA I:=KF[
MEQ'$B@9#E>0"<  X /HZBO-_V<_C+\5/BUINJP_&']F[7/AMK.DW,<<EAJ>I
M6]];W:NI826]U;G9,!@AL ;21ZUZ10 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %?.?_!4O_DTZ\_[#EE_Z&:^C*\P_:Z^ NK_M(?!N?X9:)K]MIL\NH07
MNKJ)G0",DD87GG->7G="KBLHKT:2O*46DN[:.3'TYU<'4A!7;3L?D=17V)_P
MYX^)/_18]#_\ )J/^'/'Q)_Z+'H?_@!-7XG_ *H<1_\ 0._OC_F?"_V-F?\
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M%?A_9_\ !,W]GSXX?M#K\5+KXGZ[>:C+KVNBXM;>T']IE -DB6^5B+-,CR8
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MDGGO)L8\R::5FDD/IN8@9. *[V@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
MBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "B
EBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>halo-20250318_g5.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20250318_g5.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $8 I,# 2(  A$! Q$!_\0
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MGX7D_P"$+T_4+C1M&L]/5#J=TK1J/M '$P!W;8\ #?@ D U-:_"_PWXL\2_
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M8XUV@=PN >6G]7C3]I6H))O3S[_IZE\U24E"%1W?X'SW_P -??'C_HJ^I_\
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M^BL:G_X)M(_^0J\EHH_LO!_\^T'URO\ S,]:_P"&O_CS_P!%8U/_ ,$VD?\
MR%1_PU_\>?\ HK&I_P#@FTC_ .0J\EHH_LO!_P#/M!]<K_S,]:_X:_\ CS_T
M5C4__!-I'_R%1_PU_P#'G_HK&I_^";2/_D*O):*/[+P?_/M!]<K_ ,S/6O\
MAK_X\_\ 16-3_P#!-I'_ ,A4?\-?_'G_ **QJ?\ X)M(_P#D*O):*/[+P?\
MS[0?7*_\S/6O^&O_ (\_]%8U/_P3:1_\A4?\-?\ QY_Z*QJ?_@FTC_Y"KR6B
MC^R\'_S[0?7*_P#,SUK_ (:_^//_ $5C4_\ P3:1_P#(5'_#7_QY_P"BL:G_
M .";2/\ Y"KR6BC^R\'_ ,^T'URO_,SUK_AK_P"//_16-3_\$VD?_(5'_#7_
M ,>?^BL:G_X)M(_^0J\EHH_LO!_\^T'URO\ S,]:_P"&O_CS_P!%8U/_ ,$V
MD?\ R%1_PU_\>?\ HK&I_P#@FTC_ .0J\EHH_LO!_P#/M!]<K_S,]:_X:_\
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MPQ#\:O\ H2O_ "JV7_QZOU=HH_U@Q7\L?N?^8?V;1[O\/\C\HO\ AB'XU?\
M0E?^56R_^/4?\,0_&K_H2O\ RJV7_P >K]7:*/\ 6#%?RQ^Y_P"8?V;1[O\
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** /*OV:?^2=ZO_V.?BS_ -2'4:*/V:?^2=ZO
M_P!CGXL_]2'4:* #]FK_ ))WJ_\ V.?BS_U(=1KU6O*OV:O^2=ZO_P!CGXL_
M]2'4:]5H **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ KQC]HKQI
MXJ\%P^%[G1K?7U\.R7DJZ]?^%]/AOM0M8A"QB*Q3(ZB/?R[E#A4P,%AGV>N*
M\>?#&R\>:CH.J_VIJ6@Z]H<LLEAJVE-$)HEE39+&5FCDC9' 7(9#RBD8Q0!X
MK'^U1J/@WX1^#_$FIGP_XQMKV()<ZY9:L+#[:XNU@Q:VDD7FR3"-O-E0K&J8
M8*3P!'=?M+^)? OA+QYKVIV%CXAL])\6ZQIL4FH:K!I20P6X0P6L>(V:>9P7
MVJ%).QMS#C/0:G^Q?X+O]-MK"WUGQ%IT*Z8-+N6M[BW9[Q/MAO?,E:2!R'-P
M?,)38#@+C:-M6O$?[(/A+Q+=:C<OK/B"REU"ZU2XN6M9[?YUO_+%Q$ \#;4Q
M& "N' )!8]@"G=_M47B7GB:]MO"$,WA7P[>:9!J&J3:MY5PL-XL+B98/((/E
MK-EE,@^Z,'D[?4/AE\0E^)6GZWJ$%B+2PLM8NM,M)Q,9!>) PC:;&U=H,@D4
M+\W" YYP.!\3_ ZU\'_#'XCV7AS3=6\7ZGXJTU+)K&:YM8R9$LQ:Q,&?RE0
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M_N/$D>H_\)$8M-@U3PC;-I$=E;>3-'J5K&]T&<QF0'<24*L-NYL[AM"_4O\
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M362EB7R+MN_\C\ZS#C?"T&X82+F^[T7^9^A/B[]N#X;^'9&BL;B^\03*<?\
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M-J><4PY ;)W9/K]93>'[)_$$>N/ QU..U:RCF:5R$B9U=E5,[5+,B%B!EMB
MDA1C5H **** /"OVUO\ DW/Q%_U\V/\ Z60U[FO05X9^VM_R;GXB_P"OFQ_]
M+(:]S7H*ZZG^[P]9?H<\?XLO1?J.HHHKD.@2O*O&G@'X7?$K58]3\7?#SP_X
MIU*&$6T=YK6BVMY,D09F$8>16(4,[G;G&6)[FO5?X:\PKHHTXU+W,YR<=CG/
M^% _ 7_HBW@?_P )6P_^-TG_  H'X"_]$6\#_P#A*V'_ ,;KI**Z?J\#+VDC
MF_\ A0'P%_Z(OX'_ /"5L/\ XW1_PH#X"_\ 1%_ Y_[E6P_^-U0^*WQ>\+?!
M?PK/KWBK4X[*W56\BV4AKF\D SY4$6<R.?0=!DG !(B\5?%./P_9^''L?#NL
M>);_ %[+6>F:4;59P@B,KR.;B>*-548!._[SJ!G-3[*GKY6O\Q\\M/,U?^%
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MVRY56VD5V_\ PC.H_P#/M_Y$7_&NQT^-H[*WB<89(U5A[@"N3$2B^5Q>JO\
MC_PYM33U3V9\B?M!7%U\7-'\<>,[#1-:T?POX8^'OB/3_MNNZ9/I<VHW-W;P
MMLCM[A4G\N-;<DN\:J6<!"V&(I:EI-Q\7-'T.7P3X(USP_::#\.=6T:ZAU#2
M)=.!>ZMH4MM.M_,55N KPEM\)>(;5PYWBOKGQ1X7TSQIX;U70-9MOMFDZI:R
MV5Y;;V3S89$*.NY2&7*L1D$$9X(J[INGP:78VUG;)Y=O;QK%%'DG:B@ #)YZ
M =:\^UXN+VMI^/\ F='-K%KI?]/\CXQUKPCKOBS3UU&V\*:W?:7;^$?"#7FF
MW>E36TMZECJMS+>V@AG1"THC7/DD9<,@P1(N7_&;POJ'QFN?'_B+0?"&MOX8
MU*#PSI5Q::IH5S:3ZO/!K,<TTALIXEE:.&W?:TCQ@$%@"5C)'VKZTM:7U3[.
MYFEV\OP/E'XI> Q>?%7XI:AJ>A^+!H3Z?X2N[;4?"FG">Z2\M;Z[?[1!&Z.M
MPT&(&>,)*VP >6V54^@?LPW'B>ZTOQ5-X@MUN89-34V?B&X\,R>'M0UL"WB1
M[F\LY,,)5*B+S"D8=8@5C50N?;N!2T)VOYE2]YW_ *T%HHHH **** "BBB@
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MM6.D_!77/B+IEG=:A8:?H]UK$%I>V\VGRW"PQO(%*31B2/=LX+)T((!&,O\
M$7Q._P"$?U/X>VG]F^?_ ,);J+6&_P _;]EQ8W%WOQM._P#X]]F/E^]G/&"_
M7H'9_P!:'><4<5Y5X&_::^'7Q*U72K#PYKMQ>R:M#)-IMS+I5Y;VE\(U#2I!
M<RPK%+(@SOC1RZ%7#*"C <CX9_:^\.ZOXLM],U&$Z;I+>$H_%<^OI#>MI\<;
M98@3RVL2^6$4GS'V[F.S:'!6CK_7]= MOY'T+17%> _BUX:^)<VH0:+<7RWN
MGB-KG3]6TJ[TR[B20-Y<A@NHHY/+?:X60+M8HX!)4@=K1JMQ7"BBB@84444
M%%%% !1110 4444 %%%% 'E7[-/_ "3O5_\ L<_%G_J0ZC11^S3_ ,D[U?\
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M7^EOY=_:Z3J4-S+:-EEVRK&Q*'*L,-CE3Z5U5, HHHH **** "BBB@ HHHH
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M]^HI*6OQL_>PHHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
MHHHH **** "BBB@ HHHH **** "BBB@ HHHH 2EHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** /*OV:?\ DG>K_P#8Y^+/_4AU&BC]FG_DG>K_ /8Y
M^+/_ %(=1HH /V:O^2=ZO_V.?BS_ -2'4:]5KRK]FK_DG>K_ /8Y^+/_ %(=
M1KU6@ HHHH **** &]37AW[9GA_^W/@'KDBINFT^2&\C]ML@5C_WPSU[C6+X
MP\/0>+?"NKZ)=?\ 'OJ%I+;/QG ="N?J,Y_"NO!UOJ^(IU?Y6G]S//S##_6L
M)5H_S)K\#\?-M)5G4].N-'U*[L+I/+NK69X)4_NNK%6'Y@U7:OZ.C)2CS(_E
M647"3BQ****H@^]?V _'2:MX!U;PQ*_^D:3=>?$I/_+";GCZ.KY_WA7U2*_+
M+]F_XI-\)_BIIFJ32^7I5T?L6H>@A<CYS_N,%;Z*1WK]2(94GC1T8.C ,K*<
M@@]"#7XAQ-@GA<<ZB7NSU^?7\?S/Z%X1S!8S+HTF_>IZ/TZ?@3T445\F?<!1
M110 4444 %%%% !1110 VC\**SM>UJT\-Z/>:G?SK;65I"T\TSG 1%&23^ I
MQ3D[+<B4E"+E)V2/C/\ X*"^.EN-4\-^$8')-NKZC<KGC+92/\0!(?H17Q__
M  UU/Q0\>77Q,\?:SXDN]RM>SEHHV/\ JHA\L:?@H4?7)KE37] Y1@_J."IT
M7O;7U>K/YBSK'?VACZF(6S>GHM$%%%%>R>$+ZU^K_P !?#?_  B?P;\(:84V
M2)IT,DJ^DCKO<?\ ?3-7YC_"_P 'OX^^(/A[PZJLRW][''+MZK%G,C?@@8_A
M7ZY0QK#$B* JJ,!0, 8[5^8\8XA6I8=>;?Y+]3]>X#PKO6Q37:*_-_H34445
M^9'Z^%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 %%%% !1110 44E+0 4444 %%%% !1110 44
M44 %%%% !1110!Y5^S3_ ,D[U?\ ['/Q9_ZD.HT4?LT_\D[U?_L<_%G_ *D.
MHT4 '[-7_).]7_['/Q9_ZD.HUZK7E7[-7_).]7_['/Q9_P"I#J->JT %%%%
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MWY;^2_S?Y'Z3PCD;Q598VNO<B]/-_P"2-NEI*6OR(_= HHHH **** "BBB@
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MA&Q!!'0@U\<> OVGO'V@_#G3Y#)IFK6>B:+H5[?7&K)<7%]>_;+O[/(/.\X
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M?>J_@O-_Y'W>0<-5LTFJU9<M)=>K\E_F0?!WX0:-\&_"<6BZ2AED8^9=WD@
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M[Q1<?%;1M!U)/#M]H6MO=):76A-<R^48D+X:>15CE/&#Y8X)YQT/H7@_X/\
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M!'R!MS&< C/2OIO.<5YMX$^"-C\/]42[M/$?B?4+>%"EOINH:L\EI;KC "Q
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M1BS,VU57VX4# %=+UKR*G+SOD>G2YWT^;E7-N.HHHJ#0**** "BBB@ HHHH
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MH**** "BBB@ HHHH **** "BBB@ HHHH **** "DI:* "BBB@ HHHH ****
M$I:** "BBB@ HHHH **** "BBB@ HHHH **** $I:** "BBB@ HHHH ****
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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?%%S:WEK(LL,\3Z_J#)(CJ2&5E((8'!!!%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>halo-20250318_g6.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20250318_g6.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" $8 I,# 2(  A$! Q$!_\0
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M*+A&.YPJX&20.:^CO@1>6VK?!7X>^ M0G\FP\9V7B+2\L,JEP)$>*0CU4*X
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M?_)%<_11]1PO_/J/W(/K%;^=_>=!_P +*\>_]%+^('_A8ZI_\D4?\+*\>_\
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M:*/[;QO\R^X/[/H=C\WO^';_ ,2_^@WX5_\  NY_^1Z/^';_ ,2_^@WX5_\
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M^)?_ $&_"I_[>[G_ .1Z_2&BC^VL9_,ON#^SZ'F?F]_P[?\ B7_T&_"O7/\
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M#H2>YK[\HJ/[8Q?,IWU7D5]1HV:/S>_X=O\ Q+'36_"O_@7<_P#R/1_P[?\
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M&BC^V\;_ #+[@_L^AV/S>_X=O_$O_H-^%?\ P+N?_D>C_AV_\2_^@WX5_P#
MNY_^1Z_2&BC^V\;_ #+[@_L^AV/S>_X=O_$O_H-^%?\ P+N?_D>C_AV_\2_^
M@WX5_P# NY_^1Z_2&BC^V\;_ #+[@_L^AV/S>_X=O_$O_H-^%?\ P+N?_D>C
M_AV_\2_^@WX5_P# NY_^1Z_2&BC^V\;_ #+[@_L^AV/S>_X=O_$O_H-^%?\
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MZU?_ +'/Q9_ZD.HUZJ!7E?[-7_).]7_['/Q9_P"I#J->JU)0E%+10 E%+10
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M/6FR2LL;% K/@[59L GL,XXKY3^!W[(OPF\8?"'PCK>K^%?M>IWVFP7%Q/\
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M/3[8Q;FMIS; W$CK/&R*4C4_-F0  GU'PQXP/BK6-<@MK)DTW398[5;]Y/\
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MC4-1N8K*RMT,DL\[!411R22:K>)O%&F^#]#O=8UB\BL-.M$\R6>4X"C^I)P
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MJEO^SC\'?%&FBQT_2H;NPTQ9-&D@TO6;I4CV7+SM;RB*8;C'.[.$?)C8C&W
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MA3;CA8.7F]%_G^1^CX'@;$UDIXJ:@NRU?^7YGYB:/^RS\5-;C\RW\'7D:?\
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M.T@#X)V(H49P ,X'8 >U9WQ4_P"28^+O^P1=_P#HEZNG\:]2)_"SF_V:?^2
M> /^P/;_ /H KTTUYE^S3_R0#P!_V![?_P! %>F]ZTQ'\:?J_P R:7P+T%KC
M?^$RO?\ GG!_WRW^-=D:\PJJ$(RO<<Y-6L;O_"8WO_/*W_[Y;_&C_A,;W_GE
M!_WRW^-85%=GL8=C'GD;O_"97A_Y9V_Y'U_WJ7_A,+W_ )Y0<?[+?XUY!\6O
M%7B'PS;V,NEWN@^&]'42SZKXJ\48DL;!%VJD9B%Q S/*S@!MX"[6SR54^9ZM
M^T7K\W@GX:74"6VAZWXHCNKJ9F\/7^N!K>W7F6"TM9$G*R%X74DX2-OF.1SG
MR4UK;8=Y-I7/JK_A,KW&?+M\>NT_X]*#XRO.\=O^1_\ BJ^3/BM^T9XD^'?A
M?PO>V6J>&]5GOK&^O'OKC2[JTBU.ZMY(U32[>W:X,D%W)YC+M=Y'5H'_ '1.
M0OMG@WQ1?^*]2UVY\B*'0K:X%C8R#/FW$L>1<R$[ON"3,2C YA<Y(9<4J=-]
M!<\DEYGH_P#PF-[_ ,\H/^^6_P :/^$QO?\ GE!_WRW^-85%5[&'8.>1N_\
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M0:XGPW\/_B!\-]'L)/#MUHVJSSWNHWNI^'KVY:QL!)=W'V@-!<I;2R#R26C
M\L"19&=@C 5]&_\ "$@?\OG_ )!]_K1_PA(_Y_3_ -^O_LJCVM.][_TQ\LMK
M'A?AOX=^(/"?PQUG2]-O[&U\5ZS>7NH2W:;A!9SW<[2R&/Y=TGE+(=A95,A0
M$[-YQQFA_LY7WAGXTV/B+35TJ'1;.:.:/5#,YU46J:=]D_LPKY>UK<R?Z47,
MF2_\&[YZ^I_^$)X/^F]>H\KKCU^:C_A">WVW_P A?_952K4D[IBY9V?G^IS%
M%=/_ ,(3_P!/G_D+_P"RH_X0G_I\_P#(7_V55[>GW%[.1S%9OQ ^!ND_%WQ?
M\/M2\1Z)H7B/PYHME>K<Z;KEHETKRS) (G2-T9"5\M_F)!&[C.:[G_A"?^GS
M_P A?_95T%K;BUM8HMV[8H3.,9P,9KDKSA42LS6G&43Y5OOV-;K3_!?B[X=:
M!;^%XOAW)JEMXF\-V&I6QE%O?),DTUC>0B/;<6<C(<2&0R(DA3#*B8WM&_9_
MU+3?#/BB.S^$7P4\.3ZBMK;KX?LK!KBSU&!)0\RW=T+6'AAQ&OV:01NH<^;N
MVK])[11CW_2N5:+^O0U/E30?V9O&7AWPMI2::ND6)TKQ;9Z]IO@]]?O;S3-,
MM(83"]O!>30&5=Q9Y0BPK&I(15 RY[6^^!FNW7PW\1>'TN]/%[J7C6/Q'&[R
MR>6+8:O#>%&.S/F>7&RX (W$#=CYJ]T,><TNS/<_G1%<LN9?UM_D@>KO_77_
M #/'/A!\/_'/PQU"7PP3X>F\ PWVI7]OJ(N)Y-3F6YN)+B.W:W\I8XA&TS@R
M^;(76-?D4N2OD5O^R'KD&@^!'U?PM\/O'>H^%+>_T<Z+XED>73[ZRGF6:.Z2
M5[.0VURC( 4$4JE7<;^01]@;/?/]: O3FEUOU_K] [^9\Z:+\"_%/P_O_"OB
MKPAX?\ Z9X@L+.^TV_\ "VEK+I&CFWN9HYE,4T<$K>=$T$8,A@ F#.=D7R@=
M[\ _A[XC^'?PS.B>*+^QNO$$VI:I?W%WI ?[.3=7T]P"BR#(P)A\K;L$$98#
M)].\L=>]'EXZ'%5?3E ^;O$GP:^(_P 1O^$2TGQ?#X-OYO#>IVU[;_$2"60:
MSLAGCF8Q67V58[:6=84BD*7)3#,P0C$86W^!/CC0=2O=6TM_#\VHZ9XVO/%.
MBI=7LZ17T%W%+#<6UR5@)MF59V*R)Y^2H)4 D5](;?QI=O>I6FO7_.W^0/7?
M^OZN?-$GP!\=-XHC^)GF: WQ$'B!=6.@_;IUTH6@L'T\6@N_LYDW"-_.,WV?
MEQMV!?F&E\1/V=]6^->O?#_5/&O]A"XT?2M6AO'TP2%["_N3;&VGL6D4G? 8
M6Q,3&VX!@JAMJ_0NT4;?4^]/33R_X8:=G='G:>"==\;?!&\\(^/+NR.N:II-
MQI.IWNCEC#(71XC/&K!2I92'*?PDE=S ;CR/AOX>_$7Q%KW@.7QW#X9T^U\&
ML]S%<:#?W%S)JETUI):!VBDMXA:H$FD?8'F.YE&[Y2S>XJG7FC9CO3>M[]25
MHK'SQX(_9Y\1^&_"/[/VE7-]I<ES\/[B275&BED*3AM.N[4" F,%COG0_-L^
M4,>N <CP3^SKXX\#VV@16S>%-3E@^'J^$;U=4>>:V%U$7>-O)$8^T0.7*,&>
M)@N2 V=M?3WE^^!Z4NW\J)>\[_UU_P V5=_UY:GA/[/GP2U?X7^)/$6I2Z9H
M_@C0M0BCCM_!OAC6;O4-+AG$CO+=1K/# ENS[U7RH(E7";B6+?+[MMHV<]:=
M1Y""BBB@ HHHH **** "BBB@ HHHH **** /*OV:?^2=ZO\ ]CGXL_\ 4AU&
MBC]FG_DG>K_]CGXL_P#4AU&B@ _9J_Y)WJ__ &.?BS_U(=1KU6O*OV:O^2=Z
MO_V.?BS_ -2'4:]5H **** "BBB@!N[IQ45Y=QV5G-<3.(X8D,CNQX50,DFI
M.:\M_:<\4?\ ")? OQ;>!PDLMI]CCYYW3$1<?3>3^%;X>DZ]:%*.\FE]YR8J
MNL-AYUY;13?W(_-KXD>,)?'WC[7O$,I;_B873S(&_ACSA%^@0*/PKF:**_H^
ME3C2A&G%625C^4ZU25:I*I)ZMW"BBBM3$W? _@^]\?>+M(\/Z<,W>HW"PJVW
M(C&<LY]E7+'Z&OUA\!^"].^'WA/3/#^E1^78V,(C3CES_$Q]V))/N37R%_P3
M^^'BWFJ:]XSNH\K;*-/LV89&]@&D8>X78,_[;5]NJ,5^.<58^5;%?58OW8?F
M?NW!>6+#X3ZW->]/;T% HQ2T5\.?HX4444 %%%% !1110 4444 -VGUKB?B]
M\-K7XI>![_1+C:EP1YMI<,/]3.H.QOU*GV8UW%-"^] 'Y/W]C<:9?7-G=1&&
MZMY&BEC<?,K X8'W!!'X5#7O?[9'@6/PS\3(M7MH]EKKD'VAACY?/0A9,>Y!
MC8^I8UX)6B)"BBBF(],_9P\8?\(9\8- N7<);7<OV&XR<#;+\J_@'*-^%?HW
MNK\F4=HV5T8HZG*LIP01T(]Q7ZF>#=:'B;PCHFK@Y%]90W)QZO&&/\ZB12-N
MBBBI&%%%% #17+?%3_DF/B[_ +!%W_Z)>NI':N6^*G_),?%W_8(N_P#T2]73
M^->I$_A9S?[-/_) / '_ &![?_T 5Z::\R_9I_Y(!X _[ ]O_P"@"O3>]:8C
M^-/U?YDTO@7H+TKA/^$FU+_GY_\ '%_PKNS7F%7AXJ5[H*C:L:G_  DVI?\
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M0NX]1U:SNQ;VL4Z,DGV>WG"3.[@H%( \U.,^T_#WXG67BKQ?K%G<>)=+^TS
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M@!**6B@!**6B@!,44M% !1110 E&*6B@!**6B@!**6B@ HHHH 3%( ?6G44
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@#RK]FG_DG>K_\ 8Y^+/_4AU&BC]FG_ ))WJ_\ V.?BS_U(=1HH
M /V:O^2=ZO\ ]CGXL_\ 4AU&O5:\J_9J_P"2=ZO_ -CGXL_]2'4:]5H H:YK
M$6@Z-?ZE<([P6<$EQ(L>"Q5%+$#..<#UK%\(_$?1_%WP[T[QM'(VF:%>6(U$
MRZFR0_9X=I8M*=Q50H!).X@8ZU;\;Z?<:MX,U^QLX_.N[JPGABCR!O=HV51D
M\#)(ZU\X0_#_ ,<:]^S'H_P[F\%:EI6M:'9V,\GVZ]L#::DUM/%(UHC17+MF
M0*VTR((\CYBO6@#Z E^+G@:#1[/5Y?&?A^/2+PR"VU!]5@$$YC.) DF_:VT]
M<'CO3M7^+'@K05L&U/Q?H.G+J$ NK-KO4X(A<PD9\V/<PWICG<,C%?.</P+\
M9ZI\3+'Q7=:";73;[7]:U2;2;BZMW?3DETS[- TFV1D,DLJ*Q$;.%RA)&#CQ
M;QIX#\0_#GX5^(M'UG2[6^U&Z\,>'K*Y2/4[22;19(;X@"6,2^9MD9EV-&K
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MF,GF$[]V[[XSU]NE9?B+]G_P!XLUVZUC5O#=O>:C=1"&:9I)%W*%"@X# !@
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ME\0/ GPD\-Z>FBW2S6BW<MKK%\T"2E+0!/EC83.!N;/EYQQG YK"T#PVVL>
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M..%48& ,<"N"I5I.<G!;K_*YUQIS45%OK^'_  Y\@?'NUFU+XE>-]4M[6[U
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M:6Q6^T47/V/4)=4C9[F;<UQ)*)7,C!\RHSJF8W+)A$7;M50 #NJ;MXZTZB@
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M[R:[[?<,BM4AC5$5451M"J, #T%2[>:=17R/6[/N[)*R"BBB@84444 %%%%
M!1110 4444 %%%% "8HQ2T4 -"4;?EQ3J* &[?>EP?6EHH 3;1MI:*0#=OI2
MXI:*8#=II=M+10 W;R:-OYTZB@!NVEQ[TM% !1110 4444 %)2T4 )BBEHH
M3;1BEHH 3;2;>*=12 ;MYHVTZBF 4444 %%%% !1110 4444 %%%% !1110!
MY5^S3_R3O5_^QS\6?^I#J-%'[-/_ "3O5_\ L<_%G_J0ZC10 ?LU?\D[U?\
M['/Q9_ZD.HUZK7E7[-7_ "3O5_\ L<_%G_J0ZC7JM !1110 4444 %%%% !1
M110 4444 )12T4 -VT;33J* &[:3RP:?10!7FL+>X7$L$<@_VD!JI_PC.DE@
MQTVT+?WO(3/\JTZ*M3DMF9NG!ZN*(H[6*-<+&JCL ,4_RP.G'X4ZBINRE%+9
M#=M+BEHI%"8HQ2T4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M$?$#_P -SXA_^0:** #_ (:6\(_] CX@?^&Y\0__ "#1_P -+>$?^@1\0/\
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M ,-SXA_^0:** #_AI;PC_P! CX@?^&Y\0_\ R#1_PTMX1_Z!'Q _\-SXA_\
MD&BB@ _X:6\(_P#0(^('_AN?$/\ \@T?\-+>$?\ H$?$#_PW/B'_ .0:** #
M_AI;PC_T"/B!_P"&Y\0__(-'_#2WA'_H$?$#_P -SXA_^0:** #_ (:6\(_]
M CX@?^&Y\0__ "#1_P -+>$?^@1\0/\ PW/B'_Y!HHH /^&EO"/_ $"/B!_X
M;GQ#_P#(-'_#2WA'_H$?$#_PW/B'_P"0:** #_AI;PC_ - CX@?^&Y\0_P#R
M#1_PTMX1_P"@1\0/_#<^(?\ Y!HHH /^&EO"/_0(^('_ (;GQ#_\@T?\-+>$
M?^@1\0/_  W/B'_Y!HHH /\ AI;PC_T"/B!_X;GQ#_\ (-'_  TMX1_Z!'Q
M_P##<^(?_D&BB@ _X:6\(_\ 0(^('_AN?$/_ ,@T?\-+>$?^@1\0/_#<^(?_
M )!HHH /^&EO"/\ T"/B!_X;GQ#_ /(-'_#2WA'_ *!'Q _\-SXA_P#D&BB@
M _X:6\(_] CX@?\ AN?$/_R#1_PTMX1_Z!'Q _\ #<^(?_D&BB@ _P"&EO"/
M_0(^('_AN?$/_P @T?\ #2WA'_H$?$#_ ,-SXA_^0:** #_AI;PC_P! CX@?
M^&Y\0_\ R#1_PTMX1_Z!'Q _\-SXA_\ D&BB@ _X:6\(_P#0(^('_AN?$/\
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3>&95D3?'(C@.H.&'%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>halo-20250318_g7.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20250318_g7.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_X1[&17AI9@  34T *@    @ !@ +  (
M   F   (8@$2  ,    !  $   $Q  (    F   (B $R  (    4   (KH=I
M  0    !   (PNH<  <   @,    5@  $48<Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                     %=I;F1O=W,@4&AO=&\@161I=&]R(#$P+C N,3 P
M,3$N,38S.#0 5VEN9&]W<R!0:&]T;R!%9&ET;W(@,3 N,"XQ,# Q,2XQ-C,X
M-  R,#$Y.C R.C(P(#(P.C,S.C$X   &D ,  @   !0  !$<D 0  @   !0
M !$PDI$  @    ,Q,0  DI(  @    ,Q,0  H $  P    $  0  ZAP !P
M" P   D0     !SJ    "
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M,C Q.3HP,CHR," R,#HS,CHT,0 R,#$Y.C R.C(P(#(P.C,R.C0Q      8!
M P #     0 &   !&@ %     0  $90!&P %     0  $9P!*  #     0 "
M   " 0 $     0  $:0" @ $     0  #1H         8     $   !@
M ?_8_]L 0P (!@8'!@4(!P<'"0D("@P4#0P+"PP9$A,/%!T:'QX=&AP<("0N
M)R B+",<'"@W*2PP,30T-!\G.3TX,CPN,S0R_]L 0P$)"0D,"PP8#0T8,B$<
M(3(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R_\  $0@ )P$  P$A  (1 0,1 ?_$ !\   $% 0$! 0$!
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MO@K<0P?#JW$LJH7NY57<>IR*Y,;_  S>A\1G_'2XANO!-C+!(LD9O -RG/\
M":^>:>#_ (0J_P 845U&(5T'@;_D>=%_Z^T_G4S^%E1W/KA-1LY)!&ES&S,Y
M0 -U8=17RC\2O^2C:Y_U\?T%>=@?C?H=.(^%'+!6;. 3CK@4E>F<H8)S@=.M
M% CWSX"W$-KX;U>6>18T%R@W,<?PUU/Q9N(9_A?K@BD5S&85;:>A\Y.*\BI_
MO'S.V/\ "/EJEVMG&#GTQ7KG$&#Z&DP<9QQ2N,5?OK]:^VWN(8CMDFC0XZ,P
M%>?C]X_,Z</U/,OCJZ2> 8&1E93>IRIR/NM7SA6V#_A&=?XPHKK,0K4\-_\
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M^,4?\/C],_Z)=>?^#I/_ (Q7YC44?V-@OY?Q8?7J_<_3G_A\?IG_ $2Z\_\
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MKZF&282*LTW\SQWCZTGH['Z<_P##X_3/^B77G_@Z3_XQ1_P^/TS_ *)=>?\
M@Z3_ .,5^8U%7_8V"_E_%D_7J_<_3G_A\?IG_1+KS_P=)_\ &*/^'Q^F?]$N
MO/\ P=)_\8K\QJ*/[&P7\OXL/KU?N?IS_P /C],_Z)=>?^#I/_C%'_#X_3/^
MB77G_@Z3_P",5^8U%']C8+^7\6'UZOW/TY_X?'Z9_P!$NO/_  =)_P#&*/\
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M ,/?OB;_ -"=X4_[]W/_ ,>H_P"'OWQ-_P"A.\*?]^[G_P"/5\'44?V7@_\
MGV@^M5_YS[P_X>_?$W_H3O"N._R77_QZM/1O^"P'C6.3_B;>"-"G3H?L4DT1
MSD?WG;MFOS\HI?V7@_\ GVA_6J_\Q^OWPG_X*I_#7QM<067B>QOO!EY*V!-,
M?M%J!CJSJ RY/'"MUZU]DZ+KEAXBT^WU'2KZWU+3YUW17-K*LD;CU##(/YU_
M-QNQ_.O??V5_VP_%W[,_B&(6LSZKX5N)0;[19Y"48' +QGG8^,8('89!'%>+
MC<BAR\^'W['=0Q\D[53]V<TF:YGX;_$31/BKX-TSQ1X>NQ>:5J$0EB<=5]48
M=F4Y!'_UJZ?)]*^,E%Q;BUJCW$U)71R/Q8^(VF_"3X<Z_P"+]7;;8Z3:M<,N
M?OMT1![LQ5?QK\ OBG\2-8^+7C[6O%>NW+W6H:E<-,Q9B?+7/RHN>BJ,  <
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M* "@444]] .D^'/C[6/AAXVTGQ/H=W+9ZEI\ZS1R1-@G!Y4]B",@@\'/-?T
M?!_XE:?\8/AKX=\8Z9Q9ZM:B?9S^[<?*Z>^UPPSWQ7\[8ZBOUO\ ^"2GC6XU
MSX*^(/#]PYD&B:D&BW,3M29,A1Z &,\>YKY?/<.IT%7ZI_@SULOJN-3D[GW3
M1117PA]$%%%)0 50U_6K/PWH>H:MJ,PM]/L;>2YN)6Z)&BEF;\ #5\FOFO\
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M*[\O_P![I^IRXK^#(_'NBBBOU0^1"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHI/8:W/Z&?@'_P D+^'?_8NZ=_Z31UWP[UP7
MP#_Y(7\._P#L7=._])HZ[T=Z_(:G\27J?9T_@0M%%%9F@4C=*6D;I0!^)O\
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M%O\ U]:C_P"@V]?F+7LY/_N4/G^;.''?QY?(****]LX0HHHH **** "BBB@
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M7Z;BCAYMJZW/BFBN^^/VF6FC?'/XA6&GVL-C8VOB"_A@M;:,1Q11K<.%1%
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M'3=[I;KK?_(CZNK<W-IK_D?!=%?I;_PS'X&^)GQ>\ ?&S3]#TK1_@S<^'/\
MA(]=L8K:)+*WN+5 &MC$GR8+;=RX(;RILY).?SZ^*7BRR\<_$3Q!KNF:19:#
MIE]>R26FFZ=:I;06\&<1HL:8484#) Y.2>:ZL-C%B7RQ5K+7U[&52BZ:NW_P
MQR]%%%>@<P4444 :'AW_ )&#3/\ KZB_]#%?TBU_-UX=_P"1@TS_ *^HO_0Q
M7](G;GI7Q?$.]+Y_H>YEOVOE^IQ?Q>\"GQ]X'O-/A"G4H<75BS< 3H#M&>P8
M%D)[*YKY#MYUNH5E*LNX?,KC#*>ZD=B/3L17V9\0O&4/@'P?J6M2J)7@3$$)
M./-F8[8T_%B![#)[5\:1^=\\MS*9[J61IYYB,&65V+R-CIRQ8\=,U\JO@/7^
MV=!X \'MX_\ &FGZ+(I:QYNM0;'_ "[H1E#_ -=&*I]"Q[5]G+A1@#&.U?(?
MP?\ &'_"#?$"RGE?;INI;=-O">%4ECY,F?\ 9<E?I(Q[5]>+S@TI?#'M^HX_
M$R1ONFOYN/$/_(?U3_KZD_\ 0C7]([?=-?S<>(?^0_JG_7U)_P"A&OK.'MZO
MR_4\?,_L_/\ 0SZ***^S/#"BBB@ H]:** /H/]E;]F?PI^TIJ3Z%=?$P^$O%
MLDLOV71?[ EO?/@2,.TWGB1$7^,;2<_+QZ5YI\9/!?A7P#XT?1_"/C7_ (3O
M3XX@)M2_LJ;31'.&97A\J4DG;M4[P2#NQVKW+_@F./\ C+GPYV_T&^_])VKK
MOV'=!LO^$S^./B^TT&V\3>-_"NE7%[X<TFZB\X-<;Y3O6/JS K&!MY_>$+@F
MO#J5ZE"M4DW>*2LO5V_0[H4XU(126K?Y'Q/D<<X'8G@?Y_SVI>N-OTY]?\_Y
MZU^D_P &_CM\1_CI^RG^T9?>/;6.]:ST6:WM-:73X[5Y"89M]J?+50XC^4CN
MOF').13/VK/B9;6_A7X)?"B73[*ST;QIHV@/K^ML66X-K'*@2-6R JJ?,8E@
M1\QQCFI683=3V;@KWUL[]$ROJ\>7GYC\VN&&5[].?K_G\*7ALGMZ\5^I7C'X
MR_$7P%^VOX1^#7A[PC86?PO@N[&&RT&/2(S#/;821[U9"A(:)R[AD("F+YLL
M&)T/!?@[PSJ'[:7[27BW5C;C7?"]E9W&DR76G/J0LR]HIDNEM8\/*R>7'\J?
M-\Y (+"I6:-)SG#2UUKW:*^J:I)];'Y2]_3W[?6O7_V@/V>_^%%:7\/KLZ\=
M:_X2W0HM:V?8_(^R;P#Y6?,??C=][Y<XZ5]9?&[XO>!O%G[/UYJVJ_%2/XC?
M$31]4AO/"WBM? =UI#PW$4B.UJ9/*,+_ "@G:V.Q(8@$<S_P4<^*?B?Q'X"^
M">EZEJGVBQU;P[;Z[>Q?9XE\V^,84RY501Q(_P JD+STHI8ZKB*E-*-KMI_<
M*5"--2<G?8XO1?V X-7TXZ9+\6O#NB?$2VT6/Q!J/AO5K:6&VL+-U#;Y;W)3
M*JRE@%.W/]T[CQ7Q<_93T[X,?"BT\6:M\3?#^N:GJET;?2=,\,I)>6]\JD>;
M,MT^S]V@."RHR[\+G)./2?@K\>/&WQD\)ZEX;\1MH6A^!]&T:.V\7?$"'3PF
MM2:/&<)8FY+8=YB!$B["Q))Y.[/9^*/@OX/_ &C)/![ZEJWB#0O&/BCPY/?>
M#M+TVSC;0-%TNU5S!9S,<NSE4+.Z' >0DKRH;+ZQ7HUOW\M+]%_7_#%.G3G'
MW%J?G_2T=J*^D6R['FNX4444Q!1112 *_3K_ ((W_P#(O_%+_KYT_P#]!N*_
M,6OTZ_X(W_\ (O\ Q2_Z^=/_ /0;BO&SG_<I_+\SOP7\>/\ 70_1M@/QKXS^
M(O@W_A7_ (VO](BC\O39,W>G<8 @<_ZL?]<VW)CLOED]:^S#QWKY$^,GC#_A
M-OB%=O"V[3M)#Z?:XY#,&'GR?BZJOIB($=:_.H6LT]CZ26ZL<1<W"VUO)*^[
M:JYPHR3[ =S[=Z^NO@WX';P'X(M+2Y15U2Z8W=^0<_OG RN>X10L8]D%?(\J
MR%5:"4V]Q&RR0S*,F*16#(X]U8 _A7V3\-?&D?C[P?IVLHHBGE0I<P+TAG0[
M94^@8'&>H(/>C[%UOU&_CL]NAT]?%W_!67_DV*P_[&*T_P#1-Q7VEZ5\6_\
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M^(?B)JOAV\T)M-!T^&[BFCU&YDASYK0%2I2-\X\D]0.M>;_\,Y_$+^[X9_\
M!I<?_(M=W^T-X_\ $?@[5_#%GH.I_P!EI>P7LT[B".4L8VMP@^<''^M?I7E?
M_"Y/B#_T-LG_ ( 6O_QNO$3?*N:QV6]YVO\ >;/_  SE\0O[OAG_ ,&EQ_\
M(M'_  SC\0O[OAK_ ,&EQ_\ (M8W_"Y/B%_T-LG_ ( 6O_QNC_A<?Q"/'_"6
M2'_MPMO_ (W2YEUM]P6EV?WG;_#[X#^,O#_C[0-8U0Z&ECI\\DTOV.^FEE;,
M$D8"JT"@\N/XAQGZ5]%]J^8?AI\6/&FI?$CPYINI^(&U"POKB2*:%[2"/(%O
M*XP50'J@[]J^GJFI>Z+I=>Y^3/\ P5\_Y+GX0_[%U?\ TIGKX0K[O_X*^?\
M)<_"'_8NK_Z4SU\(5^DY7_N=/T/EL5_&D%%%%>J<H5I^&-&_X2/Q+I.D^=]G
M^W7<-KYVS?Y>]PN[;D9QG.,C.*S*Z7X8_P#)2?"?_86M/_1R5G4;C%M%15Y)
M,]]_:"_9.^''P N-9T6_^-ZWWC:P@CFB\/MX3N8A/O"LJFX662-<JV[N>V*\
MD^.WPN\/_"7Q58:5X=\?:5\0[*XTZ*\EU/25"QPR,6#0MAW^9=H/4'YQE5/%
M?6'_  4>\>?#FT^,GBOP_>_"W[?XWDL;41>,?^$AN8O*+1(4/V,#RVVK\N">
M>M?3]G(L7_!0#2)"F]5^%N[:PZXNN1_GUKYJEC*].E"I-MW3>MM=NQZDJ,)3
M<5W/QI/R_@,G_/\ GVI=N.._.!]*^_M6^)VK?M(?L$?%?7/&UKIMS?>%]=ME
MT1K2PBMQI\32VZ^5$%'"JKNG]X@X).*Z']H'XJ>-_P!F.\^%GP^^$'ANQ7P'
MJ>D6LP5-)CNU\27$A*R12.RG<64(2%(?]YG."H';_:$](<EG=JU]-$GO\S!X
M==]#Y!_99_9Y_P"&F/B)>^%O[?\ ^$<%MI<VI?:_L?VK>(VC79M\Q,9\S.[/
M&.G-<C\)/AS_ ,+2^*WAOP4-0_LPZUJ,>GB^\CSA%N;;OV;EW8]-P^M?J[,S
MM_P4@N&>/R9&^&19HQ_"WVKD9]NE?FI^R./^,K/AMQ_S,-M_Z'4T\94K0J2V
MM%->6Y4Z,8-1\['J'C[]A71M)\/_ !"N/!'Q8L_&FO> E:77]$N-%ETV2%$#
M%S'(\C+(1L/ XX^]G /R4>&-?9O[7W[6GBO3_'WQ6^'&@Z'X7\*Z7?:I+9ZG
MJNAZ6;?4=5B1B,7,V\[]P8@L "<D="P/8^*/B+XG_97_ &2_@QJ'P@L+73X_
M%5L]YX@\3)IT=U)-=?(5MW9U91R\J@,,XBPN,',4L3B:5*,JJNYO2]NU]1SI
M4YR?)TW/@$X'&,=@.G\_RZTG'J,9X/\ .OU%_: ^.&I_"/XC_LJ^-]?TQ?#A
MFTB:+7=*@3RH[>&=;59H_+[!-VX(>AC ZBL;XE?#6Q_83\%_&CQSI\\4>K^-
MKPZ)X/\ LK!FL[2=?.D<-U7;EAZ9MXSW%:1S)M1O#66WWZ_YDO#:NSVW/S4R
M&7)XXZ_YXH8Y_#KCM7W_ .)OB)XG_98_9W^!4WP:T^TB3Q=9B]UO6$T^*\EU
M*](0FS=BIQ@O(NT88;<*1@U[#X3\$^'O!O[?%[#H6G6NA:EX@^'<E]J&BV@
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M*!U!_&BB@#Z<\%?M^>-/!/@CPCX:C\&>!-7B\*1;-(U'5](FN+NT?_GK&YG
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M.I/ _@>=[.7R]7OV^Q6..JR,#F3_ ( H9_JJCO7R1^YTO3U"J?(AC 5$^8D
M8 '<GMCU)KZG^,GPAN/B/)8W]AJHM+^QBDBBMKE-]LX<J6S@;D8[5&[YA@?=
M->:_#'X-Z\WQ&MF\1Z2]EI^D'[89/,62*ZF# 0A&!R0&!D.0""B9'S5^>Q2:
MWT/HI-WV/.=<\*ZQX)U1=*UY8_MDD$5VK18VE7'* YY*.'0^H"G^*O0/V>?&
M1\-^-)=#N)-MAK?,0)P$NT7CZ>9&,$^L2#^*O2_V@/ ,_BWPO#J6F6SW.L:2
MYDCAA7+SPM@31 =S@*X'<Q@=Z\Y\$_L]Z_K%Q:7^N7(\-6D$R7$<$#+)>ED;
M<ASRD6"JG(+G@\*>:=U+WMNXM5[NY]-J<].E?%W_  5D_P"38K#_ +&*U_\
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M-M5R!G;LW8.0I!!JC\,/V!IO%_PWU?Q=XJ\>6G@&#0=8O-)UJ'4K1'6R:W4
MD2&=%=FE*H%X'.0QX!^B_$7[='A?Q5?/XGTW]HGQ!X(TV:UWMX'C\$6UY=P3
MA<;4O'@:,J6P?G)SS\ZY&WYN\<_M':1X^_8\UGPUJ_B)[_XB:IXV?6KFV:Q:
M SP%,&5C'&(%)8#**>O..]<-.MCYKEDVE==-N_0WE"@MNQ[[^UYX,/BCX4_
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M_P"*<T[_ -)HZYG]I/QH='\*P^';63;>:X6CE*]4M%QYQ_X%E8_H['^&NF^
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M99QDDJ .6 K[)- 44IZ4IR4K6'"+CN?DO_P5\_Y+GX0_[%U?_2F>OA"ON_\
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M_0]S+/M_(_.+_@L=_P @#X6_]?6H_P#H-O7YBU^G7_!8[_D ?"W_ *^M1_\
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M^DD=?+5?JN!_W6E_A7Y'Q^(_BS]0HHHKN.<**** #)HHHH */;M110 4444
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MMQ\,5349.TUT/E\5AW2DVEH<-11Q17MG %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 *%[]J^Q?^"9_P"SW/\ %#XS0>+M0@D'A_PLRW0D
MQ\LUUG]W'G/8_,1@@A2.XKS+]F/]D#QG^TGXBACLK>32/#,3_P"G:Y<QXCC7
M@D(/XW(Z*#[\#)'[5?"/X4>'O@KX%TWPEX9LUM=-LTY)P9)I"/FED;^)V(Z_
M0#   ^:S;,84:;H4W>3_  /5P>&E*2G+8[)0./I3J*6O@3Z,**** "D-+24
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M'2_^BHWG_@E7_P"/T?\ #G'2_P#HJ-Y_X)5_^/T44?VKC?\ GY^0?4Z/8/\
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MY!]3H]@_X<XZ7_T5&\_\$J__ !^C_ASCI?\ T5&\_P#!*O\ \?HHH_M7&_\
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M_P __BS_ ,&,/_QBBBC^T\9_S\8?5:'\B#_ATU\%?^?_ ,6?^#&'_P",4?\
M#IKX*_\ /_XL_P#!C#_\8HHH_M/&?\_&'U6A_(@_X=-?!7_G_P#%G_@QA_\
MC%'_  Z:^"O_ #_^+/\ P8P__&***/[3QG_/QA]5H?R(/^'37P5_Y_\ Q9_X
M,8?_ (Q1_P .FO@K_P __BS_ ,&,/_QBBBC^T\9_S\8?5:'\B#_ATW\%O^?_
M ,5_^#&'_P",5+:_\$H?@K;R;S<>)YQ_<FU"(C](1112_M+%_P#/QA]5H?R(
M]S^%W[+'PM^#TD4_ACP=I]K>QD,M],GGSA@,;E=\E#_NXKU@*.F.***Y95)U
47S3=V="A&FK15AV!Z4445!1__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>halo-20250318_g8.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20250318_g8.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %Z IP# 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#]4E%%%+0
ME%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10 E%+10
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M66X%M_;%QIJ_9$<GNZR-Z]@3[5[O#,EQ&DD3K)&X#*ZG((/0@T"::W'T4M%
MA**6B@!**6B@!**6B@!**6B@!**6B@!**6B@!**6B@!**6B@!**6B@!**6B@
M!**6B@!**6B@!**6B@!**6B@!**6B@!**6B@!**6B@!*6DI: "BBB@ HHHH
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M%MDGTR,+D%G7.T#TR.%;Y5.#7T]IOA31='TV;3['2+"RL)V9Y;6WMDCBD9@
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MX[=%9>?_  /^ >VVMTEY;QSQ'='(@=6'0@C(-3BJ]G;)9VT,$8(CC0(JDYP
M,"K%>JKV5SZ*-[*XM%)SZ44QBTE+2&@!K-TK+3Q)I[>(&T19R=26V%V8=C8\
MHL4#;L;?O C&<^U:4G*^@Z9]*^;O#NGQ^ _'VEC5K+3_ !%#XAU*=M/\3:;<
MN+Q-R,-LI'+)AL85MJXSU KEK5G1Y?,X<3B'0<++1O<^CQ,-Q!/X>E.60=B/
M>O _"GA_2M>^*5[K_A^+^R_"&GV,MA=:C$[1#5)R3O<2 AGV<DS$DEER"?O5
MS5U UHGCGQKX+LVT7P]%HS6%HT*F+[;*K@M=*O7Y!N <\DC.?O5C+%<JORWU
M?X=3D>8-+FY;[[=4NNVQ]1;P5S2>8HY/2OG_ .$FMV'@OQ!'I]Y!H-I:2>'H
M-4?6[:W^S.JLX79<2L[;RV0VXL,X)QSQ/\:O#^@^,?$_AKPYI^F:<^J>()UN
MKS4HH(_.%G&-S,),9RP4 -GH".]5]9O3YTM>QI]>O1]JHZ[6/>1(.G3\13D8
M-G'-?*WQ.\+ZOX6O-7O)])EGU2ZUVU_L+6H)HBT<1*!+9%W^8,?.-BK@\GH,
MU]3V_P#JQP1Q6E&LZDI1E&S1KAL3*O.<90Y6O^#Y$M%-9@HR:-U=1Z ZD-07
M5]!8PO-<31PQ*,L\C!0![DUYUXD_:,\ >&]XFUZ&\F7_ )96 ,Y/MN7Y0?J1
M64ZM.G\<K'/5Q%&@KU9I>K/2B=OTH^[VKY]D_:8UWQ46C\%> M3U)6X6\NP5
MC!]PH(Q]7%1_\([\<?''_(1UJP\(6<G#06@#2@>H*[C_ .1!7)]<C+^'%R^7
MZNR/-_M2G)VH1E/T6GWNQ[UJ>M6&BVS7%_>064"]9)Y511]237F?B7]ISP#X
M?WJNK-JLR]8].C,N?H_"?^/5S^E_LF:-=7"7?BG7M6\37?5C-,41OU+_ /CU
M>F^&_A-X0\)>6VE>'[&VFC^[.8@\O_?;9;]:7-BZFR45][_R'S9A6VC&"\]7
M^A\C_'KXG:[\3FL[VVTG5M)\+PKL3[0CK'-*23N9A\A., #)Q@^IKM?A'\?K
M[X:^%[73/&FC:TUHS;K34I(6_P!40,+\^,@'."">" !P*^K?)7T'Y5'<6$%Y
M"\4\,<T3C#1R(&4CT(-<L<#7A5=95=7Y:?<<$<IQ%.N\5&O[S\M#D?"?QD\'
M>-&C32M>M9KA^EM*WE3'Z(^"?P%=ENSR.GUKR[Q;^S3X#\5!W_LG^RKEO^6^
MF-Y./^ 8*'ZE:XUO@K\2/ !W>"_'+WUHOW=/U7D!1_""=R_D%KI]KB:?QPYO
M-/\ 1G=]8QM#^-2YEWC_ )/_ ()]"*U*O>OGD?'SQSX#;R_'?@2X$"??U#2\
MM&!Z]67/U<5WGA/]HGP+XL"+#K,=A<-_R[Z@/(8>V6^4GZ$UK3Q=&3Y;V?9Z
M?F;4LRPU1\KERR[2T?XGIE%11W"3*KQLKJPR&5@0:>6]J[=]CT[I[#J*;NHW
M4#'45!=WD5A;R7%Q(L4,:EWD=@%50,DDGH *X/PO\:-(\27&KLZM8:9:J)K2
M^N$DC2]@ 7=*F]%& [!>">H]1G.52,79LQG6ITY*$I6;/0Z*XV'XO>%)8-6D
M?4FM#I,:RWL5[;36TL*L,J3'(BL<]L Y) '44U?C!X5_L_4+R34FMXM/>..X
MCN;::&9&D ,8\IT#G=GC"G.#CH<3[:G_ #(GZS17VU]YVE%8/ACQMI'C".Z;
M2YWF:UE\FXAF@D@EB?&0&CD56&0>XYJMJ/Q*\.Z3XJL_#=SJ 36KL!H;58I&
MR#N(RP7:OW6ZD=*IU()*3>C+=:FHJ3DK,Z>BN8L/B-H>JZY)I5C/<7MQ%*T$
MDMM93R6Z2 9*-.J&,$=P6X/!YXKI5D#YP:I24M4RHSC-7B[CJ**3-46+129%
M+0 5F>(H;NYT:[BL5M9+QHR(X[U287/]U\<X(R,\XSG!Q@Z5-;+#KBI=FK"D
MN969X#X)\!^*((_$'BKP[ING^#;S6+..VM]#E,@A@9&(,TBF)<.!NVJ$P=Q)
MSDYFD^"NMW7@==+%IIMGJL%_%JOVZ349;IK^Y5B6,Y,"%0<GD;NW%>[<<#/?
MM2;=O/2N/ZG"UG_5]SRUEU+DY):[_COZ?(\87X/ZA</KNJZCINFW^IZGJ4-Y
M'8PZI<6D=EY<9572X2/S#(<Y.%4?,>>,5I^ ?AUXD^']M#'97&FSOJ6I2WVL
MFXDGD9$<* D#DEG("_>DY/4]:]!UCQ1H_ATPC5-4L]-,QVQ_:KA8MY'9=Q&?
MPK4CQ( RD$=<CG-7'#TXN\=T53P=",O=W7_#_B>!:9^S]K$=OHVB7EQI\.AZ
M5>W-W'?6SN;N<29 1D*A5^\<D.V0JC%:G@/X/Z]HFK>#CJLNFQVGA:*ZCMY;
M)W:2\,V5!=2@$8"G. 6Y[U[7Y?.3S^%&P^M1'!T8M.*_K3_(4,MP].2DD[_\
M-_D(N.<>M/%(%I0,5W'J"T444 %%%% !1110 4444 %%%% "4M)2T %%%% !
M1110 4444 %%%% !1110 4UU#?6G4G6@",QAOK]*4+BG[>E(U %'4]4L]$LY
M+O4+J"RM4&7FN'5$7MR2<4[3=4LM:LX[NPNX+ZU?[D]O()$;Z,#@UX?^UIX)
M\1>+_#VCOHEO-?V]G,[W-G;@L[%@ CA?XMN&''/S],9QY]\'_AY\9/#N@SRZ
M%/;Z#:W4N\V6JC$A( &_84;;GIS@G:.,8KRJF,J4Z_L_9MKNCY^MF=:CBW0]
MC*4>Z/KOC_)I-H7 &,>E>!>3^T!:_P#+;0[K\%']!2?VU^T!;_\ ,"T.Z_X&
M!_[5%:_7.].7W&_]I6WHS_\  3Z!QBCZ5\_+XT^/L!/F^!])D'^Q,G_R0:/^
M%H_&2W_X^/AS#)_USF_P<T?78=8R^YA_:=);PDO^W7_D?0/7M2K7S]_PO#XE
MV_\ KOA5=R8_YYRO_P#$&C_AI#QI V)_A'K2CU5IC_[0H^O4>MU\G_D/^U<-
M]JZ_[=E_D?05(:\!_P"&H-7A_P"/GX::]!Z_(Y_G&*/^&MK2'_CZ\&Z]!Z_N
ME_J11]?P_P#-^##^UL'_ #_@_P#(][;#<9YKD-)^%/AS1?$6L:U%I\+WNIL#
M(9(8\1C8%<)A00'^\V2<DDUYBW[9?A6,XFT77(3_ +4$7_QRK-O^V)X(D^_;
MZK%_O6ZG^3FD\7A)6;DM!2S# 5&G*:T[GIUK\,/"%C*9+;POH]O(4:/?'81*
M=K*59>%Z%6(([@D4_3?ASX7T.Z^TZ?X<TJQGVE/-MK&)&VD8(R%S@BO/8?VM
M?A])C==WD7^]:MQ^6:Y'XD?M@6%C#:1^"X8]4ED!::>^BD2./L%"_*2?QXXZ
MYXF6,PE.//S+0SJ9EEU&'.YQT['N=K\/_#5AI]WI]MX?TNWLKK'GV\5G&L<V
M.F]0N&Q[U>A\.Z9;Z@M_#I]K%?K +8720J)!"#D1AL9V@@';TKP+1OVNI=:T
MVWBLO!VH:MKY7$MK9Y,6<G!4@,V"!G[N!G&3C-6VUGXZ^./^//3-.\'6DGW9
M;DAI /<'?S_P 4HXR@TO9)R]$*.986:3H1<_1?TCV?\ X0_P]::TVM+I&G0Z
MJ-SM?_9D6;)&"3)C/0D=>E<]XA^.W@3PKO6\\16DDJGF&U)G?/H0F<?CBO/(
M?V7]4\4,LOC7QUJFL<[C:P$K&I]MY88^BBN]\-_L\^ ?#.TV^@074R]9;XM<
M,3ZX<D#\ *<98F?P045YO]$7&IC:G\*DH)]W=_<O\SA;C]JB37I&@\&>#-6\
M029V^84VH/?Y _'U(J+R_CSXX'SR:9X-M&[#:TI4_P#?9!_%:^@+>SBM8UCA
MC2*-1A510 !4NWWJOJU6I_%JOY:?\$?U&M4UKUF_*/NK_/\ $\ M?V48]:E2
MX\8^+]6\13@[MI?:@]OF+G'TQ7HOAOX(>!_">TV'AVS\U>1-<+Y\F?4,^2/P
MKNMH&:4"M882A3U4=?O_ #.FCE^&HN\8:]WJ_P 2-8EC "*%4<  4[;[TZC%
M=?D>CZ""E%)@TM,!:*** $I"*=2&@!C1J_WAD=*X3Q5\#?!'C+S&U#0;9+AC
MDW-JOD2Y]2R8R?KFN^Q1MK*=.%16FKF%2C3K+EJ137F?/4W[-OB#P:QG\ ^.
M;[30IW+8WQW1$^^WY<?5#]:;_P +.^+?P]P/%'A"/Q%9)P;W2C\^.[$+GCZH
MM?0Q6D\L>@Q]*X_J<8:T9./XK[F>;_9L:>N&FX>2U7W,\A\*_M2>!O$#"*[O
M)M"NLX,.I1[%![_.,K^9%>IZ?JUGJULMQ974-W;M]V2"174_0@XK$\5?#'PO
MXU5O[9T2SO9#QYS1A90/0.,,/SKRK4OV4[?2;A[SP7XHU3PQ=GGRUD+QGVX*
MMCZEOI1S8JG\24E]S_R#FS"A\4547EH_NV/9_$T<$WA_4X[FSFU&W:VD62S@
M_P!9.I0Y1>1\S#@<CKU%>&?#W6M0\*ZM?Q>';C7/$_@'3M/D8PWE@_VB*Z5B
MHMX2T:.Y&W&W&U!UQ1_;7QQ^'8QJ&FV7C;3H^LMM@3;>P 4*<_\  &J[X1_:
M9\&:<[Z7JFBW7@JYWF22WDM#Y8=B22=@#9)R2649S6$Z].I*+J>XUWT_':QQ
MU,92JU(NHW2:[JS^_:QR6L>&M1\:>%/%.OSV&I2^+]0>VNY-+&FW4,<%K#(A
M^SH\L:K+* ,G!.XK\H/),GC_ ,,ZMXLUKQ1XAL-"U!])NSI]EYDUE-'=1;<%
M[F*'Y9&,9*@<8)+<,H-?1.@^*M$\4VHFTC5+/4HNI:VF5\?7!X_&M8[>FX"J
M^ITZBOS7OV^?^9K_ &;1JPNIZ/MU>NOXGA7PIN+_ ,"S^(GFT77-8LM1UF&&
MVU*2PD6]F#KS).LFUEBCP%W;0.3A><#!U+P+XSL/B1X7U2\TJUU&^N=6NKRY
MOK.XF>-49%5$?]S^[5$ "@ELD'I7TF,%L\4K,G0L/Q-:O")P4'+1&\LM@Z2I
M.>B=U]]SYE^&_AWQ/H>H>%M/@MM>M=4M=4N3K#3&<:>]L68[E+'R6)W C;\V
M=QZX-?3L>,<5BZQXPT+P^"=2UBQLNY^TW")_,UQFJ_M)?#O1=ROXACNI!_#:
M1/-G\54C]:=+V.%CRNH@H?5LOCR2JKYM'I^:0L.XKP2X_:\T.\F:'0_#VLZS
M..%$<*J#^19O_':@;XS?%;Q)QH7PT>Q]&U)V''K\_E_SH>.H;1=_1-C>;87:
M#<O1-GT%NI"P'4BOGW^R/CYXF^:;5M&\.1M]Z*-59A]/D?\ ]"IR_LX^+-=^
M;Q#\3=4N4;[]O;;U3\,OC_QVE]:J2^"DWZZ!]>K3_A4)/ULOS9[;JOB;2-"0
MR:CJ=G8IUW7,ZQC\R:XK5OVBOA[HQ82^)+:=AVLU:?\ 5 1^M<UI/[(7@>SD
M#WS:CJ[]6^U7.W=^*!3^M=II/P+\!Z*%%MX7T]BO1KF+SV'_  )\FGS8N>R2
M_$7-F-3:,8^K;_1' WG[7WAAIS;Z3I&L:Q<'A!# H#?^/;O_ !VJK?'#XD^(
MODT'X87-N?X9=29U4^_S"/\ G7O-CI-GIL(BM+:&VB'1(D"@?@*L^6.W I>P
MQ$_CJV]$A_5<7/6=>WE%)?G<^%OBQ\/_ (I^*/$4>LZ[X<GEN;E%CCBTT>?'
M"%'W<*S%1G)R3C+'FOK7X,>']4\+_#70M,UIR^I6\&V4%]^P%B53/?:I5>./
MEXXKL_+I54KWS2P^!CAZLJJ;;?<C!Y7#!UI5U-R<NXZBBBO2/;"BBB@ HHHH
M **** "BBB@ HHHH **** $I:2EH **** "BBB@ HHHH **** "BBB@ HHHH
M *0]J6DH :RYXZ4FWK3]M&V@!*/K2[:,4@"D_"EVT8H ;@?Y%(RKZ#\J?1BB
MPA@C4_PJ?PH\M?[H_*GXHH^060QH8SU1?RJK/I-C<<RVL$G^]&#_ $J]28I.
M*9+A%[HQ)O!F@W'^LT;3Y#_M6R'^E<;XX_9W\%^.H;=9M.72YH3Q/IB)"S ]
M5;Y2&'U!([$9.?3:0K6,Z%*HK2BF85,+0K1Y*D$UZ'.^"? FD_#[P_#H^CV_
MDVL9+%F.YY'/5W;NQ_H ,  5T&WIVIVVEQ6T8J"Y8F\*<::48*R0G<T+GFEH
MJBQ:*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ I&[4M)0 W;[UD:
M]X1T;Q5;?9]7TNTU&$=$N85<#W&1P?I6SMH*@U+BI*TE<B4(S5I*Z/#M?_91
M\,SW!O/#U]J'A>_7YDDM)V=%/KACN'X,*^=_C=X>\<>%O$5GIWB#5K[6X8D7
M[!>N6V/],]'W<'DM@#M7WNREN,XI/)Y).#SGI7E8C+:56-H>[Z?Y'@8S):&(
MC:D^1^7^6Q\T^$_"WQT\0>'=/$GB:WT.T:%0%NT!O-N.-_[LG=CU;/KS6NO[
M,^NZV3_PD?Q)UC44;[\$)9%_#<[#_P =KZ!"[:7;6D<!3LE-N7JV;PRF@HJ-
M5RG;NV>*:/\ LC^ M/P;JWO=5/4F[NB,_P#? 6NVTGX,^"-#V_9/#&FAE^[)
M+;K*X_X$V3^M=KBC%=,<+1AJH+[CMIX'#4O@IK[BO;V5O9QB*"".*-> J* !
M4HV]N#3Z0+CI72E;8[%%+;0/UH6EHIE"T444 %%%% !1110 4444 %%%% !1
M110 4444 %%%% !1110 4444 )2TE+0 4444 %%%% !1110 4444 %%%% !1
M110 4444 0W5W#8PF6XEC@B7K)(P51]2:+6\AO81-;RQSQ-TDC8,I^A%><?'
M;PSK'B3P_9KI*27 AE+2V\7WG!  ('?'/Y_6N>^&G@OQWHV@NMO>1:4LDA;[
M/>#+=,9P4;'Z?RH ]MS1FO/_ .Q?B'_T'M/_ .^!_P#&J/[%^(?_ $'M/_[X
M'_QJ@#T#-&:\_P#[%^(?_0>T_P#[X'_QJC^Q?B'_ -![3_\ O@?_ !J@#T#-
M&:\__L7XA_\ 0>T__O@?_&J/[%^(?_0>T_\ [X'_ ,:H ] S1FO/_P"Q?B'_
M -![3_\ O@?_ !JC^Q?B'_T'M/\ ^^!_\:H ] S1FO/_ .Q?B'_T'M/_ .^!
M_P#&J/[%^(?_ $'M/_[X'_QJ@#T#-5[S4K73HO-N[B*UBSCS)G"+GTR>*X?^
MQOB'T_MW3_\ OA?_ (U7 _%3P+XXUB&SFN9%UCRR5V6*YVYQR5"CKCMZ=J /
M?(IDFC5XV#HPRK*<@CU%.S[5Y#X'\-^/M#\-VEO#=VT"8+>1<$,ZY[$[3_.M
M_'Q#C_BT^7\A_A0!W]%>?_;OB%'_ ,P[3Y?^! ?^SBC^W?'Z?>\/V3#_ &7'
M_P <H ] HKS_ /X2OQG']_PPC?[KG_$T#QSXGC^_X1G;_=9O_B30!Z!2UY]_
MPLC6H_\ 6>#K\>X+_P#QNE_X6I<Q_P"M\,ZA'^!_JHH ] HKS_\ X6];I_K=
M&U"/_@(_KBC_ (71HZ\266H1GWC3^K4 >@45PB_&;0&ZI>)_O1K_ /%5.OQ=
M\.MUEG7ZPG^E ':4@;->2^.OCS:Z'%;#185OY9<DM.&50![#!)K9\,_&C1-6
MT:"YOG:QN6R'A\MW&0<<'% 'H5%<>WQ8\-+_ ,OLA_[8./YBF-\7/#@Z3S'_
M +8M0!V=%<0WQ@\/+_%<G_MCC^9IC?&30!T6[;Z1#_&@#NJ*X)OC1H2_\L+X
M_P#;)?ZM3/\ A=.BG[MIJ#?]LT_^+H ] HKS_P#X7-IC?=T[4&_X G_Q5)_P
MN"U;[FCZ@W_ 5_QH ]!HKS\?%H-]S0=0;\/\!1_PM2X;[GAG4&_ _P#Q- '?
MYZ4FX"N _P"%GZ@V-OA34#_WU_\ $5YE\3OB?XJ35[<6Z7F@VX0,(/F5B?\
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MA#2KC'.2,_B,&@#?HHHH **** "BBB@ HHHH **** "BBB@ HHHH 2EI*6@
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MR*V H).2.<8KHFKSCXF16D&I6VH)/JNF:]#"T=A=6-NTT=RYR1 RA6R>"<,
M.<Y.#@ ZF^\=:%IHTW[1J,2G4MGV15R[3!_ND!03@^IXIVL>.-&T&X\F_NS
MP9$9Q#(\<;-]T.ZJ50G_ &B..>E>?>,(]0U#0?"4FH:5<3>(8[NUN+Q[33Y)
M"L2E\@NBD#DY*9X+<"KWCN^?Q=?6VARV.J6^@#R[J[NQIMP[3\!EA0*AV]1N
M+8(Z'D$4 =M=^+--L]4:P,D\UX@4O%:VTLYC#9V[S&I"9Q_%CUK3O+R'3[2:
MZN'$5O"C2R.0?E4 DG\A7C.K:3K5KJ_BF6QAUB/5[Z[MI],N+?SD@:,D9\T\
M)\JC:1)R.PKL_%$.I>-H'T^SL&BM+.^47D6J;K=;V-""!&RJ^48XR<<X'J:
M-.+XE>'I]/MKV&]DGANIFMX1%:S.[R*,E0@0MG'M6_I]['J5JEQ&DR1MG GA
M>)^"1RK@,.GI[UXYX3\.SQZ#;R:W:ZMI<MGJL]Q;3:? 9Y [8Y:,Q,=I[$*1
MUSCC/HOPYO-;OO#$$VOQM'?L[?ZR,1NR9^4L@^ZV.U '3;><T;:6B@!,48I:
M* $HQ2T4 026L#?>A1OJH-5WTC3Y.6L+=NYW0J?Z5C_$6^UK3O#,T^@PR37P
M= ?)C$DBH6&YD0\,P'8UR&FZH]C\.-27PGJZRC3?,+#4K;;/9JL99XRH4!GW
M XR,<GKMH Z?Q1\,?#WBR&..ZLEA,9.V2U"QM[@\8/XC^=7]*\#:#H]C%:PZ
M5:O'&,!IHE=SSU+$<URFL^)O$*?".RUNRNX4OOL:7%S=31AG^Y_ @&W<6(Z\
M 9X-7/$6MZC:^"K+4TU&\MKAM/\ /Q8:>)C)-Y8;+DHRHF<YR%Z]1B@#K1X?
MTI#\NEV:_2!!_2G_ -CZ<O33[4?]L5']*P+3Q1<6_P .5UR[:WN;R.P:XE-N
MP:)G5"2 5)'48.#@<\XKC8?&NM'0Y1]HU9_$=YI?VZSMVM;9H7R1S"(PSD@$
MX$AR1U':@#U6/3;)<[;.!?\ MDH_I4BV-NO2"(?\ %<QX%UR*_\ M%M)K%[?
MZG%'$US:7]JMN]NQ7/"B*,X.>^>@Z9YZT'- #5AC7[J*/H*=CVI:* "DI:*
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M/!XYJ]10 W;1MQP..U.HH ;L'UHVCZTZB@!NW\O2E V]!2T4 %%%% !1110
M4C#=2T4 8&M>!](\0ZMI^H7]K'<S6>\*LD:,L@8$8?*DD#.1R,'FK&I>$=%U
MBY:XOM)L;VX8;3+<VJ2-CL,L.E:]% &+<>"] O+CS[C1-.GFP!YDEI&S8
MR1G@  >P%3?\(OI']I?V@=+LC?[M_P!J^SIYN[&,[L9SCO6I10!CS>#]#N8?
M*FT;3YH_,:79):QL-[8W-C'4XY/4T-X/T)K%;(Z-IYLU?S!;FUC,8;&-VW&,
MXXSUK8HH BM[>.T@CAAC6*&-0B1QJ%55'  '88J6BB@ HHHH **** "BBB@
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MQ:U\ _"JPU[?+K'BKQ+]NUER,.9;E#N'/0JC*N/53ZUEA<#"K_%;CK;\+O\
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M_P"2+^._^P'??^D[UW5<+\=O^2+^._\ L!WW_I.];X?^-#U1QXS_ ':IZ/\
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M.94'1NTXK3OJ_P .^Q^Y\$-_V=.W\[_)'H.A^)UU_;+;:?=K8R F*\F\M$D
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MIZ/\C\EJ**7'I7](1V/Y3EN)12[324R0XP?IZ _SK];/%WAW5/$4BZ:L\/\
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M6S:K1G.#BFT_PULKKJ[>J['Z9&1[/>7]O86KW%S-';0(-SR3,%51[D\"J/\
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MK)<VIT/9<UZ:>]NLO)G[AP35Y,OFK?:?Y(^S-R_WP:7<O]ZOC.BOR7_7U?\
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MN+2;^XJ/!N:)IM+[SZ832[62^2_,?^EB#R!(6/W"0V,9QU'7&:O;>_ZUS?\
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MT2^\^!\48K[X_P"'>O@O_H8M>_[^0_\ QNC_ (=Z^#/^ABU[_OY#_P#&Z/\
M6K+N[^X/]3<U[+[SXG^'MY)8>/?#%S;N([B'4[:2-B <,)5(.#QUQ7W&/C!X
MN'_,8/\ X#0__$4FE?L"^$-'U2SOH?$.N-+:S).BR/"5+*P89 C'&0*]%_X9
MWTW_ *"MU_WPO^%?AGB%4QN>XJC5RBHXQBG?5Q/T'AK)\9E=&<*VEWW///\
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M!@BOH'3] LM+O-1NK:'9<ZA,+BYE+LS2.$5!R2< *BC:,#@\<FKVSU.: N>
M^#_'6K:['I4TNH6/B.>S\47-C;7EN\%XLT8T66?"3);P@GS2062-#@%<L,EK
M'PC\0/XE^(VGW\WB,^(+N;PN)+M?*A465PTT1DMQY:+MVD_<?,BY^8G(KW?9
M[\^M)Y?O0%SYKU+3;W6/%NF:II#L_B6SU/Q%?1J[E?-DM[NV@2$X'W7M8TC^
MC"DT/XA-;^#-#V^)Y/!6CWR:WJ,6I20P[IIQ?N8K?]^CJ#M=F* ;FQ@$8-?1
M&GZ'9Z3-?R6D7D/?7!NI]K$AI2BH6 )PN0BY P"<D\L2;VR@+GA6D^-?&-UJ
M5MJFH:C)9HNMZ9I5QX?^QQK#'Y^GVTLVYBIE#++.2OSC&W#;@<"_XTNHIO&N
MBCXEV6B6'A+[/="V6XO3<V,EYF,QF<RPQHLGE>=L5LC[^"2!CV;905SU- KG
MSS?6_@__ (6QHC/>^&+328M!T\Z<GB:U\^65!<W&U;5YI4:-L;<-A^J<8 S4
MNH=#N+.96:W/QB'B!_*+ ?VH"+L[, C=]E^RX_Z9>7GWKZ0\ON3DT>6,$>HP
M:!W/"?B;#>Z;\5M1\2V"R2/H_AZU-W!&"3-9R37:SJ%'WBN$E [F(#O7->'8
MM!D\3^ WUN]\+6HC\':*T*^([2.:64[YLK;.\J>7)T^8!^J\<<_3?ECTP/I1
MY8XYR: YCYONH]#FLYPQMV^,7_"0.82^!J8871,>/XOLHM0#_P \O*SUYKUO
MX9MY=_XVM(I#):6NORB#K@>9!!-*!G_IM+-[9S7;;!5/2=%LM#AGBL8! DT\
MMU)\Q8M)(Y=V)))Y9C[ 8 P   5R]1110(**** "BBB@ HHHH 2EI*6@ HHH
MH **** "FMQVXIU1R>QPV.*3 %(;J*4L![5X?XH\+?&^X\0ZA-HWB[2+727F
M8VL$D*[DCS\JG,#<@<9W'.*\^^)VA_'32_#+RZCXA75K,R*LD.B1A9E'/S'9
M"C;>QP>_/%>=5QCIIOV<G;T_S/$KYE*BI/V$G;T_SN?6.[<.#1NV^YKY.^&.
MA?'35/#*3:=XA72;02,L<.MINF8<?,-T+MM[#)[<<5Z;X;\*_%G^RO$MOXG\
M2:?J0NM+F@L4LT"21W++A7W"*/ &3Z]0>,<W1Q;K6_=M7[FF%Q\L2H_NI1OW
MM;\[_@>G:/XRT+Q#=7=KI6LZ?J=S:';<PV=TDKPG)&'522O((Y]#6MNVC/6O
M#+S4Q/X1\,66F^&_$>DQZ=]FMM7:TTJ>WN;6T&T/##(BB20-(J%OLQ;Y48DC
MY<L@T?Q)K-MH-I/<^)H-':\U=T(N+F"Z-J 39B=\B4'(!4.0Y  ;JP/<>S8]
MW5@U&^OF+4/^$E\-V_A+^T=0\6?8]5MM+FU9O/NGE^TNTOVB*,+\R-M.#%$
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MCG'S!22O/K7G>E^#M;O/V=VTX7&J3^*-6T-&N?[6O9C-]J>!=\>9&S%SE<#
M!.2,Y-9.K>)-;U>Q\1P:%HMU9VUMX4OAI@7P[=:??:?<;(Q':QRD[9"Q7.(0
M!F),9P#0*Q[B)/:C?S@CGI7A'C;1];T/5+W3].G\737$-C:_\([/;W5W<0O>
M&9S*UT^XH1DQ9$Y$80$* ,UF>-_$GB>QT35[:-?$5I<Z8/$UQ/>M#<);B(I<
MRV1$^-K*%:/9@G84 ^7Y: L?0UU?06-K+<W$J6]O$ADDFE8*B* 268G@  =3
M7-VOQ7\%7T=S);>+]!N([6/SKAXM3@80ID+N<AOE&649/&2*Y[X4I=KJGB)H
MSX@_L'%J+;_A(VG^T?:-C?:-OG_-LYBY7Y-V_8<#C';0U'AGQ1_:MEK<*CQ2
M]_;3Z7:&6XA*R1M%<1Q%&,B!E!X20'D[2 2 =CT&_P#B-X4TG3[*_OO$VCV=
MC>@M:W5QJ$4<4X&-Q1BV&QD9QZUT*MNS]:^?M2TOQKXHMM"EM+"WM-0_L_7H
M&FN-+>&.Z5Y(1$SQEA]FEG W_O-V#N)0\J/9O JP1^#]#2VM[NT@2Q@2.WOT
M*7$:B, +(I (< 8.0.10%C=HHHH)"BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@!*6DI: "BBB@ HHHH *:P/'
M:G44 , [4,@/%+WH;[PH$-"!5P*5AG%)_%3A0"[""/Y<$YH\OW[T^B@95O-,
MM=0\H75O#<^3(LT7FQAO+D'1UST(SP:L!,4ZB@!GE"J]GI=KIZRBUMX;832M
M/+Y,83?(QRSG'5CW)Y-6Z* &A,4>6/QZ4ZB@!%7&><BEHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH *3&:6B@!-M&VEHH 3;2,N<<]
M\TZB@!NSKS1MIU% #/+]Z7;[TZB@!NWCK[U#>:?;ZE:W%K=P1W5K<1M%-!,@
M=)$8$,K C!!!((/!S5BB@!NWMFC;UYXIU% #=O3G)]:4#%+10 4444 %%%%
M!1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %
&%%% '__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>halo-20250318_g9.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 halo-20250318_g9.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1" %_ IT# 2(  A$! Q$!_\0
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M'FM%6S[4 .HINZC=TH =13=U)YE #Z*;N]J44 +1110 4444 %%%% !1110
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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MRS'&3ECQ7TI']VM\-4JU.9U%;L=6"K5ZW/*LK+IZ6'T445VGIA1110 4444
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M7W1YU? T:SY[<LNZT9XMX+_:<T;4;S^R?%=G-X0UM#M>*^!6'=_OD#;_ ,"
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !2&EIK?6@#R#]H2XU&33M(T]H+_P#X1*]DDCUNZTJV6>XBCV93
M@AML><LSA20$ !R<'#^(?Q$\0Z?\+=#U_P +^(+.YT[,<<NI?9-LURQD"*!$
MPVQ\;RQQG( "J#QZ3X]\,:UKDNGRZ%K<^CSI,D=UL=2CVQ8&3"-&Z^8 #M;
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M^$?V3O%EUXJ2VUG9INDQ-F6^MYT=I5'&(QU&?5@,#L<8/GU:F,P\HQBN=/\
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M=G*W1=-OPW(P65XNA6A*I4O&-]+OK_6AN+_6G+0%Q1C%?.GUHM%%%, HHHH
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M%% !1110 4444 %13.(U)QT&:EJ&Z4&%R?2FMR)NT6T?%R_\%&).W@%<=O\
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M0?-C;@]3TK+\%?!GQI;^*?A[XGUS2T.M2:QJ6J>(7CFBQ;>;$(X4&&.]0J*
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M110 4444 %%%% !1110 4444 %%%% !1110 4E+2-0!^?'_!0+_DM&DY&?\
MB0P]O^GBXKYD_ ?E7TW_ ,% S_Q>C2/^P#!_Z47%?,N:_=LBIP>6T6TMOU/Y
MMXBJSCFV(2;^+OY(3\!^5'X#\J,T9KWO94_Y5]Q\[[:I_,_O8?@/RKZ:_P""
M?O\ R6C5AT!T&;./^OBWKYES7TU_P3]Y^-&K?]@&?_THMZ\'/:=-9;6:BMOU
M1]'P[5G+-<.G)[]S]!@.PIPI!2BOP@_I$6BBBF 4444 %%%% !1110 4444
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MN6O$'@ZZ\221PW.I+_9T=RMSY8MQYWR_PB3=@#/^SG'&363J7PH&I6&H6_\
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M_*G^N>:]X_<?M7MI'T!_PT)X?_Y\M2_[]Q__ !='_#0?A_\ Y\M2_P"_<?\
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M^(FD?67_ -%/7T^M?,/PA_Y*)I'UE'_D%_\ "OIU6X':OW/@G_D7R_Q'=1^
M=12 YI:_0S<**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@".:-IH]
MJRO"?[R8S^H-56T^5N#?W!R,'Y8__B*O4F.:->@M]&>$_P##%/PFSSH%P?\
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M!/\ NQ__ !%>1ZU^R#\,O$6L7^JZAHT\]]?7$EU<2_;IEWR.Q=VP& &6).
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MA\0OV<_!7Q4UJ'5O$]C/J=_#;K:I-]I>+$89F"XC*CJ[<XSS7,?\,4?";_H
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M5 )+>YI:**ZAA1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M-6K_  [\<>*_$'B76K_4?#EYJ>M:?%;7=W(\=O<6Q6:%8U;(3>KO&%48R%]
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M24A47 7*_,0IW !20&P:ZA6W+F@!:*** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHI#0 M%)FC=0 M%-W>M+DF@!:*3FCF@!:*;D^E+S0 M9OB*^
MO--T6]NM.TU]8OXHF:"QCF2$SOCY5WN0JC/4GH,\'I6CS2,N[K0!X?H^@^)=
M/U31/$MQX6U2ZU6&^N[C58'GLEEF>X@1 ]O_ *24$<8BBB"LX;: ?F.32Z7H
M/BG3;+P?X<U#PQ?W>BZ7Y-_=W&FW=J5ENQ*9$B(DF1A#"Q5B0I+,BX "G?[;
MY?OZ_K3MM!7,>-_#WP?X@T_4O"=IJ&DM86_AJ+4$>_\ .A:*],KA8C"J.7 *
MY=MZI@@ 9ZU[(OW:-M !48H$.HIN3Z4O- A:*3FCF@!:*3FCF@!:*3FCF@"K
MJEQ+:6-Q/;VK7MQ'$SQVT;JC3, 2$#,0H)/ R0.>:\7L]$\47$FG^)KWPCJ#
M^(X-9AU*_M);BSVS1_9;BV$-J1<%<0B;=ND*%SENK87W$KFC8#UH&>'W6A^*
M%T>QT6[\*ZA?:-J%W=:SJD>FW=F9%:6[>>.Q_>SQ@ ;AYCH2#@JI^<LO6VL>
ML2?&:;4'\.W\&D-I?]GKJ4DUL8BZRO)OV"8R;2" /DSD\@#)'H?EC\>E)L"]
MJ N*IRN:=2=J.E A:*3FB@!:*** "BBDYH 6HKAO+C=A&TK*I(5" 21V&2.3
M]:DYI&7=B@#P>ZT+Q;XDFG\07_A"_M_$,.HV-VEG+=6;0_9;>9BMM ZSD^81
M))(7<(K-QD +4^HZ+XM;0]4T\>%M2DL/$VJ7-WJ2V-W:"ZM;5E2,0C?.J^9(
M$Y978(&."6Y'N.VD,>3D\T%<QYC<?V[K'Q"T?[;X1U.S\.Z2RO8-%/9&,SO&
M4:691<;@L2NZJB*W)+<X4#T],XZ8]J-O.>AI>102+12<T4 +112<T +12<T<
MT +12<T<T -;D^OM7AOB;0?%7CB3Q-=W?A*^L]2\M(M)6XNK0VRV\-Q'.4+)
M.S>;<-$I)*;5PBY^4LWN94FD\N@9XMJUIXR:V\37MAX8U&WG\2WL<+PQW-D;
MG3[1+=(WF^:?RVE<A@BAR%!5B>-ALZQX;U/4M2\+0:9X1U/2(])FL?LD]UJD
M,EC;6T?^L66U$S RJA=%948Y*$2KCY?8/+I?+'H.N<4!<%^[CTIU(!CBCD=*
M!"T4G-'- "T4G-'- "T4G-% "TR3MQFGTA&<4 >(^./#/B3XC7_B2SO_  W>
M6<:V%YINAW#SVK6@WI@SRD3>;ND*JBCR_D7D\L=MRZN/'2W.N^(].\(3V>IZ
MG%8:8EB]S://;I$;AY;HCS1')@S[40R L4&X*,U[ T8*X)-&T-0.YX7J7PG\
M12:7HMQH$BZ=%9MIT$.CZY:+/<VJ1W\4\\QEBNA&2YB25P,EA$JJ4)X]SM]W
ME+O(+8P2!@$^N,G^9IVP4N,=* %HI.:.:!"T4G-'- "T4W)]*44 +1110 44
M44 %%%% !1110 4444 %,D;;S3ZY3XK:S>^'?AGXMU73I3;W]CI-U<V\P17V
M2)"S(V&!!P0#@\&KA%SDHKJ9U*BI0E.6R5SJ U'OBOS$_P"&OOBZW/\ PES$
M^VG6G_QFC_AK_P"+G_0W-_X+K3_XU7V7^J./76/W_P# /S__ %WRZ]N67W'Z
M=,W(Q^M"R;NA!]Z_,0_M??%U<$>+FS_V#K3_ .-5]BWNNV_B+P-\)=2\;W$%
MQX<U"SBNM8FO41;26Z>U5H3.,! A=G(##9OV<9"UX^8Y-B,KC&59JTNSN>_E
M&?8;.9SA033CW/=]_M1O[]ORKYZO/'T>DWMY8^$]=BTZQM'M/[ T&WAC:'6$
MFG/G-&'0R21 EU7R&5$5 1\N*UI-:\7:MXN\B'Q;<:;9W7B>XT-;:&RMF\F"
M.SEN=ZLT;$R9CVY;*@$94D9/A'T_*>W[S^/THW>M?,FD?&#Q'J$;FX\4K#K%
ML-/6QT5;:W7^UG>8QS@@H7;*J&/DLOE[R3\N .@N/B)XGD\>>(K?^WM(T]+"
M:[B30KJ_B2[>".W9HYHK<V_F,20LN_SBA4,-HZ@#E/>]_P"-&ZOG6Z\>>*M)
MTVW6\\;6T)O-(T[6'O-1:RL60RM-YL%L[Q&,%@B;!*&^Z<N,Y6/Q;\5-8N/$
M>@V.C:_J&GQZA#81FWOWLX[N=;F(GS8K<6K,67Y=S^8J"3*["!@@<I]';SZ=
MJ7=[BOF?1O'&I6/A>QU*QUL>(-1C\')-/J,\$%S<6\OGPK,K/&@<B(,[%')Y
M4E\D$UN:;XQ\0:_XRL] TCQM-?Z!/?/%%XAMX+.6695M!,\:2+%Y+%7 &X)T
M9@<D9 '*>][O4C%'F<5XWJGC+4]<^!&@R2I+>:YXDC@TTK9(B22M)GSV0,RJ
MK>2DS#Y@,@<CK7/Z/XVNO#NFZ-X6O]4N/ -CINIW5A<WUX]HTUO (?/L8FD?
MS8$W12*N><F!@I!R !8^@Q)NX[_6EW]^U>"P^*-4T71/B?<VGC*]UG4]/G%S
M:6UP;:4QVI@MY!<(BQ ["&?!'R':2!N+,<KQU\;KMKO7CH?BB.&PCO EAJ$=
MQ:PV6%LEE>/SI+>;S7:0G:BC+$,-PVXH#E/H_<>.,T;_ /.*^9;&ZU+Q/\7-
M-NH+I;+5]0TF&2.Z6,,L,\FF3$.%8$<,<X((X[UZ'X&\8ZIX^\'^)=8O&\FQ
M%HMI%:% GEW"6^;HEL G]ZYCY/'DD@#.2!RGJ^\^E'F?+SUKYDT#3;_X=_#[
M3/$EO_9W@^'4].TNP7^R;N*&%G(+M>7DTUJT<1*OM)\J0D[1O.X;;5C\2O$%
MQX=M]<66UEU,^&)I)+Z.TB=@%OUB:;<$4D+'NDQ@1D@L4 XH#E/I'?07*C)Q
MBO&?AGJQ>X^)FH:?K;^*!'-');:D4C/VC;:)C'E*J/@C;N1<';ZY)P=/C\+6
M\?P^C\9MIX\*MX;CGLFUD)]BDOWV/*[E_D,I0[EW<\R%1UH"Q]">8-V#C/UI
M#(1[>M?-?@F'1(_$GB^30[[PXFNJ]PNC6=U9[M=8"PC\HQRR2^;MQG*F,GA\
MGDUI^"K7PA=:IX"3PD+.XUR1)1XB$&&GDMVMG$XU#^,N9S%@2\[\]LT!8^A%
M)(YI&ZUQ7P6NI;OX7^'S*[2>7 8(W;.6CC=HXVR>3E%4Y/7.:[20_P J3VN2
M ;/?-+NKYT\3?%/Q3I_B35K6WU1H[>&[FBC3R(SM57( R5ST%9O_  M[Q=_T
M%V_\!XO_ (BO@:G&6!I5)4Y1E=.WW&+JQ1].[J0R!>M?,?\ PM[Q=_T%F_\
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MJQ*J':./RR=Q*LH% 6/I$4M5["226S@:7RS*R*7,+%DR1SM)ZCTJQ0(****
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M:=110(**** "BBB@ HIN3WI=U "T4FZC=0 M%)NHW4 +12;J-U "T4FZC=0
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B.,],FK%)10 ZBDW4;J %HI-U&Z@!:*3=368_PKN_&@#_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>19
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">DEF 14A<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityInformationLineItems', window );"><strong>Entity Information [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Halozyme Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001159036<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>R2.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Pay vs Performance Disclosure - USD ($)<br></strong></div></th>
<th class="th" colspan="5">12 Months Ended</th>
</tr>
<tr>
<th class="th"><div>Dec. 31, 2024</div></th>
<th class="th"><div>Dec. 31, 2023</div></th>
<th class="th"><div>Dec. 31, 2022</div></th>
<th class="th"><div>Dec. 31, 2021</div></th>
<th class="th"><div>Dec. 31, 2020</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTableTextBlock', window );">Pay vs Performance Disclosure, Table</a></td>
<td class="text"><div style="text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"><tr><td style="width:1.0%"></td><td style="width:7.048%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.714%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.540%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.011%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:9.862%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.196%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:10.751%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:11.788%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.392%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.640%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:7.650%"></td><td style="width:0.1%"></td></tr><tr><td colspan="48" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">2024 Pay-Versus-Performance Table</span></div></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%">Value of Initial Fixed $100 Investment Based on:</span></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Year (1)</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Summary of Compensation Table for PEO ($) (2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Compensation Actually Paid to PEO ($) (3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Summary Compensation Table Total for Non-PEO NEOs ($) (2)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Average Compensation Actually Paid to Non-PEO NEOs ($) (3)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Total Shareholder Return ($) (4)</span></div></td><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Peer Group Total Shareholder Return ($) (4)</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Net Income (Millions) ($) (5)</span></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">Revenue (Millions) ($) (6)</span></div></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2024</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">12,741,421</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">20,745,724</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,217,194</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,315,696</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">269.66</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118.20</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">444.1</span></td><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,015.3</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2023</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">11,820,858</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">(3,608,264)</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,568,762</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">160,639</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">208.46</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">118.87</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">281.6</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">829.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2022</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">9,696,978</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">22,817,187</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,415,581</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">3,154,512</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">320.93</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">113.65</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">202.1</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">660.1</span></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2021</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">7,453,294</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">5,992,078</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2,398,657</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">591,581</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">226.79</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.45</span></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">402.7</span></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">443.3</span></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">2020</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">6,518,876</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">24,374,731</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">1,812,287</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">4,356,681</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">240.89</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">126.42</span></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">129.0</span></td><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%">268.0</span></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NamedExecutiveOfficersFnTextBlock', window );">Named Executive Officers, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">Helen I Torley was our CEO for each of the five years included in the table above. For 2020, our Non-PEO NEOs were Elaine D. Sun, Laurie D. Stelzer, Masaru Matsuda, and Michael J. LaBarre. For 2021, our Non-PEO NEOs were Elaine D. Sun, Masaru Matsuda, and Michael J. LaBarre. For 2022, our Non-PEO NEOs were Nicole LaBrosse, Elaine D. Sun, Mark Snyder, and Michael J. LaBarre. For 2023 and 2024, our Non-PEO NEOs were Nicole LaBrosse, Mark Snyder, and Michael J. LaBarre. Ms. Sun commenced employment with Halozyme on March 2, 2020 and separated employment from Halozyme on February 2, 2022. Mr. Matsuda separated employment from Halozyme on December 31, 2021. Ms. LaBrosse was appointed to Halozyme&#8217;s Chief Financial Officer on February 2, 2022 and Mr. Snyder commenced employment with Halozyme on January 3, 2022.</span>See the Summary Compensation Table above for detail on the Summary Compensation Table total compensation for our CEO for fiscal year 2024, 2023 and 2022. The 2020 and 2021 total compensation for our CEO is disclosed in our proxy statement filed with the SEC in calendar years 2021 and 2022, respectively. The average compensation for the Non-PEO NEOs for 2024 was calculated in the Summary Compensation Table above. The average compensation for the Non-PEO NEOs for each of fiscal years 2023, 2022, 2021 and 2020 was calculated from the Summary Compensation Table as disclosed in our proxy statement filed with the SEC in the calendar year immediately following such fiscal year.<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoTotalCompAmt', window );">PEO Total Compensation Amount</a></td>
<td class="nump">$ 12,741,421<span></span>
</td>
<td class="nump">$ 11,820,858<span></span>
</td>
<td class="nump">$ 9,696,978<span></span>
</td>
<td class="nump">$ 7,453,294<span></span>
</td>
<td class="nump">$ 6,518,876<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoActuallyPaidCompAmt', window );">PEO Actually Paid Compensation Amount</a></td>
<td class="nump">$ 20,745,724<span></span>
</td>
<td class="num">(3,608,264)<span></span>
</td>
<td class="nump">22,817,187<span></span>
</td>
<td class="nump">5,992,078<span></span>
</td>
<td class="nump">24,374,731<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToPeoCompFnTextBlock', window );">Adjustment To PEO Compensation, Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">For purposes of this table, the compensation actually paid (&#8220;Compensation Actually Paid&#8221;, or &#8220;CAP&#8221;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#8217;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#8217;s LTI awards granted to the Named Executive Officer:</span><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the vesting date value of awards which were granted and vested during the same covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, </span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#8217;s Halozyme LTI awards during the fiscal years covered by the table),</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In making each of these adjustments, the &#8220;value&#8221; of an award is the fair value of the award on the applicable date determined in accordance with FASB&#8217;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the Summary Compensation Table Total to Compensation Actually Paid for our CEO for the fiscal year 2024.</span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.105%"><tr><td style="width:1.0%"></td><td style="width:83.344%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.593%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:13.663%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Reconciliation of Summary Compensation Table Total to Compensation Actually Paid for CEO</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2024 ($)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Summary Compensation Table Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">12,741,421</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">10,400,065&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">14,025,875&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,744,841&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">633,653&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Compensation Actually Paid</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">20,745,724</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgTotalCompAmt', window );">Non-PEO NEO Average Total Compensation Amount</a></td>
<td class="nump">$ 4,217,194<span></span>
</td>
<td class="nump">3,568,762<span></span>
</td>
<td class="nump">2,415,581<span></span>
</td>
<td class="nump">2,398,657<span></span>
</td>
<td class="nump">1,812,287<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt', window );">Non-PEO NEO Average Compensation Actually Paid Amount</a></td>
<td class="nump">$ 6,315,696<span></span>
</td>
<td class="nump">160,639<span></span>
</td>
<td class="nump">3,154,512<span></span>
</td>
<td class="nump">591,581<span></span>
</td>
<td class="nump">4,356,681<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToNonPeoNeoCompFnTextBlock', window );">Adjustment to Non-PEO NEO Compensation Footnote</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt">For purposes of this table, the compensation actually paid (&#8220;Compensation Actually Paid&#8221;, or &#8220;CAP&#8221;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#8217;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#8220;Stock Awards&#8221; and &#8220;Option Awards&#8221; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#8217;s LTI awards granted to the Named Executive Officer:</span><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the vesting date value of awards which were granted and vested during the same covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus/(less)</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Less</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, </span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus </span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#8217;s Halozyme LTI awards during the fiscal years covered by the table),</span></div><div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt">Plus</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In making each of these adjustments, the &#8220;value&#8221; of an award is the fair value of the award on the applicable date determined in accordance with FASB&#8217;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.</span></div><div style="text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following table provides a reconciliation of the average of the Summary Compensation Table Total for the Non-PEO NEOs for fiscal year 2024 to the average of the Compensation Actually Paid for the Non-PEO NEOs for fiscal year 2024.</span></div><div style="text-align:justify"><span><br/></span></div><div style="text-align:justify"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.035%"><tr><td style="width:1.0%"></td><td style="width:82.808%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.621%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.171%"></td><td style="width:0.1%"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:0pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Reconciliation of Average Summary Compensation Table Total to Average Compensation Actually Paid for Non-PEO NEOs</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Fiscal Year 2024 ($)</span></div></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Summary Compensation Table Total</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">4,217,194</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">3,183,435&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4,164,663&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">949,818&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">167,456&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:7.95pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year</span></div></td><td colspan="3" style="background-color:#cceeff;padding:0 1pt"></td><td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#8212;&#160;</span></td><td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%">Compensation Actually Paid</span></div></td><td colspan="3" style="background-color:#ffffff;padding:0 1pt"></td><td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">6,315,696</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;</span></td><td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"></td><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr></table></div><div style="margin-top:3pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For similar reconciliations of the Summary Compensation Table Total to Compensation Actually Paid for our CEO and the Non-PEO NEOs for each of fiscal years 2020, 2021, 2022 and 2023, see our proxy statement filed with the Securities and Exchange Commission in the calendar year immediately following such fiscal year.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock', window );">Compensation Actually Paid vs. Total Shareholder Return</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt">Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#8217;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last five years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.</span><div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><img alt="CAP vs TSR.jpg" src="halo-20250318_g8.jpg" style="height:378px;margin-bottom:5pt;vertical-align:text-bottom;width:668px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsNetIncomeTextBlock', window );">Compensation Actually Paid vs. Net Income</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt">This column shows Halozyme&#8217;s net income for each fiscal year covered by the table. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last five years against our net income for each of those years.</span><div style="text-align:center"><img alt="CAP vs Net Income.jpg" src="halo-20250318_g9.jpg" style="height:383px;margin-bottom:5pt;vertical-align:text-bottom;width:669px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock', window );">Compensation Actually Paid vs. Company Selected Measure</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.34pt">This column shows Halozyme&#8217;s revenue for each fiscal year covered by the table. We consider revenue to be a the most important financial performance metric in our 2024 executive compensation program because it is used in determining each of our NEO&#8217;s annual 2024 cash incentive. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last five years against our revenue for each of those years.</span><div style="text-align:center"><img alt="CAP vs Revenue.jpg" src="halo-20250318_g10.jpg" style="height:382px;margin-bottom:5pt;vertical-align:text-bottom;width:667px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock', window );">Total Shareholder Return Vs Peer Group</a></td>
<td class="text"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt">Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#8217;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last five years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.</span><div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"><img alt="CAP vs TSR.jpg" src="halo-20250318_g8.jpg" style="height:378px;margin-bottom:5pt;vertical-align:text-bottom;width:668px"/></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TabularListTableTextBlock', window );">Tabular List, Table</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The following is an unranked list of the Halozyme financial performance measures we consider most important in linking the compensation actually paid to our Named Executive Officers for 2024 with Halozyme performance.</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Revenue (as used in our 2024 EBP)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Adjusted EBITDA (as used in our 2024 EBP)</span></div><div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#8226;</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt">Stock Price (including relative TSR, as used in our PSUs awarded in 2021, 2022, 2023 and 2024 and as described in the Compensation Discussion and Analysis above)</span></div><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In addition to the financial performance measures listed above, we view our stock price, upon which the value of all of our equity awards is dependent, as a key performance-based component of our executive compensation program in order to further align the interests of our senior management with the interests of our stockholders.</span></div><span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_TotalShareholderRtnAmt', window );">Total Shareholder Return Amount</a></td>
<td class="nump">$ 269.66<span></span>
</td>
<td class="nump">208.46<span></span>
</td>
<td class="nump">320.93<span></span>
</td>
<td class="nump">226.79<span></span>
</td>
<td class="nump">240.89<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeerGroupTotalShareholderRtnAmt', window );">Peer Group Total Shareholder Return Amount</a></td>
<td class="nump">118.20<span></span>
</td>
<td class="nump">118.87<span></span>
</td>
<td class="nump">113.65<span></span>
</td>
<td class="nump">126.45<span></span>
</td>
<td class="nump">126.42<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_NetIncomeLoss', window );">Net Income (Loss)</a></td>
<td class="nump">$ 444,100,000<span></span>
</td>
<td class="nump">$ 281,600,000<span></span>
</td>
<td class="nump">$ 202,100,000<span></span>
</td>
<td class="nump">$ 402,700,000<span></span>
</td>
<td class="nump">$ 129,000,000.0<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_CoSelectedMeasureAmt', window );">Company Selected Measure Amount</a></td>
<td class="nump">1,015,300,000<span></span>
</td>
<td class="nump">829,300,000<span></span>
</td>
<td class="nump">660,100,000<span></span>
</td>
<td class="nump">443,300,000<span></span>
</td>
<td class="nump">268,000,000.0<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PeoName', window );">PEO Name</a></td>
<td class="text">Helen I Torley<span></span>
</td>
<td class="text">Helen I Torley<span></span>
</td>
<td class="text">Helen I Torley<span></span>
</td>
<td class="text">Helen I Torley<span></span>
</td>
<td class="text">Helen I Torley<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=1', window );">Measure:: 1</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">Revenue<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=2', window );">Measure:: 2</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">Adjusted EBITDA<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=3', window );">Measure:: 3</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">relative TSR<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureAxis=4', window );">Measure:: 4</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MeasureName', window );">Name</a></td>
<td class="text">stock price<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Equity Awards, Options and Stock, Reported Value [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">$ (10,400,065)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Equity Awards, Options and Stock, Outstanding, Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">14,025,875<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Equity Awards, Options and Stock, Granted in Prior Years, Unvested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">3,744,841<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Equity Awards, Options and Stock, Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Equity Awards, Options and Stock, Granted in Prior Years, Vested [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">633,653<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember', window );">PEO | Equity Awards , Options and Stock, that Failed to Meet Vesting Conditions [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="num">(3,183,435)<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">4,164,663<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">949,818<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">167,456<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember', window );">Non-PEO NEO | Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year</a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_PvpTable', window );"><strong>Pay vs Performance Disclosure</strong></a></td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AdjToCompAmt', window );">Adjustment to Compensation, Amount</a></td>
<td class="nump">$ 0<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
<td class="text">&#160;<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToNonPeoNeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToNonPeoNeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToPeoCompFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToPeoCompFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CoSelectedMeasureAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CoSelectedMeasureAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:decimalItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsNetIncomeTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsNetIncomeTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph i<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph vi<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NamedExecutiveOfficersFnTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NamedExecutiveOfficersFnTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgCompActuallyPaidAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgCompActuallyPaidAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_NonPeoNeoAvgTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_NonPeoNeoAvgTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeerGroupTotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeerGroupTotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoActuallyPaidCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoActuallyPaidCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 3<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PeoTotalCompAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph ii<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PeoTotalCompAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTable">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTable</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_PvpTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_PvpTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TabularListTableTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 6<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TabularListTableTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnAmt">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 2<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnAmt</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_TotalShareholderRtnVsPeerGroupTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection v<br> -Paragraph 5<br> -Subparagraph iv<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_TotalShareholderRtnVsPeerGroupTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_NetIncomeLoss">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-6<br><br>Reference 2: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 9<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-9<br><br>Reference 3: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 805<br> -SubTopic 60<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (g)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147476176/805-60-65-1<br><br>Reference 4: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 740<br> -SubTopic 323<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 2<br> -Subparagraph (g)(3)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478666/740-323-65-2<br><br>Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 2<br> -Subparagraph (SX 210.5-03(20))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483621/220-10-S99-2<br><br>Reference 6: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 235<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.4-08(g)(1)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480678/235-10-S99-1<br><br>Reference 7: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 323<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Subparagraph (c)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147481687/323-10-50-3<br><br>Reference 8: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 825<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 28<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482907/825-10-50-28<br><br>Reference 9: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 6<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482765/220-10-50-6<br><br>Reference 10: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 3<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-3<br><br>Reference 11: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 1<br> -Subparagraph (b)(2)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-1<br><br>Reference 12: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 815<br> -SubTopic 40<br> -Name Accounting Standards Codification<br> -Section 65<br> -Paragraph 1<br> -Subparagraph (f)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480175/815-40-65-1<br><br>Reference 13: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 8<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-8<br><br>Reference 14: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 15: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 11<br> -Subparagraph (b)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-11<br><br>Reference 16: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 250<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 4<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483443/250-10-50-4<br><br>Reference 17: http://www.xbrl.org/2003/role/exampleRef<br> -Topic 946<br> -SubTopic 830<br> -Name Accounting Standards Codification<br> -Section 55<br> -Paragraph 10<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479168/946-830-55-10<br><br>Reference 18: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479105/946-220-45-7<br><br>Reference 19: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 944<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.7-04(18))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147477250/944-220-S99-1<br><br>Reference 20: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.6-07(9))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-1<br><br>Reference 21: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 946<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 3<br> -Subparagraph (SX 210.6-09(1)(d))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147479134/946-220-S99-3<br><br>Reference 22: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 23: http://www.xbrl.org/2009/role/commonPracticeRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(ii))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 24: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 25: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 26: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1A<br> -Subparagraph (SX 210.13-01(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1A<br><br>Reference 27: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(i))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 28: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(A))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 29: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iii)(B))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 30: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(4)(iv))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 31: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 470<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1B<br> -Subparagraph (SX 210.13-02(a)(5))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147480097/470-10-S99-1B<br><br>Reference 32: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 260<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 60B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482689/260-10-45-60B<br><br>Reference 33: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 205<br> -SubTopic 20<br> -Name Accounting Standards Codification<br> -Section 50<br> -Paragraph 7<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147483499/205-20-50-7<br><br>Reference 34: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 230<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 28<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482740/230-10-45-28<br><br>Reference 35: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1A<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1A<br><br>Reference 36: http://www.xbrl.org/2003/role/disclosureRef<br> -Topic 220<br> -SubTopic 10<br> -Name Accounting Standards Codification<br> -Section 45<br> -Paragraph 1B<br> -Subparagraph (a)<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147482790/220-10-45-1B<br><br>Reference 37: http://fasb.org/us-gaap/role/ref/legacyRef<br> -Topic 942<br> -SubTopic 220<br> -Name Accounting Standards Codification<br> -Section S99<br> -Paragraph 1<br> -Subparagraph (SX 210.9-04(22))<br> -Publisher FASB<br> -URI https://asc.fasb.org/1943274/2147478524/942-220-S99-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_NetIncomeLoss</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>us-gaap_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:monetaryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>credit</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=2">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=2</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=3">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=3</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MeasureAxis=4">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MeasureAxis=4</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_PeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_PeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockReportedValueMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockReportedValueMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockVestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockVestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_ExecutiveCategoryAxis=ecd_NonPeoNeoMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AdjToCompAxis=ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>21
<FILENAME>R3.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Award Timing Disclosure<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgDiscLineItems', window );"><strong>Award Timing Disclosures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiDiscTextBlock', window );">Award Timing MNPI Disclosure</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Equity Award Grant Practices</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Compensation Committee&#8217;s practice is to grant annual equity awards to executive officers at its first meeting in February each year, which is generally scheduled well in advance. Additionally, the Compensation Committee retains discretion to grant other equity awards from time to time when and as Compensation Committee may determine to be appropriate.  </span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">However, the timing of the grant of a Company equity award may be changed to satisfy the Company&#8217;s policy on the timing of equity award grants. The Company&#8217;s policy on the timing of equity award grants generally provides that if the Company files its Annual Report on Form 10-K, a Quarterly Report on Form 10-Q, or a Current Report on Form 8-K that contains information that would (but for such public disclosure) be material nonpublic information in respect of the Company with the Securities and Exchange Commission (any such filing by the Company with the Securities and Exchange Commission, a &#8220;Disclosure Event&#8221;) on, or on the business day immediately preceding, the intended date of grant of an equity award, the date of grant of such award will (unless otherwise provided by the Compensation Committee) be the second full trading day following the Disclosure Event. In addition, the policy generally provides that if, on the date of grant of an equity award, the Compensation Committee believes that the Company will have a Disclosure Event within the following four full business days, the date of grant of the award will (unless otherwise provided by the Compensation Committee) occur on the second full trading day following the Disclosure Event. Any equity awards approved pursuant to any delegated authority to approve equity award grants and other than by the Compensation Committee are generally subject to these same timing provisions. Equity awards granted to members of the Board of Directors in accordance with our non-employee director compensation program are not subject to these timing provisions.</span></div><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The release of material nonpublic information is not taken into account in determining the timing and terms of equity award grants (other than, as to the timing of such awards, to satisfy the equity award grant timing policy discussed above), and the Company does not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMethodTextBlock', window );">Award Timing Method</a></td>
<td class="text">However, the timing of the grant of a Company equity award may be changed to satisfy the Company&#8217;s policy on the timing of equity award grants. The Company&#8217;s policy on the timing of equity award grants generally provides that if the Company files its Annual Report on Form 10-K, a Quarterly Report on Form 10-Q, or a Current Report on Form 8-K that contains information that would (but for such public disclosure) be material nonpublic information in respect of the Company with the Securities and Exchange Commission (any such filing by the Company with the Securities and Exchange Commission, a &#8220;Disclosure Event&#8221;) on, or on the business day immediately preceding, the intended date of grant of an equity award, the date of grant of such award will (unless otherwise provided by the Compensation Committee) be the second full trading day following the Disclosure Event. In addition, the policy generally provides that if, on the date of grant of an equity award, the Compensation Committee believes that the Company will have a Disclosure Event within the following four full business days, the date of grant of the award will (unless otherwise provided by the Compensation Committee) occur on the second full trading day following the Disclosure Event.<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgPredtrmndFlag', window );">Award Timing Predetermined</a></td>
<td class="text">true<span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgMnpiCnsdrdFlag', window );">Award Timing MNPI Considered</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock', window );">Award Timing, How MNPI Considered</a></td>
<td class="text"><div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The release of material nonpublic information is not taken into account in determining the timing and terms of equity award grants (other than, as to the timing of such awards, to satisfy the equity award grant timing policy discussed above), and the Company does not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.</span></div><span></span>
</td>
</tr>
<tr class="re">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_MnpiDiscTimedForCompValFlag', window );">MNPI Disclosure Timed for Compensation Value</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgDiscLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgDiscLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgHowMnpiCnsdrdTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgHowMnpiCnsdrdTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMethodTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMethodTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiCnsdrdFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiCnsdrdFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgMnpiDiscTextBlock">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgMnpiDiscTextBlock</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dtr-types:textBlockItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_AwardTmgPredtrmndFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_AwardTmgPredtrmndFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_MnpiDiscTimedForCompValFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 402<br> -Subsection x<br> -Paragraph 1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_MnpiDiscTimedForCompValFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>22
<FILENAME>R4.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.25.1</span><table class="report" border="0" cellspacing="2" id="id2">
<tr>
<th class="tl" colspan="1" rowspan="2"><div style="width: 200px;"><strong>Insider Trading Policies and Procedures<br></strong></div></th>
<th class="th" colspan="1">12 Months Ended</th>
</tr>
<tr><th class="th"><div>Dec. 31, 2024</div></th></tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTradingPoliciesProcLineItems', window );"><strong>Insider Trading Policies and Procedures [Line Items]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl custom" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_ecd_InsiderTrdPoliciesProcAdoptedFlag', window );">Insider Trading Policies and Procedures Adopted</a></td>
<td class="text">true<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTradingPoliciesProcLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTradingPoliciesProcLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_ecd_InsiderTrdPoliciesProcAdoptedFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- References</a><div><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Regulation S-K<br> -Number 229<br> -Section 408<br> -Subsection b<br> -Paragraph 1<br><br>Reference 2: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Form 20-F<br> -Section 16<br> -Subsection J<br> -Paragraph a<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">ecd_InsiderTrdPoliciesProcAdoptedFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>ecd_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>23
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>24
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
.report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

.report table.authRefData a {
	display: block;
	font-weight: bold;
}

.report table.authRefData p {
	margin-top: 0px;
}

.report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

.report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

.report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

.report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
.pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
.report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

.report hr {
	border: 1px solid #acf;
}

/* Top labels */
.report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

.report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

.report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

.report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

.report td.pl div.a {
	width: 200px;
}

.report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
.report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
.report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
.report .re, .report .reu {
	background-color: #def;
}

.report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
.report .ro, .report .rou {
	background-color: white;
}

.report .rou td {
	border-bottom: 1px solid black;
}

.report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
.report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
.report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

.report .nump {
	padding-left: 2em;
}

.report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
.report .text {
	text-align: left;
	white-space: normal;
}

.report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

.report .text .more {
	display: none;
}

.report .text .note {
	font-style: italic;
	font-weight: bold;
}

.report .text .small {
	width: 10em;
}

.report sup {
	font-style: italic;
}

.report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>26
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.25.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>21</ContextCount>
  <ElementCount>31</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>15</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>1</UnitCount>
  <MyReports>
    <Report instance="halo-20250318.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>995100 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/dei/role/document/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report instance="halo-20250318.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R2.htm</HtmlFileName>
      <LongName>995410 - Disclosure - Pay vs Performance Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/PvpDisclosure</Role>
      <ShortName>Pay vs Performance Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>2</Position>
    </Report>
    <Report instance="halo-20250318.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R3.htm</HtmlFileName>
      <LongName>995443 - Disclosure - Award Timing Disclosure</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure</Role>
      <ShortName>Award Timing Disclosure</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>3</Position>
    </Report>
    <Report instance="halo-20250318.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R4.htm</HtmlFileName>
      <LongName>995447 - Disclosure - Insider Trading Policies and Procedures</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc</Role>
      <ShortName>Insider Trading Policies and Procedures</ShortName>
      <MenuCategory>Notes</MenuCategory>
      <Position>4</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="DEF 14A" isProxy="true" isUsgaap="true" original="halo-20250318.htm">halo-20250318.htm</File>
    <File>halo-20250318.xsd</File>
    <File>halo-20250318_def.xml</File>
    <File>halo-20250318_lab.xml</File>
    <File>halo-20250318_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>halo-20250318_g1.jpg</File>
    <File>halo-20250318_g10.jpg</File>
    <File>halo-20250318_g11.jpg</File>
    <File>halo-20250318_g12.jpg</File>
    <File>halo-20250318_g2.jpg</File>
    <File>halo-20250318_g3.jpg</File>
    <File>halo-20250318_g4.jpg</File>
    <File>halo-20250318_g5.jpg</File>
    <File>halo-20250318_g6.jpg</File>
    <File>halo-20250318_g7.jpg</File>
    <File>halo-20250318_g8.jpg</File>
    <File>halo-20250318_g9.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="5">http://fasb.org/us-gaap/2024</BaseTaxonomy>
    <BaseTaxonomy items="4">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
    <BaseTaxonomy items="76">http://xbrl.sec.gov/ecd/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>28
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "halo-20250318.htm": {
   "nsprefix": "halo",
   "nsuri": "http://www.halozyme.com/20250318",
   "dts": {
    "inline": {
     "local": [
      "halo-20250318.htm"
     ]
    },
    "schema": {
     "local": [
      "halo-20250318.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/reference-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_def.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_lab.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024_pre.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-sub-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-2024.xsd",
      "https://xbrl.sec.gov/ecd/2024/ecd-sub-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "definitionLink": {
     "local": [
      "halo-20250318_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "halo-20250318_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "halo-20250318_pre.xml"
     ]
    }
   },
   "keyStandard": 31,
   "keyCustom": 0,
   "axisStandard": 3,
   "axisCustom": 0,
   "memberStandard": 9,
   "memberCustom": 6,
   "hidden": {
    "total": 3,
    "http://xbrl.sec.gov/dei/2024": 3
   },
   "contextCount": 21,
   "entityCount": 1,
   "segmentCount": 15,
   "elementCount": 272,
   "unitCount": 1,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/ecd/2024": 76,
    "http://fasb.org/us-gaap/2024": 5,
    "http://xbrl.sec.gov/dei/2024": 4
   },
   "report": {
    "R1": {
     "role": "http://xbrl.sec.gov/dei/role/document/Cover",
     "longName": "995100 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20250318.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "td",
       "tr",
       "table",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20250318.htm",
      "first": true,
      "unique": true
     }
    },
    "R2": {
     "role": "http://xbrl.sec.gov/ecd/role/PvpDisclosure",
     "longName": "995410 - Disclosure - Pay vs Performance Disclosure",
     "shortName": "Pay vs Performance Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "2",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20250318.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:PvpTableTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20250318.htm",
      "first": true,
      "unique": true
     }
    },
    "R3": {
     "role": "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
     "longName": "995443 - Disclosure - Award Timing Disclosure",
     "shortName": "Award Timing Disclosure",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "3",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20250318.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:AwardTmgMnpiDiscTextBlock",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20250318.htm",
      "first": true,
      "unique": true
     }
    },
    "R4": {
     "role": "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc",
     "longName": "995447 - Disclosure - Insider Trading Policies and Procedures",
     "shortName": "Insider Trading Policies and Procedures",
     "isDefault": "false",
     "groupType": "disclosure",
     "subGroupType": "",
     "menuCat": "Notes",
     "order": "4",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20250318.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "ecd:InsiderTrdPoliciesProcAdoptedFlag",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "halo-20250318.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "ecd_Additional402vDisclosureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Additional402vDisclosureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional 402(v) Disclosure [Text Block]",
        "terseLabel": "Additional 402(v) Disclosure"
       }
      }
     },
     "auth_ref": [
      "r119"
     ]
    },
    "dei_AdditionalSecurities462b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities. 462(b)"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecurities462bFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecurities462bFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities, 462(b), File Number"
       }
      }
     },
     "auth_ref": [
      "r175"
     ]
    },
    "dei_AdditionalSecuritiesEffective413b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AdditionalSecuritiesEffective413b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Additional Securities Effective, 413(b)"
       }
      }
     },
     "auth_ref": [
      "r173"
     ]
    },
    "dei_AddressTypeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AddressTypeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Address Type [Domain]",
        "documentation": "An entity may have several addresses for different purposes and this domain represents all such types."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AdjToCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation Amount",
        "terseLabel": "Adjustment to Compensation, Amount"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToCompAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToCompAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Compensation [Axis]",
        "terseLabel": "Adjustment to Compensation:"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToNonPeoNeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToNonPeoNeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment to Non-PEO NEO Compensation Footnote [Text Block]",
        "terseLabel": "Adjustment to Non-PEO NEO Compensation Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AdjToPeoCompFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AdjToPeoCompFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Adjustment To PEO Compensation, Footnote [Text Block]",
        "terseLabel": "Adjustment To PEO Compensation, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AggtChngPnsnValInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtChngPnsnValInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Change in Present Value of Accumulated Benefit for All Pension Plans Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r166"
     ]
    },
    "ecd_AggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Amount",
        "terseLabel": "Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_AggtErrCompNotYetDeterminedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtErrCompNotYetDeterminedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Erroneous Compensation Not Yet Determined [Text Block]",
        "terseLabel": "Aggregate Erroneous Compensation Not Yet Determined"
       }
      }
     },
     "auth_ref": [
      "r85",
      "r96",
      "r112",
      "r147"
     ]
    },
    "ecd_AggtPnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AggtPnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Pension Adjustments Service Cost [Member]",
        "terseLabel": "Aggregate Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r167"
     ]
    },
    "ecd_AllAdjToCompMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllAdjToCompMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Adjustments to Compensation [Member]",
        "terseLabel": "All Adjustments to Compensation"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_AllExecutiveCategoriesMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllExecutiveCategoriesMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Executive Categories [Member]",
        "terseLabel": "All Executive Categories"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_AllIndividualsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllIndividualsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Individuals [Member]",
        "terseLabel": "All Individuals"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_AllTradingArrangementsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AllTradingArrangementsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Trading Arrangements [Member]",
        "terseLabel": "All Trading Arrangements"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "dei_AmendmentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Description",
        "documentation": "Description of changes contained within amended document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AnnualInformationForm": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AnnualInformationForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Annual Information Form",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_ApproximateDateOfCommencementOfProposedSaleToThePublic": {
     "xbrltype": "dateOrAsapItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ApproximateDateOfCommencementOfProposedSaleToThePublic",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Approximate Date of Commencement of Proposed Sale to Public",
        "documentation": "The approximate date of a commencement of a proposed sale of securities to the public. This element is disclosed in S-1, S-3, S-4, S-11, F-1, F-3 and F-10 filings."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditedAnnualFinancialStatements": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditedAnnualFinancialStatements",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Audited Annual Financial Statements",
        "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_AuditorFirmId": {
     "xbrltype": "nonemptySequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorFirmId",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Firm ID",
        "documentation": "PCAOB issued Audit Firm Identifier"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Line Items]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_AuditorLocation": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorLocation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Location"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorName": {
     "xbrltype": "internationalNameItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Name"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_AuditorOpinionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorOpinionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor Opinion [Text Block]"
       }
      }
     },
     "auth_ref": [
      "r171"
     ]
    },
    "dei_AuditorTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AuditorTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Auditor [Table]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_AwardExrcPrice": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardExrcPrice",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Exercise Price",
        "terseLabel": "Exercise Price"
       }
      }
     },
     "auth_ref": [
      "r155"
     ]
    },
    "ecd_AwardGrantDateFairValue": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardGrantDateFairValue",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Grant Date Fair Value",
        "terseLabel": "Fair Value as of Grant Date"
       }
      }
     },
     "auth_ref": [
      "r156"
     ]
    },
    "ecd_AwardTmgDiscLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgDiscLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Disclosures [Line Items]",
        "terseLabel": "Award Timing Disclosures"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgHowMnpiCnsdrdTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgHowMnpiCnsdrdTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing, How MNPI Considered [Text Block]",
        "terseLabel": "Award Timing, How MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Method [Text Block]",
        "terseLabel": "Award Timing Method"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiCnsdrdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiCnsdrdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Considered [Flag]",
        "terseLabel": "Award Timing MNPI Considered"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgMnpiDiscTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgMnpiDiscTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing MNPI Disclosure [Text Block]",
        "terseLabel": "Award Timing MNPI Disclosure"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_AwardTmgPredtrmndFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardTmgPredtrmndFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Timing Predetermined [Flag]",
        "terseLabel": "Award Timing Predetermined"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "us-gaap_AwardTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "AwardTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Type [Axis]",
        "terseLabel": "Award Type",
        "documentation": "Information by type of award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "ecd_AwardUndrlygSecuritiesAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardUndrlygSecuritiesAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Award Underlying Securities Amount",
        "terseLabel": "Underlying Securities"
       }
      }
     },
     "auth_ref": [
      "r154"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r153"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "ecd_AwardsCloseToMnpiDiscTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "AwardsCloseToMnpiDiscTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Awards Close in Time to MNPI Disclosures [Table Text Block]",
        "terseLabel": "Awards Close in Time to MNPI Disclosures, Table"
       }
      }
     },
     "auth_ref": [
      "r152"
     ]
    },
    "dei_BusinessContactMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "BusinessContactMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Business Contact [Member]",
        "documentation": "Business contact for the entity"
       }
      }
     },
     "auth_ref": [
      "r77",
      "r89"
     ]
    },
    "ecd_ChangedPeerGroupFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChangedPeerGroupFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Changed Peer Group, Footnote [Text Block]",
        "terseLabel": "Changed Peer Group, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year [Member]",
        "terseLabel": "Change in Fair Value as of Vesting Date of Prior Year Equity Awards Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r127"
     ]
    },
    "ecd_ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested [Member]",
        "terseLabel": "Year-over-Year Change in Fair Value of Equity Awards Granted in Prior Years That are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r125"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_CoSelectedMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Amount",
        "terseLabel": "Company Selected Measure Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CoSelectedMeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CoSelectedMeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Company Selected Measure Name",
        "terseLabel": "Company Selected Measure Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_CompActuallyPaidVsCoSelectedMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsCoSelectedMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Company Selected Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Company Selected Measure"
       }
      }
     },
     "auth_ref": [
      "r136"
     ]
    },
    "ecd_CompActuallyPaidVsNetIncomeTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsNetIncomeTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Net Income [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Net Income"
       }
      }
     },
     "auth_ref": [
      "r135"
     ]
    },
    "ecd_CompActuallyPaidVsOtherMeasureTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsOtherMeasureTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Other Measure [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Other Measure"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_CompActuallyPaidVsTotalShareholderRtnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "CompActuallyPaidVsTotalShareholderRtnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Compensation Actually Paid vs. Total Shareholder Return [Text Block]",
        "terseLabel": "Compensation Actually Paid vs. Total Shareholder Return"
       }
      }
     },
     "auth_ref": [
      "r134"
     ]
    },
    "dei_ContactPersonnelEmailAddress": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelEmailAddress",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Email Address",
        "documentation": "Email address of contact personnel."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContactPersonnelFaxNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelFaxNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Fax Number",
        "documentation": "Fax Number of contact personnel."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_ContactPersonnelName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContactPersonnelName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contact Personnel Name",
        "documentation": "Name of contact personnel"
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Description",
        "documentation": "The description of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Name",
        "documentation": "The name of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Number",
        "documentation": "The SEC Document Number of the contained file."
       }
      }
     },
     "auth_ref": []
    },
    "dei_ContainedFileInformationFileType": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ContainedFileInformationFileType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Contained File Information, File Type",
        "documentation": "The type or format of the contained file (usually XBRL but may be used for other types such as HTML, Word, PDF, GIF/JPG, etc.)."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CountryRegion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CountryRegion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Country Region",
        "documentation": "Region code of country"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CurrentFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CurrentFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Current Fiscal Year End Date",
        "documentation": "End date of current fiscal year in the format --MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DelayedOrContinuousOffering": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DelayedOrContinuousOffering",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Delayed or Continuous Offering"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DividendOrInterestReinvestmentPlanOnly": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DividendOrInterestReinvestmentPlanOnly",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividend or Interest Reinvestment Plan Only"
       }
      }
     },
     "auth_ref": [
      "r101",
      "r102",
      "r116"
     ]
    },
    "dei_DocumentAccountingStandard": {
     "xbrltype": "accountingStandardItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Accounting Standard",
        "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentAnnualReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentAnnualReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Annual Report",
        "documentation": "Boolean flag that is true only for a form used as an annual report."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "dei_DocumentCopyrightInformation": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCopyrightInformation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Copyright Information",
        "documentation": "The copyright information for the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentCreationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentCreationDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Creation Date",
        "documentation": "The date the document was made available and submitted, in YYYY-MM-DD format. The date of submission, date of acceptance by the recipient, and the document effective date are all potentially different."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Description",
        "documentation": "The description of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document [Domain]",
        "documentation": "Type of the document as assigned by the filer, corresponding to SEC document naming convention standards."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentEffectiveDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentEffectiveDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Effective Date",
        "documentation": "The date when a document, upon receipt and acceptance, becomes officially effective, in YYYY-MM-DD format. Usually it is a system-assigned date time value, but it may be declared by the submitter in some cases."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFinStmtErrorCorrectionFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtErrorCorrectionFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Error Correction [Flag]",
        "documentation": "Indicates whether any of the financial statement period in the filing include a restatement due to error correction."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFinStmtRestatementRecoveryAnalysisFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFinStmtRestatementRecoveryAnalysisFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Financial Statement Restatement Recovery Analysis [Flag]",
        "documentation": "Indicates whether any of the financial statement periods include restatements that required a recovery analysis of incentive-based compensation received by any of the registrant's executive officers during the relevant recovery period pursuant to \u00a7240.10D-1(b)."
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89",
      "r140"
     ]
    },
    "dei_DocumentFiscalPeriodFocus": {
     "xbrltype": "fiscalPeriodItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalPeriodFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Period Focus",
        "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentFiscalYearFocus": {
     "xbrltype": "gYearItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentFiscalYearFocus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Fiscal Year Focus",
        "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationDocumentAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationDocumentAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information, Document [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Table]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Information [Text Block]",
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Name",
        "documentation": "Name of the document as assigned by the filer, corresponding to SEC document naming convention standards. Examples appear in the &lt;FILENAME> field of EDGAR filings, such as 'htm_25911.htm', 'exhibit1.htm', 'v105727_8k.txt'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodStartDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodStartDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period Start Date",
        "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentQuarterlyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentQuarterlyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Quarterly Report",
        "documentation": "Boolean flag that is true only for a form used as an quarterly report."
       }
      }
     },
     "auth_ref": [
      "r75"
     ]
    },
    "dei_DocumentRegistrationStatement": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentRegistrationStatement",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Registration Statement",
        "documentation": "Boolean flag that is true only for a form used as a registration statement."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_DocumentShellCompanyEventDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyEventDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Event Date",
        "documentation": "Date of event requiring a shell company report."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentShellCompanyReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentShellCompanyReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Shell Company Report",
        "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "dei_DocumentSubtitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSubtitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Subtitle",
        "documentation": "The subtitle given to the document resource by the creator or publisher. An example is 'A New Period of Growth'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentSynopsis": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentSynopsis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Synopsis",
        "documentation": "A synopsis or description of the document provided by the creator or publisher. Examples are 'This is the 2006 annual report for Company. During this period we saw revenue grow by 10% and earnings per share grow by 15% over the prior period'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTitle": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Title",
        "documentation": "The name or title given to the document resource by the creator or publisher. An example is '2002 Annual Report'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentTransitionReport": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentTransitionReport",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Transition Report",
        "documentation": "Boolean flag that is true only for a form used as a transition report."
       }
      }
     },
     "auth_ref": [
      "r117"
     ]
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentVersion": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentVersion",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Version",
        "documentation": "The version identifier of the document."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentsIncorporatedByReferenceTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentsIncorporatedByReferenceTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Documents Incorporated by Reference [Text Block]",
        "documentation": "Documents incorporated by reference."
       }
      }
     },
     "auth_ref": [
      "r66"
     ]
    },
    "ecd_DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "DvddsOrOthrErngsPdOnEqtyAwrdsNtOthrwsRflctdInTtlCompForCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year [Member]",
        "terseLabel": "Dividends or Other Earnings Paid on Equity Awards not Otherwise Reflected in Total Compensation for Covered Year"
       }
      }
     },
     "auth_ref": [
      "r129"
     ]
    },
    "dei_EffectiveAfter60Days486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveAfter60Days486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective after 60 Days, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486a": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnDate486b": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveOnSetDate486a": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486a",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(a)"
       }
      }
     },
     "auth_ref": [
      "r179"
     ]
    },
    "dei_EffectiveOnSetDate486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveOnSetDate486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective on Set Date, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveUponFiling462e": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling462e",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective Upon Filing, 462(e)"
       }
      }
     },
     "auth_ref": [
      "r178"
     ]
    },
    "dei_EffectiveUponFiling486b": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveUponFiling486b",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective upon Filing, 486(b)"
       }
      }
     },
     "auth_ref": [
      "r180"
     ]
    },
    "dei_EffectiveWhenDeclaredSection8c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EffectiveWhenDeclaredSection8c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Effective when Declared, Section 8(c)"
       }
      }
     },
     "auth_ref": [
      "r182"
     ]
    },
    "us-gaap_EmployeeStockOptionMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "EmployeeStockOptionMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Employee Stock Option [Member]",
        "terseLabel": "Employee Stock Option",
        "documentation": "Share-based payment arrangement granting right, subject to vesting and other restrictions, to purchase or sell certain number of shares at predetermined price for specified period of time."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntitiesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitiesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entities [Table]",
        "documentation": "Container to assemble all relevant information about each entity associated with the document instance"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAccountingStandard": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAccountingStandard",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Accounting Standard",
        "documentation": "The standardized abbreviation of the accounting standard used by the entity. This can either be US GAAP as promulgated by the FASB or IFRS as promulgated by the IASB. Example: 'US GAAP', 'IFRS'. This is distinct from the Document Accounting Standard element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Description",
        "documentation": "Description of the kind of address for the entity, if needed to distinguish more finely among mailing, principal, legal, accounting, contact or other addresses."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine2": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine2",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Two",
        "documentation": "Address Line 2 such as Street or Suite number"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine3": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine3",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line Three",
        "documentation": "Address Line 3 such as an Office Park"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesAddressTypeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesAddressTypeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses, Address Type [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressesTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressesTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Addresses [Table]",
        "documentation": "Container of address information for the entity"
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityBankruptcyProceedingsReportingCurrent": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityBankruptcyProceedingsReportingCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Bankruptcy Proceedings, Reporting Current",
        "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element."
       }
      }
     },
     "auth_ref": [
      "r69"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityCommonStockSharesOutstanding": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCommonStockSharesOutstanding",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Common Stock, Shares Outstanding",
        "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityContactPersonnelLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityContactPersonnelLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Contact Personnel [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCurrentReportingStatus": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCurrentReportingStatus",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Current Reporting Status",
        "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Domain]",
        "documentation": "All the names of the entities being reported upon in a document. Any legal structure used to conduct activities or to hold assets. Some examples of such structures are corporations, partnerships, limited liability companies, grantor trusts, and other trusts. This item does not include business and geographical segments which are included in the geographical or business segments domains."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityExTransitionPeriod": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityExTransitionPeriod",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Ex Transition Period",
        "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards."
       }
      }
     },
     "auth_ref": [
      "r181"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFilerCategory": {
     "xbrltype": "filerCategoryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFilerCategory",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Filer Category",
        "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityHomeCountryISOCode": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityHomeCountryISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Home Country ISO Code",
        "documentation": "ISO 3166-1 alpha-2 country code for the Entity's home country. If home country is different from country of legal incorporation, then also provide country of legal incorporation in the 'Entity Incorporation, State Country Code' element."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationDateOfIncorporation": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationDateOfIncorporation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, Date of Incorporation",
        "documentation": "Date when an entity was incorporated"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationFormerLegalOrRegisteredName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationFormerLegalOrRegisteredName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information, Former Legal or Registered Name",
        "documentation": "Former Legal or Registered Name of an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInformationLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Information [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityInteractiveDataCurrent": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInteractiveDataCurrent",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Interactive Data Current",
        "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)."
       }
      }
     },
     "auth_ref": [
      "r170"
     ]
    },
    "dei_EntityInvCompanyType": {
     "xbrltype": "invCompanyType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityInvCompanyType",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Inv Company Type",
        "documentation": "One of: N-1A (Mutual Fund), N-1 (Open-End Separate Account with No Variable Annuities), N-2 (Closed-End Investment Company), N-3 (Separate Account Registered as Open-End Management Investment Company), N-4 (Variable Annuity UIT Separate Account), N-5 (Small Business Investment Company), N-6 (Variable Life UIT Separate Account), S-1 or S-3 (Face Amount Certificate Company), S-6 (UIT, Non-Insurance Product)."
       }
      }
     },
     "auth_ref": [
      "r169"
     ]
    },
    "dei_EntityLegalForm": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityLegalForm",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Legal Form",
        "documentation": "The details of the entity's legal form. Examples are partnership, limited liability company, trust, etc."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDepositoryReceiptRatio": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDepositoryReceiptRatio",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Depository Receipt Ratio",
        "documentation": "The number of underlying shares represented by one American Depository Receipt (ADR) or Global Depository Receipt (GDR). A value of '3' means that one ADR represents 3 underlying shares. If one underlying share represents 2 ADR's then the value would be represented as '0.5'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Description",
        "documentation": "Description of the kind of listing the entity has on the exchange, if necessary to further describe different instruments that are already distinguished by Entity, Exchange and Security."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingForeign": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingForeign",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Foreign",
        "documentation": "Yes or No value indicating whether this is a listing that is a foreign listing or depository receipt."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingParValuePerShare": {
     "xbrltype": "perShareItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingParValuePerShare",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Par Value Per Share",
        "documentation": "The par value per share of security quoted in same currency as Trading currency. Example: '0.01'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingPrimary": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingPrimary",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Primary",
        "documentation": "Yes or No value indicating whether a listing of an instrument on an exchange is primary for the entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingSecurityTradingCurrency": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingSecurityTradingCurrency",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listing, Security Trading Currency",
        "documentation": "The three character ISO 4217 code for the currency in which the security is quoted. Example: 'USD'"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsExchangeAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsExchangeAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings, Exchange [Axis]",
        "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityListingsTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityListingsTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Listings [Table]",
        "documentation": "Container for exchange listing information for an entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityNumberOfEmployees": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityNumberOfEmployees",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Number of Employees",
        "documentation": "Number of persons employed by the Entity"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPhoneFaxNumbersLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPhoneFaxNumbersLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Phone Fax Numbers [Line Items]",
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityPrimarySicNumber": {
     "xbrltype": "sicNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPrimarySicNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Primary SIC Number",
        "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity."
       }
      }
     },
     "auth_ref": [
      "r89"
     ]
    },
    "dei_EntityPublicFloat": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityPublicFloat",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Public Float",
        "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityReportingCurrencyISOCode": {
     "xbrltype": "currencyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityReportingCurrencyISOCode",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Reporting Currency ISO Code",
        "documentation": "The three character ISO 4217 code for the currency used for reporting purposes. Example: 'USD'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityShellCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityShellCompany",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Shell Company",
        "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntitySmallBusiness": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntitySmallBusiness",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Small Business",
        "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r65"
     ]
    },
    "dei_EntityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity [Text Block]",
        "documentation": "Container to serve as parent of six Entity related Table concepts."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityVoluntaryFilers": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityVoluntaryFilers",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Voluntary Filers",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityWellKnownSeasonedIssuer": {
     "xbrltype": "yesNoItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityWellKnownSeasonedIssuer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Well-known Seasoned Issuer",
        "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A."
       }
      }
     },
     "auth_ref": [
      "r172"
     ]
    },
    "ecd_EqtyAwrdsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Footnote [Text Block]",
        "terseLabel": "Equity Awards Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsExclgValRprtdInSummryCompstnTblMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments, Excluding Value Reported in the Compensation Table [Member]",
        "terseLabel": "Equity Awards Adjustments, Excluding Value Reported in Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsAdjsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsAdjsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards Adjustments [Member]",
        "terseLabel": "Equity Awards Adjustments"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "ecd_EqtyAwrdsInSummryCompstnTblForAplblYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EqtyAwrdsInSummryCompstnTblForAplblYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table [Member]",
        "terseLabel": "Aggregate Grant Date Fair Value of Equity Award Amounts Reported in Summary Compensation Table"
       }
      }
     },
     "auth_ref": [
      "r165"
     ]
    },
    "halo_EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20250318",
     "localname": "EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Granted in Prior Years, Unvested [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "halo_EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20250318",
     "localname": "EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Granted in Prior Years, Vested [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "halo_EquityAwardsOptionsAndStockOutstandingUnvestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20250318",
     "localname": "EquityAwardsOptionsAndStockOutstandingUnvestedMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Outstanding, Unvested [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "halo_EquityAwardsOptionsAndStockReportedValueMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20250318",
     "localname": "EquityAwardsOptionsAndStockReportedValueMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Reported Value [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "halo_EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20250318",
     "localname": "EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards , Options and Stock, that Failed to Meet Vesting Conditions [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "halo_EquityAwardsOptionsAndStockVestedMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://www.halozyme.com/20250318",
     "localname": "EquityAwardsOptionsAndStockVestedMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Awards, Options and Stock, Vested [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_EquityValuationAssumptionDifferenceFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "EquityValuationAssumptionDifferenceFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Equity Valuation Assumption Difference, Footnote [Text Block]",
        "terseLabel": "Equity Valuation Assumption Difference, Footnote"
       }
      }
     },
     "auth_ref": [
      "r133"
     ]
    },
    "ecd_ErrCompAnalysisTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompAnalysisTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneous Compensation Analysis [Text Block]",
        "terseLabel": "Erroneous Compensation Analysis"
       }
      }
     },
     "auth_ref": [
      "r82",
      "r93",
      "r109",
      "r144"
     ]
    },
    "ecd_ErrCompRecoveryTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ErrCompRecoveryTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Erroneously Awarded Compensation Recovery [Table]",
        "terseLabel": "Erroneously Awarded Compensation Recovery"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_ExchangeDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExchangeDomain",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exchange [Domain]",
        "documentation": "The set of all exchanges. MIC exchange codes are drawn from ISO 10383."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ExecutiveCategoryAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ExecutiveCategoryAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Executive Category [Axis]",
        "terseLabel": "Executive Category:"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "dei_ExhibitsOnly462d": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462d",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d)"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_ExhibitsOnly462dFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ExhibitsOnly462dFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Exhibits Only, 462(d), File Number"
       }
      }
     },
     "auth_ref": [
      "r177"
     ]
    },
    "dei_Extension": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Extension",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Extension",
        "documentation": "Extension number for local phone number."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToDisqualificationOfTaxBenefitsAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Disqualification of Tax Benefits, Amount",
        "terseLabel": "Forgone Recovery due to Disqualification of Tax Benefits, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToExpenseOfEnforcementAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToExpenseOfEnforcementAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Expense of Enforcement, Amount",
        "terseLabel": "Forgone Recovery due to Expense of Enforcement, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryDueToViolationOfHomeCountryLawAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryDueToViolationOfHomeCountryLawAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery due to Violation of Home Country Law, Amount",
        "terseLabel": "Forgone Recovery due to Violation of Home Country Law, Amount"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryExplanationOfImpracticabilityTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryExplanationOfImpracticabilityTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Explanation of Impracticability [Text Block]",
        "terseLabel": "Forgone Recovery, Explanation of Impracticability"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "ecd_ForgoneRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "ForgoneRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Forgone Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r148"
     ]
    },
    "dei_FormerAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Address [Member]",
        "documentation": "Former address for entity"
       }
      }
     },
     "auth_ref": [
      "r76",
      "r100"
     ]
    },
    "dei_FormerFiscalYearEndDate": {
     "xbrltype": "gMonthDayItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "FormerFiscalYearEndDate",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Former Fiscal Year End Date",
        "documentation": "Former end date of previous fiscal years"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year [Member]",
        "terseLabel": "Prior Year End Fair Value of Equity Awards Granted in Any Prior Year that Fail to Meet Applicable Vesting Conditions During Covered Year"
       }
      }
     },
     "auth_ref": [
      "r128"
     ]
    },
    "dei_IcfrAuditorAttestationFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "IcfrAuditorAttestationFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "ICFR Auditor Attestation Flag"
       }
      }
     },
     "auth_ref": [
      "r74",
      "r77",
      "r89"
     ]
    },
    "ecd_IndividualAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "IndividualAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure",
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure",
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements",
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Individual [Axis]",
        "terseLabel": "Individual:"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148",
      "r152",
      "r160"
     ]
    },
    "ecd_InsiderTradingArrLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingArrLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Arrangements [Line Items]",
        "terseLabel": "Insider Trading Arrangements:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_InsiderTradingPoliciesProcLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTradingPoliciesProcLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures [Line Items]",
        "terseLabel": "Insider Trading Policies and Procedures:"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Adopted [Flag]",
        "terseLabel": "Insider Trading Policies and Procedures Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "ecd_InsiderTrdPoliciesProcNotAdoptedTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "InsiderTrdPoliciesProcNotAdoptedTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Insider Trading Policies and Procedures Not Adopted [Text Block]",
        "terseLabel": "Insider Trading Policies and Procedures Not Adopted"
       }
      }
     },
     "auth_ref": [
      "r78",
      "r164"
     ]
    },
    "dei_InvestmentCompanyActFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act File Number"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_InvestmentCompanyActRegistration": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyActRegistration",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Act Registration"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_InvestmentCompanyRegistrationAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "InvestmentCompanyRegistrationAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Investment Company Registration Amendment Number"
       }
      }
     },
     "auth_ref": [
      "r118"
     ]
    },
    "dei_LegalEntityAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/AuditInformation",
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity [Axis]",
        "documentation": "The set of legal entities associated with a report."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LegalEntityIdentifier": {
     "xbrltype": "legalEntityIdentifierItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LegalEntityIdentifier",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Legal Entity Identifier",
        "documentation": "A globally unique ISO 17442 value to identify entities, commonly abbreviated as LEI."
       }
      }
     },
     "auth_ref": [
      "r62"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_MeasureAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure [Axis]",
        "terseLabel": "Measure:"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MeasureName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MeasureName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Measure Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_MnpiDiscTimedForCompValFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MnpiDiscTimedForCompValFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "MNPI Disclosure Timed for Compensation Value [Flag]",
        "terseLabel": "MNPI Disclosure Timed for Compensation Value"
       }
      }
     },
     "auth_ref": [
      "r151"
     ]
    },
    "ecd_MtrlTermsOfTrdArrTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "MtrlTermsOfTrdArrTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Material Terms of Trading Arrangement [Text Block]",
        "terseLabel": "Material Terms of Trading Arrangement"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_NameChangeEventDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event Date [Axis]",
        "documentation": "For a sequence of name change event related facts, use this typed dimension to distinguish them. The axis members are restricted to be a valid for xml schema 'date' or 'datetime' data type."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventLineItems",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Line Items]",
        "documentation": "Line items represent concepts included in a table. Name change event line item concepts are used for information qualified by domain members of axes in the Name Change Event table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_NameChangeEventTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NameChangeEventTable",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Name Change Event [Table]",
        "documentation": "For a set of related facts in a sequence of name change events, use this table when the events occurred within a single reporting period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NamedExecutiveOfficersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NamedExecutiveOfficersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Named Executive Officers, Footnote [Text Block]",
        "terseLabel": "Named Executive Officers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "us-gaap_NetIncomeLoss": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "NetIncomeLoss",
     "crdr": "credit",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Net Income (Loss)",
        "terseLabel": "Net Income (Loss)",
        "documentation": "The portion of profit or loss for the period, net of income taxes, which is attributable to the parent."
       }
      }
     },
     "auth_ref": [
      "r0",
      "r1",
      "r2",
      "r3",
      "r4",
      "r5",
      "r6",
      "r7",
      "r8",
      "r9",
      "r10",
      "r11",
      "r12",
      "r13",
      "r14",
      "r15",
      "r16",
      "r17",
      "r18",
      "r19",
      "r20",
      "r21",
      "r22",
      "r23",
      "r24",
      "r25",
      "r26",
      "r53",
      "r54",
      "r55",
      "r56",
      "r57",
      "r58",
      "r59",
      "r60",
      "r61",
      "r183"
     ]
    },
    "dei_NewEffectiveDateForPreviousFiling": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NewEffectiveDateForPreviousFiling",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "New Effective Date for Previous Filing"
       }
      }
     },
     "auth_ref": [
      "r102",
      "r103",
      "r104",
      "r105"
     ]
    },
    "dei_NoSubstantiveChanges462c": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462c",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c)"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoSubstantiveChanges462cFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoSubstantiveChanges462cFileNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Substantive Changes, 462(c), File Number"
       }
      }
     },
     "auth_ref": [
      "r176"
     ]
    },
    "dei_NoTradingSymbolFlag": {
     "xbrltype": "trueItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "NoTradingSymbolFlag",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "No Trading Symbol Flag",
        "documentation": "Boolean flag that is true only for a security having no trading symbol."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_NonGaapMeasureDescriptionTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonGaapMeasureDescriptionTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-GAAP Measure Description [Text Block]",
        "terseLabel": "Non-GAAP Measure Description"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "ecd_NonNeosMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonNeosMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-NEOs [Member]",
        "terseLabel": "Non-NEOs"
       }
      }
     },
     "auth_ref": [
      "r86",
      "r97",
      "r113",
      "r139",
      "r148"
     ]
    },
    "ecd_NonPeoNeoAvgCompActuallyPaidAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgCompActuallyPaidAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Compensation Actually Paid Amount",
        "terseLabel": "Non-PEO NEO Average Compensation Actually Paid Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_NonPeoNeoAvgTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoAvgTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO Average Total Compensation Amount",
        "terseLabel": "Non-PEO NEO Average Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "ecd_NonPeoNeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonPeoNeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-PEO NEO [Member]",
        "terseLabel": "Non-PEO NEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_NonRule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_NonRule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "NonRule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Non-Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Non-Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_OtherAddressMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherAddressMember",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Address [Member]",
        "documentation": "Other address for entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_OtherPerfMeasureAmt": {
     "xbrltype": "decimalItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OtherPerfMeasureAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Performance Measure, Amount",
        "terseLabel": "Other Performance Measure, Amount"
       }
      }
     },
     "auth_ref": [
      "r131"
     ]
    },
    "dei_OtherReportingStandardItemNumber": {
     "xbrltype": "otherReportingStandardItemNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "OtherReportingStandardItemNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Other Reporting Standard Item Number",
        "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS."
       }
      }
     },
     "auth_ref": [
      "r77"
     ]
    },
    "ecd_OutstandingAggtErrCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingAggtErrCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Aggregate Erroneous Compensation Amount",
        "terseLabel": "Outstanding Aggregate Erroneous Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r84",
      "r95",
      "r111",
      "r146"
     ]
    },
    "ecd_OutstandingRecoveryCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery Compensation Amount",
        "terseLabel": "Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "ecd_OutstandingRecoveryIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "OutstandingRecoveryIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Outstanding Recovery, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r87",
      "r98",
      "r114",
      "r149"
     ]
    },
    "dei_ParentEntityLegalName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "ParentEntityLegalName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Parent Entity Legal Name",
        "documentation": "If the entity which the financial information concerns is a subsidiary of another company, then provide to full legal name of the parent entity"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PayVsPerformanceDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PayVsPerformanceDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Line Items]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PeerGroupIssuersFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupIssuersFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Issuers, Footnote [Text Block]",
        "terseLabel": "Peer Group Issuers, Footnote"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeerGroupTotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeerGroupTotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Peer Group Total Shareholder Return Amount",
        "terseLabel": "Peer Group Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_PeoActuallyPaidCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoActuallyPaidCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Actually Paid Compensation Amount",
        "terseLabel": "PEO Actually Paid Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "ecd_PeoMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO [Member]",
        "terseLabel": "PEO"
       }
      }
     },
     "auth_ref": [
      "r139"
     ]
    },
    "ecd_PeoName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Name",
        "terseLabel": "PEO Name"
       }
      }
     },
     "auth_ref": [
      "r132"
     ]
    },
    "ecd_PeoTotalCompAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PeoTotalCompAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "PEO Total Compensation Amount",
        "terseLabel": "PEO Total Compensation Amount"
       }
      }
     },
     "auth_ref": [
      "r121"
     ]
    },
    "dei_PhoneFaxNumberDescription": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PhoneFaxNumberDescription",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Phone Fax Number Description",
        "documentation": "Description of Phone or Fax Number"
       }
      }
     },
     "auth_ref": []
    },
    "ecd_PnsnAdjsPrrSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsPrrSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Prior Service Cost [Member]",
        "terseLabel": "Pension Adjustments Prior Service Cost"
       }
      }
     },
     "auth_ref": [
      "r123"
     ]
    },
    "ecd_PnsnAdjsSvcCstMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnAdjsSvcCstMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Adjustments Service Cost [Member]",
        "terseLabel": "Pension Adjustments Service Cost"
       }
      }
     },
     "auth_ref": [
      "r168"
     ]
    },
    "ecd_PnsnBnftsAdjFnTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PnsnBnftsAdjFnTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pension Benefits Adjustments, Footnote [Text Block]",
        "terseLabel": "Pension Benefits Adjustments, Footnote"
       }
      }
     },
     "auth_ref": [
      "r122"
     ]
    },
    "dei_PostEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PostEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PostEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Post-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 after the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r70"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r72"
     ]
    },
    "dei_PreEffectiveAmendment": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendment",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment"
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "dei_PreEffectiveAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreEffectiveAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre-Effective Amendment Number",
        "documentation": "Amendment number to registration statement under the Securities Act of 1933 before the registration becomes effective."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_PvpTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance Disclosure [Table]",
        "terseLabel": "Pay vs Performance Disclosure"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_PvpTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "PvpTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pay vs Performance [Table Text Block]",
        "terseLabel": "Pay vs Performance Disclosure, Table"
       }
      }
     },
     "auth_ref": [
      "r120"
     ]
    },
    "ecd_RecoveryOfErrCompDisclosureLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RecoveryOfErrCompDisclosureLineItems",
     "lang": {
      "en-us": {
       "role": {
        "label": "Recovery of Erroneously Awarded Compensation Disclosure [Line Items]",
        "terseLabel": "Recovery of Erroneously Awarded Compensation Disclosure"
       }
      }
     },
     "auth_ref": [
      "r79",
      "r90",
      "r106",
      "r141"
     ]
    },
    "dei_RegistrationStatementAmendmentNumber": {
     "xbrltype": "sequenceNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "RegistrationStatementAmendmentNumber",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Registration Statement Amendment Number",
        "documentation": "Amendment number to registration statement under the Investment Company Act of 1940."
       }
      }
     },
     "auth_ref": [
      "r63"
     ]
    },
    "ecd_RestatementDateAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDateAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date [Axis]",
        "terseLabel": "Restatement Determination Date:"
       }
      }
     },
     "auth_ref": [
      "r80",
      "r91",
      "r107",
      "r142"
     ]
    },
    "ecd_RestatementDeterminationDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDeterminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Determination Date",
        "terseLabel": "Restatement Determination Date"
       }
      }
     },
     "auth_ref": [
      "r81",
      "r92",
      "r108",
      "r143"
     ]
    },
    "ecd_RestatementDoesNotRequireRecoveryTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "RestatementDoesNotRequireRecoveryTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Restatement Does Not Require Recovery [Text Block]",
        "terseLabel": "Restatement does not require Recovery"
       }
      }
     },
     "auth_ref": [
      "r88",
      "r99",
      "r115",
      "r150"
     ]
    },
    "ecd_Rule10b51ArrAdoptedFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrAdoptedFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Adopted [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Adopted"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "ecd_Rule10b51ArrTrmntdFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "Rule10b51ArrTrmntdFlag",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Rule 10b5-1 Arrangement Terminated [Flag]",
        "terseLabel": "Rule 10b5-1 Arrangement Terminated"
       }
      }
     },
     "auth_ref": [
      "r159"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r64"
     ]
    },
    "dei_Security12gTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12gTitle",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Title of 12(g) Security",
        "documentation": "Title of a 12(g) registered security."
       }
      }
     },
     "auth_ref": [
      "r68"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r67"
     ]
    },
    "dei_SecurityReportingObligation": {
     "xbrltype": "securityReportingObligationItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityReportingObligation",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Reporting Obligation",
        "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r73"
     ]
    },
    "us-gaap_ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ShareBasedCompensationArrangementsByShareBasedPaymentAwardAwardTypeAndPlanNameDomain",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "All Award Types",
        "terseLabel": "All Award Types",
        "documentation": "Award under share-based payment arrangement."
       }
      }
     },
     "auth_ref": [
      "r27",
      "r28",
      "r29",
      "r30",
      "r31",
      "r32",
      "r33",
      "r34",
      "r35",
      "r36",
      "r37",
      "r38",
      "r39",
      "r40",
      "r41",
      "r42",
      "r43",
      "r44",
      "r45",
      "r46",
      "r47",
      "r48",
      "r49",
      "r50",
      "r51",
      "r52"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r71"
     ]
    },
    "ecd_StkPrcOrTsrEstimationMethodTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "StkPrcOrTsrEstimationMethodTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/ErrCompDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Price or TSR Estimation Method [Text Block]",
        "terseLabel": "Stock Price or TSR Estimation Method"
       }
      }
     },
     "auth_ref": [
      "r83",
      "r94",
      "r110",
      "r145"
     ]
    },
    "us-gaap_StockAppreciationRightsSARSMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StockAppreciationRightsSARSMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Stock Appreciation Rights (SARs) [Member]",
        "terseLabel": "Stock Appreciation Rights (SARs)",
        "documentation": "Right to receive cash or shares equal to appreciation of predetermined number of grantor's shares during predetermined time period."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TabularListTableTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TabularListTableTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Tabular List [Table Text Block]",
        "terseLabel": "Tabular List, Table"
       }
      }
     },
     "auth_ref": [
      "r138"
     ]
    },
    "ecd_TotalShareholderRtnAmt": {
     "xbrltype": "monetaryItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Amount",
        "terseLabel": "Total Shareholder Return Amount"
       }
      }
     },
     "auth_ref": [
      "r130"
     ]
    },
    "ecd_TotalShareholderRtnVsPeerGroupTextBlock": {
     "xbrltype": "textBlockItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TotalShareholderRtnVsPeerGroupTextBlock",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Total Shareholder Return Vs Peer Group [Text Block]",
        "terseLabel": "Total Shareholder Return Vs Peer Group"
       }
      }
     },
     "auth_ref": [
      "r137"
     ]
    },
    "ecd_TradingArrAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrAxis",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement [Axis]",
        "terseLabel": "Trading Arrangement:"
       }
      }
     },
     "auth_ref": [
      "r158"
     ]
    },
    "ecd_TradingArrByIndTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TradingArrByIndTable",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangements, by Individual [Table]",
        "terseLabel": "Trading Arrangements, by Individual"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "ecd_TrdArrAdoptionDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrAdoptionDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Adoption Date",
        "terseLabel": "Adoption Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_TrdArrDuration": {
     "xbrltype": "durationItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrDuration",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Duration",
        "terseLabel": "Arrangement Duration"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrExpirationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrExpirationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Expiration Date",
        "terseLabel": "Expiration Date"
       }
      }
     },
     "auth_ref": [
      "r162"
     ]
    },
    "ecd_TrdArrIndName": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndName",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Name",
        "terseLabel": "Name"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrIndTitle": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrIndTitle",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Individual Title",
        "terseLabel": "Title"
       }
      }
     },
     "auth_ref": [
      "r160"
     ]
    },
    "ecd_TrdArrSecuritiesAggAvailAmt": {
     "xbrltype": "sharesItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrSecuritiesAggAvailAmt",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement, Securities Aggregate Available Amount",
        "terseLabel": "Aggregate Available"
       }
      }
     },
     "auth_ref": [
      "r163"
     ]
    },
    "ecd_TrdArrTerminationDate": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "TrdArrTerminationDate",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Arrangement Termination Date",
        "terseLabel": "Termination Date"
       }
      }
     },
     "auth_ref": [
      "r161"
     ]
    },
    "ecd_UndrlygSecurityMktPriceChngPct": {
     "xbrltype": "pureItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "UndrlygSecurityMktPriceChngPct",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/AwardTimingDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Underlying Security Market Price Change, Percent",
        "terseLabel": "Underlying Security Market Price Change"
       }
      }
     },
     "auth_ref": [
      "r157"
     ]
    },
    "ecd_VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year [Member]",
        "terseLabel": "Vesting Date Fair Value of Equity Awards Granted and Vested in Covered Year"
       }
      }
     },
     "auth_ref": [
      "r126"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://xbrl.sec.gov/dei/role/document/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r174"
     ]
    },
    "ecd_YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://xbrl.sec.gov/ecd/2024",
     "localname": "YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember",
     "presentation": [
      "http://xbrl.sec.gov/ecd/role/PvpDisclosure"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested [Member]",
        "terseLabel": "Year-end Fair Value of Equity Awards Granted in Covered Year that are Outstanding and Unvested"
       }
      }
     },
     "auth_ref": [
      "r124"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "2",
   "Subparagraph": "(SX 210.5-03(20))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483621/220-10-S99-2"
  },
  "r1": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "230",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "28",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482740/230-10-45-28"
  },
  "r2": {
   "role": "http://fasb.org/us-gaap/role/ref/legacyRef",
   "Topic": "942",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.9-04(22))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478524/942-220-S99-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "205",
   "SubTopic": "20",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483499/205-20-50-7"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1A",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1A"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "1B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482790/220-10-45-1B"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "220",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482765/220-10-50-6"
  },
  "r7": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "235",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.4-08(g)(1)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480678/235-10-S99-1"
  },
  "r8": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "1",
   "Subparagraph": "(b)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-1"
  },
  "r9": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r10": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "11",
   "Subparagraph": "(b)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-11"
  },
  "r11": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-3"
  },
  "r12": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "4",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-4"
  },
  "r13": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "6",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-6"
  },
  "r14": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "8",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-8"
  },
  "r15": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "250",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "9",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147483443/250-10-50-9"
  },
  "r16": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "260",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "60B",
   "Subparagraph": "(a)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482689/260-10-45-60B"
  },
  "r17": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "323",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "3",
   "Subparagraph": "(c)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147481687/323-10-50-3"
  },
  "r18": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r19": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r20": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r21": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  },
  "r22": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(i))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r23": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(A))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r24": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iii)(B))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r25": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(4)(iv))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r26": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1B",
   "Subparagraph": "(SX 210.13-02(a)(5))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1B"
  },
  "r27": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r28": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r29": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(a)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r30": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r31": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r32": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r33": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r34": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r35": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r36": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r37": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(1)(iv)(04)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r38": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r39": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r40": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r41": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(01)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r42": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(02)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r43": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(c)(2)(iii)(03)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r44": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r45": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(d)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r46": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(1)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r47": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(e)(2)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r48": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(i)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r49": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(ii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r50": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iii)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r51": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(iv)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r52": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "718",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "2",
   "Subparagraph": "(f)(2)(v)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480429/718-10-50-2"
  },
  "r53": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "740",
   "SubTopic": "323",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "2",
   "Subparagraph": "(g)(3)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147478666/740-323-65-2"
  },
  "r54": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "805",
   "SubTopic": "60",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(g)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147476176/805-60-65-1"
  },
  "r55": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "815",
   "SubTopic": "40",
   "Name": "Accounting Standards Codification",
   "Section": "65",
   "Paragraph": "1",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480175/815-40-65-1"
  },
  "r56": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "825",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "50",
   "Paragraph": "28",
   "Subparagraph": "(f)",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147482907/825-10-50-28"
  },
  "r57": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "944",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.7-04(18))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147477250/944-220-S99-1"
  },
  "r58": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "45",
   "Paragraph": "7",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479105/946-220-45-7"
  },
  "r59": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1",
   "Subparagraph": "(SX 210.6-07(9))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-1"
  },
  "r60": {
   "role": "http://www.xbrl.org/2003/role/disclosureRef",
   "Topic": "946",
   "SubTopic": "220",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "3",
   "Subparagraph": "(SX 210.6-09(1)(d))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479134/946-220-S99-3"
  },
  "r61": {
   "role": "http://www.xbrl.org/2003/role/exampleRef",
   "Topic": "946",
   "SubTopic": "830",
   "Name": "Accounting Standards Codification",
   "Section": "55",
   "Paragraph": "10",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147479168/946-830-55-10"
  },
  "r62": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "Global LEI Foundation"
  },
  "r63": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12"
  },
  "r64": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r65": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r66": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-23"
  },
  "r67": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r68": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "g"
  },
  "r69": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12, 13, 15d"
  },
  "r70": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r71": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r72": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r73": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "15",
   "Subsection": "d"
  },
  "r74": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-K",
   "Number": "249",
   "Section": "310"
  },
  "r75": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "240",
   "Section": "308",
   "Subsection": "a"
  },
  "r76": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 10-Q",
   "Number": "249",
   "Section": "308",
   "Subsection": "a"
  },
  "r77": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Number": "249",
   "Section": "220",
   "Subsection": "f"
  },
  "r78": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "16",
   "Subsection": "J",
   "Paragraph": "a"
  },
  "r79": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1"
  },
  "r80": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r81": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r82": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r83": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r84": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r85": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r86": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r87": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r88": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 20-F",
   "Section": "6",
   "Subsection": "F",
   "Paragraph": "2"
  },
  "r89": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Number": "249",
   "Section": "240",
   "Subsection": "f"
  },
  "r90": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a"
  },
  "r91": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r92": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r93": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r94": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r95": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r96": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r97": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r98": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r99": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 40-F",
   "Section": "19",
   "Paragraph": "b"
  },
  "r100": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form 8-K",
   "Number": "249",
   "Section": "308"
  },
  "r101": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form F-3"
  },
  "r102": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-2"
  },
  "r103": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-3"
  },
  "r104": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-4"
  },
  "r105": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-6"
  },
  "r106": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a"
  },
  "r107": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1"
  },
  "r108": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "i"
  },
  "r109": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "ii"
  },
  "r110": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iii"
  },
  "r111": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "iv"
  },
  "r112": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "1",
   "Sentence": "v"
  },
  "r113": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "2"
  },
  "r114": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "a",
   "Subparagraph": "3"
  },
  "r115": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form N-CSR",
   "Section": "18",
   "Paragraph": "b"
  },
  "r116": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Form S-3"
  },
  "r117": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Forms 10-K, 10-Q, 20-F",
   "Number": "240",
   "Section": "13",
   "Subsection": "a-1"
  },
  "r118": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Investment Company Act",
   "Number": "270"
  },
  "r119": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v"
  },
  "r120": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "1"
  },
  "r121": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "ii"
  },
  "r122": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii"
  },
  "r123": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r124": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "i"
  },
  "r125": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "ii"
  },
  "r126": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iii"
  },
  "r127": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "iv"
  },
  "r128": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "v"
  },
  "r129": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1",
   "Subclause": "vi"
  },
  "r130": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iv"
  },
  "r131": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "vi"
  },
  "r132": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "3"
  },
  "r133": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "4"
  },
  "r134": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "i"
  },
  "r135": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "ii"
  },
  "r136": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iii"
  },
  "r137": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "5",
   "Subparagraph": "iv"
  },
  "r138": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6"
  },
  "r139": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "6",
   "Subparagraph": "i"
  },
  "r140": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w"
  },
  "r141": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1"
  },
  "r142": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i"
  },
  "r143": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "A"
  },
  "r144": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "B"
  },
  "r145": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "C"
  },
  "r146": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "D"
  },
  "r147": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "i",
   "Sentence": "E"
  },
  "r148": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "ii"
  },
  "r149": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "1",
   "Subparagraph": "iii"
  },
  "r150": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "w",
   "Paragraph": "2"
  },
  "r151": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "1"
  },
  "r152": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2"
  },
  "r153": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "A"
  },
  "r154": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "C"
  },
  "r155": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "D"
  },
  "r156": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "E"
  },
  "r157": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "402",
   "Subsection": "x",
   "Paragraph": "2",
   "Subparagraph": "ii",
   "Sentence": "F"
  },
  "r158": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a"
  },
  "r159": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "1"
  },
  "r160": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "A"
  },
  "r161": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "B"
  },
  "r162": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "C"
  },
  "r163": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "a",
   "Paragraph": "2",
   "Subparagraph": "D"
  },
  "r164": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Number": "229",
   "Section": "408",
   "Subsection": "b",
   "Paragraph": "1"
  },
  "r165": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Number": "229",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "C",
   "Clause": "1"
  },
  "r166": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "A",
   "Number": "229"
  },
  "r167": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Number": "229"
  },
  "r168": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-K",
   "Section": "402",
   "Subsection": "v",
   "Paragraph": "2",
   "Subparagraph": "iii",
   "Sentence": "B",
   "Clause": "1",
   "Subclause": "i",
   "Number": "229"
  },
  "r169": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "313"
  },
  "r170": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-T",
   "Number": "232",
   "Section": "405"
  },
  "r171": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Regulation S-X",
   "Number": "210",
   "Section": "2",
   "Subsection": "2"
  },
  "r172": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "405"
  },
  "r173": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "413",
   "Subsection": "b"
  },
  "r174": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  },
  "r175": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "b"
  },
  "r176": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "c"
  },
  "r177": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "d"
  },
  "r178": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "462",
   "Subsection": "e"
  },
  "r179": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "a"
  },
  "r180": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "486",
   "Subsection": "b"
  },
  "r181": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "7A",
   "Section": "B",
   "Subsection": "2"
  },
  "r182": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Section": "8",
   "Subsection": "c"
  },
  "r183": {
   "role": "http://www.xbrl.org/2009/role/commonPracticeRef",
   "Topic": "470",
   "SubTopic": "10",
   "Name": "Accounting Standards Codification",
   "Section": "S99",
   "Paragraph": "1A",
   "Subparagraph": "(SX 210.13-01(a)(4)(ii))",
   "Publisher": "FASB",
   "URI": "https://asc.fasb.org/1943274/2147480097/470-10-S99-1A"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>29
<FILENAME>0001159036-25-000016-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001159036-25-000016-xbrl.zip
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M9]UY-0)YVMP5V_NOY.M7K=>O"Z19_ZW^]IP.\K'LAG&(]S6;<_SLI+2SN>V
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M*[,,>:&#/!('(Q]Y W8HMSM1@]]'47('GP'5(PE<D]:?Q_$XS9&1P@'6):-
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M0.!+V'UJHR>QTP#8R)$4&;;1[&+1]X0[.=C.WE&"\I3,X$#F\ 3S% R4# ;
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M#-2M\.31UY%E]XA5%]<*=3PWCH%]\9W:RZZ;C >8.HPC>@K?"31Q"%)^M70
M_'!FXYD%)[AB%E^)IU-B!5:*C>)[*UC4[9YSU&W X1.8!QY#MP(">*JH,F*]
MX#"))^>"KZ7K%:#38!3EX3"2&M20F=H'BF5D;8(XJ.;M2^G22,;9*-6W,?!U
M^76T[&?NW%XP_/J8:XI,*[RRK/!(^2IP*# ?*1P*SC6I.D4J\,L1-:?,R"/<
MK5(]#E*8PHMD3VB&TH$K'1=TPV"LJ$!!U8RZLF!(LDDQ5!>HBP6E/LLE+O+5
M-%#7HYZ+2E1"LY(P%T3A)1857C4T3FLZ&F<M@#5+PIU5$_/1_8SY*@6QCD_E
M;9B,,GLA%[#E8(+,3N6HDHCIC!W,_T2](>O-Z4MG?0,B.\#NA8$-1L"IT6GN
M+G0.(%L-=.> T\=$ZY#U,^$C<#64E*,(4Y+\9-=E7YW:6* +[E*N?%4UE8J$
M3VT0W:M1Z'9VE/;4K#1H!J:@@NR.TX6W*<&M4/??+J& OI3VJ3\%0S) 6S/S
MT[ C'<NU:(Q6@WFT:54P5AS$)\,4*"V6?X;&*5N[^!>!/-!9@S.-U\HG_X/3
M._GWB"YTK;F+0!'8C52YT%. ,W%@,T1)7^)I,'2R (<IF)R*E6@KC^Z"<.9)
MU_7WK*>GM.C4&7=D++NPN0CDOHMYVNH]^AV3KFY=^[H?2T^#.4S9N@S(";/*
M>8J"KI^8JM?C8BN1N@?4MG'AM'7M.>^FR4!E,^"XF1XXFQ@9ODJ%!=@8%J 1
M1AD+ KQ[GO!&:!EY/Z6@S'WSGY 3%>ZTEZE$#N6KDWT=*M 172=>\YMQH0SY
MTAM8N6N=44['=CH3HH"#XY)87X50.VD28_(Z4&&JX'NFKO^5O$W\DEH)9;;<
M^&N[L'L]&P5#F=<7"MM!:"D":]P""Z)OJ!(]\] 6B62/T=R[(Y<IOYVV.=%H
M'%7SQ\V+%:0I<G2-B6<'#)>'EQ4#"GQG*CEG@R8:C"+]@0E<D% %;P EMO41
MYKO,=<%<1DX^4X;\R/+D/(FW":BVW&A4VROAW[S$]T<DX0G7J+YE!9\9'J6H
M2AEW45(HCB8IIFR+:L%&V,FD'W8HR9NDM<7W"66>C"*1:G!'1_H"LZY)5/(\
M\>QP%%B%S*N$LE8ED]-0F<8I'ZT@D3P::?0@S/ 0441&J?2J,8R!9P)'12(Q
MFDPA%7_#>V"V%0A$1U_V$,05&_4&JE:'8!AI,R_1K88T%DG%&J@HK<;9QA[H
MOAP/I$*JUHS*@>^014K?UX$)"Q_H2J"\J%(2S\*I.74Z)NF,5U1C4G7&>*%$
M-F7VFL2S0G*:7LWSE#C77#G!;(/&ERU5\/PA=4Q5\ G X!89K@RT5.4>= F(
M4%H78#3TT0;K6:_F-#;57>E,V&<+6$T5QC8F'O*C' RC9$Q6XYW4IBAC$DMV
M)C(5FX ^['D2A+#\6@FB%08C$ 5IR&E3:A[\^P&.P78>BY^Q*M2O$:4,@.,)
MA(,."&%B<0-)ISQ> 8H1W<\:9@UL)]WM(3PI<R(;G,8_)%F 6BIB?C#XV9D^
M?(G*MJR5S@HMJS!E1?.:TL5D.K(Z=Z[>4!9A$06GLJY[K":/T\R8Q\N-.^U,
MCSLMD 6VMP998*N2]J7[&GOG%W6O^0"QO]39GWPY,4U238V.-=%=,P_"'Y)M
M%>'Y6#:!BA%4)9Z2G01F:@HSIJ+Y<0:&A+K5  -(5UVP8JY6*,8P82HXS[C?
M<LJ2\V.G8H+JK(+E%LQK,74XJZGX4BQY%4739#3DS"EMMT@P]L;T(+B%[-E3
MQ9_9Y7:LLNIH&PC]J^J>,)@A%4:L$28(4QQ%FIKE,(G]^VH7:3.K@JS31WU[
M7R6AY\#(-WV7GXR-8)*N;:),!7<7^$-,YPG@QD/OG[+;3<&6^*/N?<:!.<((
M&_,9AHB]4[Q82R,YKGMG:?DGQZG^EF.&?*# K**(O;(9*B8(SQ(R6FVNRJA4
MQ4@RE]FI!@F.<@\G@><"*WR')H9;MV2>8B6P,#BG9R+/1B'WN,H]G4Y)I$SE
MMJ4F/$F103RVG.'U;8AFI[T2U7'J@. &IUV*N.B@7R!]W.S,%E])R ]-D'=&
ML;T=X.RSL;+8N'T!>KZWPA>Q/]9>MI-*8>;XRN#"X(Q_C9,[G%F<J*$XP<$$
MZE5_LE"=.!KV=<T$;] 018.PD%G +M^HHW,?K0F;3=MQ'".07#-=KE\-A#.=
MBZ@3H)$_8)'/0=1,2ZK%&QA@0-=!5N4V"7[B*#5*P+47["KU>#*EM>;FK>+P
MA"5D$)-^C:I-9&H=86Q2G5HE\-@5[Y:2?O4WF:<;N)1BW%61%+L*/JCVM29T
M8Z\5$%5C9^FLI'H94Z97*[R6[])S$JH>'D+.=,99TE%1_FBUG =O#58$$SMH
M(!X4-J*K[^0I\5I#-+#P;+D4BME5>-,HRDV2'AQD6_G4UGS_A4)*=!M'"9AY
M+LWX%:?]E;GL\,VO5=QJS*F^2A+,T&*O62 -Q%<TYXJ=56:4%($O=3JWRG0<
MYIP1_!=M.\%0#'%)KNK?\XQ5RK9"A,)D<YB!:FY8\3Y]V3H8HB&)79KP8120
M9NDFHE=:!"684M@*KU7"C+$T=[RG7;JETZ :VEZ*8AXI':N25N&S3WAI_6[[
M5Z]+Q0I5XIGTKD^./ RY@LH),_T^'55#7QMCC_"J@*>K?S:O<%Z2),:0-RS^
MWR/8@6<A?D^[5:)R(OO?%<-N>4$TV8W^1>5<U=,Q97IE/TY^SI]<WRYET9?3
MY_E$D1<'-@L8IY+/%(Z1C'+J;^;,=\79]:IPY!]4\?)IF/.AM9\$\Y.Z_/]T
M<:7O_"O[+3&T5W1 G<RU<0=FY??$_#;//-TSQ4C?BPBP[JX_L&])$H2EQQ&Z
MTV24GGP;HCV:(:9 J[0C4$*(TGH.ZOQF43-:1?O">#C*[<UR5=%6O)MVBN28
MSN(61230Q2<+P5!9E59R+K]#U<['9T@9N7ST,-;>',(VH'D \\P(?:8DN%.Q
MG$Q96\X(;W_@94)EL+6I! *,AZW#%_<I,BF_H@FBV,7>V56%N9!8 2)5N+%#
M5U)=&$RF-W!NB@QQ$[E2EL*40<.,KJ!2PL)0I7&;F()=*? =L!1@-Q@,'4-+
MZC N.,@3]9]I=^:J]-QL30M^/&W7&Y!)]0;+I47:WNR^K>^]VWV4KC![C7JK
MN;]X5Y@=VQ1F MK?:.P>O.W.UPUFX78O.-PBO5Y4GL%#!%)SKF8OUU_!GBXT
M!OD1='KLKCDK1\8K[31/]EB9P7M/QF(PR-,K/"+,F0Q"7T/PKOT02Y;-PVXK
MU(MI><1KHP.E=*L%&B,E4>\8Z/EM$MU:9'L@*?N2"YF9^MKX$'EE*6+)PO^8
M<%^0CGI8\MW54P-WTS+>-$H<]+[*L?;MD[B7<'L#U'I<O1(LB83<=X$9X7=>
M+OU^G& [9/3<&3PB?(HVU#<GI;C9EWV1#H3W49M.7Z3 N$H_'-(V7!@KJFC<
M;\[0;+*21Z$X..8J8'CI%<F@QZVOZ2Z+:.]3#Q\T$/4>4))1V!GE?"472#GT
MJ+B.N0%T<QNS'"W7'G8?-YM5HR,#?U+V#<^"4F]='"&AFO*0@(,RO@W3A*K!
M;HY(:2^/*.<828-8<WU2WIS& 7 =?'(M>R2'[)YOCLF<I#U6CI*TQZ7'Q2?(
MCQ+!7\+75=?]PC:$3'V4\*7C0FV/[=T2U8$%730RN@=51#)$?W,4VV*>\)C(
M-KQ?[LI(B8S*S#2\O^'O[R*?R^ZP&.):O%F;D/$ZCF!DO2.FT7H"SD\&H8\G
M@+&JS,K^*,I'V/(;8:ZJ14ZF[\]1(S BHA<E'5?M<+U7_C&98$JQK/2A,-''
MI][:SR,8PCL20T2L>V<B%CT23HL$1S?'YSXKBA(;;)Z%9LGBY:'C>^B*('R9
MAX_U83PLR(\1!X6RTL<*FP3"+R(V>=DNDF*@H&(;95#>CD\A1T8I9&H8/_TJ
M\XU&>(!C0/%L*3DM""F+_JM3H=] GS+'=R#!C+R<@1V#,$(TAC"*S"8._T"-
M7!DD9Y@+FSS&H-*'Q<Z#](C:8Q%%B;*FU %T$VTVIT/%G*AM4WMS$A[B(G--
MBH+E7@,&[R5DD6@SWE4'BMSW'ABTK68<!QLYT@/B6+?<1^8!+%[9Y_T)P_K+
MV\^K,/M:90?=>PZ^@V0O[)"D2.*!(7'9\ZTZ0\,T1#B5"KW6W+@I]9&'KWI&
M_%,1/GP6TUCQ75WAZQ1WU3ZYXDQ,;><^]?[['BS'YKG-<XL\]P*Q/WLE3W(M
ML#^/SA=/3?6/(N,BH AAQFI<\LY 7S7HU%@6[&D6NR-;L\-%AKCA( 2?FDOO
MAX!5J@ YZ#KK/*@.P4N4BULY20TI*=[.58%Z8LJ^H3K!TR$DB^[ZFN!)FHWZ
MWL'>H^!)8*A&L_J190[5JN\>S$:YK/D"'V^H_?K!;O4W#YK4;)C2PM@BWY>R
M^Y38(CY?3ZPY#^:"?FI0W?R1V TY9^4@S@+:;$C[/:2='YFQH?=CT/L[KODW
MA/\>PM]SQ[PA[O<0=[YKR@UY'TC>>:[$-A3^+@NC=*WR8ZGY%)#Q%2;VM!B^
M)?K"SH<"P2\AL6$9T! .$Z$Z"V2>8UPFCL4(OBKGV2[$P8]'PP924#F7J[]]
MJQ9U_==F#S=[N"'D*A%RB8?AA[[ZNPP1,[/5#Q7.RI_[\8I:I!V1"N]X%/LB
MG@>Q\ ,)MC [_="]8M&R4KOUK\T&;39HLT'?@29:]@9MJ+14Y?X"7?&J0K(O
MW6[=^!X;0FX(N2'DAI ;0FX(N3J$?-)R16M"YS4*8"W-QCT3?9GUO5_3,.O'
M(JYY9_7C^CK=/J\H4S:^]_!O'.>E4VG#;B^/D-^MM!\[(CD7@18M$+'9_LTY
M>D;G:$U"HHWG8"[F>1^&^E+W+I-LHE_0#_43'Y5\*W14OEOF/!XA?WA@>;.'
M&T*N3M!D0\B-5-GLX?Q&U!Q;O$8QMZ783TD<>F?A6&3],!<O%_*R0=NL7SAL
MM:BT$J"Q#94VAWTM-NBQKP=7BX@5$O,[@SF59>4<@KV(N\%2OW2\&_Q8]X[Z
M\+_X[ZOZ4?WR>^X*5YKDS]<-V!#Z&1#Z.WWJ%SJU#7MN"+TA](;0&PC=(A"Z
M1Z_1^P)KKNZ_I)JK*]2G^9C:=83Y>%F3;<W%'E[A__1<E\&H7*9V-$QB+Y49
M_">36*[6E^&M[JQ%)6M54Y7 ]!FFIL_X"/Q-G><TY6N5M?.G="KF0K/1>'K/
M8M-1VA:4#72K(]LE^?%*RLY\[FFKS;[;J3??O5VTV.Q^J[[_6+58W]8;C4<J
MH(I#[2Q>J_3@>SL S%+WTW7]@QM,+4\138C%9FM2+'IG(D_#;]ZK-K59/Q.I
MW__[WYK[C??-=S6OU6CMO7X LOYA=NWZ-/$B2MXD6+#M?(3%L N"[!Y[=O\'
M]W)9/&Z[E!851,-WWQ>T#0[P_UM*T.+Q7KWN$N63'+A=Q!=WXA8AY5,X:2M+
MZ;-J.B_QV*R:I*ZFVZ5(<^_TT/N%LOB]4VIS4W8)?AC++E'P/ TP^OFQ4;6R
MFE?!_VC2K)H2WYOG^GIU;JF71ZB=5;%V5NV\S1+;(+>/Y2#II6+8#WWOHR'+
M1GQOQ/<BIZ_=3;$[G=<>2/Y'DGH?(]B@)8OS%35!JXG86.TNU&M/R\UA58<U
M$ME7>.TYW0CA457_TJ=W<V@WAW95:+DYM.K09N'2#^:JV?RMC7,T'Z&:J]P3
M?FE'ZG.(;P6_!S3@%^SC^6VC^#:*;U5HN3FE3!MEFWX6=R(,V;.\%#YV0_=.
MLTA@U'ES;#?'=E5HN3FV3)L_^F&^P,7EB[!7=S;VZD,,^_F.U H@P9<-FKE+
M4#N>):GTKH0/ \-?)WD?3-PP#^7"5VNK1-%U$/T_D)@;-;N8FM6HT#B)Y?0;
MI/*O?MR@B\/\GQJ;[-TD7B8E 8^GX!C%!(QQCV",NS5O&$F123/ ,$V^C6$%
M(J=VE5XWC&3 *&9$%U^?''E)7#52?3&(\+U0_*<&QEO ]7DR"&-8?^!U40I'
M\'$(:Q8Y40#!GUX[CD?8EE;*'([ICP%5\_']:Y3E87>\)&A55:^/9>'P:4*O
M1$]Z^XW73S.':J)XR^?8 O#&NPYC7QXN=5]:C>;>%+*LRBEO[AF<]U%?A.FJ
M3]?"TH^2P2#,<VGMP&5L\:'7'@5A;F<S[1RL% 5_!>EU_36,HB73SKOLBW0@
MO(^C#+[-,N^+%"A/^^&0.IU?#&4J4,]D-4H*BDC]BG1LGGAS&@>@#."3:]DC
MW7SR#1X*)1S^FG>*5EY,(X!BTL_4O&G-ZFO>C#[K-4^U"*]Y,]M7K^:67X":
M3KTCSIGR+D>=*/1UHA4;2$OFA;GLA;>M91B4+'50K<1@1?I?PQ@U/K$($[#F
M"6\@ W0^O%SZ_1CFU..\-/AVU5?V/V"UP50'>%[\.J[E#I1HA.<1/QZ!O\V'
MD):<R4'H)W#J2,L^<(EK8.IQGWKITW$16?69<:3-,A,Q09)^"CMITI.QW<1.
MF"S*BU4D7[VMFE(N,77-\4X*+@CX=^#R>3L-;RQ%2MY>E^1[**(:\;9,\=_$
MUT-21;X<40P!TTA9KTC<X3P$;S!/R->9S$;%%WM]<"=AZICY"O^Z3&46(M?C
M#__YQV=@FS@;1>@8>5^^','^Q/"*6YGEI+1P AVM!$5P&V8)O+H;IG H,S1D
MO7\*<*[@,[ IW]6]3YC8BN8E3@K^>U#S^M)YO8 9B2CO^R*57EN/9VQC>.BC
M3+^"GH6O$3H; ]5P7G6O2,9A*F_#9)1%8V=P2M'MA[*KM"52\*+;#7W.;3L"
M\H2H;WD*EB$'M'ZMC?OTK4<SQ+%##/#Y6IY2YNZ9P/4V:)'GL)64/0>KW:T1
MP4*4P; _TA_1E9HOAL)'_WX4YR&\(,1DY!R6R#X[CFCF!L^V1SW88:*B(FCS
MX. =$[0!_GN1$GT9!=ZM2)$:,-\X!#(.C 7@Z2H#&7K$)U'H?0'K:CRA(PH4
M*'&<63OL=S3"2)?#13C0+Q*VR=@K:<UYSQ%\% @FM7IIG*=)% '!\,^;5(IL
ME/(&F<?4[X%Y3=(V$NWC-9)'HHN?TLQDW /.E'BDF(R_2C!UZ<_?8INZ_0D.
M)9A09Z'?K_,.X6AG']O\T&>1WN+)^245P4CDTKOV^TD2X8R,_=<.!F$<PKDC
M&DU&3U;0L+*V-"UYZ0J!S:D5H1R->(A6=.C/(</G=@?HSVKK?MTT54_ #P(O
MD'+(NH:8AX0;:+%$!%XJXI[$8V(U!*P^T<1 FS,9AG[F!2,ZDWCJ8E!X(!>:
MC6U4?6"4QG#Z47A/$]P8U9N0W,+[[V:C 99$%(4D ZW('J8)FH#:)BS*[[IW
MS%,1(!A3"A3"]'.<F)H)J) [U%-1ENC:$2&61^BR3:D5<V)W' @"<X^%<LU0
MWM6]F[X$Q6S)E@&-PBCW2'6AB#;:NS;=P7B!)6;>KFV)F54XP%BW! $[ E6O
M.K_ GD5]GM6\N[Z,BW993ZEPMAR*VE@Q=4E]OZE6W:2YUU/(+Q[(67V1WLXH
M J#+.Z"%W-%N@BU[@Y9.*8J ,C8"+8?"LA<E'>2-J8$$-JH<*9_#&LC<=\U@
M,$ G!'G)ED5.9+851O$DR&2@2?@E!4U4\[Z"D2.H7$^FUZ>G&4@4_47=-*"(
MV9KRYXP0('VFHH"KSY2G,3&)B 8)^#G@*[(7[&SM#'M@DHNF"R;7Y2GSFN(S
MH(D$%7\K2S9.UR&VKXC-W),9(\(Q&ZIX&YE1'1!/^/\>P7$##D302-X'HH/W
MS]^&$D1R-AS%VTFWBU 2T-4!NV3;RL+9#K ,4VJ866;Z," N$X4\>(<Q[$Y/
MFB33*'&C8SQWD/@DPTIKP--J+HTO3\B_9Z%0]L5KVD *X]LDNF7]@D^1-TBZ
M!]]9\^2MB$:"KV)IIB0%V-ZBI8&H9:JPB0(6%5IDHY@0-'K4O@T69"2KUO3H
MWA>77]4CZD0/4)$L8*,_[% BH(.$/\IU>)*.8HK$*_(7C4Z?#V!^/7;*O4^C
M%"\3JK1*1\K8]4PP!.+[R2CFXF<SK7LPI_O*Q']56N5KQ^CW7I7"*Z6?:J<
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M%7Z@KF,XQX^JVL(DB/INZC[,FT6>QNYA%M:N+1E@0P@4T<;]HELA[D>*B]J
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MC[P_P"\;I; ",#U!6ES!CA;'I8Z7.#YS,5U5WB5@S''>\Z4<9N%14BL\].Y
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M@%,5)\G7BDOHU7> 9KOG1;L"^*I^7*_I&^D!9J*#N877D?9:FEUKCWQK;CY
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M*3Z!"EH%:?F<F755%<.SWJI)R_XEZ,$I14!70K:^T.?7X[C\ZU&BF6MU5 J
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M_P]FC9'1  Y>']Y#5E0@<J'Z2QJ.J94\H2)1L#\"=X05=/6*G3LP)RV=VO>
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MZ4.ZMVJ]#X/O(J1 +?^([D:1 3^0W=/JX056SK97K5TIN+%,.KV4G&?7(BV
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M,'FIQDO!KR]Y$Q1@0"]=P5<MIVR&'5R>]KZ^/]3ZQ;"+:,:ALHV(-TBW5XR
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M;X2EZ8] #Y,]E].CP"8SPOX%CS4M6FE81E2NE%F"FMPEXU]R$E)V5J-Z..5
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M#H))R*W&!$X&?[D4I.>'G66@380*>$,<#5T/9VE&4ZR[)4=8#O&4Y;D@,F$
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MF]+I@C=6#K:44<UX_%,!NDR)'I/N@M0K1H?'$[""@=T7O2VO#+C.R4HS+2/
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M LPA306RCU''"/W^V5.7WY^0B3*NCNTOX:Y(A//\R90W0T3^T)*&BQ]AUF5
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MF9F1AY)G^_)D6K^/5ZJ/#9PNH#[ZR;1O.]_32*4\06C($2;/* F2"V-2%B#
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MBH)G\A%P@..(*$(XR:GEP79$@D:96BG8GXM3 6T^ZGB0*?R;!@56$*'/2PC
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M\=_?N0_QST/W00R.B-,D QZ_^X=F=L(E0.O@__\I\]!_5*0AZYKMVBF.YKT
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MG/3@X2 N*+B#Q"?_C_32/=MVLMAPH=])VT)6E4!SFWP12^5 \!VR4/AY*A0
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M,HKB$?7364P!MH&7@0G0]\,?T*L'+X$O?N#CL-1!% Y]7%TB2^^C6$)LX9\
M"#^$B29\Z?!_^#;$!?_"2Y+99,H&2C.<\.$)_HO0!?@/9O!6G!W&)//5QW1$
M8US*IPB0Z^*B&>[@KP2_?@N318$_9"N>(P2@F=()T@<!_ ;PFY=(4R]FNXYF
ML703AC-X[BN=1OAEB!N92*IR]7<$!7M'B2XD"DPYE-[1 9T\T/C__(]J*:]T
ME1&*D;V@( O$ TY('^*9%S_QAU6'/6S*L+1JDJ0_Z6"6^C^0;IF;!HD]3/R$
MK?GKW>\)H\@O\$&6;B1<-X/R: ';,=L0S.@C].<,@YNBWF",5#__H[Q%@'1
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M5NWR7G/'N>I(WE#ROC1-M@K#9>[H:90P?\=UG-U$9]>2?)'E<=FEIC(?XCV
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MP4J<68YR\]0[4*D.<=2*^R71E6#_70F<16@LMP'PAW]YX5-C8'CT074473.
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MKQVBJ:TSXOKS6)=IAYD<VN:Z9<+D$":'>*P?CW59EFDVL;7-$77"LMAS&)P
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MUF+<.#8Q3W73T)/69Q_]P=BC@?0W&=N?>7$LNI^)[F>B_M5^2K0Y1-V2QRE
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M N+90]<F>N/R0"+?\$!]+SI+1;JI$55K6@9,N P[<K[K[+U#:RX'Q=6MP([
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M.NH:GX@UO+1R5/DP?-878*\_]*[ VWGQVM'<O9]JM]=N;1_@X52KG?(&K5/
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M<8[$@*3![*%E"5I!9DA"&0$-9S&.Q%D2, F$6&P%1;5?+"Z0W,&%8$:LZXV
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MOSA%OKWY(EV4Z QD$D)KR*, +A?"' "DI/BB[/W/I%X6+)!1-LR<E"FX*FQ
MWG96[@A@YWXP#F*@%K1MP/(&:,..!G[@%URQA0AY0V4@U@V-PY=#6I;D+PO\
M6$^BE:#C"R]N$UBCHP$:A].$7N<?7@W]9!IX3]=^R #!!KW*,)-=0: -M!20
MS5[(?\[.XZXFJXJ)1_(LR39[<79:EP&P+U>_=W19-XS*GQ19;?B]Z>J-1JQ;
M%!:-L[9.51'PGL,2-73]I[+,Y*7[(I6;E'OIK+V?QYZUNWTFO&_K@GUT*UC5
M6+/K9;&P!Y$ XJ!^G_L3%'IH34/RFDAZST7JOW*1BOW(:P/X2 RPK35=4WS
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M,;W))$>=6-/\V2WBI2Q:1/"I"#X5P:<B^/2HA[\]->VQ7.SLHJDV43=TB>[
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MC6!\,R=*X3A>?18AP!T45?TERX>E?A]W3&7]<0>7BT3E4V-@>/1!=11=,^
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M1_WRCFVK5/UF+F$^HX0I]5'I64'F>6W@.^Y/9:;!'#Y@/_.JRP"F8;E"3K_
M] 6,<UA4J7O'LUJ/[E0CM769N&\"V-]7IGP_A(.#)4IJ>RPPK4@5@(UQ3ZV"
MK.H02W.)HSI9;?0EV.X-'O@K@TM=>.PUB?5X%&W7 GNI[\LN5+QKF?,VYO*:
M8!"<M$?GNCQA,*RTDYRL>#]A1?IU-DS ]/\77IL3-N^_HAA$X*=_2?",LIQ+
M>\(Z%JT9WX<.W?_PPF\S]!7\%<]O+*;DE!JQBTI/)YKI$E,U=E-Z0J^MU6OF
ML_1:QU27(ML'45V<BS2F?EHMBN!?J1!';X(?0YE('[T 0Z^)].5&4EW=--M0
M:*DUX_N@H.XPWUFZ2V-*TR(DWS]@]?#SU%(6L723.)HME-2>E935(R5ERD:_
M==3GD+70^A9C.@872D2ZF_D@HE0BO8F2%..4/]Y(BJ:JK2BBV)KQ?5!6O]*
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M*HVU$/&7\_]Q^@]$U8NGZ^( M;_9[7F9]:K/[ZRN&^7XV_Z:3X]Z>,!CXD6
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MK'XG:?4;P)V!Y\Z43JJUXX<RJ&,)>A_TDT1Q).LTR\Z\ L==1R^(<@M.Y*J
M4\KWCB;O5K9:OT445*$4P\@(9A3$3Q-U<*#[1(=2XLC"(Q^3765K"))ON1W=
M1?W@BN?FW)QZ5D>R0D6(&"=-CCO%.0.Z*8@P8J+9(!5$X-HK^XH3/U.QDKXE
M@TIT[N<<V[&>R:ZPN[6!_H$B3]J.ODBXOJC?^9!=HZ[T(NNED C*&> ">N@H
M4!)OD8M$0,'4L!H-3_0Y?&E;$5'PXO;2&W:XK/@ETB /@%0-V>(+-6:"#+,H
MUD'"CSY,!3%W7/QE[I!==-O#N='V@L.E*6\N/N1\#ZJM>=MOP?J:/3]H+FNI
MA&Q5*RIV7#C5-FA($(Y],#6ORMT$LB(0O?U53?0(ZI4L6?P%1D6*LAUXL1_]
MQ?C2H)?ERE$>D-9PY;N&%5WJ3LP+?[4-X R+!P@<HO. Z=6RM"KLC3:_P=U0
M0^%T>D'.CNT5\M"5S6 W7\UR9FK6<N#2?;I2VDHPHSZ)[<J0K94AW6&'DJ84
MU!ANI<',!#OGS@+"0%B(X,&GEY7XDU2Y3MV&X>'A8*CIP/2RH6.83D-8:&BP
M(='DO2VW[-S+5Y5BJG.6-)QH.I"01*<'K\1-FD@.@=O8%@R#I*&6]3CP-,,P
M+G2*^,Y/QNP!9N?H:..22O7B$@\X,]+M0O<?HB1R37$L"PA#[S_RL8M]IL"6
M5=0_TC.1R@/FVU8GX3R$V6[MC5PU(+\%>^J9$I G:R?.0"UD"H>W8&B=*[Y=
M[LK@/UER" RA?/+;.QT8A;V@<C[6BJ(H;5)] S#;P$D"AQ(K).A%SCX)Y(OH
M0JB^9O!TV%D>(#I=H$W5D+$E7UFEHH;G3^+O>B0UE@@X83Y*7>34T9>CB] ;
M_9P)UZE/MA]KU3/5Z<7H<=0MW\7;MD][PG<E67Y027%1\L?[W<IRDD8*-]L/
M<X8:2L,N]VZXMO</.2^?R=U^@H<6LY^N_[*(?*"IW>I)_W>\Z_]ZT[N0^_.G
MA1]6H^;[NWH)C/*V(1&15L$F'E L.*-/SV4>@8QHY 2R5+GYMG@J2M@%G\JD
M<W*<&**+K(J&EQ/T,9V?+:K? $#M>[)>H)5*%'L.''J&HI^B)*+H)[5BMTYR
M]Y5G5)$W%;E:6A/DV#M^D+RYU?0.3[,SG<-@XPPCR0S34>Y%W*/FR>F,*&5O
M<^!NDGS#[2<7P:PDABV;_].:+DC5?!U*)4:7N3Y.X#RA13R\L&]202F->[4Q
M5'4+#V@YX*3T1=S&\-%R*5N\E"ND'L[(.D*?F^%C>?1?Y,I H:_SG,DW*C8?
M7/ C[&(4%P3+=Y%"A%+KOL$(#A*H"0<+PXPQ9^[<=X ;R)5F2T!D1H93RD'(
MAEY=SP/$ESXH+;QH8XM2Y<UK'=]:\0#3"XE]NTT^?)[JYJH1JN",A*P$-Y/C
M*W83FI%2)ENI+CC"CS":*;K2\<?X56<>T#[:FO2M1&&>1FXG4NTJDVX1UYMH
MY4#J5,-K)EKTY2IG+Y>]B\A-$V)^V\0B6[WFA^TR#TM<L.*,W!0/[OJ4[WFD
M/317=@!UJFVZ6-;V<)>+>J-+CU)FUR^C+-],(T\3XZ/2[X7&G@W' 3Q >=OF
M//OK(ILWO5VYA31S5!:4WD ^CAHJ  L1<.KT1O3GT+JK08$)^H39^LY=18RY
M&T7QO@8N$U>NUN8Y!O4>_DA3]R<6NQP^8"YQF*RGXR0G<@7._Q%H>H#CC #(
M<&3NZ>#*^)>6;B\C?<$BS^/LCD<\XK8?\"U[''BQ[[+?U0N[?3H5G6*T:WVV
MD,8MT",>&S;_3.<>)@]U9GPB:3%[WB;[^.]'4I=JMHUQG1H-V;MN>$*Q-!Y
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MQ&K@#0W(M)9;9:G/0C3T/IJICQN4;4X+5_F,HKEC0H/]8+*)#;(X'S,]!\?
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M%&XY88I*OH<#HX.SUARR6P+%ZH@#?-[GZ1@!SP(.H6-3&P[DMG74/-#_>"%
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MDI/V-5GD#C&FYAHZJE,/ON./%L8.0(QPH_MC(6+I3J$", UA[1(ZWSJHZ5+
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MU"OVK21J7H\5/P]=A,C,U;[T.F5K4R(&Z"U9J$L7S[M_5JQ/IV&8%'?\+F:
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MM3N6O:?./[?<RT'^L ;-44%LZ4Q0AFGI[)ZHYD_'E6A=^LJXHSJY U+?KQB
MG,8>"J^8!IW18H #;Q!LE1\#/+^ P+&W-,OE1>4\:Y_:A,9"RT-C^2]L*_FE
M&* ).SI>/M-&DB_;F:M.NLXMX-GSU:HI[5([U78MM33+O"7PU]MJ8/0L#U>"
M,P7G>.9H(D@3/@7I0T.D?+Y.Z3T8>_31)'>?ANF#7G\HFNCA)MKZ$@,L;V*
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MZ74,\ 0#7(BA<,]\AC4.HX>C14!MT#3_AVAA370>].)/#;$8X*P=#16\),
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ME7-,4=?4';F^-O7%5$YD K3[($I>(.,0<.;M/BC/@V. 3Z?0N\_NJ;QW8Z5
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M%%T#$/;VYU*]/W^=R::MUQ?)N#K :$A,<AQOTVXK HR)?DL</KP*+L4[<%1
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MGAZCC"/\09(A%&%?G,R&:^BR8+L[4H(WS)N':CP[9=Q"HT]:CQ%)+<O:Z&L
M]C6,*F@I:^4:$($H[O^E">R[4R*K&1K :+4>%S: 3FPFHN:]W5:7BW-O4 P7
MLQO<9]T;:JF9BT2'B%Y6]%/YWWL:F3HRT3R_ITGX)H/LK<+EA5'7@.X64B?&
MS##Q0>DNZE?V]8UC+R)YCB"\,3_Z +UL%+[Q?-G4[<>/CAV,@ 6]N7ZFD&M
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M33Y2%9JG]/_A- R\ZY__!U!+ P04    " !3@7):/TJ!6-HA @!%E@( %0
M &AA;&\M,C R-3 S,3A?9S$Q+FIP9^RZ=5R47[<W?"$M2'=+B)+2T@)2(BF=
M4E+"T U#HW0H""B=2D@W0X,@W=W=/< P\XQWGOMWG_=YS_L^YSGG_'%?NCZS
MYV)?UUYK[;V^Z[OV;,0T8AD@>"FG* >@H*  <<A_ &+EWHVLI\U; %!6!M@
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MW2&C F5D+UU#S&L4?'^I6D7//1_D=<IX;61I)@3[)$X.;VV(A<=69.(U_#=
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MCUO&>]__=YL]?RX*$, ]R76>$QQXMS#D_%'9FS)Z*!))'L:^-[GD&4 6R@*
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ML'+.T'K6]X>A\M8 \6P.1P78+Y""\]"K8-I:1.Z3'6=-<I[NC)30S71)28)
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M%T.(;0M>')<6%94M5E4G:*T)O\D-O%YM&KQ=%:S.AQJ\3KC9<;U[]1,CY:T
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M!"E65.8),BBX8-JFA3ZBWW"\JC)3^O(R6;T*?<80_2&L-T6QE18HJ)BZ64(
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M+.QAX(<L4I'/RN61)(-<\DV4"PT&F:4-^S9F*$(W>)V!MJN]Y,OJ6000WH@
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M/Y?+;WHY=)92Z9A]13%:>GQ@'*!"<K56[44Z6)]E[,FVNGLFE2IJC_?&]=:
M\ZU%G1"7+M;\0YT8PR]G=< ,VIGB!94.ISPPO'D\F(<?#!/.7S014U=@&KU4
M;AZDX A P2..HR@W<T=)MV,;TQL1>+Q5E=C>0MG 2V%14VTD#![A8OW<5?%N
MG?S:@P=%M4\^JX3=A,C30^/$XAXGD5Y9RCLT51985$**&E&7:M\1R3N\2_08
M[XCM)OFL;6/:XZ@=C(]3_GX#34Z=5V?,L4_B-1A8^T70.;LEM@?1#;2]KQ
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M_;P*%*?T1NAU9?KU]]TL3;8 @ + ^UCUGW\ 4,8'I>%'7:T&23\Q VN-'/N
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M3NE)9;C9@)@KX)>RCC '0V9?G ?8HJ)V#CP#'>BP]R4>XBM4N=-HB]2;GFD
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M@A34G:G@*5E*9FM1R&N;P%YA4&]Z;.==^;]4/\[J.AG(3ORC*F_N_PE=ES]
MND:5LMQJQA/OVVAV-8*<"\Q>%YR@YE!.K$_'&3- O4I@[Y#^T"0[N^)^_=W@
M''4Z=X-2X2/_-;F"6L Y)%E?Y=!-'K.[(+LMV4IX.G]AT$W;E55T!5>>]!2J
MFK9N0"3+L]#\WCXUPS4L2K'IFM?V.ARGX4JMO@*N@?&7@/O !4B-I8 RSVAK
M;7#8L/.BQ1(1I1CQB_> O_Z]CD>V4X:^!=:+0"YGX[YQJ_+U)O)5H+2*42#5
M-PSX26.J\=,KDX+@C^0!W3YBF:6@^B%+I[CNZLM:](!:U1Z)0@BMVJ*Q.N%
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M %U$&V5##3G_!Y/J9-SGMS*K*F],49^#/IRF:WAO.(N/:M==F>4AWR7(%SE
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M^4?&"L9R<IT1HKPF5%%_[]A&JED(FQ5H.^4&[+XM^-Q84QMG EE[FS&5H;:
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M1^KUI%4G*?1BD522P :.-S1(R*:7"<\:P]B2UG"X/D8S!87MVZ7RZO$3,Z7
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M6VZ> Y2"WA_9>/:$G66\MDG%SW]&4\>*V8#&N([M4-VF,MW -0J'.D"H+EU
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MTGJ"2M/]K-X5] &7_0E=#)3J]:%+?OCFA(I:DG1Y!2L"1!CS7.Z57M'\F#\
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M6?7+;GK@AGRH:GIDEGNZ*AD44HVK>R4<L^!\-^_2H]P%<&Z8FKF5A\>/@Z_
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M!\:$]9=GV?]58[ R_XQ=2A0?65YHR_AYB^7MXGOPN7J:53WOJ>/MD4W4-"7
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MQFOV,"L]%(_C8Q?C8:T'E8F*-8Y^I##M94EZ2W6 5JW4OB38*3.1'-OGZSV
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MUC678<33T=72TLJP0<U="YG1Y*7*<L)]^4WQZ:S1Q<GKL!+,]%)LIW9HQ<K
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M)80J,2_?SN]&5LT'S>G(:YV9!>/7,TJQ%=F)-/J&O?0VQZ1P\JT_RAF,Z\K
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M*UH95(?+<8 I^U7E<4*FN\4K)\:;EL"FADZ+<KZKNB-:+)$X>?(<^S<580)
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M4[[PFFWU4J[/Y(*M?6FK9I+6^%[7U]15&S/4-D2:Y4F+]RAAY,QXB^=?0Y1
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MY_X=K#<R)U(IQLN'<3C.52(O1Q2(W?QEM4(K_,:WNC[;1F#H8+RT+-//(JN
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M5AY$\0FQW4+/G9G)7OJC7T4UGTP7Z7MSM@ OK +69D@^%.N&N-W/>R3/TB1
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MS'7LJC9BK2Y6)>YULHA^A 6?5J\^52)?!N9_:&CL ?#L5O(!D![A]?B+^0&
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MH:^F*G7JIE6C[P6:))I-F"]AO2\P^_7%B8=DEG.2:5^U#.Q7MJ_410&9:'P
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M]=#0[<ZDG"O5 9(([@'SZ $6#@E3U?>*'TOW36>I,&1%<D8QQ:6<_8[#]AX
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M%<R]>.#XJ"-+L(F4PFP'B7/C%K^IQWH><_K)<H@OO,C&:7X'Z9'0F5! +6@
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MSH>\])!P&:]=-!0[T^I3<-Y7C+DJ7+0O\3A8C$'"'-H"5P&'N?4G^F[O#0;
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M*E$W).#>Z%!>>0A^Q'56/CCX>47LNN9]_WQ)4NH0CC?+GT+[I9=."_S]:K
MA!,6 (<">UN<%*#G.P%A.2BM;E&O$JUT]YKTGNVQY3W'W0WV9LIR0\ZWZNQ!
MLL%  [&OE/*B%U5\B97[B/J5=YF30RBV3JD EJH)N\G\((BN86OBY2[BUGVU
M-X"BID2 7G\/^.NG[^1*,QT,'I_?]=\!,MO&3JS!/S=ZUM5=I+!-'[9FO>M
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MS!M)YB)BUV][2"EUBS[:UGT'Z*8_=U>(C0"5>'XYA#9 ]KG+R6DE-VKY0AY
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M8VY([NH"2=^D$ A;L&=[1X6T&=A\^&E6_=MR)B?4O:S%VX]-7,UNG-7$N'S
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M+3,.H(+&FMAN=5M)CVYM978=]86XF<$7S56\ZZ/+H0'9/\QS!\<=Y]F0R8\
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M)#G7T!+IJ3J>V$)=4I/H%O8I5OH#2_LU_D3]AOI*[6O"#>[#MCS;X&5"CP#
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MW(;:-,&U9&DY-I6_G5?T?ELO1@=^:9MO:!2[,]4]*:_!8B,+K.-RP 6X',5
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M#3[8$,NR<Q;B2RT1X2KK$_X<^X:B,U(F5N;=8#/-%ZPOS +TN"Q'-S X]\=
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M(/DE_&3IJ/L4+R32'3Y_C[!I-X,[O9AIRO)KN6H*<@JY4S>QL!R=\V61[Q/
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M!P8QW;[Y=I64:Q>^V^_C/56.\1D2.6GHC;;="-3[DMC0R= H5I@&/=5]^&2
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MVY]\N>NB]D.H%>_K[]]6ZU?G*M'VA88V6/?MFGR84S4ZB17?,GWV[A]]7Y\
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M*,:-VYWIJ5@A9?:#< TU16JT(T<+MN#CZ_[T=(B1E<A?@(" ^2TX& D<JLP
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MNMKP2Q2/+]Y^@D*/7HVW3PYD?[9I^N8_X%<,_P>/,FGL?P!02P,$%     @
M4X%R6C_>&8-O%@$ ^H0! !4   !H86QO+3(P,C4P,S$X7V<Q,BYJ<&?LO054
M5%^[!WR0$D$1I5M20;I;0$! ! 3IE!P0AFX9$0%!&@$E1;H%Z1HZI9NA4WJ&
M<JB9;WQO_]__^M[[W>_&>^_BP+/./IO]U&_O9S_/7C/K@)Y"+P*W5125%0$L
M+"P@&O,#H)>NG2EX@:P!0$T-X   X#J @R4!7,.T;@, EDH(",#!M+$POP8I
MJ;_O ", 7!O9H@7P,7U$F&=I# &T6_\PZNH" "4K-W-7*T]&?2M7*QMS-P#
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M\M9:.%!Q4R821O'F;=<C[0W (6<.LYXRX(:F^K1E&MN99:4(2\5J:]LLX_>
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M1^</.$.&>5Z9!2M8T:N>3BU$MP<_%ZBX^%KW'7ZN$ M3JZH5H;@-.C-*>J[
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MSYL\%3RG$3W&)8" [4O%LZ>PP?W)3+T>B(\<3[9 B?YW)_?VN&=!XFX$+O?
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MAS&R$)3W+=%G^'TCGZV6YBB>50??E%'Z5A$\KR7(UV+WOJQ;%G<,J\TL)F:
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M]FO%3.C^KYI1WN[_!!+;<7X!5#:*78/]W_ZK*!<D&O+_%Q7Y_W7[K_$LP=_
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M(F\$S_(  (ZX[$LVT;6XG+- L()',R2PQ^06WB& >J^J/BQ13KG\8@1O!L)
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MO6T #E&@1;^(--*"BP*PQL<.4+\RVD?)<KIN;_?,+(G5C0,"ENLE-7/9< M
MNY(<R=:XGAK#0:MI70HPD-)]>N)*:)AI-!<F6K2ABF^X:-U.:>TVUYS^I:DV
M@HB+&-JY:2;(3N5;/8XA/E HL 5S*-A %2$'FNGJ.D)O5)+0B4QCM?>1HT8W
MF3I.043H56:$$]Q)+0\=V$/ZK$;Q#KFMFJJPRN\GY8M;\VXP[C';VAY'R@G6
M'.HT#AFUHL4$Z?.6V"2A]D\4/W$UO#+[!/O3/2MM/(GW9GJU/;$+\D'7Y[Q]
M#<PT&;@X["3?6/EZEX*@7#WJCO='W!7'NV:+>Y6$,+JXJRS!U?7C5BD6=^J,
M [&C^-KN526.)2688DAFNVGD(G7)'J"K#'H3Y:>:.R&:G;'EB)TT)^\NM!,Q
MHT]=/2QW@8 1W9*GAMJ_YHNP%8*KK4-GY[UV)F(9#2/S[86"7P%8!?!1?(/$
M5^3>XT&K(8;PRM0\T0"=6F&L'@_SI!LSTY-1VL.8+>+<D63_P^)]"M1^<I_@
M'.5O')\#\?(F#A,K2K_7_C29M>W2W?.[]0\^VK+>TE[=7J=]:3Y9+2\ &YL&
MZ8T&Z\L[RY[E_K.\UC)DB*>#7N=7QMSCNV\(:;:B###WB)R\:AA9'>V%<O2=
M@SL*99"ARN8/;)PY20I2LN\-DBT1(CE,;>TF\\L*21X0NV>3'5\6O"U>_?;:
MZ\,6=%2=\WK%6.-CXD[]-]'AJ-Z+[LL2C>HM0@' ?(>NBMJ>5<;6N5:^\MNH
M)&LP%49#0S]@/((>1C?29;9S:FB%]*6?*R.G=FS;I7V>+2MN.!JFJ!I)G _A
M-!C;V$M335+D(\[-M(F1I_M)0Z0;9@L7ZW/*]*CD_6:TG6?V4Z(ES+D>6U^1
M-HMM89U.QSU]CO6=WU(GO+VOXI72.X]7>#[_W!RW5K3ABX>WI1/ /E<0MV=D
MRYB1*3+*1T[J:_U3W+ZZ26^0J0/)-FM4@6S).4///1#;T'H>IP\\\5[9BWOO
MF*(^B#%/KVR++!."*$"Z^?,+3&,E^?S)#7^,;NX%$'R8HA-_Z]@'^7-P_S;%
MF)HX_&>"OC19OBE^DI;UV='0=AZ[]@L E-BD]4Z259QGRJBK0AG&9/3</>/V
MP,Y=)L9MK"LR_@+(WB3Q&"-??7*]U9)W*7PP.7MO-+]RF[6-M]Y.#).-8@$_
M"A09'.C[QV!#=0O:LGH?C)_(N2^(3/%/3F.JAN6"/;8;#VES-@*Q=2N2OQ8=
MZ ?DO!'';H"TY)B9@!(AX3$&@^>;A51N3#,PY?XI2%;$9=L]^8JT$SG!',_0
M52RGLJ1VT@FZ_.DD. ,YE1)K6 */\7=M'(8\TA_BJ;/ME39(=.OG--P^W(FR
M 5(FJG!.L85U(1T1%3A^LN#\U->"QMVAIE^6!<3KNIWN;B>?\?NZGADK*3'-
M6MC<X75"G3W.9Y.B/RQ13<4,I_9)-'2J*4NQWV<NLVB-3$A;JP-",#F2"ZX3
M=QO\&*>)]@NX"K?X@56AX060\@ZG<0J8'V^:V^JJ/W.UAFF7MF8Q1^ _K M>
M+0NDUAYQ"'<@]-M BD7\6XHJL^*DHF*GJ0A3C<JZC!4\OV;*C 5.@ME8OK+@
M#+R/W7T<P['B8$SH^T0S9,RAFF: 5>#N.KU7R7F;O"DB^6DV_YOR[-RP@8'<
M"6C.A ;_D'7I^;YE\$TE8S#O+DVG )X%3#::Q7Z\"%@\%'!#X)-5QXMN1Q0K
M1>X<63&+,2I<)6"*?)QM0PUM4E7M@8D81U^\  "KDOX;@5C*P W,6SFL);WX
MAM08G$#?U"=HZ9D+/ZF;<*BQ(5K/^O"MF%^[7 /Q\Q&I-YF'P_X+X /IYE16
MVXG)X7W]0N5)D\=SAXBHU12W3O2:G\1<7DN'8$!S$B*D%14A"LY.P%2,XCP5
ME:&3.HK:=#FA5-#>QM.G,!YF?#]\<*]WQ$K3$.<OH14_FF2&2KAI\?E=L3=)
M$-)'61<E,'"'U6RFN)('=J1/?)M8X6[7AN^;:(F_ICR/-=#490JV8Q!C#DL@
M,:UURF+GPHNKWT!MTMX0T3[H)^+Y/)U7!4+.')2MUR%)3VF1*W=-6CA,L-9_
MQ4<>C,HR:_.*V3G2WO*PPGJ_,I:=PGO$K+>C/@YY/E]B_#/6J3Q2>^0*)&KO
MK(F"C54$*.;%S#8JL75MKK6;C:N+%I>.078V;#3G'746=B6A]/%'YW4_W]Y1
MT?=X:B9&5V56G\SH,/S-4C@Y52#PV:G>75XS4GV//UXM4TP%DEXB?$<4-SLT
M),(UP#-VV]/?')&V*557-0O"=O2T>M_LUZX099HZ:_RI@%@>L!8[/%F:X*+"
MKM6V3;Y.,%H1KYK;&F*"=YO1/Z'0F&:8I'MEIT?3F K^VI\=Y8Q#I(9PE,0A
M=(,6Y 2@K'_D*S5<\N+J%P2%>_$<_JBD!<UME2:Z="-?_Y0!..1TL_MB6"O*
M/';0)BIS3YV\ &2?9?/5C?D<-_UM12A5(5ZE?<?;S='4,V#6KS\D^J@M9;..
M<\,%M #O$X/YJ9B1Z_-N-[7:E:D>S'HY]GUSNSFAY3T:60[&=-])X#F0HP,]
ML$*6(@' W(G[RR:^5]PW=RUB&WWA"%BQU=;11X_)B$GCU8_(<A=;S*;O[IQ4
M"/; 4QN@E,SJ:X(GW-?+_@CCK73B492>SX=TV%0<Y\A$$T(,H*7R-5LXX?T2
M):N]OU?J $ZV%KD=5X7AQ<M7PTQC/ ;(ER:(MY0D_@K*O..H@P@U,@F]X&:"
MSJ^U7T82^.%IVISL<J;KU[!O73OON7T<"JY3FO_\S9(>=<[5I4^B7YP%\7Z4
MD)-GI>XRW"3"\VNN7UPZ:V):USAU[%NX;F8: #\J;Y0MX'/#A!'YCTY/-"Y4
MSBND!Y(HZ-'B'2*76T+,/B%O"D7(FJS'>IS=AFRJSEU)_9RPL7%WH-;=I)37
MUIB4 ;Q-08X"G-A;46_$Z3SYO0 &R:.X:G);1P8"N#HF6]6O?=&_ I6+&UPM
MZ))"ULF5A+XF;B7 /4TPLPF8:;?B;<0JJL.RKK.*;4>*T6L%(A!B"@H7 9]Z
M;!6Q&0..@F^ - ;PZ?%MD)R_=$7KM]G?I+TJ(X7-RDQLB0NSK"KDS!KCU>M]
M>;#*&\9(-;A]S3Y;:?AUM)[[=6ZK66W'*\Q;3+N7_3"'+9_MSSLZG-LF^R?<
M<?BG*EFHIFZ7MIPH]V*??_'KS< OX &*!*(&IA_/Z"0-;)C@F=C<QZ[/6=38
M"=EIOK>QP=*+J17T+B=#1<LM>XM@QCWFVF=,.U7)QOV[4AR]'OS0?=__FYLW
M7#81K81$;'$K!L?<2<R#DX!H0@<(? K4CQ8];Q;QB#Y?>-3;2&"I:SK)>YYL
MJG^>,6@\6LDU< \[58M@W[WYS0_]8/_3A4EG_0405<FC_$'3;D6YWK-.*L&P
M]V,ZIQI(VBL$B2+T/$6&"+ KD'^IW)XS_XB9X'$A!&7JNUPCLVL.G]*'>B4Z
MX,#*TUGQ@-O6?D/="L$:["5!GZ!C5&Q$MK457O&:1FSJT^[Q.&VQK=AKDGA;
MH+.(&6K)^J^.R0X>/X]CF/C48XC)HY\[@FA_@O=OLSNDG?2?:^ZUX]?YEWH_
M+."GF8TTM2YB0W-7?J!/E3$^=KK(0GPZZV&JT17<69(:S;.%#7%3=M882_S=
M^9SLF&[#:E4?19VXZEWD$= 09PM,S5C-TU\;=VI'3'WDD<7SZ.R2=CCK*F$E
M:)6.<S%RTX;U6?K=JB876C%TA5W9RK:=>=Z^@OJ[TJS;"N=DQ<DBFP--W**#
MN0Z<V2 D14Y.@/%-BX<#@SOD:OKQ!2#13#XB[9T=NS%F:1*9L \%E;U?=;4'
M"L[Q/$W="4%J!*D'^4*$1YO).K^JRO.8X!Y4W]:<C(M\!5=LSGRIKYO41AYJ
M:@AD\^]<+AA?&?>$K_;X$CHF)"+<FYTF0AE]3CW] JAY1K5QE2V=L.C0:FAN
M:9<*)CQI5CO9'8$Z"3#W5 U14>;5S#Z*OP800]8YWX1GKYDX4]J*FF&[=W*9
M Z- TYN?^B<(B92%F'[M?I'](,UUP;J"H+-YKKK4VJ<\3;\MKNKC"R#>H(PI
MV!6T(*])N=1#@N7<73(@.?;E%0NS&)/1DM$9FG#: 478:*()EP>$D\-^8.G
MP1)T;E6_2N=PQA=M!I[C)JF[^#(]X[\RQ#GK2ER8:N05W]D+(+(NR['7T>8M
MN&"+=UH>X6.][-N9_C5:SO<,O5]5Q[*#9AM@\=%F\VRF1IJJ#?B'3B6%W%T[
MNAJT#.QA!B"B[H;KM!&!?LY/!45L?*/3J:\0?<&ZDJX=QMJ69Z<OK"-*ZYO:
M"('\A/Z@T*O0EV<_J/XQ/ZI6%,_Z:3^FRB]F^GL_<6QA,@#H(T*INP'AU>:
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MA<I#S]VDS.']8PZF3H'%9AKIB7J-:$$A<CN9[1/WSQ5,199ZTX\?<_>3)47
M=6!AG'0-[Y."#(F^=Q99"[5^^4$H%!@_2NH[T/9%*77[*^TOD*?DYLW/I13D
M6HSD98@0/(2=,-48T:GZ!6F; NSK#M,SG,J[+.LRR-;E=*#F:H0E%.Q$C%[\
MW&G/W'\N5R0,2#)+T'OY=; -%"G+$E-CFDO4J="^<C5N?2&-5JXO(W7SE$I[
MQIET9Z &'<P^[B.8M$=OR.6K,K-+Q,40(6/T,(I3)+CJV%]FDJ#3N(T86!BP
MEQ?2TD 0QX][MZI?2=D0]<]Y#B ,A61]#/+=D;LE,K<IB8.LCH&YLGX+.3^>
MF<_O+/_#.DN"TKULKS*)NLUFF^?T=H1=RM.C"_)PYU&YWU0P']"HCZL1_C@#
M**)Y%UY>851U)O;M<ND'*XO]%I?!('6$?,5.:FXW)V.))_^G&GYD4?7&OY]Q
M'H7.1D>WRVE1/XXF%AP=))'M?!H-[JY&ZPV1D;77SD[<(!,RO.BHW<KT([R@
M;&P K4HC"1F81X/K_JY7AX:&]EGJ>>5HSI S+1FAFT_2IO2G29S>W"[KC)U[
MF(UL"JRUD![GGMQ_E_GN28XYR>IV:Y\-U=T(D:>) I\41$A9F4Y$88<&]<7)
M./FX%1\+8Z\?HDLPC;"(#7HUI$0+;&%%:$$KMQW.1\(!CDPM\&#QU]S [7X!
M6(%<BQNC1?*%]$<12L>QC<62;TKU4AR41P9W,M:P'UE!Q\+0L*K^$BHA90MA
M7S2_9MXM$D. 2L^%V4^S#+P;R47=F3D_OH+#,=0#-;FI3X2RS*\,:=V ),W-
M/K^D<S@Y-#A1<_]>-*= &%QDP-*145V&0.> +5$,_PON$ZFVR2.=/M*BOK.K
MB\+HQP?!!14'U-1EP#>K'S)_##XZQ_FX*HEA"7/31G,4"Z7C,,#3E(]&UB1A
MM2#\#][>*BC.J-L6;0+!/;@%:8*[.X0@#2%X</= XRY!$@C:>.,0W"%8XQ;<
MG08:U^"N06[^6_N>6WO?NF^GSM/WNKZYYAQCS+FJQOS]2BLV%>(M/HV5.+%>
M^>I0/?MFLZ\@8<LE0; I[O?H2$W.\,HO$0WYL]9?OC.T9T(_CJMIFR'CFD!*
MS C.70]/Z5=BY2)ZU-( L5<]R-FL3]#.H@->?04;MUV)G9J6[SX.?&2TA*Z2
MQKK85#1MSO:X\$W)"';-ALDVF'<U4X-N1Y_8X.:['D5B33$T<@>P89"BN'KC
M]8*0";S4=:WK*V5#"RG^?J]B;<50RZ8\03(P*-( O=G<DQDK<;J!PST*BX/*
M[O/-,+LVMCD:(]QL7&=W@FJ+&K!5J#[WJ&I7N&"7,OAY%Z[6#"&""@TN'2C5
MKE,O=G51NZE)Q?H+0^.6GV"?(]5&/WHFBGQG([9@_?X.OP#_8[ T[1Y9WI*N
MZ'+"0+<^;@Z],MB&+IX11 BJ*DR.^TE'Q%=#1^IFAC;,Z\SV^?!30WM+75-S
ME#],(PV,<*$DRZ<31LM)3G7+;DC9Q",V\/;=4C9(+4BG?J\3+8Y^47L<D4D<
M0YQVV4A&TURT?+?6<P/SA&L8MW:[D6;'XM37?H]]]@4UJ$+S6R4GN5V]\S:7
M/4Y#KMC^[K4U-:0Y6J:.7O1X\7\<55<+4>_7*J-EN_V$*E-"NO$"",NO459D
M!X8(PWQ47R]/#9'T+K1:ZN!V<HUTDU.[Z?W8#$L2E[#[6E.?(@2BBG+"]R$@
M 0FRV"5C<OHP> I91/ZYSB&T\\5ZGYYTP9X8QM.'TY;8K-V_BZ"HP>3E[36U
MM)R:>?BCC6"66Y= 7;KG8L_OJ$\F)OZ,T&R.Y'US\HU"D> '$RW$U2TSW?''
M>JL$K\A.YT75:97'FU(5<1XR_+&8,FTA*D";:6(V:'L&/I!-G?"HU_UU>G@\
M_H>RST>Q%>2\M/='KY-3R!W=@A/[;/8#">O+*SFG3]51YY6;-FTK*[?2#S0F
M\#+JOL@-8>(*[@D?>1>7P1].'[ \G@(-*.KNN*1;&B)7 \3%G2/\:W:;F*U<
M&.*\+*G7N26T(#PZ5UD4 Q_J[0-$A;2]>!4O1B]!##05X]MU5 !>T#J2WL
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MM='0E/UN=N[#J_<S_!KH!B,H32"E(T\U7&T0 QI]S/5S_0N ME'U4&,^9B.
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MW@BV/H1#+G0LM$)2X=&OCXV-=<^+CB>(6[CK> QX9\=KEZ](L?0"L"Q(6%9
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MX&5;HYCX(3*S;K%'_&PLM]6W*NTP -IK@TK/H# UK1#T089VCK<[9O]:?:'
MPYG<T>4[L6>62E+%Z6L6]LZ:[="-K#P]O;8&5B0TB-O$5K0'U=/I;V6_D6 ?
MB?X,KT!A%Q_)_/P!]X+ZZ)U<!8</,N:H7M$6=#7I5VQ^X8['\W[_ZH.47(_!
M='CMO>ALTFGEPPDUNY6QK;U;R1\X"W>$>REUKSG/WZXI?N\M))=6"3'S9JS3
M[_-P%SUK,.^F+<?7(6 +))YZ;:@]DU_I.'S923RKZSQ9N/H#$ !:QRW*AS6'
M7,R+98#RLS&TQ%U[-Y)GKV@AZ+<%U[,D&53$U3ULE5(*L<HS#7\V&[Q_0OZ
MBL/L/G(EL_QX)0Y![Z;F@;5P>/7 4QX:8*7Y!^H+QCU.C.7DE?Y7WIFE4IP[
M=,'2,N.BVQ1K>4'Z5)]RSE:I^4!@2;AZ(-/Q?(JB,7MM.$.$8+8/QXZ-N(77
M)^9)2>I LY7]Q!? EW^X:4H0TVF#V'6 <0=Z;XFLK,VLM@*;0_0*PUCR?<QH
ME2*[:BTM+3T']](Y3NA:&_6.K2'>AE:6,=_8 M /M;97'E\ PUW7RY<[=PJV
MC9[_&C:C(=TMT';'5'Y3RK:Y3.A*>!3M^K;P%@-J"]CM__V%_=M?B*$O_?8F
M$C1,K*K#Y(JF:OAND&;4QC^E^TZ':H=N,5.2-+*Y=C"88,K)Y-(!SVK176TO
MD(WFM]OL\?CIU^3)+P]2-X7S*4(Y.X$VJU@5#BN[YD(J[?*2SVX32M-Y68CG
M=JFA5S,/IX&7-DPEWL0"9$YFT,<RHP/K)UC?\#?T\&(3AY,GUJP?05QY<Y4"
M.)I&D!-[JP9I^IJ+I H:1ZF=?%?_5=62=;?@96VV,7NEF:WDTVLQ,:W0.4:[
M*F(4AS5W0564O2#?:7WPSIWMM_S[9]$Z2,9&XD2IL2&U&2W$+GU3H+X.OR:I
MI:4>86+9JD>*9EZ#G  "%KP <*^5AZIL.N#'G,"V9KNJW ">CC'Z5(LHI^0]
M5^E8VAJS2WR9JN=(45W_\5OQPY[5U^W3XB#SM79["=*/D%46(,'W]F8MYMH*
MLR&CFCJZ91VQ=H# [(&HQ$2XN(294^D0=<.TBKV',X/*H+$(B;PTWV0R@XCP
MA.]R7D:BX^G#_*;XR<2&%E20M\=IDQQJ#G_%TDMFF^_^(9(G#.T+*Q(\V]>Z
M[$L@;@-;P+L3Q*<T8,<<U\^D%5V#PC+=9*.$8=G!440^.\\E#P><*E:U;*)T
M0<$7YFJ,J)SAU@XN5-N.Z\5I'E>49UA4S2V$/_QY59BDME]NX8CB J0G CB7
MH:+MZW6\G7%R%Y.04EBCNA$4]5?#BLG0!Y'NC M186-O4?EF([0T6Y\[ G?9
MV P>GNM%V'(P[74>&AY;LAO,W(I7%3A:NMP'WL@@5PD"L[].NH7HYC+1!)E7
M/])U /''6._RQ@3(S4+@QP3['TLXMMB5CB]O'<WW.,E,W0&71NU$+;KE=<DY
M/:+'_6'I>O-7?\ %C?8&J3^GE?HM1-ZVH)JKPS*MHJH!QX=9BA75COQB8Y*;
MG^O9@8VP[#=_>V,IU2\3+[TF9H*G&THC^#7:HJC"CRG!SA48LD'. ;CH4C%X
M!FLEQO,7XL\C&S$KA4<I6[JUI%7S$&,.GGCJGYZFH]A]J;4=T\HNP1#4I3_7
M_Y+!Z$O*OE?Q6H\]@X%$YJ'+%QN=T$&.>C2CZ@'-)M_2JI!(FM87@+[!!:G!
MOX^#F] J^6P6_U;AP?S\C)WCZXQE/?Z>$1X?AUHDUE/@(R+8T)G;9UREN">C
MG)'DE[W:"\!&E:.][TK%(LTF_1U.LR4A(#BR2N;S.A6-?5M>ULH)L#)/1(K<
MFS.01+1DUBQLKK*@,7UU=W:9;B5:,=^WQ 520>:G77@V-C-6(#"?CU65H)K$
MT,!L2.E&L*R<[:ILB9M*<SVE(59A.WY$K&59(PSPG3U*I]0)A%]/[M2;H"W;
MRH+^TA2^$<PI5BBN29B-9V4KYP-0@8$LR%48$Q*LXXWK[6R]7^EJ9SU&Q"3>
M8XG9F1DHCWQ(4Q:C6Q6R?/6*8.:NY>&HX2G=[@7@Y-=$,C%"&/!S$,4/?1"\
MP@.Y-B]M#/@G JE? #R.B!/G5?8[UU4&KTB$.JSNE_V'1F60@_].HR6[]B:-
M>1F-_%>-K^HA!=:9XLA?.9:ZO+_CL#A]OJ%4MVS]]E3H2":>4;L<IMUEB+KG
M^=KS2JU@\F%YX^U&J91=@H2)Y01/4_#S6#Q5CH-],M#Q/HD$4UY>>ES>^_"J
MW/Y0181^SJD_UP-JQZ2+PNH*^OV3"5,4.\%9!'BIPYSWH M>:988%SWL>FLW
M>5Q_>LS1:=/1VGHI'GUR.>_22-F$V+L^;?PY06AX1V2HX/E#;6#)_%=T#L/)
M4]KM"\ O:T6B_;#L,N]-^,>(W61.AF4A8C24K1G@5_<'3J9RE:L7P _A3HQ'
MD?JSHNJ;<K/">Y</4]*3=CP]KMWA(NG^T+AHBZ"T$[)+;8'3L!31DVJ)Y:59
M.HKU";0,<ZMTZJDDV]ZPCRC=@YAE :"J);A&30=TDXT-X9?&87EQ0DBN/<H5
M?6R*-^RR,-T=:./!$[ET@E&@14@$D>ZE Z)V'2G]0EMXT/CR%W+ZV17^%1EJ
MI('S:4);EPO,<6P.LX&M1IY%R.\:;3E;I85-RI"-?YDK_GYRW$8<D$=MU@'W
MXN@M>B 3;X]ACV%"I_RY$MO&*Q:Y?U#_D!53>=V0/';<)J1C$-I&J%1V"287
M(\J$H3$1(9P49J54)[?X)WZ04CB6TQ32E%HW8GU-J8JSZQ=.#=<G);M4MDJ^
M;*JAA7CAL@:2W[W:ZFO4;+RIYT:H.ORZ)Q6TWAKR8!\!!K9I?Q[!W@&)R6/&
MIQ]R-K!1DI.((1!^7A[LY>QEH4&TA$@2O,.2%1)?QDA],9=TMTRZS4<4&D'8
MZ3_K('<"%>IE I--YDJO3HA=,EV= \H&0OWY HKND/]RJ7>D>1@,%MB7]YI:
M@BRI9;%?:9DB/P]6I6_N8BE^A&LJ8"M)<S&\5D\,'KJEU4IJO0^9GO_C3*'0
MPU+_Y")@D/5Y;F_-\2(*+-[+R'V?"DPSBB)XAP%\FH((OX;W&.3;E/84'=8@
M!"NI1X7 '+'IV*XC[&5$3I1Z'RMX7=&/<'G6ICX=^8]]?1LV(+&IBF-XZ.G)
M;6#2]VJIYM*\J=$NMTDC5-%2Y^/UX! MS<]YH;"O%"^ WV(>Q6-/9751+%YE
M'"71W/CUTLX+5(+>U#61)V5D7!Q5!B1P B7/'[V.E#O (.\CYT &Y<JAG<\U
M@][57:0T3'.,60VZ%K!X,S;L&VO/X"UP=_X[Z?+L%P"+Y/?/G\K/7@"?0^:'
MV<2F2A"+ S=L8I8PQ70R?=O,M@3^',$I$DGMH<%[T)!DBAR62IBSEQ2.5?O,
M>)I'I8U*(PBN&L/Q:@0IB7ND8Q.X1!;TJKI#5<!UHENHO%JAXDOZJ([.^T"1
M7D%CC;=7GC\ I.9H8LU,,_L+Z@K*F,.WPM9W3JVJ4QR=#8';;^Q>PT[K7@"5
M%\5A1@LK_?Z9%IF.$\+=*3IW;DZ5NNU9*Y?HC)TMK7'L#$"5-P.-B1"A/2#5
M%MENRVQ'?<)8U59+:&6BYSY46MTS@9)CTC0$KPA'*0%84Q'/V\*-75%,^VWR
MF\I0Y\#Y'.0% !]>B^_YTXEC/NUT5$VB\FY5V:"AB:7PS]1B0; YE!MWGMW@
MMB!!%\)-9#F+<_9;G7K9Y<M\K8)[>0=;._>GT/E-O;@X0Y>_NVAD#D&R7$I7
M%,RN#KAF_A03Z_&Y1@>)*KRCG"2G=I*&4<S)@N5\U)%=@,+889[LJS&^[MO/
MSPRQ1K/7NB>G(XK6%V#_U 6R.2+6%/.?KR<8(X!79,1SZG)=6X\R&V,VNN<?
MCBW\J,-RW J?()N?@SZ.8\%V9)K IL5A="G9,A5_G4)_SRC#ILSF_BG?F[2K
MO]:U>L"( @5#Q1,]*S6@ XL,@K&\+6P7*RS9-%U$G_1B!WT#)HBTY#*Y_NW;
M :N2LIS38>?AS]/*%T#56E%QYM#9FGK]U-I1>@6O87^=CV>-/K_G7_WEOIW^
M&#Z?#V=N356!814]Z]0:VPM?TB$-I#<KWYTK,RJA]$'TO]CH,?CH)"U>R3*O
M@['6VO,@C<_UI,J^STSXDM2MNH<$$^7W*:+M_S3Y&RP')&#5J)&.%Z:0*:=;
M\,B;,>O&[D/NEN_.*H6]*>K+WYLH^.7/C:U,E3\9L/]L[D+ZQ(U% )]RY*2K
MAR5LGMBNAS!R 6M_:<LA Q.\__&9?8E>^V]$Y3(.'R'*>_6F."1Q&W%4M#\*
ME?Q+"UY^]VM[N>,'-.A&LL>YI[#*E;FL'B0\&4>M?S)U$P&'^<V39)U%PC^%
MTH> .5^'KE]8U4^9A]DH%H$" YC!TSP778-+(D,:+L91P @B,+"B)!+#VB((
MK52 NGVE82WMQB"\^ )A<>](:6]*1>4N3+NUK$XRTW)-,D0%?@'T-'->1QW^
M:="-,PG(M0ZS?YVFI/0KILEZR=D491M?EB#(>:[TI[>&$8-TQTS5-9++S>]E
MF3<*V)AJ[Q;RO5SSD867Y4'B[E4)Y9R%Y@\9^Z5^CO"I?D8_==8T;8PN\[1!
M\M-HC57Q=@ZG.(?32Q$QIQ^753&,R;N55-,@@>@8=L]05(Y(?,$4*6]Y5+=^
MMV.]>1/T8W9"W<K"Z?586T7&;_(0L024R!= 1X;G/MY(=$R6JRS%J>5LA5D;
M2<(JHG ($:ZOC>MEXS22>=E0<UC_H)WNY1<VM?/'.240J_[O!.'* 6]5ZJ2Q
MTHR2"2CF%+GVF,Y1-Z%\C=(+>2IH,_OK6V,CQLZ;HJ840KW*MG^ F)("(RN&
M& JO>HGY*&'A_/3 .EQ2<7O='&VH0B6O0S#0'G)J,27OFXU'S$C@#[,O_H.G
MXZDUDWY_O"V:+I]P?X%"$(W'+K*@RI30-"$5](=C2H[V?_O&+1ZI_S&B:D/\
MSS&6[?_:@E)-.:LY -KTJ00'PK+[13) $&U.9,8>_I!#3Y^+1'.G US[1>9<
MV].GP,^3HKKG6-5X!XU"P:?@AGU.1\D)"B7]G2[=:WES56V-&B)3 YCBJ7'&
M!J7?"-FUO1BT/0$K0&9^K-K*Q["GALP<A&%#&66:$,#7YZZEV0&]?M1_ 7#U
MTL N7@!L-(RTYQS7C_E'2Y>(%>FU+["6L/U>M\)11N>)\.<-?S)UK:!/!HT>
MA0->18\<LVV]Z=.[ IWQKIBBNWIZNEY4^#(/%$?[M7U49VV:>4-4D=I3_;+(
MW2@T>47Z/<DX!EF*%VR>\\#(52.)1XWGMQZ-HN6?X._^P."7V.1/)\OW!FW5
M*6_=VG7F:,];=?M08]YUT'?R-K35\6=;U7N>3/<"@2>:K'$_O$:ED9K'_%CI
MY2@&",OH@\K*N '4 *(#V'7+<^=&"P;8YBFPY_K$NV'TJU!;^NK%[JW^3,PV
M_<$T>@6G(P6YL8ZD9O@NA)\U6ZUWO1BMXVAA]NK8AYWDQK[S#<;.+%?R5F@U
MN5*$H4QHZ*T\3TBQ1>Y;/UH./QRBC.D1F>*UA^4M<2L;C_)'WAC'2JZ.:9R"
M2P1"<=<#P0ZF1:4B,44.F!JBPMYLM@>+&4S]TX X]#@>Q4WM<_XCVE U;,O1
MLWC*D)(^&/Z.J[)%G(MQLQSIZLJ'#F*:@:B%Q2\IHF/YJP.;Y%>M1I^G=TGB
M!5Y;XE -[MU66)J^M3YY%?3UCX:R1R!A?3.7HWMYZG$#QF/)*?VKB7%3\G73
MC'E)='; "+;;M_G6)1:0&UN@@2[)/X::/WXNCCL0M8FX&L2!)GI4*!1+5$8W
M:@PV"JF2TYMQQZC/2W_5K8WG3:8*GI!H_)X[1]K5870\MS(VI?>==\6@O:T5
M),9;S="T1<:).(]9$*G*BW3U'ZI:KV],[JS.T1Q*V.K5[Q55:1G8%-.&(%1#
MKI=$UBV8,S'&MT*^&NX,H%"%R*F=X^949C$8S3C-],(%[9V\4.-@_;O6"2H3
MP2PH:42Y:D4:6M&7F3KUZG+7G>5_7P C/Q56O(Q-?MQ?B_LJ!Y(%.IF(F1Q,
MC>>M*X"=BI=353J35C\S\J$CC:^UOLUHA:0)6#\,&$Y?5U(MJFXJY]_X>5WH
M&Q0I) VE12FG1/L7A"32JO'L)(L,5*B_]WQNESFH? HTR=W22?&=@Z80+6T_
M,X2<6M4NM'&(]B4*,KXAN#@10;[-W*(4&=--'^@G25<I:-'NKX>GI+L?^SIF
MV_4ZU/4U?N$#Q.[4-V%JP42W+7W!_<'Y*P>3!RF^*M$/WY$)C(8<8M@MGE(8
M&$K_V+]/^->U%-NX#5;0SN?7A7J(K1$:_PGS^34_KP.#8[WKO>B'0Y6AL5YI
MMX/D_?*C.JH%^P^9)J_Y#PWD6AKFP/4EZ<R#MCN$_;DAW.L7.G;&]_2M7UA6
M%JM5N]XLG(OQG;\Z,N*K:B32R#EVRO$%4;F)LC1(JZY!>%@6%R/C^")79TX]
M5(1TP@[0_96%?G1,L7_>=\,9K7N<K,+*_\8YP<V-0[N>.&A(<77 (J'=67WX
M*Y9JZKAAX9C#&KY^_DI_%/I#S4\[TT@\9!8I\>TI.J$SPF_+B[PJ@0MF)P4X
M ?VU2E[IB!=[=0_Q3F7#5_5P_->]GAZ(17D['A<TMH:)K"<K@8C*R(T4_P$!
MNF02HO6KE=R2TL>+V+N,C'I[M\W$#?F$-[Z&*Y1K?):MCYWW3CNG%VX[YW"G
MD?3J+_Y&)(U6 MWG1,>[P7:.0[QX=?<3WQA")J$7D5"].1-:L$.V1#B@[%40
M@ S@65BTLD@RO0:_7CYG<S^/W-<TZ'&I]D%5C'G:&6O84FP;:@-2]J9)M0XU
MIA:CF5(?M7UE@<4J):W<0>[SY06GHI0SG/CO%]6V09PS=<A/+*HC(4JP@QLE
M%I/_[%Z!F[7K7#_Y9GNMYU<.;+'-=CXO9).36*<KSZ4+;SIQ^WPA'I$?L#.E
M0,,*OF0&FCW<) :6W=5\G4S/6$(<"KKV[*CPVY;0@8\$XP1/#A%,J^VHD28C
M.P]B/P*EYG0W_7V<(RIM/6_=[$$VO,L^-7].A9,'M1'Q:./23(U;_?:QTZ;G
M6_90<-6!: &I/5!2BV=!E56B8VYE5S&Q\I=3&Z4K*5KRQ##;0O8J!B=#MJ*%
M71Z* @,S>]KAMUD;JMDD: [\^@6 +7A5LZ5#(DE?<W;ZXX0D\,U( $<XU%M\
MI)'+\[TI7SEW^'E,;;_Y=N*WS$Y-27:PY.,25WBB,?W?XTCL_F69G9%M=/2G
MU<=[X8L._ST//V)B_Z6G?Q+X>O)-??._Q+F>O8@QA^O--+#4_UGK==U/S/#!
M^3WFPP/2%Q'"F?IZZ[B>IN6N+3R.U#TZP^^$?_  B7MHZ"C'/N'8:FJSM8Q4
M'$88YP:L:(4,C:NRMV6&!)1EL*M/8/6)VP-=6704#,O_;RY)7BWH<T7LW67^
MZ#F6U8)SG#: 34:CTUXG.=]GY+_#+DA@'I>T$[J<+:NRCX0SP3EUC)UP53;U
M/+RKN2R>$./S(XX, 64Y%Q/> :WOGR^ECN"_EI8,%O3E["V<B!O:6 F%S:3#
M(T4!^4$2I6:-(0O"C6'"WR&6 9&D;C05+K,Y^ERG)@_[3_[#43O_@&KBX9Y&
MI\+N*[#^7*"-1+2H :=E $LO&=;6OKH3D3(:9PBTG[ +5I/<%=4F'XA.4-'G
M$#1R696W<',1%Z)]GV-KS!#> 7=B[L"IC^KZ0Q;M)T#D\7=(:2UX.]TXL7I-
MQ<G)I_0N#"QL8"*NP6JT(+BQ[2-]FK8K)92J,VHZL$N&@.ML#*6 <M2?UV*U
M?JC/556N><RZ)<4O39&MQZE_VD["YXEFS?3/:Z=(/1M@Z+^0KYJ";;/_3!)F
M8)A<C[]++V0+F']TQ#%>51#;]$.,">E/G>3]4$L?N3W_!%4;XAH?%*\=#,JT
M)&B*?N7#4.E3'58E#G+!B'EW3I4-;&RJE5-.8Q*L*5Y<YZOHRF&G(@5*C24F
M[PD<7Q-]_B7#/BV#XC(D]B-M"L#+C>3:ZR$,L+QY521JV+IO,?C!F"E]>)R-
MZ5STT[YC"\*0?[VRN_F;R_?L5T>7=3M?3QW9)OT9G'PL:"IM7.&U,DXEHHL-
M1]5LJ9X,V" Z]BT7!T+5(N^JR$C_)0/XU2/,^$,[^,E=7&UH<R3FO74##3"8
MLS++47WZJ)X/*[RF88T@-JX)E4B;E@IZG%^R^.4FO;_8S-=?5>C')E2[5C!A
M>8Q-:?*WIELIY_D)'UYJ:O?&+P#R?$GIOA-;H'&6&%&A3>#APXE+;7<IPI\T
M#(OL9',V;YK^ X38*@U(4-*%O(LM(3KO^<VJLKMJ_Q9.>,@.IZC*)9[U>O-Q
MLK+)[J-4JT6# D9#$$H(JDNP\0\Y@^3MG>4A^4GUJT?<-_U0BNO=2C_.*,%\
M2L2^V#$*X6 -^>-O7&T][85WS@7KYT<*S. VZ73\\?)-EJ.O\^B+15^X.\3K
MXA.=;TT=:;^%I+UUKV98+*F8KFV\;A_Q;7T!&.B>CXE>]I(N90U^OPOVE\$Y
M3B_@'6-8DGT;CY1EQ8HBTNTVB,;$BC3&I_2MO[3(!,296S'F"4X\G@RT6>Z#
MJ0J(3["";#QL,';!?T51) =LJ\TBY]$9TQ5I(2),SI>BM*CR $Y=2#$ .[M+
MJ\'1V&2NDVL63_1L)9(+<N2!\J.W:/'J?KTQ19LOT]RT2U@"==KSODND:UR1
MJ(/M>?$%\#WA\N@%@ BTN]AX[OM+FG%CM/BTEU5W&^![W]ES*U+](2_%B>NR
MJ;(SYY%G\ Y-#LS5HQ]:/[7:.W/@51V5MF/-:N-<43A$2]P]V._66CKF<Q*Q
M,:8Q\Z$UNQ\/7]]X_X&Q5EIH.=<O*=UU)"30-Y\!Z_(=F:EIY"TFRZ7>VL-D
MJ5@IYPM@SVWTD1HOHG-#P,<C2U;=>D5JZ;A@YH1D&3N'RZ'VDYFX!<U'TVPO
MTYG'@((OKM[#,UK3^7.P ;-_5V?!_S.\8XHTM:3,\Y0GA1:I:8MA5WN@8$JC
MWNZ&L;SHWQ5TO0 8^DZO5K[\5;OD.&J(BN$A\9A9NF')]@@?L73>E=D-V$F*
M>0$($MT0!_P\E^B*TP-MHE\7D!(>T/A]A%5H<KSJR5F)TZ7M-=+Z]=5^WK8X
M@#1>(7(AA]HH(ZS%R).YT*5<H75,/G8\GACLC!OHF?=^:-+213_&8C/#2("S
MPAH.[&@QDG$DT2MP+GOWCB-\[XO@Z!'M*^_M:)UR+1W!26/](; /MELW:U("
MBQIO2_;/;]U$V4N$T$8;NG7*^APU>&Y]CD["\*KM9Y2Y= MVGW 2LHS;(,N]
MW;VS/G.]/^EC\S]I+DY[F5.\1-.7F=N:Y'3G-<"_UV/9+5[K.2MN,7I7?YCA
MSQ*3JR-)EPBMRG' ,,.I8"-\Y9M5!BAWE_!DY1Q>M8GN<=ML;7VB,6AJD\%9
M:H\TS(4<CG@;"_>.?4=@^H_^;42+(V;:(6-+++ 5'8\O'N9O\I>Q<GF78X/3
M6SL0(#D'L7O=)8=;$)_$RF"*4"9[R/R[0_S)V 1^[W5MOG\;:-QYAL<R73^!
MOWRO[%'J'6)+]ZL5.O\ATD^>%TV5F0AJ;4/KM%0GJ?BWYU7C,T46R.'4;!:U
M&,ALP3-1$I"KW&PHK-4T6H8$>+HUR=@1ISC^4QC \>3(%F@"OV[>?#@>B$1H
MS1;.O.E5']TOD04JI3B6_RW%QJ%T01_26K+06*3EVSMU,%DX>/ L9:Q(N(.
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MY01^KMF&M_2+XD,Z1?,.EK$6:D+?'X4?7&;6I*>7!FN;88+JJ2/,F,6./'$
MP U +3N'_J13:G(3W$%OG^(I^UFW?K#^CW4-Q!93\0)T$U*FI$@&0 )W'8G]
M(*/^4OW(WHE_'QF%F\6$^ EKJDTY&H__#MT5;AWID(F0P?[,J2 [+L%37RDR
M-W?$H6<4GTFF%<82\_U\R!#;U]2\%'&GW .%&,.EI]?-_XXH6%$D()(;G45/
MY$2NU?PP71JN3^^P<G]8;,;H^:NCA0D@6PB6U?$W$LHB]\;8[&PKE1B%,PY^
MTHW^IO?,<+Y;67 7L54#F=Y2#;MA(]?J0D 5Y!S2/D8B4<*WM?QC-XT]KV]:
ML$E6Z=OFLWU..$_,=77&V&#H28DU /4@W030$%,' &GFSDFV978\WRW?[M*$
MNKDE88Y"LSZD4X1\/4A!')_5+]!D/@=28G3\%*AZ)HQCTY\^GUML.U1HO*@W
MYH&:YL4?]0;T3>!W/B?*MVV1_<SX^&Q7AOKSHLZ-)QS.ZM49M<:LZL=XIE1@
M1'X3:Q$("U\39Y)YB;2TZDF<96.ALK@Q5F9Z&BOV>HHCT\QJSVN4Y]N$^.UN
M95%BL0*5;7I 68'9;^90:;470" RE>/IX6II UBL\?;J_HV-1_7U"P!EH_C<
M)&+&.+8G0C*&\5*)^'1^V@3(( /\Z6/L*(N3^O<Q# V2'+\12V8/G1_0FW.J
M-)"'S'SR*]$7T:O,A_*UR# ,#R"%L^L2:E%E\QFG6&T\47X,(W-?H>^?9J;.
M!H8L,N@N!F-K(773QBD>IN>7W?$IS%[=UBE;_@+1&>@9#Y-M^7 $OP#4=$OI
M^6:P0L0(E)[:PF!US*#- .5G?&450XX*H9;H$E@ID)<W-/D?U2=I0L'?"7E_
M9E[D-0?>Z4DR"++PP&9FCL"N'FBVRG&_!DG?">_:A!/DI/ITT:!7*[5/US\I
M?!+]FF\!]K+L8OF_N/N+J#B[H'\4;8(F2(#@'CRX.R1 < LNC04-TC3NT 0-
MC4-P:!+<'1HGN+N%;ER#NTM.WC.XYW[?\$[^=YU!K?4,GUVU2WZU2QIAQ(E\
MF!]T@D7Z=" O;ST5UQ4F!1I5?/S_Z"SV?P0/C+<Y+^$I2+PB;JZ:N7]NZ]'[
M%](^QMH.T##.7N):JL]RL$0>6LQP.^W46X$O@Z/(S;)XD#'+REDX9WM%N;<1
MFL^3<QR"0^5<C#5UX1='>IIM+J DR+!.758<MRAFO/2O/1/T^6QK/PY"TT7D
MDI)3W[J/A3XO+QF3$A45(9\X19SZ5'T[S=Q1?8S0=#>FQ1AQ.39AC:32*P!S
MJGR"R7^;-0]]9FGQ'Y5O9*9^SJ@NF%DD(O0:O2<5))"O1W92_?%D"6@@K?JV
M9]=5!8C!EBQ/OB4!. E)' Z80L,WED008?(-CU+<5?'W$FPYH"C,7[(HWE&
MFN]W&2:-6I9=. X9#:;)+]KB,:&+'B'AENR8I;#-V/'URI1Y)CFHX2"=\E\
MUT8/"]4F"R,A"B[PXND]$P2V=>!W']B9"1\<.,N)% 01BCL$T"$D#XS&/.B'
M'*>/#:YW[>\22J.;1@1"J)Q]^FFRSUZ;M-;%&2:N:H@YF!3 %^EC1G<]:D?)
ME%K!: DQ6=&N[!VS[FKL!E\H]68X3F):3T*7D.4P;=_*->> /LZ.J +#+BJA
M#.LL @6Z9 ;HLJYN]Q$.@ H?0'Y)5C#U%V "&='HI56!&$'2AVXU].>NWI.<
MS($/BZ";\N''K(Y>I0H=\OVZV;6_-R&4-9,6S2?XWC= OP 9-&_"\?WIH\-C
MD*6W*3\V^F!"_M+6199\$ V*_64K+K;B=%$*B%NYMC;%0K46",P'O65A<?G$
M/R$QB]H-HS;<2?M"89"RGEX8;SC0(M.#8["9J&!\5>3A<?%&K>C\,=9FH#<U
M0[_G25;;4]CK9=D24GZ!C["8XBI7:Z#X(YK+GZ:-YCCBV[P^^@?M&?4*VS=[
M+=9W&0Y85M&JW5C+KYXOTY;])_0&S#8H T#N#P+UB7.<=$"?J/2W!(!8X\3>
M:/.M1(U*-4T:HM,_U>&]_WZE/J@&NGKH<N>2@L:KVX\A3;=9S!QUX*;+6.#G
M(9+Y%T#IG:?<0L&&,+(7^SZ-K&B;/_VL:Q6KT,-8]\.31I/\XHUXW==H:NY7
MWF6]4F\7].;/J:7ZV1T$8/N"+VP3,@SSNMO<^%CN?[BD,B1OG8N-C+U6FOV<
MP2FK4ML2NZYKHW0TU?LU\(^Y IW5IB2_%F*O48@#-SFYO8: @ZZ'L)#!^$@=
M<YE<A!I#3;RL3B C)N>JI#>'R#LWP-L(T9A$W3[^TZ,(>9<R7==K(>_"D$"'
MAS<M!&AW:VVP@72/SMN$J+8W!@\B59BR2!.PJ*/!SCJVHW9$7,+!1!RA(>,K
MBI?),XYZN@F.%;V1#,KE],9EU3T\(OO2=+ B0<5;C9X*%^J>+Q2&&8P&F_&+
M \T$ZKK2_1_07F!::E-S0KAOW_N83'#,2'S>.&(3/3X^.;H*!M$;@%)^#T0R
MM2?2];8]J/-.)J.!C"M?2J)'1#\:>I3(%BXC[5)("0IFX=S.!' .*2541WV\
MMXS*TDM'T1C](I4+SP0!J/YQ3Q&%Q]\5&<&U"JF$5(.OJ8[IWOPWWXGSM=*,
M99C $=?P%.=47I@Y_"-!&;ZA/FJ0(MK7A1<92+/WM[1>&Q1F]T=/OE2KP8\:
M90<U*\ #^FGL+3ATAPFZ_)U-D0SG^6Q:;CA+3.D";V0UYA0>Z6\(MN0J\"HU
M,NLCAN4PGHWAI+MP)+Y[^=!-4"W-&8PW*02]"A"6F[ZT3G8/$!KOLH7P:3J\
MZ&4$GPA-\@6,*8#7EPFGQ;\="?AA$6[WC-<8Y48:4/^J1MT19=RZ$2WR\*NB
M!Q7$"9RQQ+7).'HHEN_4!6-'42XZ5N8V>O"2X8G8?!<(C3YG^%!$U2AZ>'6D
M;U)M@C&@EJ,AG!$BX;:T!!27%Y(9-[0D1!TR#8O#K+!G"6M[3]U[,?#3KD2P
MRR9#KBY:H.#K/SUBH8MWFZ5HIDG_3*17TV?ME+ 8TSA8PXJ/V^H<0LL][#+@
MQ!8X%GX".1B\:)*B.Y@QVH-9[-5H5"S*NEE%@3C"F<%MH9@T=@.CHM$>:#?O
MK,^X]9(4X(G7\]/BR](%==72Y(B;A"4RY6I#,O/@J@:#-8X<7E3!Y:5;6^GV
M.A65L3?J38VQO(2RG/F.T* M5BT> !V^F(LNLMO7]KH@;$GS#G_O^$+:&LTE
M_X4-&KDB=N*M#;7+D,B$H%+9O] :$ !Z@JB.GDEUEMO=;^F)Z?8G.Y453@2P
MK_8?=8Y84>H[5$[*4M6,BXA(LK^:&#!EF*NLZ/LQ?6C1V4&BM[&/4/BBL9CB
M.A%)ZK+U0QH.\W()6=PW)9X6C+%':L^!Z-L2$210UDIZ)0;CEL93,BH>-A[I
MS8P&CUP[_?E4$GB+=79?^\A=4H]@BYCRDO]H_N<XU*0_[^2'')X<GC_6GQ1=
M%=T][6;_!73W+VQ':#='/-"(U/OQN[F\&6 07%?:B0Q5:P/A;@7GAW<YNF7-
M>M&^D5"-WQ>+]N4@V*OAW =FAD<J>A,/,C[EC28QB4H3QN.Y?A@ZAJSC3*JW
M9=1G>+0ER:%] @XP$GQO)$AEFXIIEG]:)\?\00QZ%,U5\G/S88XI:I];LF%/
M1\QACX::ES7R]5#'$1U7VA4)__<VU=S=M[$,[/$M+ O8B$(:7E["B+-_1FZJ
MF%\_Y"$HY/N-02RW4:A?IUNH%4SG*R3$?Y+$CB/UY@JARPB#Q1^-GO)NR3C8
MEDZ3PCB)HA6<ECTD%+,J. \_PHIB'=)^Z&AZ;:_E*BHGZN"+H+GWN\2[@R\?
M.+6&5235Q[%'##%HL+^E? 27QDN7[#V!_L5*R47+MUGX9RO5?P%?6I0$]!MG
M;!L:6Z D/FK(L3ING,P@7?13%+TEG>C8!EU_EXV>(DDDQ/)S??.5XBQ0Y9R#
MBZ@?XG=!BAE.AOQSM4K[^DO_^?SA'@G&SI!$JV'':.::::9F33)-=\'SP(Q$
M%?>#V,S(N1%NA\SFB&6*JN5QTJR[P/T_[]8Y8=;S>>\.TO6(QZ!PMM)9>EO*
MVI] 9,0!3S0$)ZPKX)2JK_5O^M&F'F-)=XUO8/),;"RK*)P)?U,VEO8!@\N-
M?LWC'5[<N<F^BF-UZ@;T99*][7!*&SK.FZS_Y@$^4JPO8YR5Z&0_<G *-LE9
M7HW>1 K\!1P&\#_('OTWA"#'<<GLB$;F+A,:QN+)G_T#YQ[ VMY9)?AL]HVK
MZ+O)[4+?_4W8,3:P)Z\/XD ]5C%<;Z$X51CS*H[MS^#2^_M1A6#>(,4^Y,DW
MH^.H]>U9>C6A#4S83C]B+K1"0,.)\6FKTHJIZ[R9#-T+I\[K4M%?]"=2< ;X
M!^&OYKU^K.I97.B)2=>!.>HVKN%+V]/"F)HJ[/KEWF]IN2C51=SHIT_J0^7O
MD=>6,@[PJR=(.M?Q?\^0JZ<B93GDM[43O3%%?P&V_Y#I[PDP[E%WOM[>VU0[
M=%6X=!)*$*I5YB =01;J "*VU:YJC":SI*"]=B^2_A?!7'3XON!RF\@ VNL6
M[\$3D['^R *3?<_[Y/ET6\FKZEY2+6">"OY?@/7@\#-&MD_>7D9,K_8^A4?!
M[&0P?:(W,8+'65%+7MY9S/>520<D];)KO^-D]*+LA-:[%FG<?/I4$)9]G6?'
M4:A23*<;LZFXGO1D#.<]>M_1)65IZ>1Y,:!0XAUG"&+H>5TP8.G@4S%:,W0=
M=YFV-M:6F%@H_.F6E4?6//9Q!\[=)IIK;W]0\N4^8&.(-;VOKU2IY<-/V:Q8
M P"&[QJ*/F-]8_H/.]"&FQ-RG2/H3BVXV4PV6%[!0DZ2$RR37>6Q"+-U.6/H
MU1.S3NZ]%A+FV]?[>I0+E^G0"?9>9XH:)/Z>+HORO5\H173Y4V>O!H7/41%S
MB!/WD9ZA$U5#B=Y'9)=&X]>7=\W,2J^BJ9N<)-_5J[U;Q^](MYG",@*$+RM_
M^QT\%!TP_8'17838I(UE?:&ZL28 5<5!1>&"\V@LRT8$^##8U)WCHG#U;.:U
MP7UP_UPO,;W9W_%V!JDW6Y2!@'#M>S4V,JM5@V9"NUXJ>0XVT[GW>_'L"UWB
M;JP2*E1PA7!D**\:C[Q.\KNVDTA+5"Q(<E#8V?[MP_B"VJU5A*SKD.7T.LK-
M37!L/.ZSP$7ED'7B''F^28%S;W1" W3MFM&KM(/NM"#BF_M>!3.V(\MOID1Q
M%1]5:&BRWAOY_0]#_0K4-6I#0+G?2E)/?:>Q56Z5M_:4#ZMU=Q,<@_U(*<-%
M=CKV1'6L3P[VM9<:>'LMZ-])[@-:PH,9\+-GR<E52.FJ48-[LW!P8( *90WG
MF*-B33FB<")-.<#_KT3\/W?[.OQA^Y\5:O4HE\3_)1/_5_U9R_[_WOX+L B<
MR#F7\9?\"P"_O]?F]%7S@1_>_04PLO2L7E_\!13P+>1/HOR7<OQ_&_W/[;X=
MP?^C*?4#K?3_G1G]'SVG#I7_<_GO) ;+_V;50N;_9N?_([+1][WO\09\/!P$
M6D+Y##>/,$R8CT@DLMYQ66 '^U)=_+-T"P0;[]%6'""GW^G\M$GJT/,URZ.7
ML-)2E\/6\+W[(:_0QE>@YY+ZZW@_W23+/4E)KA$>#4>CU8M(U6KL+UM6UMXW
MTJSZ)A5!I?E.ZP.B?QXA:V6K;TSV2'V-%C/')(>4JO+U8WF4$_U3PN7<SJ\P
MA*C3;#+JE&X>48%U536S%8+<]0%0,^'#F8:VSG>45J9Y"1.F>= &T\\>IS-:
M4;J=<_5IE]K%IL:F;57NT2,N1,6Y(EN4ZMOHZM*#Y(.8&>,S'7C[*KAM1M$(
M^XIZL6\-7\(O;)FZHONGOA*RLNK>?6I:"^+OK= ?_@N0Z@$^'IT?^Z$3;[*?
M>NE$]7AZ3E8DV9,LJ$E8;!R_ YDS$7MQO+? 6D2\-"E='"*TCJP\Z#-]#7ZS
M3T.3N&6D BY48ZPK'\JJ"4L@)T6S$L4=(NO3GC$7&V;OH5WWK/OYQ\@CJW'*
M@6^D B@PV9:K8I=,^&%ZF'!9V6D)E=\G_RS%Z5YH%:.!<>K*^YBK7&K5PQJ]
M/7\OA8=M^(01)1V/GFV$5C:9JE+*2* .,C_T_'..^\"/ID_.1["SNT)]_*#G
M1LAFRLG]FM[0Z=BRV0!_I"V?]RGAPUI\>3AA&Y[,5TV[]UB"["9<.Q.:+<$G
M$YT-&6Y,W?5>FGWOTXX'J]\2\B7B[<3#4!Q19)1:41?KYE*>YQI8J@TGEP?P
MT]<Q=W08@P9^QT,8-/=;*F"1!6/%^VX^)-4 JZ3/H&8Z/ !+"?&VQBE$!Z@F
M0VD[O>%71M( M;*@(0+"DRW(O\5QYEK'-/U"8"Q0Z1A%=%/;F-"OS/^V6U#E
M5&43Q![K4;=\GV:T-."8AZZ^A!8'0)F!$NH_MW7]R>ZLB#-*U:^),&B<SL\!
M'<WRJ>$ *7<^LI'MDI&MM+U9J=3/\9<[9<[;&%/OW^G'Y5JGJVYN8(<PE$"5
M5/V8U(I7^1P9W7?)&(HKUL#8RPCO$]V6%F%".X23Q4S&QO(&)T>7T?8O<^$7
M?WAZ0IJKU0CJ'B'O;\U]&>!2]-,=R[AI;7HPO]3Z&%W#.K:WGJI?@V2"?>X]
M-JKD7)/4!!1KP[\&-WNG$R6BW"D!>+KVF\D'][&J!%IO-:^/E#][%/VI->BH
M<2FNMF8J) 2VL+HOQHPP6+EZ[X;TV1K[,\WOGM[!FT!B%Y\,*[:AAL?"'Z-3
M$KI']YC:HKA'0X-TJ*C"M640)[6/7@\A5:M_ :@GDN'0BYQO@=2S'NF/3'8T
MJ79E9#9IQ@7#?(B_@(&Z2N/2QK[E&;J+KX:-.2^YCRZ758Z$A81;HD]_RU'/
M=L$UJ%[!'/EXM?1$7YEO>DIOT7PW(&F4M(">:]SJ^G;-UOLUFKPUGZFD\:PA
M'+:P\H%'?0X%#.!3)K'?_ 6$R3D^<IT^C87LM\2<JR?<%0ZH +_1D*J0+4>;
MYP4I<"U_&-3]R5[UST6F2;Z6R6TKZ: \F#+<=T8BO7W73Z@B=UNY&59_IG7L
MR<I/E95FO>,=F73%'-$56 U!)'=$0G O6T!]#WOSC7IUVY%(HM@)2J'1<J<"
MG2/,Z+-?PT!CL=]7:N]U:^<H_ABH[62*AS?F;%DOT@<IGV/XQBH02XZ->L;?
MU9:7MR:[$*DQ6,5COGK9K\'R@RH+)6-#X#7*$O"6MI>"I@@][-O<,4LBJ\ >
M^4:C@ISN)V66Y0'K%\V2I&LWD15AHXB5.NL -X[3987@+LOD2OJ,W5LQ6B:9
M9]$^@>3I@-05["N(QX3V=)M:OH,7!C77R43\!SBZ?Y'9<JH5Y@[J;=[GV+8
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M&[]X2&L)*@N,W>Q7(/:L/^]ZNX9R>OGA9I/EM5S=[Q.L=W"WP>J^'2&?$>8
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M:FGB5N)=2X$7-*\U%X7WGHT"+8RJ#B:>4?8%]!,6_9GG28WA[7,-KQM*]Z:
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M->+18F1%GK &.;] $EL'@"HE&B_TIHAIA(56W/^_#7_)?P&4-$@YG]2H-MD
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M'/)SL;8LW*=(WN*7D,'6C2878B.UMO7X5+;#EMCK%H^25]%9=?!)3(P].6F
M;NGW@.7ZD>D==Q2'M@PH0;;2*^\ELQY.J[IK>].8R92$"E>S<S<GIG9CW3)]
MQ>4)>%M4GLV91"\I$8\O;Y7HU9_EW.:13G)DESLG2&!,]E,+OQIM@B,][K?&
M$TCV++YP%2!%=-T^P*\O18IFVF*6V[S5NP"JI,L0A?="9CI>]QO=D0R/WQJ5
MYO0V$$CY79_!ZXQ%KO&!)Y9RI+!Y&JGS,>R-U">V%]FC  L@@$9*;XBL)'6
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M]P0U3L;^T&@EVZ. .:]H!;AJ)!ZJ5%$4DQ!IWB9T5(1VOUL]]']SX;KE.2X
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M]+NE6CR1S4I8V1KR"=S;DE]G(NM0N.2#@[G8,\+07X0FXJSSP@==W8\@"8:
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M^C\__(A)A2K_;:*_U%O:6$AMP?1:):X27G.#=?"T;J?K \=&)<O$&5E\A(5
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MK9(Y,4#6'&I<9@O/0=IHUH?"MEQ^("2NII(-4FM2[ -6]"EG<,MO[(C+B33
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MD4H94.A$1/86:G(QF0;\3"_Y*42$K/J.G%3/:X*=.]F9H+K^"$Q>'\*+*/<
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M85J'A0SGE#L,T/L^+_%9B65-6%Q6.(R/9?1+B&Q(Y6,&X"4X 2=[T))1B@R
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M^F9ZL>]O^O$O;,O<N3OU-E_PAS6=B^12C![$$6TPX/&2Y03\0E<E'A('WZ\
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MKL1<IGX[X=4\RJ/S[."ZV-,];Y2* WX&,QIJH*S6"+\TQ<&*2N=%LJN+QVZ
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M.IU9)09PA8T&<["EFS4A#QZ91W40G)#$214_97RRH9D?C7CC;P K?Q5,/RR
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M<%MPZ*>*<@-01A0N*TM<WZ@,/>* P,1<"[''OM1MJF@NME&HF^7V)'@[Z9M
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MH?;/HRY08,V\DOSFF&LAY872-N!SV?3!\A_1_KW;I\\Z<FS9Q0O;!>WK0F'
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MJWYMKT^__=S69@H])CZ)">,=!5UXT]TG_;@X9BYC?.V2-GD,ZI"5@I3*?>1
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MP50-0GVE[F+H:'_KG$#;T:*F?\.M=)D40Q4K)EZNGA)\A-10G?SWZ?(_*%-
M"\=XB:/#A6_#3P*-(:=PX1L%XZZ!BK;5D0X#DE8'H5\QV!1L/41AR$8TW?I%
MOW<*EB =A&G66JVBUVKX4K&"Z?9I3X_VA_8'(*#[H_L,$'F#%KX./^L.Z6:
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MICW;.2IAG*:&%?WJ]S4K]R1]_[<C_11FMF'KC[=:+!K\GVV=A2DQ&Z\4HZ4
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MY]Z&D-C2U"8Q0!V0R;IP;EI,H4:G4]30 L$0R1U.P\.L@AS:<T6)MV+8(YO
M>,I5)6BM;?E]2VOY.V_)9J!0Z%- ?C:I/.C)KSF']5/4 0/T&)VK'^7WBJBJ
MQ#MF[+Z0M%7&]&2Z $9ZD0$:3Z5S)!.[\3+I='F@2EE*#I>/[?:2@9"4JI%D
M!T\G:<JW"X,O6)U:4&;W;D>_!9T'21PPTD7 7CM9K@UC:CKZ>^A<0X];]']9
M2C2RI0^1+5W.H#OWFYE67[ ](.*?8.WC/RJD#$DHLA0MFWZY1_4=P>M ]\/B
M_I2)KLCV[W,5]-,3J@:ATY:X7I0P9BX9PU_-GGH;4)LW4N*U/O)J9%?>RI9'
ME_NKU^XIK;1];MV0O4#^I?N.^3=+?&!.5NANLRT78M51\9YMN=XRY8+];GW
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MSY1]_>OP=\Y:0WQ:;\[*E>P[(!?Z Q]?!6[UTW&5*S>L>Z2K&] B3LMF@%S
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MK^%$7.<(X&;X5-5O@".BF&0:MVNPG4HY@>A[L407$(Z $$V$@7OE]!X&J$J
M4Q#"+(#]95$"7:K.:S%*95G9/.G"5ZG=]PS0<\CVB0?GY>BV3$0=@"WX-GBU
M8L*LSK/H QIX:^,G%+6HLOQNVE98@X*&X7!U$&*@X%<ZN2(U5;+Z7-S>&4'[
MV*4<MS&$NMK*AA>G<C'UF-&?29/[6?]H_/]W_-<+L"+<!&!C>I"+0 5A]A@0
M=9U6LZ,4)68CEM,+7,+F@HF/+ CNNLD131EUPB+^:8-G_:\MOT]D%W=C8C5C
MW9ED32X"E A<R,3:6N<N*7:28]?S,C<Q^+F7L]5NI:<YZ\T>5\FQ';@UV,H]
MJ:]-":3_F"7V(WBJB,)8R5--NB3KKO>E"#!PJY\UI<]['%;3B\&RZB^>*A?Y
M-/7\<_HLE1]'UF. (E5H;TKI$NY6E2MVI\:4'+]K/BPN$;+.N>G=XO1=\Y7N
MC7C^A$FN!T(GGVEYTY)'Z)R!% ?XF>QY\P3FEPG5$FM*9TZ,/GXPE(U730U>
M*&O&ZD&>FG$].CJO5;"+KD5P \X$:'B+Z"\[,0!#4H$[$HPL;?VA?(4)0KE*
M;[Y\+2,'(0R($:9<.,^GJ;#SKA#B32]QZEEBSDP218T^PP )4,^J32IZ/9G6
M,FH,KJ[?..6[%%K9E?VJ8J_%\^E\Q3K3#Z3/UJAU(">PY$<9G3!A?*V70)![
M!RY7$J=42K DM&1-V_M<^?CLXTWC9^L'C.1X!7C?LE32&I!N<K ?FV0'$K@;
MLE:_RT41F:\=4O[U^L7GELP.'SD'UK<*S<^.I^FUL0MNHSHP+,@V\Y8C5% S
MK52%9_)BGSE)**) ,A &.*L]+QTQ%AHJRKZ:9_SZ5;5/Y-XS<_L7AU@W-"!$
M6U5WKW%^;%;!+.FG(\E('W57=B/ZH U+XZ2/U;XU&849J=X<1Q&DBCX:A V#
M#ZX,VUP"9_0)^:8/U%ZZ!M:$7Z=5(J3AR"&(,X2-/C"CJ,7Q&=B6I&V\)PA4
M1&Z%GIR%5@H+FP^6]CI<K'[1(>-X^8>!J.:3V<JH=:YY!H@3Z)Y/:O.:<">\
M;_G,WA:W*IXZ7[(J\GC&0W&KYQ-NG>NPY>^.#VV9]SP'C'>W(3\LR/K#= BR
M397.MF)5%U\SP!F$;AM>$:M[T63VMLE^I74@U#]M\N(50X&7E8?T;,YS31XG
M::D"UG-QLZ+4&X"AQSR,%RAJ17"D0\7H(PB-T<7X::#D=O6S?@\\\/5F<JE/
M@75! N@PR+CDZ#6M3%I,$XQ410X?HVI3K.#:8S579=NESG!Y$/M:MT$QAY+%
M'?WE(KI,.GO$NR'RCT"6Y[L'TT@XK-(DC/R.N-[=-B!*]68^7$$#O]050K%5
M:R?G"N5N4O2U0^J/3#RU$47Z7VQZP/*S-$1]IXTB] ]?@_//'EK"<72.>4I(
MD /Y+2EJ77?.:Z*HC<]]YM3G=#D%G0XI_I">G76-KPZ"!>);Y6=,8J\[: 3+
MRFHQ0$1I?-UZQ?MEK7/#$%>E"5ELPW1749&\E.BHYB7\<]?3:1<,S18?_+AO
MH,!_+CG^W5(6.>L,RT*9Z9P:51!K/O0>\(>L%Q'WKUX,2FB:.5]+-$YVOWY2
M-</R5;20\9-SVNPO6Y^Y#]-Y$=U9@6MC%/ L_>MLU6S\QI,<<UNA/05-VT"1
MX*X2'W&>NH;$BY4")_1U$RQD1;7&=$%!,K,5W=%:BO3V?/)-6DG+&2BAWVW;
M.*@&)HP5W3;IG:HF;Q?2+3NC,Q3"")=03>Y?:J _G.F<<B0E_&-PY6P7>%*V
M?0NNSJOK4+PRH1198!)B.C(_P=:4N-1WO??=_38GS8V+!]M:?N0]T]SL!G-3
M0^9@XQ]A+Y"5!H,[ML[&@R>&X=**C?)QKD5YYSI..4CX7FKR"5OA?+GQ4>29
M82DT8K:B" N-1%5&,$!K[P4[^Z<CF_/L)H**K)(QP[ON)3\R%3<?.:0X^JYI
MRZP?L+A\QPZC"X*G$AO)O+2\;_G$HC9D-4]7$N>JUB'@+))[Z85'-3<G8?;V
MF'/MB[9'O]'R91*(F\<ZKFUT<:A/:=7^$VQ#_N_X[_BO$'+=#) G-$%*#> B
M"LT3>+"_UO-''4;7WYHWU/$5=MN+_[P*H!^@WS#523%RRQ6'(DM4,D"#_<'J
MZU;5%Q_KWO0<OIUJXIF3J-GN5Q16?*91.7,+0[VJ1*Y@@-ZV1#% 8?<8(#$(
M_A>R)HG&M@.A\A4!N&]/+/#(5:E0!DC[$@/4FDF$3 1'46D9,Z&0.11P%K-N
M\@D8,!A2VO40: LNGFR[;"NI?6;KW!L)4IO*O@XL#GD$N5  A-"QZ:A]=3ER
M"L9P3AXKF91O2W!3'^_"!=;&[R.D.G =U_-+9.54,%_EWI "NY1>('EV+S^!
M2<%-B8LQP=[ORM950GUG)NYK7V8SUV>+#)J[2[4E+4 XZ?Q /B&TX^"?0SDF
MI^\09 ]T-O&<!2=^M>B"$6]M_G"84UJ7ILA/TH?!-<Y8BI(D,$N(Z%PL+ENU
M(N^="E/--<B+G:YC.1@]9'"V.NP'.^=;1%BHZ._'EW1]^*:L>]'B'QX]>1S)
M_E);4O=*BRJSAK17<V6(H:A.!FA<W!JW4:/!?-5C&T\&CMK8]=H9[/1(04_+
M[[-PU4LVM;.##I!-0'[\< _@@L>ER2FX#;'#5Z_3%@RK93.X?#R,*C8S[)\@
M"QO)^ZZL<'>"/.P_S396L"KC>V3^7*^!]/$==!\$D,W S@(RO^-:V*Y#W!HQ
M4>[S)4G\*S&^N3(D\+BB,=+-Y^C/2\=!A>>#!@3W78GY^-_8I CDT1WT ?C)
MP;6=6>X?ULB.O &H[V#!K2[C?+[ 0XK6ZNK36:"A4;@%W@-L64G<*"/8:N%N
MC\8E7.E:)/&YE^4K_,SG'7BFK:'=Y18*LQS6A!1"RU;WRVH2TDJ=C+(;>[Z?
MR=,>R_SQ+'\J:P]%YZRA: 6A"!FM&M $)(=9'A!.3#*%"03=6A'XFGCBW&^A
M.?\'/2+>^9N:AYO[@Y;6E2AZVDP9?XZ8T089UYCKI*:3&2"A,CQ)MB.J.E6A
MP.6[[S$?S^XJ\0^.\?QCZX-/GH(H%)/1ZG5G:+C%L!*^H;HAPK&VH?:5II\>
M]MQ*KX'C\;##<^&F%C'T(7"-+';VQZ8A$=D..415':6:$)"\!PJ#>/ ,4,2\
MMC+3G[Q-^7:]S8N/C6WRLL1<A'T]A /I!>9S0TI4H\>QY%Q:5@TF0DN.I%"
MD^*W7O?$W2L?ZY!^4J'O[['%D8;P>/'TH/:C(P=VS 3Q8#&,NU+"#"^0B22B
MYY363.;!T8%/C7E[BMUYBB>6)VY?U*L\C&]HT'#V+E4[E_3JC;-Z5]):,,71
M!5R3EA13G9T4-8$)IUK/Y=Q_LBD,0*T=@TM//^@4?71+)J'V,G>$3+Y//-^!
MM5&++JECS*;7Z(81+JP?0CJC?^"Z$&IC.Z&W"&"!\5]U%0573!IN#>E+&P^E
MI=R_KE%ZG*4&VM_6G4>UI37 G?.IP=\A3K/C^>0'WQ%G@U#M$Z$U2W$1==$>
MRMDF"HJ\FA<R-V[)I+V,_ &:(QH>$6!9_BB7 5P@L=L"1<01$]) #%W,7>OH
MJ!)K7S"^.?2V[7U#B8%C1VZG.=IG#W4?24SH\K']5RLG\YG_6QX:6NLBHK_E
M(G$CAMCU&QK+;62<'O(N^,'I4]]-\EES#\DM(8&G@>N.3*J$<C% K"5TE2ED
MFSV&B0HU>FL@>/^R1;<*Q>+(PF<]N9/OS,L.]YIHU*;-E%)#HK?C<=PYWXMN
M5N<+C*5X3DHO;_[;DM8@Y0/K_:35^:7N$F04AK>&6]%$U41Q,<#:1,4^=/DM
M^BO/+7<\Y[X&G>,A R3KZ,H /9";I;&YYVM^V7HJ>O7IJV5M0^WJ88M;W5I&
M.4Z[VVX"*Q:I<2DFJKL6$),/>4U*=$XCBJ[[;"5N[>$\-"Z7]XWN)QUGP<2H
M"[?AV269*6RO6-HN1+F"U%F[P[@18HCAIX$Q+<I4":)Y?:X(*:,3=>37E5?/
M1'9H4+NZL( !8[T-D25-'UMY7YD/E1WXM&=_CN_=%23"VL#/,40#V(&@6UB\
M13<X&L9%?4@2-GTNWB4V&]MDZ!48&OC1X,";X"T#>/HVAYFNH^<AWX[4WY!(
M38UW@ [6*O!%TP7[V@;/# ?NPIS'\??MPY0YQ X:RK#=OFBH>9MM94!*GE@5
M] JX #<JRGGH@1B>,&B"5D?[):GU?EO//.[9==']$F$V$NX_KQ0E5A?1(@:_
MKB6 4UIORN8Y]BDKP^.!$?>PO.+U1H^I0[<.'">CF8K2B0G&52RD"D85<H.R
M!"$[]C<:?4*(>K9&5CBJ4;'*],;[$(4M^=3>I6<&-P[< QU,W)-AV3D9/%?S
M?,/3R6 ^@<M0)O[@Q^<IAE=!DJLH8E07^ 6*MT:T&@FBWB4N?@Y\_/Z3PI-0
MSYE%@V>73Z6KG=(+6FRQ^G.1R(H5IM,K%L7" #UL# W8Z+X!O",TQE"='LNZ
MO/\\(F^N+C7IO5SIY4??N1GR@(@AFJ+'6>;0:TD4K5^8FLVU=\1M*%$MKD44
MB#)IJ,,,FKVCV%;7<3P>_':@HRW+<LM:WL(W1:?\./BM&>IM$+I]1LXH4U.)
M8 NY:ZV17MOHSM7Q6OLB;7GVH89-H.F7]\269@\"^LBOF3.5U\M7S'FG;Q1L
M"=TXRK[@3@"DD\C,MPQ[URN3_+A%C#Z4K)P]7=M6%)1UI.I1KO WQ5 UE<%U
M81#8Q3:HI)U\A8:.4&HR?'BT.%2\Q[&P+RC.QSN:P\F@9VH.9'A<PAZ-Z\24
M2V7Z4VP1H[.\D+D"K3.U@4,WAH.,\!*FQ1U/;1O3<M</+#O"MZY<FE(RMG N
M88#:=)J"YY'B0!(64LFS%DY0BFUP#M^5'6G2)80@><=_F9_<T'*,'/O$H?8X
M$_2")>5P;V45*!2B&\S>BI[4QQ=USXY3K( ]//0H$'8"_SR4)P8NIYAE;5[>
M7!W?]!UQ/;7EL8-]^+;GG;8O4OKS3)D0V V-L!.&B+2<8S[\BF;@6ZIZK"5]
MDJ"!YK6LH;U17 DSK![3>@0O_[8(XH\?9,<]L8AC?D[M)C9I'#F'_+-!30$*
MS;A/7(I1:5;]QM5HV%0A6#.A7!+@6U I[V;M(JK>Z8<\Q !Y]3L33L<1DF*1
MO,S&"!$*XL>W1.&#J=H%P&0'WUGZ6&7<$8-:LVG^:F23[M3DJ,_H(Y;E";E%
M9-AL':P;%7\E*1)N"E[CFI>$X)?B-CQPNB045<9<F%^A:8W5(E#H6%WV$5;>
MM;T'O!OBD9=V.O^^0FG;N1,]@22@P^DR[E(B0YYKZ=][U[I!*5\OL;6N^/6'
MRL($Z(.P+2M-768+%6+J,EVD:NCI^@P(/I&_#=?K8_I.W>*G)Y^/1XAZHVJ#
M[6E$.'X&]ORKWY7R3E/3F\(W;^YO2[]C@"*QP! #!)D(I(-X2/ET<9YY?2H#
MY#H+@"!=396Q]+,,4'0-P8MV] (84(4M(IKII=Z;M(,C3.UV9W=@#4NRZ)P5
M?")I>IOT>% S/<-5XO3A@Z#WOGZ)3;@B7"0""]DZYXXA'TMB@'1QGW'[*G/?
M7%\OV8DZUD^%WC<KN]S3Z^O1,U'PO6PSSX#*$^<]>OZ-;G2^WKD+)O<5^'[?
M-D=$$ :X@O*,ZIM4F'WCCCM7JA>B5BWF0NUK_T23%VL^T[>XO9'5LZTH,?K@
MC-@(E>4=W.\[]5B>85 _(1__(5EIU\CD!9?EAG7V;<N?.??26;RNNR^B 6GV
M,.I5XJ0%[1U=$K@Y-#=<S9/P-#*G4%NF7UK?BT7S3K'3J=<OS$1E4D=QOY:^
M@5V#,CKM1(AV24K130X$#6Y9:+A4*+DHZ*6.U%//P!/Z!#<>]B!**^J8<M?W
M%C" ,\0]'M81GUZ>>&5Q1R[QHY7J YY:]WFP!""+1=:I407].L!L=.4)28=6
MV"%-45=_+[QK@5?%C-OO$H&\X)<2AM&%D^'=&Z^>*(IK$"#M2!9$*P-$-(6$
MS9R@Y3X1:5+!H^(J5J3 )*_(ZO:[O:[O++_R'ZZJ$8>3P*] FH6MXK/>[#/5
M%G',SG$=Z<( B=)[()5*L70(56MHIX\&N^Y^P-6]M%-Z$H(*]?*<_*ZF=]G0
M,O[\PI$%[]#T[Z97J_W*VYX<N?9;X "T(U>.B E_,KN.$@92L#>KMH4@-6X6
M,:PADQ&VWZ[UK&F,$;5%#S4MD:MI.4TJ%'/Z@-89X!@A-+GP<]'%'],-SFN!
MT3J3WS2H*1_YV,VFFCG0,=4HX(QPQ[02G:/*AVCN\@F)AUL&Q<//A=_D0[ZO
MS>O 2OY84A?"8X*"+G4ON[#LZ&!SSQ$Q\?+B9L2,&'D5([/,//><*R39> -,
M,-<):>^-*[$8F 9@#.=C4O V BNFFCFOT2.&Q0;XZ 32LKT6;=V?-JU__BX@
M(QSLZ#S!(7Y'S^">C)\%C'@7&@,^XO4$RHL80U5 8EO$ -F.*_&JYG87&DAL
M.?OW>]3VJT*]CLI4F<XB#-1%9,1 ^[6Q6Z@)?7("J:XM9%VX??8(4PH)4?5Q
MNPNY1M8F;/9U536))Y]GK6S92]?U)%\/3_GA^7HID9:+\:0Y$Z#=V>AQOWG<
MVF897(FTXE)D,?*D6<>\;M3#7^X\113_.9QS[; F2/\+ Z1Z+Q:T+Q6[9SK/
M3A7D@0+!%%T 2V8.*6LD DPL:!N[Y5J<YS*AT'Z@I*S_96.ZN>\+J\Z#%^4T
M//L,ZD5ZQ#%\$"_4L2!V;2 0[PX;C^MXBNJ$Q@BE#KRG7DBZ&\;Q^ 6G5<#G
MQHQC';&'=-(6#GJ#+H/VK\1N(\<'YI4ZH7%6GB4\7>#Q1AO H_27VH7N4Y%%
MQ=:SUM,EQ0]/-8]]'C\O<J+\T+!^V=-__&+._^5BSVT455");G)EF^D:8?NB
MZ'RYKQ!W]+,&S/H)HB<RTNHTQJ-P0/$=6VM#0TP.*#Y%3SC7S\XN\/HGN3-H
MO92F]T(I&Q/J%W:6+-CO\EIX:("31RU^H(A+23&0'4NFK05E)0%^W1VH??FG
M8#K(!!;# 'V4T&> KFUN)NVAN&@)F0S00-UO]+:6!>#  )UB6@JR1#4#--0#
MJTXCHEXP_74*Y)BF!B'G4@<_U7;HD9'D=?&H!'DGMK#+]NR?.T/'87G>JJ:O
M'>^YEYIIZ<N*N]744%1#%;7#._ G[I@GH-T1LL(4 T#.%$BE: "_\=_CCJ5L
MPXAVQ843Q^EGG:O33X&S.8E,Z@UT>G$$E= YEO!<7NLE+HI-8+:93,)EV=?2
MKL,Z/G(\:K(+ATZF/)J/)*OLFL#723IT#A,*!]6.1/O=@1:F"G 4KXR(UB2_
M=P^L/>]VU-K'U3[LWG6C1Q4@(9D4P\46XCX+%C.'HK.3EM:Y'E*,X.Z .LGJ
M=]MYJAY0WH<'BXR[^MBJ5U?E3/5+F,(3*V6Z-,FG*GIQPQ!0RV%J,"!:NM)R
M'MBD/%Y!0(8B4^;7GN(BUZJ7Y47OVWXRKI# W['A-;"Y(/L6?9<(?M8D3,2T
M[2.Q#%!4KDCE4+7MN2GMHE]9\(.7WVI_.YATUU"VF/E2,F/K[GK#3;KYTP#2
M=H306(&I39G9&L:SZ"O?>F\K(O7QWDM];Q>6'BT91#^F/"D:(>CVE %*HG-3
M56&<_0\5QLC5RNYG[!.%;&K:I[K>ONL^>>/!>!N[ROPL44=C0,26CCU6B D,
MU4IBC_>_#!=5H >JII2)&#L#-Y@20^I9&/O-7U'48U@ZQUQ#[TKXG$W7M*(F
M*;\N5D7:87%W>B$[ 4,$-TZ*$%I2B$M1FI YVJ&!]AF!(07EZ4O0.J,0;JWV
M:?O(F5,B]V[</OB!!70@%M1P[8'9L^.)VNBP/\MHV!&205SD#[0B3[@<OM[#
M6@<(VS^=5">[9H6<4"R@: 93/MR_G3S;![M)^5Z/B9BMFFU7"I<Z0_**IXL'
M02D:=TG?*OUA C:A#<$MXP&!_*?';=.U;+^-<F+4;KT& 0/D:2(N$0V9^\0
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M\X'K5?B^J^#.&>ZP?<A!E]S#E4;J$<,%R9;=P<H)&E]T#J2I][Z\E-"]CHJ
M56:L;1.A>+UW1 T\NKW_"K:]H>K61&W2V92?2E^'2N]F3@0$O*X\5ZP(Y637
MMG-XBVP[!7D X^'Z<1R0\"S[M+;A85\QVJ2#]&-[%7BX1VD\Q?#+\R\.,?Q'
MB](<E0]L+ZWW>W@@F=^32<N1WRP;=G$>;>),U3T7>5_@5X'@<:(V.ZL8!4O
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MZ2[-GL*T+$.>PL7CC_Z?/>!ZGT'!)ME1/(I'\1#"S/]O @!02P,$%     @
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MRNWA^+*F83AH14,VU6S$(PCLK(#)S/*,/-')_1JGX[!Z$O-QPRZ.[;WK];R
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M2\E?!KT&.WJ\KM]O0[+ Q&\3O;WR?F%N#MOJ[Z'8']KH>WN)R1VP\.K077A
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MAQC+.F>F#%V!5XR'6KTGU2IN)U2] +B-1Y5(:)$[50CE?9?@"P8Z7!%<QCK
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MWJ<RYW1GF^PUK'09&;8A.HA6^0(JT%]+N0DAY/R]%XXPV[MK5G >*B#7M*Z
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MQG=%/0=QK?&7E.9_M/S5?"&U#=^AD1SD+IO+5G&!7FQ*7Z%4FY/Y]L:[@\@
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M?8.8M0"*VLZ=K-*;%-T+[TM!/IDS&;R\>O.=RK)>K$A;&Q6E=:[D-IF#]((
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M$VA!/2?$&8Y/;V_F;&OAFJ@N>NB073\N02=HK<-V;;1IJ/S3#TQVS+<M?B_
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MZ$W\!+$*SW61<M9O<E(0QKNF\AT]22PQ?B&0&V^<*7HM5I(EJNA#MAD \ [
MVK[@-P]YD" J@+'_ -O2 7$A?Y1#;U*!BCX[*C"<W^^Y>Q#,RA2><BK=:W2]
MP1\D&M%A'FLE+MFXMN0%PE4V!5(!'85N*D"\LPHG)^J191'"5&#0@!A"!4+C
MBJE +^_ H"W<N(T*#!0=]K2O\2(S#Y<O4P%6F6[DC@GE#.SOX_ZCJWDF"I]Z
M(140LP3K@/[13+O"9G]VQNNOE8S_TI'GCO'N:07R0?S4R_\:Z__>L0*9VF&,
MY$!BO;UW( ;,0]89?8+-T!-OQ7?N<&YV^82E8*^>.)]P(29FES==/+QK''K?
M%^.L:8D_KTRZGN6_GMYY\/9\5TE]GJR;SRO6;^L+B2^>R8R<P?$UXS<)OD18
M+ED[:=:D"?>C+K+4">P:=^Q5I4&#VI>>+Z6-^K>GZTY<V+:?;&):<#70(S:_
M)XH:H5QK%+BMB"+KWN>RD]1>';RZ/"/PJES[D2$VRZ-W8/KB_F1YLII!RALA
M1'Z-Q2H9GJ-U"KIEW+185M.2UMP,ZR'VF8QIRSAK"PPV7?5=H (1G$X'[?U"
MR0-DB<EH_WYNA@17?O%4AN?[S[_Y]3_XQ\J* /UM94 @?H[SX.@F.@P5>&EA
M*NCG7>;>.9D95R-6^[%/E!%IGB7NFB?E\TP_YOD-A8L"Y<@YP[CX?'@DH86G
M=N0>WA 9[3:?QL$NGZ$@6GG\FD'T['2$HL!]_X$;XM:A4E],VSLW7:S1:%NF
M/A.+&[EV2'#W58P"T<I.BPKDI-(FBR!+J!> =W)JR?PE4$MBZ+P+F(,(ZYX]
MH<QNA_OT8I;"[:HK1S+.;'&L-Q<PEWP]V9+WLFN,<GR,"CC!.8FJ-^/;43X^
M:9[Y>7W.3^7*]Y(3:]NVKC;Z*\1VLX\<98D_??C:>XT*\ 2/!0N->1N\]"V&
MW+6;FKJK_B$UL:Q C/P>.*;%=!H_V?"^R*Q0/>J528Q[Y0RJ%BTPDGS#-1C?
M_,3#@!9C,9/$K#GB[/QI#^+#,:T[!@NV.J=&TXRDSID^8Q4BW[^\6TX%C(FL
M),,5=<.90M]R\J6HKC'^3VD0XIU4IB>/&]]]5*CZS+2U:0>?Y^!T0G(C'<%1
MVMHUG-;$% +::!AZV5Z Y=0\:S7Z&: EIBO4D'TZP= ;5NW8=HZL7^)78EY#
M%#JL]Q"/J@Z6%Y;C(]U %VT'=]V%E72I+"Q-;-I!/PP;ZDWHJD],RP]NH'RW
M-,S5O#+@_91(N#*1'X/ <N(EVY'H%B$\1T<@5JI*^BXXSOT]%^\WGV/R(Y_H
M.9/I'3A'..V"2OR&YRU>?K!U;HCO $746A(J!0IKX9V3'WH%Z5Z<O+E/#[,^
M$.V"LT*M\-N7B2X(Z,6&VN9!K\SCPT9I]"/VM:["&V>A**]')O4BMQ89WDIX
MQ.8=&(4VN7B7D_WQ^SB+=Y(1&V)5P^L;4)ULR,I*($]"P81#J()B4M</UP>,
MVCIJB]?163'^>2N7)P^L)$J'1M_J3>J+#\BLE.WL!X XJ0 M=/<N$E/QP!X5
M2.PV6Z$"L)^T=)Z\,'MP#G8"C*L8O7A !?(L'4D&3E1@'"980W(I<P.?^#JD
M)]?_0^7[)=*7<UY>KYA?13P[F?IB0G*I1P#&1=MA;& ==11>*D 6%Q(CN9/%
M9A]2 <>^K28XD<\WT!)Q*XXOS[EO'.'O92TG_\RLV)K[35#N<*,Z6N$HY;MZ
M^'-05RU%E)@L&9;"[4$8(!IZ UTB8Y<Y&[99=C5>+-!I24N1A? $]_"RA5=X
MA8X"7$/VFQF:,<Y%;ENMK:^_D"S?52'ZZP26"Y4W9@2)@7B;JT0-CECVO!E1
M%$)3Z>!6)LN4C37:*4W?=DF?I_+DPX>DJ"/HT<@S4N.U=8G5?>Z1[$631K@M
M<%AL3F-0!4]0Z;7;D_[^O<\.*U MNC(=Q19O'LI;/W76<"4&M,2CKM;"-=\(
M9M1L[Z"VM7TJ<0I8NB*_(V07]WEPI(F?\WU5T!,J\ IUF^V!D .G(.*/<D5?
MAB[& $L-# D1/2.%HS26K02K$<.]\YT\9"=#O^,+<J*/UDV34*(>%W_6:^&C
M#@S:(1S!,DY(IFQ\KK7AO%; =KM[GO/WLLZ:LMK(/-X9AP2^J[*E2(]+&@$5
M8@R"+=QP3%8^3J,SF!>'ZA!_V4[0%OZ6@QRWO#R&6;PJ-Q4SOAWYT(PY5ZKY
M^+DO95+;SX9B:FH3T:@=].T7&?5:!,0T1>\+\CC-CT_)%JAT'1PB+OC,X[2T
M-A0C!_&6PGS'O><V7JDWFN]X9&P/U06+^X$6EMN$)%"F>/=H*"QOXNXWN9Q4
M"O=:;YU^=>UY(31GV^LD8&$%+CJ\/R+GV;-M1@46VLE@:Y*]!6ZCKCQXT@Y<
MCQNK3'.K+W1.M+6QZ79U4>['D#19%]O<+L>IJ"W=?'I,X$S:SGDSY]L9UJ_4
MGLQ48-V0VMURTE5I2<^2-QKVM,'_C%IU1XJ>D"D52)+Z739C1)9%@N8<*8Y"
MIG6@;?P:Q/^QY6MGN% V7J2N]K49+,S74M63+\ION3',!!3857(Z]$;H@_=L
M;/?8CBQ#V,@>"X@(."-4?]Z( ^+4$!XOKUP-X9I^7#'1!:M,F9(N"3_")WS\
M4BL&_\TE2?GC5E12MG#ZY&1MHVL!)5Q/_)8;Q.G@8!V^"LW_Q\Y*AL633M>
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M19[Y;?Q-*O!^-C1([\!V@":'Y'?^.76:L8A&.$6/AKTT%:C%P[^VS/_&/N,
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M@V -RYPH;$1+U2@EDI:N$8_X*Z[5UZL?;6R-E#O*!'L9WG@DX3M)E>LW86O
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MZSL1K=<A#!IVM1/T9Y1_.M4KV:.X?"9!VGE-QB 7HEP%><V2=@4_,["Y<A@
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MX!0V)RE1@5Z-42JP[HEWI.2IQ_($]X/_Q$AT %"5)?EU,X32#>:#K5XM0GU
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M!MRN#O>$CDBOMHN$2.2J1_T;!?X?G9HE!&<JD.1;0HOWY?F!P^O>IZ3^*J
M\%^T$8*FLY!_KM9L\9?NN37-:9M>Y7<O=.Q5X_JH+U^FV9(&-!BN&?>*I97-
MN_,XMW!\W_2.?; EPZX^J-GK^&9.BI*7 3"))3 I[[>2=(*'3A5VE=F68F,:
M8*%RLX?"/1E*W1>Y^E9GH@?U6O3W*C-R:ITM4]1UW*A >>'797\L6U;R8NE,
MSPXD'EZ;DCLO$QW+_=FTMV!%X'QOR5Q99S<B^;!S!^Q'0$.D>R\87N@5K6JL
M>.2C)MNQ++97X#:P,/;F><L2TOGS(A':DE9XV65T%W9AGPJ<_XI7R[>TY)0A
MV)YX/I\4)3.L&>(+LKYYL*W#\UEFND4$UAM/%*5T^<-V!#_@TO;<(R!;]A1F
MVB+*@APRKK;0Q<)^6&U#$G<F),D=L!"*TWY:E!1B>2%&JI_'Y$C :*:"6?.@
MMV#@H?9&H.":SRQO?U.H>&RS>?C9#X.&SA_D%=_8SN]J+QZF(]UT&I/0[4C.
M#:YC'I7L,$'C0WJB %,MOGNO8J\$&QCXMCQ'/]L[28U'L:=0^G/,#^$%7F+D
M7L/V+J*0"CP$38XM8URGA/GQME_K@CF3">T>(O('+MPQ<4OR_A#,JL;+E=L=
M:WT7=IJB(S,>GI977AF"+ 4G_"#PU'^HM0YMR7?F'2T=G$+??'&](/2E3#$0
M1N]-+SSZT&5X&VQV:W7MWC1$Q ^\\ @11#+1+M0N*>F=BW4Q:\)EYF?4H@P*
MVF4YL\.<%J5%G!^F".:U5=S+<S@^:WN1Z]P5 4:!N3D4)T<KA/'JW#1_6\7/
M125#OBV90VWZQ@RMYK8;#_6O-9+[6R?2Q>--,UY>&DBOGITD=??-"68&'+2W
M)]V]ZR=OQ#W1[N[\-)(M<58\5^_<A<Q5]%YL(\O.?L7K<6=D=7B,"+ZY,'17
MQI#+!DXT6-_1+R_%+L6>&IK_/!4;-53!5<+>&"FMAV/9:2>I0"_:"LM)4CAG
M=YAWPK^;@.KNXA]LEV+Y-B]H]GQ 5S7&.)XVQYK.J8;L1B*6/@TN\?.CQ@[R
MZE0.0K]RLQ:=W;J?HL9U>["R.WF?Y0=W5N$98?;B8)2P]$>B/0;)RXU);FZ(
M,XANYM.0Z=UX&.MM5.DF"'(MO:^V7?"(0Z&'Q[*<\NU@++^L&R]*TKO=@"1)
MQM;8V,!J;@[Y_Y$KT3,LAM7I;8MC]#OZP8;R#<P$-2Z(%@+?"-MHOVFEY'QF
M:#<]_SKA;A/672KJ_J=NC:I7T+?C,:Z?$3=QW2^]8(RQYEZ!1I7LIK?3S9L.
M%Y#IGN<8];4?>"0QT0$^1Y^K,CR;Y07_>$MLI+3RPP[$UXJ%2E*(Q32UU-TY
M2V!NI *#"I9&"W9Y1AA'U=\L&L Q'89@J<#.$;LTEZ_(1_#],\( %?BHA:0\
MEQDV"ACF)#L?(+^F08[N\-?XAP8$>2!QX7948. .>+. "K T:2[P[;\U,UR_
M;VR#Q(7-_/,*&,/>3 6R/L)F#2F\*&SQGN*/5/MOP=(_Z[+$B/?G#R5OA6/Y
M]PYTILN:;$95O^ :<C8> +UGGETJM[&HP3.%_L#=*G29>PN]JS2MMNYVIL+&
MN,3JYLJ)67H4=^>)5Q$38K;HR*V('J9?;((YZ&?K]CWZI]KVPUNYE!.DF;#K
M'&Z%6Z2:TSN;DD%4@,8?WJ[O#+N/[ \;$<W]06WIK<5$(WT4V62RF5*?N]+0
M\71:(M'#VVNK,RPAV2+4@6WIK+\E9\J^@3W1$@./@XKBHUKE',<D<:/-/;XC
M^:,APP45*K*5EPAV[JKQP=9S7T7HV/32XZ=1(S :"#'!!+;CZ'3R.=@_,5C9
M*3SU)F?C[;/>,EC)6R6+3;)('7)[C(.T@FR+)UYUARV7@O:&8:&6M8536?H^
M?Y1(=K=PH9Y '\XA(B@"PV#,6>2@%RE6@G25G[-5:SJV-V2B;.9*Q?Z*>-,U
MV9BH+W?=36,(L#_Y9O6):W]9!N?YOK/2&5YS]U!R_ET6BX&P=D%30RVC-\%:
M/[.DB*%S5"#"3I.&]P:4.Y_H^]GNS'!U_P63IKHLRJI-B=.D\Z*-E7C8Q1&;
M#^^Y&L\_$CO#6K\WPX)'=0?Q7V^IQ[GXG5.*IU]-N\L:"'-17_5-'1O4+7'_
MT;/H^OK+=,-]P0H_*N"C4JM=,.H5+>=IV#A<(WA=F5U[2^+%TM#J>3%3W<\E
MHKD.BLEB)W29)965FTLM?/#M1V7_Z&HTN3@B_2'D.7 :8'H\5^G<B:U;AGU%
MI_5KHV"I^R ).Z@0?CE"#KOK1)8_"-J 8Q L^^H6A8%/V/N74HL'/)6S_?*2
M>1J>3$C<H#OK$/.'58L$5 $_VR5WM5-8VHC)SL_-&8.CI#[,7O5-,?+7]$GK
M\*WC5ZR^T,OR(=LU0OR1AL-%AF2CL<OJ@2;8W3+W#ZF.,/AN-A]ZD>A*<?P&
MXM+F63N%[(B/M!X="%G"QX46K]@)1@T-#5C9JJPZERDHB">7+1V/Y<%%/DAD
MU;S\%A"WN[Y&!1R%F+HHH._>19I6GO.,P]KCN5>J\-Z+^4L5KH]%;_=Y>CRV
M5O.4V,KKE<%V[<D^;?D\N(RD G;Q"K.@&P8&R0J!QCO&.@#/_\+I;[D^3%O_
MF_^\A:]D_%?]#/Q5&]N9DY1A?ZH54/:GGL4O>P?QQI;6\1__>)DKU5_L'J\9
M6Y+1Q_X;_9#3P5-@H;0A4=RV3CK7S6@)A)+CFULGSU"!$+8+L*H0LFZS;".=
MZ?D.W5!MY O-&)1B?C+F843Q\,/I+ W2+<H@/_BDYB6O:47],[C,5X7K^"WV
MX3C-95#6X/CI.6Z[DV2[B8&AY^.,"9:;?IKBLKP"WW.J];8M- 1M0'9WHKYA
M0Z6Z/=)NR%1OOX@RS1S7<OD>S$UFQ;MWR5W2R[[SH-/FR63F-Y-)!4@Z,9XD
M\WHMJJTFX(Z3>G+^EU3/0HZPDJBBXMOQ2O!K_E@GIRRA4:B!-\%5]&;3J!ML
M.3FY\>MLT@N7S<TPV$<J\ (JRJ.J?69VODS_J7[]5Y_5F4&Z 3(S/#^((>]G
M@$_H0Z&L3'MW>V>!MJON7%W1.\ ]RS;[BRVA*@NA+U/3!V'P'\'Q(7-/#!T*
MH])>K-? %O?A;]/ ZU5X4YOXKW4X[Q\T@F=DHN,&.R=DM&(WL: PT3W/6$R2
M(4):"6EG^^=EA#PV':OX$]@_)F<PSMP]!VZR.[()<9T[?CYD1;_N_3>F IGY
MJIO;G.G&!%X3XZTIDB:(>>[C8VCEZR6+P.!3H*2TO?4ZO$V[QV833KM@+2[E
MOGS\(K>R?U=Q[JR3;ZQSL=64\YY!WV5O;ITS!R6 3O $EGW$XPY%#&?W<H%5
MU+'L)T&]&4'&-]=9F8%N"YP&!1#K[Z%T_7>)\J\AGSZ@R@OGOTW>.&0A(J@
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M?>/WY$NC;C5&G)??DY5JSCU->S-$]]0\4F+:;,>;3C#^D0EOG#GTP[BE]_I
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MQONBB(K6PO3R5+J<TQ=C?6J#:?EG1\--FQ-K:[]XS,R^Z0@)\*_J Z*I:TB
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MJ\L4$7;C,7N5)I'J_?*CRI_;$:!8G,85='5570A;%N$4-DX,723TRK9>_B*
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M,I9 ";1J&\/RJT- 2I!XNQWN.,)=B0O?8(7:D[KA_R?7F3W.T]6,.%H?=#=
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M43E9D!C C*"7IYM=*3K8N*/@"<^-QBK4VXX*9ZI>'UC5'DC<_)+Q[DIF1B2
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M@)  Z+ P3PJP<+>R] 91-*+6V$P058AF&-.F:RE]<.Y5V,_OU\<",J/GVBD
MTT1$JR/1NS9\N>F\;-.I3]R-U)Z9H'%0V<Y3H!AG*0"7\6V=D[?I'F/F_'L1
MRZO0K*OD$V:^&K4&.CUZ-,Y>O'+*%ZA];/HM.J'',7/YKL@M/(G6?Q@2M\>O
ME!#&]\;\WA1;?"U[RF)F;HC7X[YR]B,[V$<UQT8('A:I_B?D.44593IP0Z;X
MNS/<9,[E$#&.SW<YW(IS-Y*CU\\B&N$]PQ3@R*Y+FJLCE_)F6\#\L3M[/%?Y
M'/E,:MM@:(S5OMO/DY&K24Y?9O.E.>9G=Q(^+[9LJ77-EA9D4SU.3'DV47S6
M4V/9HH?C'0M!QX<LG5?_6:M:#;2^D$XR:*1$Q()M$8R1SY<;10$^=KQ"#(UA
M]KA+4UVGZ^3W?1I=:W\^0BCDJ2D*>5P+ J>GV/JZS6*0+A=1NO+MN1T4HY;T
MSQS93PU%=%P=0_A%T^=J)X7;CL]?B]-_8J'4_/K"1(N'$K<2C6,Q.TIFOUA1
M).T'YAF7;NT*D^>#48VM-<S18UVX] GVL((7:P6LJ_Q' P:5L--IVC."A/IK
M1/FO6A?M1CTYGB7, '-DD71<@)_1-*U'Y%@EXNC[ MM=J>,^%\KNM'/]5-M8
M3>@L&X,P6'T\\<W]YW-9=^>C;%RWA]M9;K>LE\/4/]XJ.I,SZ!&P9AN?.D]K
MO(?BBR]6*)_RV!7PANWM&\U?EWH\IC^C\>PM/3CMWFF'!@8Y'UX>CJ=^_(GH
M3UR>AT7!UHVKL7L$,I@)8+R;*N)$T;MQ13")VJ3.'VV-<Q8II].<8^UGU>4R
M!91W^,6M-4M/<:Q[:[WT?.NN6:=5L3B4BT49;@V=R9"Q>$,WM#KSJ:;W7?VQ
MY75XY_GDI^KG$]IKQPT[ WE;^#M2?JA$0;VG']%E#YBM!M&*#V]#0ML0T[1#
M+3KV$BIG7W+OOL,A&!;@[N%2H>ES4HRZ\IX7A<=4D,K**)7B_8[/BPDX;';5
MOME[=/R$WB"-I^^5EI,Z<NFKJXCJ\O)\^[I>RT&:RV\U/1O.>P;RV2F3KR_T
MK_0X1=$/7F]UE0R?/\DB%']Y/MY3$SMO.9+RKM#?9MM9^&M^U(7,YYF2JSF/
ML:C/?LO7REX8S@MC@H*KMS"1]T3J^CEF^^(^#!_&?88FOH8_Q.^FV^QE2K4]
M%YB<]BGPO+G+)-7Q<]U0"6&%*Z67L&W4;8PJ?'1X+/J^7E/'<O00/5'B2#D^
MXQ)19$.EXZ7[:#-_@Q<2RU4D3K#U\1+V?:K$=>W)L?OYV8&IV,6;@7.!!8IN
MT]^KGEM*+-^2.015=6>_8X]?2X]H0:S+.T.W=CG)X6(-ZPU15DLM"A1@EVO+
M:&\_C0)H*V1=AX31_V2_?D1\$14"63>TI0"H$L3SUVH>N.X%N ZB [/+5H99
M7D$LG$'[O&H"0^[ZKUB)U:IGH49\W,BC $,C")47Q',O?P:%1N\*S5@0G[EY
MD='0')0J-1ZC7<R*RT_]Q-_-K5'T7I4OMP[3B%"Y.E]^@GJ!Y=L^^0)/#0F.
M(H?>-FI;VST]@OT*(?&ES)E1 +_=K$0RZWHUQW*FYJ437*4[0\NP^P]1JI#M
M8$=#2,GW20'HW,50,@9<?#5==M'O?@G6@VEGM[",-"\.IP!S3E\1R^M2)":S
MKFF[^/D'>/'I=\4%RT,!6<]<SV?XRETI_GRMMY(O11!IVL313 'N+"$V5BE
M(B?1E>?ZS%2<B$$)W?;18@J@,;G+BFA/6.$W(@=AUD^!:SWLW6.UV.IB/^V;
M U)YE=65S/(1#$POZ390+QN9IU&$BXTBS@55(7K)4N(HK17/!ZNCN-=J#C<Z
MSXI./.'Q=8!%HH\GMVMP)#5/7-*O'=.G0M3?> B]-?0Y#<T^6+5?)^%^;]N
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M)>*?)FWH>LY CPC]?S5G B-4'WM0'R:9%6#'77#O/^L?S6!Z-';9WN0RWRK
M-S?4GS(_>U;LT^DOB[F<' ^]!-1Q*.(9 0[D5;T3RBWT-@\7^+RQ%7,6W6E(
MED8C.Y_352/WCY]L:L4_1>"7^NBM9!+$SU3Q^EZ$X)X08LB/P0#C@9+/)A"T
MX*#)+E  8AR$ G#<SAXY+- #4J C1I&8!?!*8CX%F"FM(7CA4!;U0^4*!N;"
M[]Y4/]-/D+$L=% &:$6HU;TL!UHU-8=?FL(_4KY1IF46G+R][ZM(2;E[2=K8
M>]@Z2-IYN$GYV=R7DI&4E@+4H'[W;>Q<';P%;1T<G=W51=8:,"*"SO;J(A8*
M!M(&][4=G)PO!W@ZF 88FMD%N-HIVXM -9@9U/Q4_-SNNSEXVPCZN=US]U+Q
M4S_UV^@J8/_79:E3&FJ>]G=53"[J_'$'>*9^Z@]9?'U])7WE)#T\':5DE)65
MI:1EI61E)< [)+S\W;UM_"3<O83^&."B@Y>=I_-];V</=\%?YS:V'C[>ZJ=\
M?)SM5>[:W%6PM;=7D+"UD;.7D)&QMY&PL9>3D;"7D[-75)!1DKTK8WOJ;P*Z
MW?\[_'\T!8@'WJ.B[>E@X^WA:>;A<4_C+^VYJTG]^67_&,?A(GAH_"J)):1E
M)62ES?Y6$H,#G/^G%_Y^GYK4GQ3^XPIH0[#W=XN#YA?\?Z =@!R '( <@!R
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M+39\IB=WN>2Q>WLQ%$";@W0JFH ^.9&&W53_7+,*CP!SV#I=+7O<U]3$^FM
M2RBL>RA*V%GMTJM*OHKZ9TD!R,RAS>A)[Z&-!S.0798EY-:6"/F)ZXI28 !&
MJA^W :W<(#'MB>:A/^.:_YJ,!52P8B1.9]WP,5Z?C/:F *3#,[]LL48^,@[:
M A(-V]H \_:"(L>L(_2GZ6ZP8S C 4^NA^17&5\*OA=TV<3DZ[5#%FT4 &>N
MZ$0![O(*%CR:.%E%1X?Z68RJ4A>?F22(*Q(S^"-(L>;(O3,S#>L48.=5<+&D
M.$$6*K!N9.V4%TVZMGOLOTO7_Y*Z0:ZJ%^>.T(8!NP1NW,H.!7CB:T@!OCHM
MO^=H@E-3@"1.W!JY;5R5 NCEO][T17UT01RW+O[61S@&BGS7B3UNQT!"R#N'
MI76-()9<&3PL(&[B6>IJ\WB1',.-2G5=@A'$THC9G#&(Y<$6< PA5&KIUBV6
M_7(I'.HC@:B+=UQB-[[DRS?]O_;H:U1Z^GH7(*:()CG$'*Y19,T-@232IF+N
M+>/ER/0@ZQ()FY;:V\: TENZ;O=@H%C,A!V98[=R479M&@I;!_,*^O[6;S.5
M6.+,6P@$@W5)$PPZ5^>G!E;%3WP0FT4!!"WT&A@P:,0G+UP$*0:DGX5R0\T<
M>P\MR/-&7W;Y+/ %H+P!Q:+&E]B!OW!0Y4ZO[;(XY]>,V(&<KPUQ>7GG$D)1
M@)\")(:"]1WJ)693!O95A=0+XVSE_;I+CJA+#<(D[H(>0!M/ 9[2-4_N[?4C
M-GD#B&VH/A3AG"_QD<8)"C TF$\!<D:'?D@$*D/WGVD@,I0>3':D?13-B][N
M^:NS3ZW=@EF7=@;=GI,<+KYWB8,X[N=+UF&6(Z/S?A<V#RT5Z5NX06+QDMB'
M2?4'L1O#! ,?7QX7^V4^YAT#4).3H)3D7W]PU02QH(,I>+A?A,E( &N3CPBS
M7W]D$;HI!+-I&1W8#2Z.>$%"(A<<P:#<=@P'C0C\A4.0@01Z7H@BXB/=3!H)
MOD@!]IC!\M%B<9+(VD"^ &7'+,\;@;*ZB[?W(,:*UXD]1$[\+,D;J@L& G%X
M[RE(F')H-E$QB*FRR?5[#R';,E:(A8SH??VO: EPX$K$IXIAQ'";,UAJNXMC
MI"A 8/&2YPPF5 C_$UR,!E@20:]Y]!>/Y&%7KSUN DCVA:6F)TDQ];[D9-W;
MN+5;G!^@NR<18%&[<KL/LYFNLJ8;0 POQI]>"LJ"/F:\Q&Y^]V\V#08K@Z:K
M&-"];U( ZW>0/3U^>#7,Y#]=?#6%&'=&A 7K=LQ 8Z#7P%1:._^7!+UB=078
MR_A/$<,&G7J!6?>S/@[.G"N8O$[_"JX-XC[I!W0:EJ&1+$EFVP+3& @USW+M
MMRU2GE^9E6X.0^38(.LCGT!7;L-(8MGH8Z@&D&2AD.NWB*!_V"Y1@,6K6[BP
MX*P4,/WW;6KH<A"=P67<NJ3S+_H!X/0GS_Q_;QA=[*%%* ;_23(1%P):\&\+
M$Q%CVDQTV]>_1)/\S<^D:W6'M5)G+VROZB'^C3!_!6[]F";7+AV?S.O1J8Y6
M2XV3?OI8M%-[A:/X3>L";9=4B.QENOQ<\\V>::+"- 7@(_)2@".(!.'&$/7Z
MNW7UJ](:9G5<&WVC#\T- U*3O]:M4<.U&@DVKV^[O'N7\%+;QV6[<J2#Z ET
M4[.M[)H$GHM'A*/M4J7&];]L20Z]W\FNQFO/]I1.)T#XI;1">K:[#./,2>Z^
M+.<=J8A5]X.U7IK];&')#-&P^HGFA=_YJB&L=[K@V+CS7A6K?]_P6-'])X_K
M[+G-;^&;L"\YUDTJ5U-=2XC[4;>+:^O@P>NZI[,(LTEZFZ@BJ".4MB:"*# R
MT!^HP.]=_LD<(O]P*O@[]-2MG<]/'A;L^L.>#OQLQ-[TJ'?=K<6S$".VC/;V
M0/:@I4 2JAE7(([Y19"U]XI)07I@X<RSERTP@>K:4BO#KA!!)O"K6JI4D_YK
M$R@&6"P.$5D_S(+KTZ]\8OA;/MDX@3'$3,51@'4I(AA_J"PH!="L1?$J4P!/
M9->&*@[6D;#U91\QH]NV*C)=W^+AQ3&^7>+%G<HH;K_?><2D^V2S*$W\[GR8
MRQ29AP@?:-3''Y*0NAW2V=YBHJ,ONKIS(MQA-T3M"7$T[7[/P'<SJ@V+2_O:
MA'.$Y";,R&#%6O^F^I 3._RK]B.1V" S=^H&G?SW\';+;T*I@P]#_+[=K<E6
MNZMHPLT?:"]-8S$?DSJH$3>QNJU10^C",QA%H%F2?F#MECF3&/79G[H+V'G>
MBI]FE[.K ^SOUD)IR7W2E9><9Y8A;QJ>QI3<$-=SG\MD[EW'S\=G=,">6R03
MEF=.S[<QW\6:-%0'BMY;/3$AKK-P^DZY6LPDT]2IY $[TXD:#3J"(ID- FE2
MZVHPZ#UO;3"F-D>>AAXJ/[DIFEVU:[)CJ>BYDU!V/4KC!2H6+,21Z_?._SW[
M:@8,_<9QC';/\[+L<Y5#-PW:O+]3@#5ODK$2:JIS?G8<7&I*D*=^#_\K=1*/
M!Y.=73Y<D6EW745%F0?3D<+AJM,P)D1S VZ^52K:"ITF4%KNHB%9H_CN_)45
MK29F](6ILE!$9_ U0U\ +89/GJEIP<1,G.AU[-7@U)Q"16*<UE'(EJ0CWAG/
MWQS:?5A[^E:%$#57Q[E=7C^QF4+S;LUU- :GRB];D.O373+#;M'710%H\(2,
M;?FP:J,CJ)AT[.KR5/C@4U>W$W*)1\??0T<[T*Z0:98513S;K-%C;'25:]R)
M#H/H[1_MBSYZ/\)OZH9(K,M'OZGIRA1M$O'R!&AB_,94;HTM5V@T%ZXD;G1S
M; Y&[!\B8,T)B&DD[VU"UX=@/MQ:I,1@H&MWH&6@@M8']J@=[;C5Y+#;D]YS
MF]@LXA72<[(@7)R05>3'8OKUQ,[-@7290HT,D:S#.<)N+VV"Y7HTQZOB"ZA"
M#97JV=QETC&[S+TE_+W?Y06J-Y'1F#N(R&QN'+DFR*V4H-\:\"[,8SL+UF)U
MXHVDSVT-]888_:--7QZ:"X/910%92&X-5A\@,XBT75[;Y&H\XQT39Y.M_^+)
M)SY)BT[Q[\?LX3+7Z/D\NSZ(V=U?]?)ZW;K/DS:\NQZ]I]L">0-+ %<-N@65
M[=QR K19EO"8>F$/&J6 >@MS$7QT35N@F?Y."\,- 9T+W8&<*UW[)\;@RB24
M/ 5@(.HVX SK4P/T^I&Z]4_'7N<D"R^$<-U]0F]]/K8!O_[HB,B[ZW),ZDJ?
MVBT>2"H%)+EJ3W6*+TP2[";9_39F*$ K/Z0E'15FT3+!5^N_UJA/RA/JO6<7
M]/7<W3M(?YWK*6:KHA]FN5^+SUJL],U@'^^Y)Y0N6:A (^%R9?8W_&):?#%N
M??/WCU[3K[)Y0\]-+<CGZ-QQ\8&9PVD:TCP%.'JQQ%#13< (K,B,(_^@>X_(
MX<%4%. 3(\$W'H.+7YS<,^!WA%\A+!;Y'=XS.,M[,^[FK1NMX0.Z*>PNDSX%
M*>& DIJ@78?AK.Z4*-V41<N;0(*7(617G/\!I H;"A_EE>*T*KI;(>X:5%-Z
MLP&.VM)CF7JKO I+4@A(,OJ\+Y%3=IL@A4>:XHLCJ_DAK8>^,M8DK#X\U<MM
M84M\J^-[7.]6OF/)V!A078KOFLF:;-GGE^W3=?4JG^R\3=O)?5Q)J"DQ.OS6
MW#/-C_MSH>M#W3S!);XY+JD\Z*QN,E)V3"MG2B\V/';OL,G'H,S!B!@B3#&!
M>/VE7\B-[R'*[UJ</41;6MQ?#!<\M+7,3+ 0JE;5G:WY:(&@_SG)@G"*D6*=
MM%Q4^1Z;;ECN/</E$"IWTW ^QT3#7J2WG6XG+O"HZP_,-TP39E1#I!XOT1SJ
M7'AW\ MDILYA=PQ1QTL+V>I]+[[H+M/FH K3FGZ8\*O ^',E\1^KBW-_5!>[
M:O]:7>BNOQZ:BD>ZEL+OXOA3MJH44RUXMI[(C8[I""C;N3YABBT.-Z&G$:A#
MO=20#&[?&VI/&(F9/9.&FQAM"8;T-9[=]LPZ;[K-];#K7MD)CG@AKN]\66TZ
M1F=J7]GF7H&GR'_=V<=\GI#/G/7;"Z9KN[&9'[V-C8.^A<60Z0F.+>33M?U$
M]9DUYF6OC)OJL.: Q^@:Y_ 5W=J\XX8=3==TS$)T9*PQN.)M*GSJ8[SX],J$
M9#^<C>/S2%P6:2A$0<+J_(#(6[;<C/.?,X2-N3R[:N<.R62?=8C/Y0HT= -7
MQ?R(EY,2"7&BJ"]('KCDUQQ"UKZ5I1.,N9$CL' A_>+QYJ%O56[\!HE>IY\]
M&*U?.\==*P/_ )]C@XD2UK;OXCT>0Z=O*V85N^+\]B;$-E7C3GZW?_;Q(XVA
M<!S#1Z:H%&#6=S O7B7KIDA^WWJM6:XHPMHQR1CF0H!LWQO08%^@ %5T8=5Q
M=" AB=^*HVLQ'A]W\;(>XY:WQ1M.C;I7JQ8QY%8\QX3*0IZSG":X[G,1^F9$
M6EZJ>?F^]K/X,,'5F/'Q#1H?7++-@;YS94:0HZ&4Y?GK!^W^"L8=QNXF[EU&
MNCDJQQ<2:/+0!%(1PH&S'P6].QFAP=?;J#J-Y';E8<>Y6#QH?=KVP(?IF%QC
MWX58>^BYYXCG2=]FE5$OX%+[LH3\M@VX270/!="-0O.U/- H<TR_=N:&U:4'
M'I'Q,U<-XO:]$C,?FN&K7FE>V:8 $6_WF\U$Z+KL/CJAX 1G4%XL*.^PV@/_
MUP2+#VCNAHR/%>_QX:7;I]'PQ,@WY>.7>2LR'R1V!PPU0X8G+0GB^V9P@5ZR
M\$T_CU851!3YFW2?W9D]_HJ;,N*RGXYI^:HDUMSO3&+1<BDZ_T3YF7T&K&@F
M7L"MM!P;[?1Z?W;[A7,^W(L09E,\TF)GYSK#2+A3_2Y6E]VXO"7LXC7@.@
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M""-B>=D89)]NRQLGWF<B29T0:'>FTMILUQPXO8&.1XS7"+VZBVN+>H\WYT/
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MK':<4*]<DH+N!9OL;.ZL;J%@I!RH(X9@; 5K6:Y$\;N2CX\S2+@Z#A,3WGH
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M(]G49*98V/R.]FZ6KD+::C"V(=XV7!O3]_CG6:D?*8]ICL8'A=XDA.'66B@
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M$!Y7,S(N1YU*YZP*47OL(1[+<2$@9VT$G5U2$IBWZ/,S^.H?GS,B:)/;!BC
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MSU<U>#.-(;5D=CX,7K_K7Z\ZPW?YU7+[X_;>#U?.![>Z0[NN:95%6%7M5Z^
M>97H=:L< _]54?"D?:JG,Q@R]WP0N+KRL\<V"NZJVXXA_U44A#K,^3I!FDWA
M<Z?0U83&2JXC\NE?:?HYCG_N])7</0@W[M4BS--"%WK9/3#S)ZV7#>5O^#CN
MX$\ZDM/0NNL'*"U2+'>+ FMT<P;I,!*=8W@S4D5WX-KGN@K(P2I;<I/N\K9
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MVJ_^B8R7_;3N]UT8R4IYQG6W.H-I+XZ5PB>F7-HKDD=^KAI .@/LZ6, 2B?
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M% ,&?*=!!+KDG6PQ<<"5]J^,ZF=U_??3<.5_QX@*YL"_ I\,Y=DB_LM#>8]
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MN(%L>,ZW',6756/^V UT<VKL>R:K=;\.!U'CZ)_00X['_@=02P,$%     @
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MKRB-H<L7-&-:]J2/'!>L5'-D/DTRFHR:=AY;:K&)\ W*Q=#A'6CYS7P$.8X
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M&-YW3MDU9]7L[;&YUI9.B"U_H_VA>9_IX8T#CWN**H^_F1RR?=K_5"IBGD6
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MD$FXF GS'5YQ]SJD"<KRBKM9]2"F^8E&(=SP)Y[U?/B#/%F/!N]@NX314RQ
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M@?? N!CY0BTMW9DB_V=>4-'KM#6)AS6$O4,A36_R\"QPJ,Q48\([M+W$O2&
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M]#Q=W2X1*D28R7#_*5NL:.^?>1#?(:S6\;<\?OCS\QK\2)Y_.%0B.O5@2D$
M+/#LH*/4?^*4OMDRF?N+*3<SES$Q&1WK,X(8,$^3/*O1<-MH\<,<KH7N-,8@
M1J2(A]WHO*Z][_ Y[SC$Y*GA O!@7X<(!QAJA5'EM/S98OZ_1=DV9-O <NZJ
M$PG<LG$<OM_X'YE3[-_]8%*QM[]'];<X0T)":N*,P&>M]))[G+4A^O X2786
MD00U:7F/=K\.!1%P+:3/"@=8% =AE'D2+J^CE53'!?>S4)2U(]-]\=E=!PF"
M)0RO23L9KS?18QD7_AY-B"7+8'"0/G,ZLF"\YYYT!_^"X9UC-J9N5+(YXR]X
MDM\@/B$,:D7B*2,Y$$.,Q^O0'"P]%?YS0P1RP'0?R]%$]0^Q605IE;=''-/^
M"3PZ! ^V'6EYC@/<QU!DO.DVK%O/.*CUM<0':2"><P]#4#207XLHKRMBT*$%
M\)\[RCGU_CMJE$K$H;AQ@&A\-P%!VNN9:)53)\U66:VYWO.D.]/*@M%5%'U=
M-Z19921^"'"J#^^]]Q,>Z2 K,!&P,Z"Q_9AX5Y& %V)VLVX5/_)@/P)+@/<
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M#Y2!2+&7WZ=2(1Q3;W=79NKG>=]6=AC%]77"W"QL<0"*,!2D)N(W9%9V% >
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MQI=%FCXLU[Y.=W(\$G1W]L7 9.[2JJ#BG_KF#V<KVL?-<HE61?7$%@@.M $
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MB&WO&!3+18V6;+A03*^:M=RFS%!M#@WR?")"8!.J^U,7R J=&/Z037,<_R&
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M [PR"^KS.7.NBZ1=]<4E$/BZ0I1TDD;@ZMXE'%/'VG FHQ)9 "MXJP4L2%^
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M%'#Y9?^;$/L]6+-_%1-;5N@8UVZ(OK)6CXRJ<C'JN G<#\?UH&.GJV1+<,0
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M"3Q._/N6V:<-.O5L@W<Z>8QV.+4W;C_T-M)>VT?V&[\!4$L! A0#%     @
M4H%R6A>\8=\Q3P$ &-D. !$              ( !     &AA;&\M,C R-3 S
M,3@N:'1M4$L! A0#%     @ 4H%R6D]\6,$N P  5@X  !$
M ( !8$\! &AA;&\M,C R-3 S,3@N>'-D4$L! A0#%     @ 4H%R6M1&!,&R
M P  (!,  !4              ( !O5(! &AA;&\M,C R-3 S,3A?9&5F+GAM
M;%!+ 0(4 Q0    ( %*!<EIL,Z-_5TT  !R6   4              "  :)6
M 0!H86QO+3(P,C4P,S$X7V<Q+FIP9U!+ 0(4 Q0    ( %*!<EKHRDW*>&8
M -!Q   5              "  2ND 0!H86QO+3(P,C4P,S$X7V<Q,"YJ<&=0
M2P$"% ,4    " !3@7):/TJ!6-HA @!%E@( %0              @ '6"@(
M:&%L;RTR,#(U,#,Q.%]G,3$N:G!G4$L! A0#%     @ 4X%R6C_>&8-O%@$
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M              "  ;TR!@!H86QO+3(P,C4P,S$X7V<U+FIP9U!+ 0(4 Q0
M   ( %.!<EI4!L"[PGD  #>0   4              "  6.D!@!H86QO+3(P
M,C4P,S$X7V<V+FIP9U!+ 0(4 Q0    ( %.!<EIUN^*WQ',  &3-   4
M          "  5<>!P!H86QO+3(P,C4P,S$X7V<W+FIP9U!+ 0(4 Q0    (
M %.!<EJJHO/A=',  (A]   4              "  4V2!P!H86QO+3(P,C4P
M,S$X7V<X+FIP9U!+ 0(4 Q0    ( %.!<EI];/0:H&D  "9T   4
M      "  ?,%" !H86QO+3(P,C4P,S$X7V<Y+FIP9U!+ 0(4 Q0    ( %.!
M<EI98JHFB@,  "P:   5              "  <5O" !H86QO+3(P,C4P,S$X
M7VQA8BYX;6Q02P$"% ,4    " !3@7):C]Z\J\ "   J#P  %0
M    @ &"<P@ :&%L;RTR,#(U,#,Q.%]P<F4N>&UL4$L%!@     1 !$ 8@0
' '5V"     $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>30
<FILENAME>halo-20250318_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:ecd="http://xbrl.sec.gov/ecd/2024"
  xmlns:halo="http://www.halozyme.com/20250318"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="halo-20250318.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-2">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2023-01-01</startDate>
            <endDate>2023-12-31</endDate>
        </period>
    </context>
    <context id="c-3">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2022-01-01</startDate>
            <endDate>2022-12-31</endDate>
        </period>
    </context>
    <context id="c-4">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2021-01-01</startDate>
            <endDate>2021-12-31</endDate>
        </period>
    </context>
    <context id="c-5">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
        </entity>
        <period>
            <startDate>2020-01-01</startDate>
            <endDate>2020-12-31</endDate>
        </period>
    </context>
    <context id="c-6">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockReportedValueMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-7">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockOutstandingUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-8">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsUnvestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-9">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-10">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockGrantedInPriorYearsVestedMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-11">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">halo:EquityAwardsOptionsAndStockThatFailedToMeetVestingConditionsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:PeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-12">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:EqtyAwrdsInSummryCompstnTblForAplblYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-13">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:YrEndFrValOfEqtyAwrdsGrntdInCvrdYrOutsdngAndUnvstdMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-14">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValOfOutsdngAndUnvstdEqtyAwrdsGrntdInPrrYrsMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-15">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:VstngDtFrValOfEqtyAwrdsGrntdAndVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-16">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:ChngInFrValAsOfVstngDtOfPrrYrEqtyAwrdsVstdInCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-17">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:explicitMember dimension="ecd:AdjToCompAxis">ecd:FrValAsOfPrrYrEndOfEqtyAwrdsGrntdInPrrYrsFldVstngCondsDrngCvrdYrMember</xbrldi:explicitMember>
                <xbrldi:explicitMember dimension="ecd:ExecutiveCategoryAxis">ecd:NonPeoNeoMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-18">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>1</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-19">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>2</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-20">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>3</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <context id="c-21">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001159036</identifier>
            <segment>
                <xbrldi:typedMember dimension="ecd:MeasureAxis">
                    <ecd:MeasureAxis.domain>4</ecd:MeasureAxis.domain>
                </xbrldi:typedMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-01-01</startDate>
            <endDate>2024-12-31</endDate>
        </period>
    </context>
    <unit id="usd">
        <measure>iso4217:USD</measure>
    </unit>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-2">0001159036</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="c-1" id="f-3">DEF 14A</dei:DocumentType>
    <dei:AmendmentFlag contextRef="c-1" id="f-4">false</dei:AmendmentFlag>
    <dei:EntityRegistrantName contextRef="c-1" id="f-1">Halozyme Therapeutics, Inc.</dei:EntityRegistrantName>
    <ecd:InsiderTrdPoliciesProcAdoptedFlag contextRef="c-1" id="f-5">true</ecd:InsiderTrdPoliciesProcAdoptedFlag>
    <ecd:AwardTmgMnpiDiscTextBlock contextRef="c-1" id="f-6">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"&gt;Equity Award Grant Practices&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The Compensation Committee&#x2019;s practice is to grant annual equity awards to executive officers at its first meeting in February each year, which is generally scheduled well in advance. Additionally, the Compensation Committee retains discretion to grant other equity awards from time to time when and as Compensation Committee may determine to be appropriate.  &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;However, the timing of the grant of a Company equity award may be changed to satisfy the Company&#x2019;s policy on the timing of equity award grants. The Company&#x2019;s policy on the timing of equity award grants generally provides that if the Company files its Annual Report on Form 10-K, a Quarterly Report on Form 10-Q, or a Current Report on Form 8-K that contains information that would (but for such public disclosure) be material nonpublic information in respect of the Company with the Securities and Exchange Commission (any such filing by the Company with the Securities and Exchange Commission, a &#x201c;Disclosure Event&#x201d;) on, or on the business day immediately preceding, the intended date of grant of an equity award, the date of grant of such award will (unless otherwise provided by the Compensation Committee) be the second full trading day following the Disclosure Event. In addition, the policy generally provides that if, on the date of grant of an equity award, the Compensation Committee believes that the Company will have a Disclosure Event within the following four full business days, the date of grant of the award will (unless otherwise provided by the Compensation Committee) occur on the second full trading day following the Disclosure Event. Any equity awards approved pursuant to any delegated authority to approve equity award grants and other than by the Compensation Committee are generally subject to these same timing provisions. Equity awards granted to members of the Board of Directors in accordance with our non-employee director compensation program are not subject to these timing provisions.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The release of material nonpublic information is not taken into account in determining the timing and terms of equity award grants (other than, as to the timing of such awards, to satisfy the equity award grant timing policy discussed above), and the Company does not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.&lt;/span&gt;&lt;/div&gt;</ecd:AwardTmgMnpiDiscTextBlock>
    <ecd:AwardTmgPredtrmndFlag contextRef="c-1" id="f-7">true</ecd:AwardTmgPredtrmndFlag>
    <ecd:AwardTmgMethodTextBlock contextRef="c-1" id="f-8">However, the timing of the grant of a Company equity award may be changed to satisfy the Company&#x2019;s policy on the timing of equity award grants. The Company&#x2019;s policy on the timing of equity award grants generally provides that if the Company files its Annual Report on Form 10-K, a Quarterly Report on Form 10-Q, or a Current Report on Form 8-K that contains information that would (but for such public disclosure) be material nonpublic information in respect of the Company with the Securities and Exchange Commission (any such filing by the Company with the Securities and Exchange Commission, a &#x201c;Disclosure Event&#x201d;) on, or on the business day immediately preceding, the intended date of grant of an equity award, the date of grant of such award will (unless otherwise provided by the Compensation Committee) be the second full trading day following the Disclosure Event. In addition, the policy generally provides that if, on the date of grant of an equity award, the Compensation Committee believes that the Company will have a Disclosure Event within the following four full business days, the date of grant of the award will (unless otherwise provided by the Compensation Committee) occur on the second full trading day following the Disclosure Event.</ecd:AwardTmgMethodTextBlock>
    <ecd:AwardTmgHowMnpiCnsdrdTextBlock contextRef="c-1" id="f-9">&lt;div style="margin-top:6pt;text-align:justify;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The release of material nonpublic information is not taken into account in determining the timing and terms of equity award grants (other than, as to the timing of such awards, to satisfy the equity award grant timing policy discussed above), and the Company does not time the disclosure of material nonpublic information for the purpose of affecting the value of executive compensation.&lt;/span&gt;&lt;/div&gt;</ecd:AwardTmgHowMnpiCnsdrdTextBlock>
    <ecd:AwardTmgMnpiCnsdrdFlag contextRef="c-1" id="f-10">false</ecd:AwardTmgMnpiCnsdrdFlag>
    <ecd:MnpiDiscTimedForCompValFlag contextRef="c-1" id="f-11">false</ecd:MnpiDiscTimedForCompValFlag>
    <ecd:PvpTableTextBlock contextRef="c-1" id="f-12">&lt;div style="text-align:center"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:98.684%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.048%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.714%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.540%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.011%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.392%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:9.862%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.392%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.196%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.392%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:10.751%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.392%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:11.788%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.392%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.640%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:7.650%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="48" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center;text-indent:22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;2024 Pay-Versus-Performance Table&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="9" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:700;line-height:100%"&gt;Value of Initial Fixed $100 Investment Based on:&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Year (1)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Summary of Compensation Table for PEO ($) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Compensation Actually Paid to PEO ($) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Summary Compensation Table Total for Non-PEO NEOs ($) (2)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Average Compensation Actually Paid to Non-PEO NEOs ($) (3)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Total Shareholder Return ($) (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Peer Group Total Shareholder Return ($) (4)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Net Income (Millions) ($) (5)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%"&gt;Revenue (Millions) ($) (6)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2024&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;12,741,421&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;20,745,724&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,217,194&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,315,696&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;269.66&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118.20&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;444.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,015.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2023&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;11,820,858&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;(3,608,264)&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,568,762&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;160,639&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;208.46&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;118.87&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;281.6&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;829.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2022&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;9,696,978&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;22,817,187&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,415,581&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;3,154,512&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;320.93&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;113.65&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;202.1&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;660.1&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2021&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;7,453,294&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;5,992,078&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2,398,657&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;591,581&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;226.79&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126.45&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;402.7&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;443.3&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;2020&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;6,518,876&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;24,374,731&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;1,812,287&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;4,356,681&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;240.89&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;126.42&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;129.0&lt;/span&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:center;vertical-align:middle"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:100%"&gt;268.0&lt;/span&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:PvpTableTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-1" decimals="0" id="f-13" unitRef="usd">12741421</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-1" decimals="0" id="f-14" unitRef="usd">20745724</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-15" unitRef="usd">4217194</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-16" unitRef="usd">6315696</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-1" decimals="2" id="f-17" unitRef="usd">269.66</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-1" decimals="2" id="f-18" unitRef="usd">118.20</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-1" decimals="-5" id="f-19" unitRef="usd">444100000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-1" decimals="-5" id="f-20" unitRef="usd">1015300000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-2" decimals="0" id="f-21" unitRef="usd">11820858</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-2" decimals="0" id="f-22" unitRef="usd">-3608264</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-2" decimals="0" id="f-23" unitRef="usd">3568762</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-2" decimals="0" id="f-24" unitRef="usd">160639</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-2" decimals="2" id="f-25" unitRef="usd">208.46</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-2" decimals="2" id="f-26" unitRef="usd">118.87</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-2" decimals="-5" id="f-27" unitRef="usd">281600000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-2" decimals="-5" id="f-28" unitRef="usd">829300000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-3" decimals="0" id="f-29" unitRef="usd">9696978</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-3" decimals="0" id="f-30" unitRef="usd">22817187</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-3" decimals="0" id="f-31" unitRef="usd">2415581</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-3" decimals="0" id="f-32" unitRef="usd">3154512</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-3" decimals="2" id="f-33" unitRef="usd">320.93</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-3" decimals="2" id="f-34" unitRef="usd">113.65</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-3" decimals="-5" id="f-35" unitRef="usd">202100000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-3" decimals="-5" id="f-36" unitRef="usd">660100000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-4" decimals="0" id="f-37" unitRef="usd">7453294</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-4" decimals="0" id="f-38" unitRef="usd">5992078</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-4" decimals="0" id="f-39" unitRef="usd">2398657</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-4" decimals="0" id="f-40" unitRef="usd">591581</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-4" decimals="2" id="f-41" unitRef="usd">226.79</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-4" decimals="2" id="f-42" unitRef="usd">126.45</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-4" decimals="-5" id="f-43" unitRef="usd">402700000</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-4" decimals="-5" id="f-44" unitRef="usd">443300000</ecd:CoSelectedMeasureAmt>
    <ecd:PeoTotalCompAmt contextRef="c-5" decimals="0" id="f-45" unitRef="usd">6518876</ecd:PeoTotalCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-5" decimals="0" id="f-46" unitRef="usd">24374731</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-5" decimals="0" id="f-47" unitRef="usd">1812287</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-5" decimals="0" id="f-48" unitRef="usd">4356681</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnAmt contextRef="c-5" decimals="2" id="f-49" unitRef="usd">240.89</ecd:TotalShareholderRtnAmt>
    <ecd:PeerGroupTotalShareholderRtnAmt contextRef="c-5" decimals="2" id="f-50" unitRef="usd">126.42</ecd:PeerGroupTotalShareholderRtnAmt>
    <us-gaap:NetIncomeLoss contextRef="c-5" decimals="-5" id="f-51" unitRef="usd">129000000.0</us-gaap:NetIncomeLoss>
    <ecd:CoSelectedMeasureAmt contextRef="c-5" decimals="-5" id="f-52" unitRef="usd">268000000.0</ecd:CoSelectedMeasureAmt>
    <ecd:NamedExecutiveOfficersFnTextBlock contextRef="c-1" id="f-53">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;Helen I Torley was our CEO for each of the five years included in the table above. For 2020, our Non-PEO NEOs were Elaine D. Sun, Laurie D. Stelzer, Masaru Matsuda, and Michael J. LaBarre. For 2021, our Non-PEO NEOs were Elaine D. Sun, Masaru Matsuda, and Michael J. LaBarre. For 2022, our Non-PEO NEOs were Nicole LaBrosse, Elaine D. Sun, Mark Snyder, and Michael J. LaBarre. For 2023 and 2024, our Non-PEO NEOs were Nicole LaBrosse, Mark Snyder, and Michael J. LaBarre. Ms. Sun commenced employment with Halozyme on March 2, 2020 and separated employment from Halozyme on February 2, 2022. Mr. Matsuda separated employment from Halozyme on December 31, 2021. Ms. LaBrosse was appointed to Halozyme&#x2019;s Chief Financial Officer on February 2, 2022 and Mr. Snyder commenced employment with Halozyme on January 3, 2022.&lt;/span&gt;See the Summary Compensation Table above for detail on the Summary Compensation Table total compensation for our CEO for fiscal year 2024, 2023 and 2022. The 2020 and 2021 total compensation for our CEO is disclosed in our proxy statement filed with the SEC in calendar years 2021 and 2022, respectively. The average compensation for the Non-PEO NEOs for 2024 was calculated in the Summary Compensation Table above. The average compensation for the Non-PEO NEOs for each of fiscal years 2023, 2022, 2021 and 2020 was calculated from the Summary Compensation Table as disclosed in our proxy statement filed with the SEC in the calendar year immediately following such fiscal year.</ecd:NamedExecutiveOfficersFnTextBlock>
    <ecd:PeoName contextRef="c-2" id="f-54">Helen I Torley</ecd:PeoName>
    <ecd:PeoName contextRef="c-3" id="f-55">Helen I Torley</ecd:PeoName>
    <ecd:PeoName contextRef="c-5" id="f-56">Helen I Torley</ecd:PeoName>
    <ecd:PeoName contextRef="c-4" id="f-57">Helen I Torley</ecd:PeoName>
    <ecd:PeoName contextRef="c-1" id="f-58">Helen I Torley</ecd:PeoName>
    <ecd:AdjToPeoCompFnTextBlock contextRef="c-1" id="f-60">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;For purposes of this table, the compensation actually paid (&#x201c;Compensation Actually Paid&#x201d;, or &#x201c;CAP&#x201d;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#x2019;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#x2019;s LTI awards granted to the Named Executive Officer:&lt;/span&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus/(less)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the vesting date value of awards which were granted and vested during the same covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus/(less)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Less&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#x2019;s Halozyme LTI awards during the fiscal years covered by the table),&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In making each of these adjustments, the &#x201c;value&#x201d; of an award is the fair value of the award on the applicable date determined in accordance with FASB&#x2019;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the Summary Compensation Table Total to Compensation Actually Paid for our CEO for the fiscal year 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.105%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:83.344%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.593%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:13.663%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:15pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Reconciliation of Summary Compensation Table Total to Compensation Actually Paid for CEO&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Fiscal Year 2024 ($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Summary Compensation Table Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;12,741,421&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;10,400,065&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;14,025,875&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,744,841&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;633,653&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;20,745,724&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;</ecd:AdjToPeoCompFnTextBlock>
    <ecd:AdjToNonPeoNeoCompFnTextBlock contextRef="c-1" id="f-59">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:10.84pt"&gt;For purposes of this table, the compensation actually paid (&#x201c;Compensation Actually Paid&#x201d;, or &#x201c;CAP&#x201d;) to each of our Named Executive Officers (including for purposes of this table, former named executive officers who are included in the Non-PEO NEO group for the applicable year) means the Named Executive Officer&#x2019;s total compensation as reflected in the Summary Compensation Table for the applicable year less the grant date fair values of stock awards and option awards included in the &#x201c;Stock Awards&#x201d; and &#x201c;Option Awards&#x201d; columns of the Summary Compensation Table for the Named Executive Officer for the applicable year, and adjusted for the following with respect to Halozyme&#x2019;s LTI awards granted to the Named Executive Officer:&lt;/span&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the year-end value of awards granted in the covered fiscal year which were outstanding and unvested at the end of the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus/(less)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the change in value as of the end of the covered fiscal year as compared to the end of the prior fiscal year for awards which were granted in prior years and were outstanding and unvested at the end of the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the vesting date value of awards which were granted and vested during the same covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus/(less)&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt; the change in value as of the vesting date as compared to the end of the prior fiscal year for awards which were granted in prior years and vested in the covered fiscal year,&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Less&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as to any awards which were granted in prior fiscal years and were forfeited during the covered fiscal year, the value of such awards as of the end of the prior fiscal year, &lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus &lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;the dollar value of any dividends or other earnings paid during the covered fiscal year on outstanding and unvested awards (no dividends or other earnings were paid by Halozyme on any Named Executive Officer&#x2019;s Halozyme LTI awards during the fiscal years covered by the table),&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:58.5pt;text-align:justify;text-indent:-22.5pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;padding-left:19pt"&gt;Plus&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;, as to an award that is materially modified during the covered fiscal year, the amount by which the value of the award as of the date of the modification exceeds the value of the original award on the modification date (none of the Halozyme LTI awards held by the Named Executive Officers were materially modified during the fiscal years covered by the table).&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In making each of these adjustments, the &#x201c;value&#x201d; of an award is the fair value of the award on the applicable date determined in accordance with FASB&#x2019;s ASC Topic 718 using the valuation assumptions we then use to calculate the fair value of our equity awards. For more information on the valuation of our equity awards, please see the notes to our financial statements that appear in our Annual Report on Form 10-K each year and the footnotes to the Summary Compensation Table that appears in our annual proxy statement.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The table reflects the CAP (determined as noted above) for our CEO and, for our Non-PEO NEOs, the average of the CAPs determined for the Non-PEO NEOs.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following table provides a reconciliation of the average of the Summary Compensation Table Total for the Non-PEO NEOs for fiscal year 2024 to the average of the Compensation Actually Paid for the Non-PEO NEOs for fiscal year 2024.&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;span&gt;&lt;br/&gt;&lt;/span&gt;&lt;/div&gt;&lt;div style="text-align:justify"&gt;&lt;table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:89.035%"&gt;&lt;tr&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:82.808%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:0.621%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td style="width:1.0%"&gt;&lt;/td&gt;&lt;td style="width:14.171%"&gt;&lt;/td&gt;&lt;td style="width:0.1%"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr style="height:0pt"&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Reconciliation of Average Summary Compensation Table Total to Average Compensation Actually Paid for Non-PEO NEOs&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:bottom"&gt;&lt;div style="text-align:center"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Fiscal Year 2024 ($)&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Summary Compensation Table Total&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;4,217,194&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;border-top:1pt solid #000;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Grant Date Fair Value of Option and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;3,183,435&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value at Fiscal Year-End of Outstanding and Unvested Option and Stock Awards Granted in Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;4,164,663&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Change in Fair Value of Outstanding and Unvested Option and Stock Awards Granted in Prior Fiscal Years&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;949,818&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value at Vesting of Option and Stock Awards Granted in Fiscal Year That Vested During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Change in Fair Value as of Vesting Date of Option and Stock Awards Granted in Prior Fiscal Years For Which Applicable Vesting Conditions Were Satisfied During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;167,456&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div style="text-indent:7.95pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%"&gt;Fair Value as of Prior Fiscal Year-End of Option and Stock Awards Granted in Prior Fiscal Years That Failed to Meet Applicable Vesting Conditions During Fiscal Year&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#cceeff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#cceeff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#x2014;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#cceeff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:2px 1pt;text-align:left;vertical-align:top"&gt;&lt;div&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:112%"&gt;Compensation Actually Paid&lt;/span&gt;&lt;/div&gt;&lt;/td&gt;&lt;td colspan="3" style="background-color:#ffffff;padding:0 1pt"&gt;&lt;/td&gt;&lt;td colspan="2" style="background-color:#ffffff;padding:2px 0 2px 1pt;text-align:right;vertical-align:bottom"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"&gt;6,315,696&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%"&gt;&#160;&lt;/span&gt;&lt;/td&gt;&lt;td style="background-color:#ffffff;padding:2px 1pt 2px 0;text-align:right;vertical-align:bottom"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;td colspan="3" style="display:none"&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/table&gt;&lt;/div&gt;&lt;div style="margin-top:3pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;For similar reconciliations of the Summary Compensation Table Total to Compensation Actually Paid for our CEO and the Non-PEO NEOs for each of fiscal years 2020, 2021, 2022 and 2023, see our proxy statement filed with the Securities and Exchange Commission in the calendar year immediately following such fiscal year.&lt;/span&gt;&lt;/div&gt;</ecd:AdjToNonPeoNeoCompFnTextBlock>
    <ecd:PeoTotalCompAmt contextRef="c-1" decimals="0" id="f-61" unitRef="usd">12741421</ecd:PeoTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-6" decimals="0" id="f-62" unitRef="usd">-10400065</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-7" decimals="0" id="f-63" unitRef="usd">14025875</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-8" decimals="0" id="f-64" unitRef="usd">3744841</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-9" decimals="0" id="f-65" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-10" decimals="0" id="f-66" unitRef="usd">633653</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-11" decimals="0" id="f-67" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:PeoActuallyPaidCompAmt contextRef="c-1" decimals="0" id="f-68" unitRef="usd">20745724</ecd:PeoActuallyPaidCompAmt>
    <ecd:NonPeoNeoAvgTotalCompAmt contextRef="c-1" decimals="0" id="f-69" unitRef="usd">4217194</ecd:NonPeoNeoAvgTotalCompAmt>
    <ecd:AdjToCompAmt contextRef="c-12" decimals="0" id="f-70" unitRef="usd">-3183435</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-13" decimals="0" id="f-71" unitRef="usd">4164663</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-14" decimals="0" id="f-72" unitRef="usd">949818</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-15" decimals="0" id="f-73" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-16" decimals="0" id="f-74" unitRef="usd">167456</ecd:AdjToCompAmt>
    <ecd:AdjToCompAmt contextRef="c-17" decimals="0" id="f-75" unitRef="usd">0</ecd:AdjToCompAmt>
    <ecd:NonPeoNeoAvgCompActuallyPaidAmt contextRef="c-1" decimals="0" id="f-76" unitRef="usd">6315696</ecd:NonPeoNeoAvgCompActuallyPaidAmt>
    <ecd:TotalShareholderRtnVsPeerGroupTextBlock contextRef="c-1" id="f-78">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt"&gt;Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#x2019;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last five years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.&lt;/span&gt;&lt;div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"&gt;&lt;img alt="CAP vs TSR.jpg" src="halo-20250318_g8.jpg" style="height:378px;margin-bottom:5pt;vertical-align:text-bottom;width:668px"/&gt;&lt;/div&gt;</ecd:TotalShareholderRtnVsPeerGroupTextBlock>
    <ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock contextRef="c-1" id="f-77">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:10.84pt"&gt;Total Shareholder Return represents the return on a fixed investment of $100 in Halozyme&#x2019;s stock for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year. Peer Group Total Shareholder Return represents the return on a fixed investment of $100 in the NASDAQ Biotechnology Index for the period beginning on the last trading day of 2019 through the end of the applicable fiscal year, and is calculated assuming the reinvestment of dividends. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last five years against our total shareholder return and the total shareholder return for the NASDAQ Biotechnology Index (each calculated as described above) over that period of time.&lt;/span&gt;&lt;div style="padding-right:-6.75pt;text-align:center;text-indent:-4.5pt"&gt;&lt;img alt="CAP vs TSR.jpg" src="halo-20250318_g8.jpg" style="height:378px;margin-bottom:5pt;vertical-align:text-bottom;width:668px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsTotalShareholderRtnTextBlock>
    <ecd:CompActuallyPaidVsNetIncomeTextBlock contextRef="c-1" id="f-79">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:6.34pt"&gt;This column shows Halozyme&#x2019;s net income for each fiscal year covered by the table. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last five years against our net income for each of those years.&lt;/span&gt;&lt;div style="text-align:center"&gt;&lt;img alt="CAP vs Net Income.jpg" src="halo-20250318_g9.jpg" style="height:383px;margin-bottom:5pt;vertical-align:text-bottom;width:669px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsNetIncomeTextBlock>
    <ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock contextRef="c-1" id="f-80">&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%;padding-left:6.34pt"&gt;This column shows Halozyme&#x2019;s revenue for each fiscal year covered by the table. We consider revenue to be a the most important financial performance metric in our 2024 executive compensation program because it is used in determining each of our NEO&#x2019;s annual 2024 cash incentive. The following chart illustrates the CAP for our CEO and the average CAP for our Non-PEO NEOs for each of the last five years against our revenue for each of those years.&lt;/span&gt;&lt;div style="text-align:center"&gt;&lt;img alt="CAP vs Revenue.jpg" src="halo-20250318_g10.jpg" style="height:382px;margin-bottom:5pt;vertical-align:text-bottom;width:667px"/&gt;&lt;/div&gt;</ecd:CompActuallyPaidVsCoSelectedMeasureTextBlock>
    <ecd:TabularListTableTextBlock contextRef="c-1" id="f-81">&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;The following is an unranked list of the Halozyme financial performance measures we consider most important in linking the compensation actually paid to our Named Executive Officers for 2024 with Halozyme performance.&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Revenue (as used in our 2024 EBP)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Adjusted EBITDA (as used in our 2024 EBP)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;padding-left:36pt;text-indent:-18pt"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;&#x2022;&lt;/span&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:14.5pt"&gt;Stock Price (including relative TSR, as used in our PSUs awarded in 2021, 2022, 2023 and 2024 and as described in the Compensation Discussion and Analysis above)&lt;/span&gt;&lt;/div&gt;&lt;div style="margin-top:6pt;text-align:justify"&gt;&lt;span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"&gt;In addition to the financial performance measures listed above, we view our stock price, upon which the value of all of our equity awards is dependent, as a key performance-based component of our executive compensation program in order to further align the interests of our senior management with the interests of our stockholders.&lt;/span&gt;&lt;/div&gt;</ecd:TabularListTableTextBlock>
    <ecd:MeasureName contextRef="c-18" id="f-82">Revenue</ecd:MeasureName>
    <ecd:MeasureName contextRef="c-19" id="f-83">Adjusted EBITDA</ecd:MeasureName>
    <ecd:MeasureName contextRef="c-20" id="f-84">relative TSR</ecd:MeasureName>
    <ecd:MeasureName contextRef="c-21" id="f-85">stock price</ecd:MeasureName>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
